Anexa 2

DCI/DENUMIRE COMERCIALA CONCENTRATIE FORMA FARM. FIRMA PROTOCOL

1

SUBLISTA A - MEDICAMENTE CU NIVEL DE COMPENSARE 90% DIN PREŢUL DE REFERINŢĂ A02BA02 RANITIDINUM
NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A02BA02 RANITIDINUM
ULCORAN 150mg

CAPS.
EUROPHARM SA

150mg 150mg
ARENA GROUP SA MAGISTRA C & C

A02BA02 RANITIDINUM
RANITIDIN RANITIDINA 150 mg 150mg 150mg

COMPR.

A02BA02 RANITIDINUM
DIGEN EFF 150 mg 150mg

COMPR. EFF.
OZONE LABORATORIES LTD.

150mg 150mg
FARAN LABORATORIES S.A. AC HELCOR SRL FILDAS TRADING SRL ANTIBIOTICE SA LABORMED PHARMA SA GLAXO WELLCOME UK LTD.

A02BA02 RANITIDINUM
GERTOCALM RANITIDIN 150 mg RANITIDINA 150 mg RANITIDINA ANTIBIOTICE 150 mg RANITIDINA LPH 150 mg ZANTAC 150 mg 150mg 150mg 150mg 150mg 150mg 150mg

COMPR. FILM.

A02BA02 RANITIDINUM
ARNETIN ZANTAC SOLUTIE INJECTABILA 25mg/ml 25mg/ml

SOL. INJ.
MEDOCHEMIE LTD. GLAXO WELLCOME UK LTD.

25mg/ml

A02BA02 RANITIDINUM
RANITIDIN 300 mg RANITIDINA 300 mg RANITIDINA LPH 300 mg 300mg 300mg 300mg

COMPR. FILM.
AC HELCOR SRL FILDAS TRADING SRL LABORMED PHARMA SA

300mg

2

A02BA03

FAMOTIDINUM

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A02BA03 FAMOTIDINUM
FAMODAR ABR 10mg

COMPR. FILM.
DAR AL DAWA PHARMA S.R.L.

10mg 20mg
DAR AL DAWA PHARMA S.R.L AC HELCOR PHARMA SRL SEDICO IMPEX S.R.L. GEDEON RICHTER PLC

A02BA03 FAMOTIDINUM
FAMODAR 20 FAMODIN 20 FAMOTAK QUAMATEL® 20 mg 20mg 20mg 20mg 20mg

COMPR. FILM.

A02BA03 FAMOTIDINUM
FAMODAR 20 FAMODIN 20 FAMOTAK QUAMATEL® 20 mg 20mg 20mg 20mg 20mg 20mg

COMPR. FILM.
DAR AL DAWA PHARMA S.R.L AC HELCOR PHARMA SRL SEDICO IMPEX S.R.L. GEDEON RICHTER PLC

20mg

A02BA03 FAMOTIDINUM
QUAMATEL® 20 mg

LIOF. + SOLV. PT. SOL. INJ.
GEDEON RICHTER PLC

20mg 40mg

A02BA03 FAMOTIDINUM
FAMODAR 40 FAMODIN 40 FAMOTAK FAMOTIDINA ZENTIVA 40 mg GASTROSIDIN QUAMATEL® 40 mg 40mg 40mg 40mg 40mg 40mg 40mg

COMPR. FILM.
DAR AL DAWA PHARMA SRL AC HELCOR PHARMA SRL SEDICO IMPEX S.R.L. ZENTIVA S.A ECZACIBASI PHARMACEUTICALS S.R.L. GEDEON RICHTER PLC

3

A02BA04

NIZATIDINUM

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A02BA04 NIZATIDINUM
NIZATIDIN 150 mg NIZATIDINA LAROPHARM 150 mg 150mg 150mg

CAPS.
VIM SPECTRUM SRL LAROPHARM S.R.L.

150mg

4

A02BC01

OMEPRAZOLUM

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A02BC01 OMEPRAZOLUM
ORTANOL® S 10mg

CAPS. GASTROREZ.
LEK PHARMACEUTICALS D.D.

10mg

Prescriere limitata:
LOSEC MUPS 10 mg

Boala de reflux gastro-esofagian. Se aplica pentru toate denumirile comerciale si formele farmaceutice ale concentratiei de 10 mg.

A02BC01 OMEPRAZOLUM
10mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR. FILM. GASTROREZ.
ASTRAZENECA AB

10mg 20mg

A02BC01 OMEPRAZOLUM
HELICID 20 OMEPRAZOL 20 mg OMEPRAZOL BIOFARM 20 mg OMEPRAZOL LPH 20 mg OMEPRAZOL TERAPIA 20 mg OMERAN 20 OMEZ ORTANOL® 20 mg ULTOP

CAPS GASTROREZ.
ZENTIVA AS GEDEON RICHTER ROMANIA SA BIOFARM S.A. LABORMED PHARMA SA TERAPIA S.A. EUROPHARM SA DR. REDDY'S LABORATORIES LEK PHARMACEUTICALS D.D. KRKA D.D.

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Boala de reflux gastro-esofagian Sclerodermia esofagului. Sindromul Zollinger-Ellison Tratamentul ulcerului gastric si duodenal. Profilaxia ulcerului gastro-duodenal la pacientii in tratament cu AINS pe termen lung si care prezinta factori de risc gastrointestinal.

1 / 153

DCI/DENUMIRE COMERCIALA CONCENTRATIE FORMA FARM. FIRMA NOTA: Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiilor de 20 mg..

PROTOCOL

A02BC01 OMEPRAZOLUM
RISEK 20mg 20mg 20mg 40mg 40mg 40mg

CAPS. ENTER.
GULF PHARMACEUTICAL INDUSTRIES S.R.L.

20mg 20mg

A02BC01 OMEPRAZOLUM
LOSEC MUPS 20 mg OMEDAR®

COMPR. FILM. GASTROREZ.
ASTRAZENECA AB DAR AL DAWA PHARMA S.R.L

A02BC01 OMEPRAZOLUM
OMERAN 40 ORTANOL® ULTOP

CAPS. GASTROREZ.
EUROPHARM SA LEK PHARMACEUTICALS D.D. KRKA D.D. NOVO MESTO

40mg

Prescriere limitata: Boala de reflux gastro-esofagian Prescriere limitata: Sclerodermia esofagului. Prescriere limitata: Sindromul Zollinger-Ellison Prescriere limitata: Tratamentul ulcerului gastric si duodenal. NOTA: Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiilor de 40mg..

5
LEVANT 15 mg

A02BC03

LANSOPRAZOLUM
CAPS. GASTROREZ.
15mg RANBAXY UK LTD.

A02BC03 LANSOPRAZOLUM
Prescriere limitata:
LANZAP 30mg LANZUL LEVANT 30 mg

15mg

Boala de reflux gastro-esofagian

A02BC03 LANSOPRAZOLUM
30mg 30mg 30mg

CAPS. GASTROREZ.
DR. REDDY'S LABORATORIES KRKA D.D. NOVO MESTO RANBAXY UK LTD.

30mg

Prescriere limitata: Boala de reflux gastro-esofagian Prescriere limitata: Sindromul Zollinger-Ellison. Prescriere limitata: Tratamentul ulcerului gastric si duodenal. Prescriere limitata: Profilaxia ulcerului gastro-duodenal la pacientii in tratament cu AINS pe termen lung si care prezinta factori de risc gastrointestinal. NOTA: Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiiei de 30 mg..

6
DUSPATALIN® 200 mg

A03AA04

MEBEVERINUM
CAPS. ELIB. PREL.
200mg SOLVAY PHARMACEUTICALS BV

A03AA04 MEBEVERINUM

200mg

7

A03AA05

TRIMEBUTINUM
COMPR.
100mg 100mg 100mg 100mg LAB. FOURNIER SA GEDEON RICHTER ROMANIA S.A. TERAPIA SA MAGISTRA C & C

A03AA05 TRIMEBUTINUM
COLOBUTINE® COLPERIN 100 mg PROMEBUTIN® 100 mg TRIMEBUTIN 100

100mg

A03AA05 TRIMEBUTINUM
DEBRIDAT 100 mg 100mg 24mg/5ml 300mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

100mg 24mg/5ml 300mg

A03AA05 TRIMEBUTINUM
DEBRIDAT

GRAN. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

A03AA05 TRIMEBUTINUM
IBUTIN® 300 mg

COMPR. FILM. ELIB. PREL.
ZENTIVA SA

8
PAPAVERINA 100 mg

A03AD01

PAPAVERINI HYDROCHLORIDUM
COMPR.
100mg SINTOFARM SA

A03AD01 PAPAVERINI HYDROCHLORIDUM A03AD01 PAPAVERINI HYDROCHLORIDUM
PAPAVERINA 200mg

100mg 200mg
FARMACOM SA

COMPR.

9
A03FA01

A03FA01
METOCLOPRAMIDUM

METOCLOPRAMIDUM
COMPR.
10mg 10mg 10mg SLAVIA PHARM SRL TERAPIA SA MEDUMAN SA

10mg

METOCLOPRAMID METOCLOPRAMID 10 mg N - METOCLOPRAMID

A03FA01 A03FA01 A03FA01

METOCLOPRAMIDUM
1mg/5ml

SIROP
BIOFARM S.A.

1mg/5ml 5mg/ml
TERAPIA SA

METOCLOPRAMID BIOFARM 1mg/5ml

METOCLOPRAMIDUM
5mg/ml

SOL. INJ. PIC. ORALE-SOL.
7mg/ml BIOFARM SA

METOCLOPRAMID 10 mg

METOCLOPRAMIDUM

7mg/ml

METOCLOPRAMID

10
A03FA03
MOTILIUM MOTILIUM 10 mg

A03FA03
DOMPERIDONUM

DOMPERIDONUM
COMPR. FILM.
10mg 10mg JANSSEN PHARMACEUTICA NV TERAPIA SA

10mg

11

A05AA02

ACIDUM URSODEOXYCHOLICUM *
CAPS.
250mg 250mg DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

NOTA: Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare.

A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOFALK® URSOSAN

250mg

12

A06AD11
Prescriere limitata:

LACTULOSUM

Tratamentul encefalopatiei cronice porto-sistemice Tratamentul constipatiei la pacientii neoplazici.

A06AD11 LACTULOSUM
DUPHALAC® 66.7%

LICHID ORAL
SOLVAY PHARMACEUTICALS BV

66.7% 66.7%
ALIUD PHARMA GMBH & CO.KG

A06AD11 LACTULOSUM
LACTULOSE AL SIROP 66.7%

SIROP SOL. ORALA
670mg/ml FRESENIUS KABI AUSTRIA GMBH

A06AD11 LACTULOSUM
LAEVOLAC 670mg/ml

670mg/ml 66.7%
ALIUD PHARMA GMBH & CO.KG

A06AD11 LACTULOSUM
LACTULOSE AL SIROP 66.7%

SIROP SOL. ORALA

A06AD11 LACTULOSUM

670mg/ml

2 / 153

DCI/DENUMIRE COMERCIALA
LAEVOLAC 670mg/ml

CONCENTRATIE
670mg/ml

FORMA FARM.

FIRMA
FRESENIUS KABI AUSTRIA GMBH

PROTOCOL

A06AD11 LACTULOSUM
LACTULOSE AL SIROP 66.7%

SIROP
ALIUD PHARMA GMBH & CO.KG

66.7% 670mg/ml
FRESENIUS KABI AUSTRIA GMBH

A06AD11 LACTULOSUM
LAEVOLAC 670mg/ml 670mg/ml

SOL. ORALA LICHID ORAL
66.7% SOLVAY PHARMACEUTICALS BV

A06AD11 LACTULOSUM
DUPHALAC®

66.7% 65%
E.I.P.I.CO. MED S.R.L.

A06AD11 LACTULOSUM
LACTULOSE 65%

SIROP

13
NISTATINA

A07AA02

NYSTATINUM
COMPR. FILM.
500.000ui ANTIBIOTICE SA

A07AA02 NYSTATINUM A07AA02 NYSTATINUM
STAMICIN® 500000 U.I. 500000ui

500.000ui 500000ui
ZENTIVA SA

COMPR. FILM.

14
SALAZIDIN

A07EC01

SULFASALAZINUM
COMPR. FILM.
500mg 500mg AC HELCOR SRL

A07EC01 SULFASALAZINUM A07EC01 SULFASALAZINUM
SULFASALAZIN EN

500mg 500mg

COMPR. FILM. GASTROREZ.
KRKA D.D. NOVO MESTO

15
PENTASA

A07EC02

MESALAZINUM **
SUPOZ.
1g FERRING A/S

A07EC02 MESALAZINUM

1g

Prescriere limitata: Episod acut de proctita ulcerativa forma moderata NOTA: A nu se administra in tratamentul bolii Crohn..

A07EC02 MESALAZINUM
SALOFALK 250 mg COMPRIMATE GASTROREZISTENTE 250mg

COMPR. GASTROREZ.
DR. FALK PHARMA GMBH

250mg

Cod restrictie 1708: Cod restrictie 1709: Cod restrictie 2268: Cod restrictie 2269:
SALOFALK® 250 mg

Colita ulcerativa asociata cu hipersensibilitate la sulfonamide Colita ulcerativa asociata cu intoleranta la sulfasalazinum Boala Crohn in cazul in care exista hipersensibilitate la sulfonamide Boala Crohn in cazul in care exista intoleranta la sulfasalazinum

A07EC02 MESALAZINUM
250mg

SUPOZ.
DR. FALK PHARMA GMBH

250mg

Prescriere limitata:
SALOFALK 4 g/ 60 ml

Episod acut de proctita ulcerativa forma moderata

A07EC02 MESALAZINUM
4g/60ml

SUSP. RECTALA
DR. FALK PHARMA GMBH

4g/60ml

Cod restrictie 1707: Episod acut de colita ulcerativa forma moderata

A07EC02 MESALAZINUM
PENTASA 500mg

COMPR. ELIB. PREL.
FERRING A/S

500mg

Cod restrictie 1708: Cod restrictie 1709: Cod restrictie 2268: Cod restrictie 2269:

Colita ulcerativa asociata cu hipersensibilitate la sulfonamide Colita ulcerativa asociata cu intoleranta la sulfasalazinum Boala Crohn in cazul in care exista hipersensibilitate la sulfonamide Boala Crohn in cazul in care exista intoleranta la sulfasalazinum

A07EC02 MESALAZINUM
SALOFALK 500 mg COMPRIMATE GASTROREZISTENTE 500mg

COMPR. GASTROREZ.
DR. FALK PHARMA GMBH

500mg

Cod restrictie 1708: Cod restrictie 1709: Cod restrictie 2268: Cod restrictie 2269:
SALOFALK® 500 mg

Colita ulcerativa asociata cu hipersensibilitate la sulfonamide Colita ulcerativa asociata cu intoleranta la sulfasalazinum Boala Crohn in cazul in care exista hipersensibilitate la sulfonamide Boala Crohn in cazul in care exista intoleranta la sulfasalazinum

A07EC02 MESALAZINUM
500mg

SUPOZ.
DR. FALK PHARMA GMBH

500mg

Prescriere limitata:

Episod acut de proctita ulcerativa forma moderata

16
TROMBOSTOP 2 mg

B01AA07

ACENOCUMAROLUM
COMPR.
2mg TERAPIA SA

B01AA07 ACENOCUMAROLUM B01AA07 ACENOCUMAROLUM
SINTROM® 4mg

2mg 4mg
NOVARTIS PHARMA GMBH

COMPR.

17
IPATON TICLID® 250 mg TICLODIN TICLOPIDIN SANDOZ

B01AC05

TICLOPIDINUM (1)
COMPR. FILM.
250mg 250mg 250mg 250mg EGIS PHARMACEUTICALS PLC SANOFI-SYNTHELABO FRANCE AC HELCOR SRL HEXAL AG

B01AC05 TICLOPIDINUM

250mg

Cod restrictie 1719: Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de episoade ischiemice cererbrovasculare in timpul terapiei cu doze reduse de aspirina Cod restrictie 1720: Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii la care terapia cu doze reduse de aspirina prezinta un risc major (inacceptabil) de sangerare gastrointestinala; Cod restrictie 1721: Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de reactie anafilactica , urticarie sau astm bronsic in decurs de 4 ore de la administrarea de aspirina, alţi salicilati sau AINS Neutropenia severa este un efect advers comun in primele luni de terapie. Monitorizarea hematologica se impune la inceputul tratamentului si apoi la fiecare doua saptamani in primele patru luni de tratament.

18

B02BA01

PHYTOMENADIONUM
SOL. INJ.
10mg/ml TERAPIA SA

B02BA01 PHYTOMENADIONUM
FITOMENADION 10 mg/ml

10mg/ml

19
FERROGRADUMET®

B03AA07

FERROSI SULFAS
COMPR. ELIB. PREL.
105mg TEOFARMA SRL

B03AA07 FERROSI SULFAS B03AA07 FERROSI SULFAS
TARDYFERON 80 mg 80mg

105mg 80mg

DRAJ. ELIB. PREL.
LAB. PIERRE FABRE

B03AA07 FERROSI SULFAS
FERRO-GRADUMET

COMPR.FILM.ELIB.PREL
POLIPHARMA INDUSTRIES S.R.L.

3 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

20

B03AB05

COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT
COMPR. MAST.
100mg VIFOR FRANCE S.A.

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT
MALTOFER

100mg

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT
FERRUM HAUSMANN® 10mg/ml

SIROP
VIFOR FRANCE S.A.

10mg/ml

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT
FERGLUROM 50mg/5ml 50mg/5ml

SIROP
BIOFARM S.A.

50mg/5ml

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT
PHARMA-FERRUM® 5%

PICATURI ORALE-SOL.
TERAPIA SA

5%

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT
FERRUM HAUSMANN® 50mg/ml

PICATURI ORALE-SOL.
VIFOR FRANCE S.A.

50mg/ml

21

B03AEN1

COMBINATII (FERROSI SULFAS+ACIDUM ASCORBICUM)
COMPR. FILM.
EGIS PHARMACEUTICALS LTD.

B03AEN1 COMBINATII (FERROSI SULFAS+ACIDUM ASCORBICUM)
SORBIFER DURULES

22
ACIFOL 5 mg

B03BB01

ACIDUM FOLICUM
COMPR. FILM.
5mg ZENTIVA S.A.

B03BB01 ACIDUM FOLICUM

5mg

23

C01AA05

DIGOXINUM
SOL. ORALA
0.05mg/ml THE WELLCOME FOUNDATION LTD.

C01AA05 DIGOXINUM
LANOXIN SOLUTIE ORALA

0.05mg/ml 0.25mg
ZENTIVA S.A.

C01AA05 DIGOXINUM
DIGOXIN 0,25 mg 0.25mg

COMPR. SOL. INJ.
0.5mg/ml ZENTIVA S.A.

C01AA05 DIGOXINUM
DIGOXIN 0,5 mg/2 ml

0.5mg/ml

24

C01BA01

CHINIDINI SULFAS
COMPR.
200mg 200mg LAROPHARM SRL ARENA GROUP SA

C01BA01 CHINIDINI SULFAS
CHINIDINA LAROPHARM 200 mg CHINIDINA SULFAT 200 mg

200mg

25

C01BC03

PROPAFENONUM
COMPR.
150mg ARENA GROUP SA

C01BC03 PROPAFENONUM
PROPAFENONA 150 mg

150mg 150mg
ALIUD® PHARMA GMBH & CO.KG HEXAL AG ABBOTT GMBH&CO.KG

C01BC03 PROPAFENONUM
PROPAFENON AL 150 PROPAFENON SANDOZ 150 mg RYTMONORM® 150mg 150mg 150mg

COMPR. FILM.

C01BC03 PROPAFENONUM
RYTMONORM

SOL. INJ.
70mg/20ml ABBOTT GMBH&CO.KG

70mg/20ml

26

C01BD01
Prescriere limitata:

AMIODARONUM

Tratamentul tulburarilor de ritm severe care nu raspund la alte terapii sau cand alte antiaritmice nu pot fi folosite: a) tahiaritmii asociate sidromului Wolff-Parkinson-White; .b) flutter/fibrilatie atriala, atunci cand alte antiaritmice nu pot fi folosite; c) toate tahiaritmiile paroxistice, incluzand tahicardii supraventriculare, tahicardii ventriculare si nodale, fibrilatie ventriculara, atunci cand alte antiaritmice nu pot fi folosite. Exista dovezi ca amiodarona poate produce toxicitate frecventă şi potenţial severă. Se recomandă monitorizarea periodică a funcţiilor hepatice şi tiroidiene. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C01BD01 AMIODARONUM
AMIODARONA 200 mg AMIODARONA LPH 200 mg DARITMIN® 200 mg SEDACORON® 200mg 200mg 200mg 200mg

COMPR.
ARENA GROUP SA LABORMED PHARMA SA GEDEON RICHTER ROMANIA SA EBEWE PHARMA GMBH NFG. KG

200mg

C01BD01 AMIODARONUM
CORDARONE 200 mg 200mg

COMPR. DIVIZ.
SANOFI-AVENTIS FRANCE

200mg

27
NITROMINT

C01DA02

NITROGLYCERINUM
SPRAY SUBLINGUAL
0.4mg/doza EGIS PHARMACEUTICALS P.L.C.

C01DA02 NITROGLYCERINUM
NOTA: Sprayul nu trebuie inhalat..

0.4mg/doza

C01DA02 NITROGLYCERINUM
NITROGLICERINA 0,5 mg 0.5mg 2.6mg 25mg

COMPR. SUBLING.
ZENTIVA SA

0.5mg 2.6mg 25mg

C01DA02 NITROGLYCERINUM
NITROMINT 2,6 mg

COMPR. ELIB. PREL.
EGIS PHARMACEUTICALS LTD.

C01DA02 NITROGLYCERINUM
NITRODERM® TTS 5

SIST. TERAP. TRANSDERM.
NOVARTIS PHARMA GMBH

28

C01DA08

ISOSORBIDI DINITRAS
COMPR.
10mg E.I.P.I.CO. MED S.R.L.

C01DA08 ISOSORBIDI DINITRAS
ISOSORBIDE DINITRATE 10 mg

10mg 20mg
TERAPIA SA

C01DA08 ISOSORBIDI DINITRAS
DINITER SR 20 mg 20mg 20mg

CAPS. ELIB. PREL. COMPR. ELIB. PREL.
BALKAN PHARMA DUPNITZA AD

C01DA08 ISOSORBIDI DINITRAS
ISODINIT® RETARD

20mg 40mg

C01DA08 ISOSORBIDI DINITRAS
DINITER SR 40 mg 40mg

CAPS. ELIB. PREL.
TERAPIA SA

29

C01DA14

ISOSORBIDI MONONITRAS
CAPS. ELIB. PREL.
40mg SOLVAY PHARMACEUTICALS GMBH

C01DA14 ISOSORBIDI MONONITRAS
OLICARD 40 mg RETARD

40mg

4 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
60mg 60mg

FORMA FARM.

FIRMA

PROTOCOL

C01DA14 ISOSORBIDI MONONITRAS
OLICARD 60 mg RETARD

CAPS. ELIB. PREL.
SOLVAY PHARMACEUTICALS GMBH

60mg 60mg

C01DA14 ISOSORBIDI MONONITRAS
MONONITRON® EP 60 mg

COMPR. FILM. ELIB. PREL.
ZENTIVA S.A

30

C01EA01

ALPROSTADILUM ***
CONC. PT. SOL. PERF.
20µg 20µg PINT-PHARMA GMBH

Protocol: C002I
20µg 20µg

C01EA01 ALPROSTADILUM
ALPROSTADIL "PINT" 20 µg

C01EA01 ALPROSTADILUM
VASAPROSTAN 20

LIOF. PT. SOL. PERF.
SCHWARZ PHARMA AG

31
TRIMETAZIDIN 20 mg

C01EB15

TRIMETAZIDINUM
CAPS.
20mg VIM SPECTRUM SRL

C01EB15 TRIMETAZIDINUM C01EB15 TRIMETAZIDINUM
DILATAN 20 mg MODUXIN® 20 mg PREDOZONE 20 mg PREDUCTAL® TRIMETAZIDINA LPH® 20 mg TRIVEDON 20 20mg 20mg 20mg 20mg 20mg 20mg

20mg 20mg
TERAPIA SA GEDEON RICHTER ROMANIA SA OZONE LABORATORIES LTD. LES LAB. SERVIER IND. LABORMED PHARMA SA CIPLA (UK) LIMITED

COMPR. FILM.

C01EB15 TRIMETAZIDINUM
TRIMETAZIDINA 20 mg 20mg 35mg 35mg 35mg

DRAJ.
TERAPIA SA

20mg 35mg

C01EB15 TRIMETAZIDINUM
DILATAN MR 35 mg PREDUCTAL MR 35 mg TRIMETAZIDINA LPH® 35 mg

COMPR. FILM. ELIB. MODIF.
TERAPIA SA LES LAB. SERVIER IND. LABORMED PHARMA SA

32
DOPEGYT

C02AB01

METHYLDOPUM
COMPR.
250mg EGIS PHARMACEUTICALS PLC

C02AB01 METHYLDOPUM

250mg

33

C02AC01

CLONIDINUM
COMPR.
0.15mg 0.15mg ARENA GROUP SA SINTOFARM SA

C02AC01 CLONIDINUM
CLONIDINA 0,15 mg CLONIDINA SINTOFARM 0,15 mg

0.15mg

34

C02CA04

DOXAZOSINUM
COMPR.
1mg 1mg 1mg 1mg MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

C02CA04 DOXAZOSINUM
DOXAZOSIN 1 MEDOCHEMIE DOXAZOSIN AL 1 KAMIREN MAGUROL

1mg

C02CA04 DOXAZOSINUM
DOXAZOSIN 2 MEDOCHEMIE DOXAZOSIN AL 2 DOXAZOSIN SANDOZ 2 mg KAMIREN MAGUROL 2mg 2mg 2mg 2mg 2mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

2mg

C02CA04 DOXAZOSINUM
DOXAZOSIN 4 MEDOCHEMIE DOXAZOSIN AL 4 KAMIREN MAGUROL 4mg 4mg 4mg 4mg 4mg 4mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

4mg

C02CA04 DOXAZOSINUM
CARDURA XL 4 mg

COMPR. ELIB. MODIF.
PFIZER H.C.P. CORPORATION

4mg 4mg 1mg

C02CA04 DOXAZOSINUM
KAMIREN XL 4 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO

C02CA04 DOXAZOSINUM
DOXAZOSIN 1 MEDOCHEMIE DOXAZOSIN AL 1 KAMIREN MAGUROL 1mg 1mg 1mg 1mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

C02CA04 DOXAZOSINUM
DOXAZOSIN 2 MEDOCHEMIE DOXAZOSIN AL 2 DOXAZOSIN SANDOZ 2 mg KAMIREN MAGUROL 2mg 2mg 2mg 2mg 2mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

2mg

C02CA04 DOXAZOSINUM
DOXAZOSIN 4 MEDOCHEMIE DOXAZOSIN AL 4 KAMIREN MAGUROL 4mg 4mg 4mg 4mg 4mg 4mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

4mg

C02CA04 DOXAZOSINUM
CARDURA XL 4 mg

COMPR. ELIB. MODIF.
PFIZER H.C.P. CORPORATION

4mg 4mg

C02CA04 DOXAZOSINUM
KAMIREN XL 4 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO

35
NEFRIX 25 mg

C03AA03

HYDROCHLOROTHIAZIDUM
COMPR.
25mg ZENTIVA SA

C03AA03 HYDROCHLOROTHIAZIDUM

25mg

36
IMPAMID SR 1,5 mg INDATER SR 1,5 mg

C03BA11

INDAPAMIDUM
COMPR. FILM. ELIB. PREL.
1,5mg 1,5mg 1.5 mg GEDEON RICHTER ROMANIA S.A. TERAPIA SA

C03BA11 INDAPAMIDUM

1,5mg

C03BA11 INDAPAMIDUM
INDAPAMID SR 1,5 mg LAROPHARM

COMPR. FILM. ELIB. PREL.
LAROPHARM SRL

1.5 mg

5 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
1.5mg 1.5mg 1.5mg 1.5mg

FORMA FARM.

FIRMA

PROTOCOL

C03BA11 INDAPAMIDUM
INDAPAMID MCC 1,5 mg

COMPR. ELIB. PREL.
MAGISTRA C & C SRL

1.5mg 1.5mg

C03BA11 INDAPAMIDUM
INDAPAMID LPH® 1,5 mg RAWEL SR 1,5 mg TERTENSIF® SR

COMPR. FILM. ELIB. PREL.
LABORMED PHARMA SA KRKA D.D. NOVO MESTO LES LAB. SERVIER IND.

C03BA11 INDAPAMIDUM
IMPAMID® 2,5 mg 2.5mg

COMPR.
GEDEON RICHTER ROMANIA SA

2.5mg 2.5mg
LABORMED PHARMA SA HEMOFARM S.R.L. TERAPIA SA

C03BA11 INDAPAMIDUM
INDAPAMID LPH® 2,5 mg INDAPAMIDE 2,5 mg INDATER® 2,5 mg 2.5mg 2.5mg 2.5mg

COMPR. FILM.

37

C03CA01

FUROSEMIDUM

Electroliţii serici trebuie să fie verificaţi periodic. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C03CA01 FUROSEMIDUM
FUROSEMID 20 mg/2 ml 10mg/ml

SOL. INJ.
ZENTIVA SA

10mg/ml 40mg
ARENA GROUP S.A. BIO EEL SRL LABORMED PHARMA SA MAGISTRA C & C SRL SLAVIA PHARM SRL ZENTIVA SA

C03CA01 FUROSEMIDUM
FUROSEMID ARENA 40 mg FUROSEMID EEL FUROSEMID LPH 40 mg FUROSEMID MCC 40 mg FUROSEMID SLAVIA FUROSEMID ZENTIVA 40mg 40mg 40mg 40mg 40mg 40mg

COMPR.

38

C03DA01

SPIRONOLACTONUM

Electroliţii serici trebuie să fie verificaţi periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C03DA01 SPIRONOLACTONUM
VEROSPIRON 100mg

CAPS.
GEDEON RICHTER LTD.

100mg 25mg
BIO EEL SRL

C03DA01 SPIRONOLACTONUM
SPIRONOLACTONA 25 mg 25mg

COMPR. COMPR. FILM.
25mg 25mg AC HELCOR PHARMA SRL TERAPIA SA

C03DA01 SPIRONOLACTONUM
ALSPIRON 25 mg SPIRONOLACTONA 25 mg

25mg

C03DA01 SPIRONOLACTONUM
VEROSPIRON 50mg

CAPS.
GEDEON RICHTER LTD.

50mg 50mg
AC HELCOR PHARMA SRL

C03DA01 SPIRONOLACTONUM
ALSPIRON 50 mg 50mg

COMPR. FILM.

39

C03EB01

COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM)
CAPS.
TERAPIA SA

C03EB01 COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM)
DIUREX 50

40

C04AD03

PENTOXIFYLLINUM
COMPR. FILM. ELIB. PREL.
400mg 400mg AC HELCOR PHARMA SRL TERAPIA SA

C04AD03 PENTOXIFYLLINUM
ANGIOPENT 400 mg PENTOXI RETARD 400 mg

400mg

C04AD03 PENTOXIFYLLINUM
TRENTAL® 400mg 600mg

DRAJ. ELIB. PREL.
AVENTIS PHARMA DEUTSCHLAND GMBH

400mg 600mg

C04AD03 PENTOXIFYLLINUM
ANGIOPENT 600 mg

COMPR. FILM. ELIB. PREL.
AC HELCOR PHARMA SRL

41

C07AA05

PROPRANOLOLUM
COMPR.
10mg 10mg 10mg SC MEDUMAN SA BIO EEL SRL SINTOFARM SA

C07AA05 PROPRANOLOLUM
N - PROPRANOLOL 10 mg PROPRANOLOL PROPRANOLOL 10 mg

10mg

C07AA05 PROPRANOLOLUM
PROPRANOLOL 40 mg PROPRANOLOL EEL 40 mg 40mg 40mg

COMPR.
SINTOFARM SA BIO EEL SRL

40mg

42

C07AA07
Prescriere limitata:

SOTALOLUM

Tratamentul aritmiilor ventriculare severe. Tratamentul aritmiilor supraventriculare. Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare denumirii comune internationale.

C07AA07 SOTALOLUM
ALS-SOTALOL 160 mg DAROB® 160 mg SOTAGAMMA 160 SOTALOL AL 160 160mg 160mg 160mg 160mg

COMPR.
ALSIFCOM INTERMED SRL ABBOTT GMBH&CO.KG WORWAG PHARMA GMBH & CO. KG ALIUD PHARMA GMBH & CO.KG

160mg

C07AA07 SOTALOLUM
ALS-SOTALOL 80 mg DAROB® 80 mg SOTAGAMMA 80 80mg 80mg 80mg

COMPR.
ALSIFCOM INTERMED SRL ABBOTT GMBH&CO.KG WORWAG PHARMA GMBH & CO. KG

80mg

43

C07AB02

METOPROLOLUM
COMPR.
100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg AC HELCOR PHARMA SRL KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH MAGISTRA C & C SRL ALIUD® PHARMA GMBH & CO.KG LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L.

C07AB02 METOPROLOLUM
BETAPROL 100 mg BLOXAN EGILOK 100 mg METOPRO TAD 100 METOPROLOL 100 mg METOPROLOL AL 100 METOPROLOL LPH 100 mg METOPROLOL MEDICO UNO 100 mg

100mg

6 / 153

DCI/DENUMIRE COMERCIALA
METOPROLOL TERAPIA 100 mg VASOCARDIN® 100

CONCENTRATIE
100mg 100mg 100mg 100mg 190mg 200mg

FORMA FARM.

FIRMA
TERAPIA SA SLOVAKOFARMA

PROTOCOL

C07AB02 METOPROLOLUM
METOPROLOL RETARD 100 mg

COMPR. ELIB. PREL.
TERAPIA S.A.

100mg 100mg 190mg 200mg 25mg

C07AB02 METOPROLOLUM
BETALOC® ZOC 100 mg

COMPR. FILM. ELIB. PREL.
ASTRAZENECA AB

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 190 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

C07AB02 METOPROLOLUM
VASOCARDIN® SR 200

COMPR. ELIB. PREL.
ZENTIVA AS

C07AB02 METOPROLOLUM
EGILOK 25 mg METOPROLOL 25 mg METOPROLOL LPH 25 mg METOPROLOL MEDICO UNO 25 mg 25mg 25mg 25mg 25mg 47.5mg

COMPR.
EGIS PHARMACEUTICALS P.L.C. ARENA GROUP S.A. LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L.

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 47,5 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

47.5mg 50mg

C07AB02 METOPROLOLUM
BETAPROL 50 mg EGILOK 50 mg METOPRO TAD 50 METOPROLOL 50 mg METOPROLOL AL 50 METOPROLOL LPH 50 mg METOPROLOL MEDICO UNO 50 mg METOPROLOL TERAPIA 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 95mg

COMPR.
AC HELCOR PHARMA SRL EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH MAGISTRA C & C SRL ALIUD PHARMA GMBH & CO.KG LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L. TERAPIA SA

C07AB02 METOPROLOLUM
BETALOC® ZOC 50 mg

COMPR. FILM. ELIB. PREL.
ASTRAZENECA AB

50mg 95mg

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 95 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

44

C07AB03

ATENOLOLUM
COMPR.
100mg 100mg 100mg 100mg WIN - MEDICARE LTD. AC HELCOR SRL ARENA GROUP SA LABORMED PHARMA SA

C07AB03 ATENOLOLUM
ATECOR ATENOCOR 100 mg ATENOLOL 100 mg ATENOLOL LPH 100 mg

100mg

C07AB03 ATENOLOLUM
ATENOLOL 100 mg ATENOLOL 100 mg MEDO VASCOTEN 100mg 100mg 100mg

COMPR. FILM.
TERAPIA SA MEDOCHEMIE ROMANIA SRL MEDOCHEMIE LTD.

100mg

C07AB03 ATENOLOLUM
ATENOCOR 50 mg ATENOLOL 50 mg ATENOLOL LPH 50 mg 50mg 50mg 50mg

COMPR.
AC HELCOR SRL SLAVIA PHARM SRL LABORMED PHARMA SA

50mg

C07AB03 ATENOLOLUM
ATENOLOL 50 mg 50mg

COMPR. FILM.
TERAPIA SA

50mg

45
BETAC LOKREN 20 mg

C07AB05

BETAXOLOLUM
COMPR. FILM.
20mg 20mg MEDOCHEMIE LTD. SANOFI-AVENTIS FRANCE

C07AB05 BETAXOLOLUM

20mg

46
BISOBLOCK 10 mg

C07AB07

BISOPROLOLUM
COMPR.
10mg KERI PHARMA GENERICS LTD.

C07AB07 BISOPROLOLUM C07AB07 BISOPROLOLUM
BISOGAMMA® 10 BISOTENS 10 mg CONCOR 10 mg 10mg 10mg 10mg

10mg 10mg
WORWAG PHARMA GMBH & CO. KG ANTIBIOTICE S.A. MERCK KGAA

COMPR. FILM.

C07AB07 BISOPROLOLUM
CONCOR COR 2,5 mg 2.5mg

COMPR. FILM.
MERCK KGAA

2.5mg 5mg
KERI PHARMA GENERICS LTD.

C07AB07 BISOPROLOLUM
BISOBLOCK 5 mg 5mg

COMPR. COMPR. FILM.
5mg 5mg 5mg WORWAG PHARMA GMBH & CO. KG ANTIBIOTICE S.A. MERCK KGAA

C07AB07 BISOPROLOLUM
BISOGAMMA® 5 BISOTENS 5 mg CONCOR 5 mg

5mg

47
CARVEDILOL SANDOZ

C07AG02

CARVEDILOLUM
COMPR.
12,5 mg HEXAL AG

C07AG02 CARVEDILOLUM C07AG02 CARVEDILOLUM
ATRAM 12,5 CARVEDILOL 12,5 mg CARVEDILOL HELCOR 12,5 mg CARVEDILOL LPH 12,5 mg CARVEDILOL TEVA 12,5 mg CORYOL® DILATREND® 12,5 mg TALLITON® 12,5 mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg

12,5 mg 12.5mg
ZENTIVA AS VIM SPECTRUM SRL AC HELCOR PHARMA SRL LABORMED PHARMA SA TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. EGIS PHARMACEUTICALS LTD.

COMPR.

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 12,5 mg 12.5mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG

12.5mg 25mg
ZENTIVA AS AC HELCOR PHARMA SRL LABORMED PHARMA SA

C07AG02 CARVEDILOLUM
ATRAM 25 CARVEDILOL HELCOR 25 mg CARVEDILOL LPH 25 mg 25mg 25mg 25mg

COMPR.

7 / 153

DCI/DENUMIRE COMERCIALA
CARVEDILOL SANDOZ CARVEDILOL TEVA 25 mg CORYOL® DILATREND® 25 mg TALLITON® 25 mg

CONCENTRATIE
25mg 25mg 25mg 25mg 25mg

FORMA FARM.

FIRMA
HEXAL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. EGIS PHARMACEUTICALS LTD.

PROTOCOL

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 25 mg 25mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG

25mg 3.125mg
KRKA D.D.

C07AG02 CARVEDILOLUM
CORYOL® 3,125 mg 3.125mg

COMPR. COMPR.
6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg ZENTIVA AS VIM SPECTRUM SRL LABORMED PHARMA SA HEXAL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. EGIS PHARMACEUTICALS LTD.

C07AG02 CARVEDILOLUM
ATRAM 6,25 CARVEDILOL 6,25 mg CARVEDILOL LPH 6,25 mg CARVEDILOL SANDOZ CARVEDILOL TEVA 6,25 mg CORYOL® DILATREND® 6,25 mg TALLITON 6,25 mg

6.25mg

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 6,25 mg 6.25mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG

6.25mg

48

C08CA01

AMLODIPINUM
COMPR.
10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg OZONE LABORATORIES BV TAD PHARMA GMBH VIM SPECTRUM SRL TEVA PHARMACEUTICAL S.R.L. HEXAL AG PFIZER EUROPE MA EEIG DR. REDDY'S LABORATORIES KRKA D.D. LABORMED PHARMA S.A.

C08CA01 AMLODIPINUM
ALOZUR 10 mg AMLO TAD 10 mg AMLODIPIN 10 mg AMLODIPINE-TEVA 10 mg AMLOHEXAL 10 mg NORVASC 10 mg STAMLO M 10 mg TENOX® 10 VASOREX 10 mg

10mg

C08CA01 AMLODIPINUM
ALOZUR 5 mg AMLO TAD 5 mg AMLODIPIN 5 mg AMLODIPINE-TEVA 5 mg AMLOHEXAL 5 mg NORVASC 5 mg STAMLO M 5 mg TENOX® 5 VASOREX 5 mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.
OZONE LABORATORIES BV TAD PHARMA GMBH VIM SPECTRUM SRL TEVA PHARMACEUTICAL S.R.L. HEXAL AG PFIZER EUROPE MA EEIG DR. REDDY'S LABORATORIES KRKA D.D. LABORMED PHARMA S.A.

5mg

49

C08CA02

FELODIPINUM
COMPR. ELIB. MODIF.
10mg 10mg 10mg 10mg 10mg 10mg 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg 5mg 5mg 5mg 5mg 5mg 5mg ALIUD® PHARMA GMBH & CO.KG

C08CA02 FELODIPINUM
FELODIPIN AL 10 RETARD

10mg 10mg 10mg 10mg

C08CA02 FELODIPINUM
PLENDIL

COMPR. ELIB. PREL.
ASTRAZENECA AB

C08CA02 FELODIPINUM
SISTAR 10 mg

COMPR. FILM. ELIB. MODIF.
GEDEON RICHTER ROMANIA SA

C08CA02 FELODIPINUM
AURONAL 10 mg MIVARA 10 mg PRESID® 10 mg

COMPR. FILM. ELIB. PREL.
EGIS PHARMACEUTICALS PLC STADA ARZNEIMITTEL AG IVAX - PHARMACEUTICALS S.R.O.

C08CA02 FELODIPINUM
FELODIPIN AL 2,5 RETARD

COMPR. ELIB. MODIF.
ALIUD® PHARMA GMBH & CO.KG

2.5mg 2.5mg 2.5mg 2.5mg

C08CA02 FELODIPINUM
PLENDIL

COMPR. ELIB. PREL.
ASTRAZENECA AB

C08CA02 FELODIPINUM
SISTAR 2,5 mg

COMPR. FILM. ELIB. MODIF.
GEDEON RICHTER ROMANIA SA

C08CA02 FELODIPINUM
AURONAL 2,5 mg PRESID® 2,5 mg

COMPR. FILM. ELIB. PREL.
EGIS PHARMACEUTICALS PLC IVAX - PHARMACEUTICALS S.R.O.

C08CA02 FELODIPINUM
FELODIPIN AL 5 RETARD

COMPR. ELIB. MODIF.
ALIUD® PHARMA GMBH & CO.KG

5mg 5mg 5mg 5mg

C08CA02 FELODIPINUM
PLENDIL

COMPR. ELIB. PREL.
ASTRAZENECA AB

C08CA02 FELODIPINUM
SISTAR 5 mg

COMPR. FILM. ELIB. MODIF.
GEDEON RICHTER ROMANIA SA

C08CA02 FELODIPINUM
AURONAL 5 mg MIVARA 5 mg PRESID® 5 mg

COMPR. FILM. ELIB. PREL.
EGIS PHARMACEUTICALS PLC STADA ARZNEIMITTEL AG IVAX - PHARMACEUTICALS S.R.O.

50
ADALAT CR 20

C08CA05

NIFEDIPINUM
COMPR. ELIB. MODIF.
20mg 20mg 20mg BAYER HEALTHCARE AG

C08CA05 NIFEDIPINUM C08CA05 NIFEDIPINUM
ADALAT® RETARD NIFEDIPIN RETARD TERAPIA 20 mg

20mg 20mg

COMPR. FILM. ELIB. PREL.
BAYER HEALTHCARE AG TERAPIA SA

C08CA05 NIFEDIPINUM
EPILAT RETARD 20mg 30mg 20mg

DRAJ.
E.I.P.I.CO. MED S.R.L.

20mg 30mg 20mg 20mg

C08CA05 NIFEDIPINUM
ADALAT CR 30

COMPR. ELIB. MODIF.
BAYER HEALTHCARE AG

C08CA05 NIFEDIPINUM
ADALAT CR 20

COMPR. ELIB. MODIF.
BAYER HEALTHCARE AG

C08CA05 NIFEDIPINUM

COMPR. FILM. ELIB. PREL.

8 / 153

DCI/DENUMIRE COMERCIALA
ADALAT® RETARD NIFEDIPIN RETARD TERAPIA 20 mg

CONCENTRATIE
20mg 20mg

FORMA FARM.

FIRMA
BAYER HEALTHCARE AG TERAPIA SA

PROTOCOL

51

C08DA01

VERAPAMILUM

Efectele de inhibare a funcţiei miocardice ale acestui medicament se cumulează cu cele ale beta-blocantelor Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C08DA01 VERAPAMILUM
ISOPTIN RR VEROGALID® ER 240 mg 240mg 240mg

COMPR. FILM. ELIB. PREL.
ABBOTT GMBH&CO.KG IVAX - PHARMACEUTICALS S.R.O.

240mg

C08DA01 VERAPAMILUM
ISOPTIN® 40 mg VERAPAMIL AL 40 40mg 40mg

COMPR. FILM.
ABBOTT GMBH&CO.KG ALIUD® PHARMA GMBH & CO.KG

40mg

C08DA01 VERAPAMILUM
ISOPTIN® 80 mg VERAPAMIL AL 80 80mg 80mg

COMPR. FILM.
ABBOTT GMBH&CO.KG ALIUD® PHARMA GMBH & CO.KG

80mg

52

C08DB01

DILTIAZEMUM

Efectele de inhibare a funcţiei miocardice ale acestui medicament se cumulează cu cele ale beta-blocantelor Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C08DB01 DILTIAZEMUM
DILTIAZEM ALKALOID 60 mg DILTIAZEM EIPICO 60 mg DILTIAZEM LPH 60 mg DILZEM 60 mg 60mg 60mg 60mg 60mg

COMPR.
ALKALOID DOO E.I.P.I.CO. MED S.R.L. LABORMED PHARMA SA PFIZER EUROPE MA EEIG

60mg

C08DB01 DILTIAZEMUM
DILTIAZEM ALKALOID 90 mg 90mg 90mg

COMPR.
ALKALOID DOO

90mg 90mg

C08DB01 DILTIAZEMUM
DILZEM 90 mg RETARD

COMPR. FILM. ELIB. PREL.
PFIZER EUROPE MA EEIG

53

C09AA01

CAPTOPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C09AA01 CAPTOPRILUM
CAPTOPRIL MCC 12,5 mg 12,5mg

COMPR.
MAGISTRA C & C

12,5mg 12.5mg
EGIS PHARMACEUTICALS LTD.

C09AA01 CAPTOPRILUM
CAPTOPRIL 12,5 mg 12.5mg

COMPR. COMPR.
25mg 25mg 25mg 25mg 25mg 25mg AC HELCOR PHARMA SRL SINTOFARM SA BIO EEL SRL EGIS PHARMACEUTICALS LTD. LABORMED PHARMA SA MAGISTRA C & C

C09AA01 CAPTOPRILUM
CAPTOPRIL - AC 25 mg CAPTOPRIL SINTOFARM 25 mg CAPTOPRIL 25 EEL CAPTOPRIL 25 mg CAPTOPRIL LPH 25 mg CAPTOPRIL MCC 25 mg

25mg

C09AA01 CAPTOPRILUM
CAPTOPRIL 50 mg 50 mg

COMPR.
ARENA GROUP SA

50 mg 50mg
AC HELCOR PHARMA SRL BIO EEL SRL EGIS PHARMACEUTICALS LTD. LABORMED PHARMA SA MAGISTRA C & C

C09AA01 CAPTOPRILUM
CAPTOPRIL - AC 50 mg CAPTOPRIL 50 EEL CAPTOPRIL 50 mg CAPTOPRIL LPH 50 mg CAPTOPRIL MCC 50 mg 50mg 50mg 50mg 50mg 50mg

COMPR.

54

C09AA02

ENALAPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C09AA02 ENALAPRILUM
ENAP®

SOL. INJ.
1.25mg/ml KRKA D.D.

1.25mg/ml 10mg
GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH E.I.P.I.CO. MED S.R.L. MAGISTRA C & C ALIUD® PHARMA GMBH & CO.KG FABIOL SA LABORMED PHARMA SA SANDOZ SRL TERAPIA SA REPREZENTANTA DR. REDDY'S LABORATORIES LTD. KRKA D.D. NOVO MESTO MERCK SHARP & DOHME ROMANIA S.R.L.

C09AA02 ENALAPRILUM
EDNYT® 10 mg ENAHEXAL® 10 mg ENALA TAD 10 ENALAP ENALAPRIL 10 mg ENALAPRIL AL 10 ENALAPRIL FABIOL 10 mg ENALAPRIL LPH 10 mg ENALAPRIL SANDOZ 10 mg ENALAPRIL TERAPIA 10 mg ENAM 10 mg ENAP 10 mg RENITEC 10 mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

COMPR.

C09AA02 ENALAPRILUM
EDNYT® 2,5 mg 2.5mg

COMPR.
GEDEON RICHTER LTD.

2.5mg 20mg
GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH OZONE LABORATORIES LTD. MAGISTRA C & C ALIUD® PHARMA GMBH & CO.KG FABIOL SA LABORMED PHARMA SA SANDOZ SRL TERAPIA SA KRKA D.D. NOVO MESTO MERCK SHARP & DOHME ROMANIA S.R.L.

C09AA02 ENALAPRILUM
EDNYT® 20 mg ENAHEXAL® 20 mg ENALA TAD 20 ENALAPRIL ENALAPRIL 20 mg ENALAPRIL AL 20 ENALAPRIL FABIOL 20 mg ENALAPRIL LPH 20 mg ENALAPRIL SANDOZ 20 mg ENALAPRIL TERAPIA 20 mg ENAP 20 mg RENITEC 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR.

9 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

FORMA FARM.

FIRMA

PROTOCOL

C09AA02 ENALAPRILUM
EDNYT® 5 mg ENAHEXAL® 5 mg ENALA TAD 5 ENALAPRIL 5 mg ENALAPRIL AL 5 ENALAPRIL LPH® 5 mg ENALAPRIL SANDOZ 5 mg ENAP 5 mg RENITEC 5 mg

COMPR.
GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH OZONE LABORATORIES LTD. ALIUD® PHARMA GMBH & CO.KG LABORMED PHARMA SA SANDOZ SRL KRKA D.D. NOVO MESTO MERCK SHARP & DOHME ROMANIA S.R.L.

5mg

55

C09AA03

LISINOPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C09AA03 LISINOPRILUM
LISIGAMMA 10 mg LISINOPRIL 10 MEDO LISINOPRIL ANTIBIOTICE 10 mg LISINOPRIL SANDOZ 10 mg LISIREN 10 mg MEDAPRIL 10 RANOLIP SINOPRYL® 10 TONOLYSIN 10 mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

COMPR.
WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL ANTIBIOTICE SA HEXAL AG AC HELCOR SRL MEDOCHEMIE LTD. RANBAXY U.K. LIMITED ECZACIBASI PHARMACEUTICALS S.R.L. GEDEON RICHTER LTD.

10mg

C09AA03 LISINOPRILUM
TONOLYSIN 2,5 mg 2.5mg

COMPR.
GEDEON RICHTER LTD.

2.5mg 20mg
WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL ANTIBIOTICE SA HEXAL AG AC HELCOR SRL MEDOCHEMIE LTD. RANBAXY U.K. LIMITED GEDEON RICHTER LTD.

C09AA03 LISINOPRILUM
LISIGAMMA 20 mg LISINOPRIL 20 MEDO LISINOPRIL ANTIBIOTICE 20 mg LISINOPRIL SANDOZ 20 mg LISIREN 20 mg MEDAPRIL 20 RANOLIP TONOLYSIN 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR.

C09AA03 LISINOPRILUM
LISINOPRIL ANTIBIOTICE 40 mg 40mg

COMPR.
ANTIBIOTICE SA

40mg 5mg
WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL HEXAL AG MEDOCHEMIE LTD. RANBAXY U.K. LIMITED GEDEON RICHTER LTD.

C09AA03 LISINOPRILUM
LISIGAMMA 5 mg LISINOPRIL 5 MEDO LISINOPRIL SANDOZ 5 mg MEDAPRIL 5 RANOLIP TONOLYSIN 5 mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.

56

C09AA05

RAMIPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C09AA05 RAMIPRILUM
RAMIRAN 1,25 mg 1.25mg

COMPR. FILM.
RANBAXY U.K. LIMITED

1.25mg 10 mg
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

C09AA05 RAMIPRILUM
EMREN 10 mg VIVACE 10 mg 10 mg 10 mg

COMPR.

C09AA05 RAMIPRILUM
AMPRIL 10 mg PIRAMIL 10 mg RAMIGAMMA 10 mg RAMIPRIL-AC 10 mg TRITACE 10 ZENRA 10 10mg 10mg 10mg 10mg 10mg 10mg

COMPR.
KRKA D.D. NOVO MESTO SANDOZ SRL WORWAG PHARMA GMBH & CO. KG AC HELCOR PHARMA SRL SANOFI - AVENTIS DEUTSCHLAND GMBH ZENTIVA S.A.

10mg

C09AA05 RAMIPRILUM
RAMIRAN 10 mg 10mg

COMPR. FILM.
RANBAXY U.K. LIMITED

10mg 2,5 mg
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

C09AA05 RAMIPRILUM
EMREN 2,5 mg VIVACE 2,5 mg 2,5 mg 2,5 mg

COMPR.

C09AA05 RAMIPRILUM
AMPRIL 2,5 mg PIRAMIL 2,5 mg RAMIPRIL-AC 2,5 mg TRITACE® 2,5 ZENRA 2,5 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg

COMPR.
KRKA D.D. NOVO MESTO SANDOZ SRL AC HELCOR PHARMA SRL AVENTIS PHARMA DEUTSCHLAND GMBH ZENTIVA S.A.

2.5mg

C09AA05 RAMIPRILUM
RAMIRAN 2,5 mg 2.5mg

COMPR. FILM.
RANBAXY U.K. LIMITED

2.5mg 5 mg
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

C09AA05 RAMIPRILUM
EMREN 5 mg VIVACE 5 mg 5 mg 5 mg

COMPR.

C09AA05 RAMIPRILUM
AMPRIL 5 mg PIRAMIL 5 mg RAMIGAMMA 5 mg RAMIPRIL-AC 5 mg TRITACE® 5 ZENRA 5 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.
KRKA D.D. NOVO MESTO SANDOZ SRL WORWAG PHARMA GMBH & CO. KG AC HELCOR PHARMA SRL AVENTIS PHARMA DEUTSCHLAND GMBH ZENTIVA S.A.

5mg

C09AA05 RAMIPRILUM
RAMIRAN 5 mg 5mg

COMPR. FILM.
RANBAXY U.K. LIMITED

5mg

10 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

57

C09AA06

QUINAPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C09AA06 QUINAPRILUM
QUINAPRIL SANDOZ 10 mg 10 mg

COMPR. FILM.
HEXAL AG

10 mg 10mg
PFIZER EUROPE MA EEIG LABORMED PHARMA SA RANBAXY UK LIMITED

C09AA06 QUINAPRILUM
ACCUPRO 10 mg AQUIRIL 10 mg QUINARAN 10 mg 10mg 10mg 10mg

COMPR. FILM.

C09AA06 QUINAPRILUM
QUINAPRIL SANDOZ 20 mg 20 mg

COMPR. FILM.
HEXAL AG

20 mg 20mg
PFIZER EUROPE MA EEIG RANBAXY UK LIMITED

C09AA06 QUINAPRILUM
ACCUPRO® 20 QUINARAN 20 mg 20mg 20mg

COMPR. FILM.

C09AA06 QUINAPRILUM
QUINAPRIL SANDOZ 40 mg 40 mg

COMPR. FILM.
HEXAL AG

40 mg 40mg
RANBAXY UK LIMITED

C09AA06 QUINAPRILUM
QUINARAN 40 mg 40mg

COMPR. FILM. COMPR. FILM.
5 mg HEXAL AG

C09AA06 QUINAPRILUM
QUINAPRIL SANDOZ 5 mg

5 mg 5mg
PFIZER EUROPE MA EEIG RANBAXY UK LIMITED

C09AA06 QUINAPRILUM
ACCUPRO® 5 QUINARAN 5 mg 5mg 5mg

COMPR. FILM.

58

C09AA09

FOSINOPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C09AA09 FOSINOPRILUM
FOSINOPRIL TERAPIA 10 mg FOSYPRIL 10 mg MONOPRIL 10 mg 10mg 10mg 10mg

COMPR.
TERAPIA SA TERAPIA S.A. BRISTOL MYERS SQUIBB KFT

10mg

C09AA09 FOSINOPRILUM
FOSINOPRIL TERAPIA 20 mg FOSINOPRIL TEVA 20 mg FOSYPRIL 20 mg MONOPRIL 20 mg 20mg 20mg 20mg 20mg

COMPR.
TERAPIA SA TEVA PHARMACEUTICAL S.R.L. TERAPIA S.A. BRISTOL-MYERS SQUIBB KFT

20mg

59

C09BA02

COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
ENALAPRIL HCT SANDOZ 10 mg/25 mg

COMPR.
HEXAL AG

10mg/25mg

10mg/25mg

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
ENAP HL

COMPR.
KRKA D.D. NOVO MESTO

10mg+12.5mg

10mg+12.5mg

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
ENAP H

COMPR.
KRKA D.D. NOVO MESTO

10mg+25mg

10mg+25mg

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
ENAP® HL 20 mg/12,5 mg

COMPR.
KRKA D.D. NOVO MESTO

20 mg/12.5mg

20 mg/12.5mg

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
ENALAPRIL HCT SANDOZ 20 mg/12,5 mg

COMPR.
HEXAL AG

20mg/12.5mg

20mg/12.5mg

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
VIMAPRIL H VIMAPRIL HL

COMPR.
VIM SPECTRUM SRL VIM SPECTRUM SRL

60

C09BA05

COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM)

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C09BA05 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM)
HARTIL HCT 2,5 mg/12,5mg PIRAMIL HCT 2,5 mg/12,5 mg RAMIPRIL HCT-MEDOCHEMIE

COMPR.
2.5mg/12.5mg 2.5mg/12.5mg 2.5mg/12.5mg EGIS PHARMACEUTICALS PLC HEXAL AG MEDOCHEMIE LTD.

2.5mg/12.5mg

C09BA05 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM)
AMPRIL HL

COMPR.
2.5mg+12.5mg KRKA D.D. NOVO MESTO

2.5mg+12.5mg

C09BA05 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM)
HARTIL HCT 5 mg/25mg PIRAMIL HCT 5 mg/25 mg RAMIPRIL HCT-MEDOCHEMIE

COMPR.
5mg/25mg 5mg/25mg 5mg/25mg EGIS PHARMACEUTICALS PLC HEXAL AG MEDOCHEMIE LTD.

5mg/25mg

C09BA05 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM)
AMPRIL HD

COMPR.
5mg+25mg KRKA D.D. NOVO MESTO

5mg+25mg

11 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

61
COZAAR

C09CA01

LOSARTANUM
COMPR. FILM.
50mg MERCK SHARP & DOHME ROMANIA S.R.L.

C09CA01 LOSARTANUM

50mg

62

C10AA01

SIMVASTATINUM

Protocol: CE01E

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

C10AA01 SIMVASTATINUM
SIMVASTATIN 10 mg 10 mg

COMPR. FILM.
TERAPIA S.A.

10 mg 10mg
IVAX - PHARMACEUTICALS S.R.O. TAD PHARMA GMBH ZENTIVA AS WORWAG PHARMA GMBH & CO. KG HEXAL AG LABORMED PHARMA SA RANBAXY U.K. LIMITED AC HELCOR PHARMA SRL MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A. KRKA D.D. OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SA MERCK SHARP & DOHME ROMANIA S.R.L.

C10AA01 SIMVASTATINUM
SIMGAL® 10 mg SIMVA TAD 10 mg SIMVACARD® 10 SIMVAGAMMA 10 mg SIMVAHEXAL® 10 mg SIMVASTATIN LPH 10 mg SIMVOR 10 mg SINTENAL 10 mg VABADIN 10 mg VASILIP 10 mg ZAREDIL 10 mg ZEPLAN® 10 mg ZOCOR 10 mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

COMPR. FILM.

C10AA01 SIMVASTATINUM
SIMVASTATIN 20 mg 20 mg

COMPR. FILM.
TERAPIA S.A.

20 mg 20mg
ANTIBIOTICE SA IVAX - PHARMACEUTICALS S.R.O. TAD PHARMA GMBH ZENTIVA AS WORWAG PHARMA GMBH & CO. KG HEXAL AG LABORMED PHARMA SA RANBAXY U.K. LIMITED AC HELCOR PHARMA SRL MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A. KRKA D.D. OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SA MERCK SHARP & DOHME ROMANIA S.R.L.

C10AA01 SIMVASTATINUM
SIMCOR 20 mg SIMGAL® 20 mg SIMVA TAD 20 mg SIMVACARD® 20 SIMVAGAMMA 20 mg SIMVAHEXAL® 20 mg SIMVASTATIN LPH 20 mg SIMVOR 20 mg SINTENAL 20 mg VABADIN 20 mg VASILIP 20 mg ZAREDIL 20 mg ZEPLAN® 20 mg ZOCOR 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR. FILM.

C10AA01 SIMVASTATINUM
SIMVAHEXAL® 30 mg 30mg

COMPR. FILM.
HEXAL AG

30mg 40 mg
TERAPIA S.A.

C10AA01 SIMVASTATINUM
SIMVASTATIN 40 mg 40 mg

COMPR. FILM. COMPR. FILM.
40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg

C10AA01 SIMVASTATINUM
SIMCOR 40 mg SIMGAL® 40 mg SIMVA TAD 40 mg SIMVACARD® 40 SIMVAGAMMA 40 mg SIMVAHEXAL® 40 mg SIMVASTATIN LPH 40 mg SIMVOR 40 mg SINTENAL 40 mg VABADIN 40 mg VASILIP® 40 mg ZAREDIL 40 mg ZEPLAN® 40 mg ZOCOR FORTE

40mg
ANTIBIOTICE S.A. IVAX - PHARMACEUTICALS S.R.O. TAD PHARMA GMBH ZENTIVA AS WORWAG PHARMA GMBH & CO. KG HEXAL AG LABORMED PHARMA S.A. RANBAXY U.K. LIMITED AC HELCOR PHARMA SRL MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A. KRKA D.D. OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SA MERCK SHARP & DOHME ROMANIA S.R.L.

C10AA01 SIMVASTATINUM
SIMVOR 5 mg 5mg

COMPR. FILM.
RANBAXY U.K. LIMITED

5mg 80mg
LABORMED PHARMA S.A.

C10AA01 SIMVASTATINUM
SIMVASTATIN LPH 80 mg 80mg

COMPR. FILM.

63

C10AA02

LOVASTATINUM

Protocol: CE01E

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10AA02 LOVASTATINUM
MEDOSTATIN 20mg

COMPR.
MEDOCHEMIE LTD.

20mg

64

C10AA03

PRAVASTATINUM

Protocol: CE01E

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10AA03 PRAVASTATINUM
PRALIP 10 mg PRAVATOR 10 mg 10mg 10mg

COMPR.
SANDOZ SRL RANBAXY U.K. LIMITED

10mg

C10AA03 PRAVASTATINUM
PRALIP 20 mg PRAVATOR 20 mg 20mg 20mg

COMPR.
SANDOZ SRL RANBAXY U.K. LIMITED

20mg

C10AA03 PRAVASTATINUM
PRALIP 40 mg PRAVATOR 40 mg 40mg 40mg

COMPR.
SANDOZ SRL RANBAXY U.K. LIMITED

40mg

65

C10AB05
Prescriere limitata:

FENOFIBRATUM

Protocol: CE01E

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

12 / 153

DCI/DENUMIRE COMERCIALA CONCENTRATIE FORMA FARM. FIRMA PROTOCOL NOTA: Riscul de toxicitate musculară severă creste dacă fenofibratum este utilizat simultan cu inhibitori de HMG CoA reductaza sau alţi fibraţi. Terapia combinata trebuie folosită cu precautie la pacienţii cu dislipidemie mixta severă combinată cu risc cardiovascular înalt, in absenta antecedentelor de afectiune musculară. Pacienţii vor fi monitorizaţi regulat pentru semne cronice de toxicitate musculară Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10AB05 FENOFIBRATUM
LIPANTHYL® 100 100mg

CAPS.
LAB. FOURNIER SA

100mg 160mg
TERAPIA S.A.

C10AB05 FENOFIBRATUM
LIPOFIB 160 mg 160mg 160mg

CAPS. COMPR. FILM. ELIB. MODIF.
LAB. FOURNIER SA

C10AB05 FENOFIBRATUM
LIPANTHYL® SUPRA 160 mg

160mg 200mg

C10AB05 FENOFIBRATUM
LIPOFIB 200 mg 200mg 200mg 200mg 200mg

CAPS.
TERAPIA S.A.

C10AB05 FENOFIBRATUM
FENOFIBRAT LPH 200 mg LIPANTHYL 200 M LIPIVIM

CAPS. PULB. MICRONIZATA
LABORMED PHARMA SA LAB. FOURNIER SA VIM SPECTRUM SRL

200mg

66
MICONAL ECOBI

D01AC02

MICONAZOLUM
CREMA
20mg/g FARMACEUTICI ECOBI S.A.S

D01AC02 MICONAZOLUM D01AC02 MICONAZOLUM
MEDACTER MICONAZOL NITRAT 2% 2% 2%

20mg/g 2%
FARAN LABORATORIES S.A. SLAVIA PHARM SRL

CREMA

D01AC02 MICONAZOLUM
DERMOZOL 2%

GEL
PHARCO IMPEX 93 S.R.L.

2%

67
MYCOSPOR

D01AC10

BIFONAZOLUM
SOL. CUT.
0,01g/ml BAYER HEALTHCARE AG

D01AC10 BIFONAZOLUM D01AC10 BIFONAZOLUM
MYCO - FLUSEMIDON 100g

0,01g/ml 100g
ANFARM HELLAS S.A. PHARMACEUTICALS

CREMA CREMA
10mg/g GEDEON RICHTER ROMANIA SA

D01AC10 BIFONAZOLUM
BIAZOL 10 mg/g

10mg/g 1%
BAYER HEALTHCARE AG

D01AC10 BIFONAZOLUM
MYCOSPOR 1%

CREMA

68
ACICLOVIR HYPERION ACIKLOVIR CREMA

D06BB03

ACICLOVIRUM
CREMA
50mg/g 50mg/g HYPERION S.A. A & G MED TRADING S.R.L.

D06BB03 ACICLOVIRUM

50mg/g

D06BB03 ACICLOVIRUM
ACICLOVIR ACICLOVIR 5% CLOVIRAL® 5% ZOVIRAX 5% 5% 5% 5%

CREMA
OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SA ANTIBIOTICE SA THE WELLCOME FOUNDATION LTD.

5%

69
HIDROCORTIZON 1%

D07AA02

HYDROCORTISONUM
UNGUENT
1% ANTIBIOTICE SA

Protocol: D001L
1,00%

D07AA02 HYDROCORTISONUM

70
BELODERM CREMA

D07AC01

BETAMETHASONUM
CREMA
0,5mg/g A & G MED TRADING S.R.L.

Protocol: D001L
0,5mg/g 0,5mg/g
A & G MED TRADING S.R.L.

D07AC01 BETAMETHASONUM D07AC01 BETAMETHASONUM
BELODERM UNGUENT 0,5mg/g

UNGUENT CREMA
0.1% E.I.P.I.CO. MED S.R.L.

D07AC01 BETAMETHASONUM
BETADERM

0.1% 0.1%
E.I.P.I.CO. MED S.R.L.

D07AC01 BETAMETHASONUM
BETADERM 0.1%

UNGUENT

71
MICONAL ECOBI

G01AF04

MICONAZOLUM
CAPS. MOI VAG.
1.2g FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM G01AF04 MICONAZOLUM
MICONAL ECOBI 20mg/g

1.2g 20mg/g
FARMACEUTICI ECOBI S.A.S

CREMA VAG. SOL. VAGINALA
2mg/ml FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM
MICONAL ECOBI

2mg/ml 50mg
FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM
MICONAL ECOBI 50mg

OVULE CREMA VAG.
2% 2% FARAN LABORATORIES S.A. DAR AL DAWA PHARMA S.R.L.

G01AF04 MICONAZOLUM
MEDACTER MYCOHEAL

2%

72

G02AB03

ERGOMETRINUM
SOL. INJ.
0.2mg/ml ZENTIVA S.A.

G02AB03 ERGOMETRINUM
MALEAT DE ERGOMETRINA 0,2 mg/ml

0.2mg/ml

73
NEBIDO 1000 mg/4 ml

G03BA03

TESTOSTERONUM *
SOL. INJ.
1000mg/4ml SCHERING AG

G03BA03 TESTOSTERONUM G03BA03 TESTOSTERONUM
UNDESTOR® TESTOCAPS® 40mg

1000mg/4ml 40mg
ORGANON NV

CAPS. MOI

Prescriere limitata: Prescriere limitata:
ANDROGEL 50 mg

Deficit androgenic la barbati de cauza primara testiculara sau secundara hipotalamo-hipofizara (confirmat prin nivel plasmatic al testosteronului la cel putin 2 determinari in doua dimineti diferite mai mic sau egal cu limita inferioara a valorilor reactivului utilizat). Micropenis, inducerea pubertatii sau intarzierea constitutionala a cresterii sau a pubertatii la baieti sub 18 ani.

G03BA03 TESTOSTERONUM
50mg

GEL
LAB. BESINS INTERNATIONAL

50mg

74

G03CA03

ESTRADIOLUM *

13 / 153

DCI/DENUMIRE COMERCIALA Prescriere limitata:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. Aceasta limitare este valabila doar pentru formele farmaceutice Sistem terapeutic transdermic si plasture transdermic. NOTA: Estradiol trebuie folosit împreuna cu un progestativ oral la femeile nehisterectomizate.

G03CA03 ESTRADIOLUM
OESTROGEL® 0.06%

GEL
LAB. BESINS INTERNATIONAL

0.06% 0.1%
LAB. THERAMEX

G03CA03 ESTRADIOLUM
ESTREVA® 0.1%

GEL COMPR. FILM.
1mg NOVO NORDISK A/S

G03CA03 ESTRADIOLUM
ESTROFEM 1 mg

1mg 25µg
NOVO NORDISK A/S

G03CA03 ESTRADIOLUM
VAGIFEM 25µg

COMPR. VAG. IMPLANT
25mg 50µg/24ore ORGANON NV

G03CA03 ESTRADIOLUM
RISELLE 25 mg

25mg 50µg/24ore

G03CA03 ESTRADIOLUM
CLIMARA

PLASTURE TRANSDERM.
SCHERING AG

75

G04CAN1

DOXAZOSINUM
COMPR.
1mg 1mg 1mg 1mg MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

G04CAN1 DOXAZOSINUM
DOXAZOSIN 1 MEDOCHEMIE DOXAZOSIN AL 1 KAMIREN MAGUROL

1mg

G04CAN1 DOXAZOSINUM
DOXAZOSIN 2 MEDOCHEMIE DOXAZOSIN AL 2 DOXAZOSIN SANDOZ 2 mg KAMIREN MAGUROL 2mg 2mg 2mg 2mg 2mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

2mg

G04CAN1 DOXAZOSINUM
DOXAZOSIN 4 MEDOCHEMIE DOXAZOSIN AL 4 KAMIREN MAGUROL 4mg 4mg 4mg 4mg 4mg 4mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

4mg

G04CAN1 DOXAZOSINUM
CARDURA XL 4 mg

COMPR. ELIB. MODIF.
PFIZER H.C.P. CORPORATION

4mg 4mg 1mg

G04CAN1 DOXAZOSINUM
KAMIREN XL 4 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO

G04CAN1 DOXAZOSINUM
DOXAZOSIN 1 MEDOCHEMIE DOXAZOSIN AL 1 KAMIREN MAGUROL 1mg 1mg 1mg 1mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

G04CAN1 DOXAZOSINUM
DOXAZOSIN 2 MEDOCHEMIE DOXAZOSIN AL 2 DOXAZOSIN SANDOZ 2 mg KAMIREN MAGUROL 2mg 2mg 2mg 2mg 2mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

2mg

G04CAN1 DOXAZOSINUM
DOXAZOSIN 4 MEDOCHEMIE DOXAZOSIN AL 4 DOXAZOSIN SANDOZ 4 mg KAMIREN MAGUROL 4mg 4mg 4mg 4mg 4mg 4mg 4mg

COMPR.
MEDOCHEMIE ROMANIA SRL ALIUD® PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD.

4mg

G04CAN1 DOXAZOSINUM
CARDURA XL 4 mg

COMPR. ELIB. MODIF.
PFIZER H.C.P. CORPORATION

4mg 4mg

G04CAN1 DOXAZOSINUM
KAMIREN XL 4 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO

76
LEMOD SOLU 125 mg

H02AB04

METHYLPREDNISOLONUM *
LIOF. PT. SOL. INJ.
125mg 125mg/2ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

125mg 125mg/2ml 20mg
HEMOFARM S.R.L.

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg 20mg

LIOF. PT. SOL. INJ. LIOF. SI SOLV.PT.SOL.INJ
250mg/4ml PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

250mg/4ml 40mg

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg 40mg 40mg/1ml

LIOF. PT. SOL. INJ.
HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

40mg/1ml 500mg

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg 500mg

LIOF. PT. SOL. INJ.
HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.
500mg/7.8ml PFIZER EUROPE MA EEIG

500mg/7.8ml

77

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

78

H02AB09

HYDROCORTISONUM *

14 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
100mg 100mg

FORMA FARM.

FIRMA

PROTOCOL

H02AB09 HYDROCORTISONUM
HYDROCORTISONE 100 mg HYDROCORTISONE SUCCINAT SODIC

LIOF. + SOLV. PT. SOL. INJ.
HEMOFARM S.R.L. E.I.P.I.CO. MED S.R.L.

100mg

H02AB09 HYDROCORTISONUM
HIDROCORTIZON HEMISUCCINAT 25mg/5ml 500mg

SOL. INJ. I.V.
ZENTIVA S.A.

25mg/5ml 500mg

H02AB09 HYDROCORTISONUM
HYDROCORTISONE 500 mg

LIOF. PT. SOL. INJ. + SOLV.
HEMOFARM S.R.L.

79
J01AA02

J01AA02
DOXYCYCLINUM

DOXYCYCLINUM
CAPS.
100mg 100mg 100mg EUROPHARM SA ANTIBIOTICE SA SANDOZ SRL

100mg

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02 J01AA02

DOXYCYCLINUM
100mg

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V.

100mg 100mg
ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

UNIDOX SOLUTAB

DOXYCYCLINUM
100mg 100mg 100mg

CAPS.

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02 J01AA02

DOXYCYCLINUM
100mg

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V.

100mg 100mg
ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

UNIDOX SOLUTAB

DOXYCYCLINUM
100mg 100mg 100mg

CAPS.

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02

DOXYCYCLINUM
100mg

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V.

100mg

UNIDOX SOLUTAB

80
J01CA04 J01CA04
OSPAMOX 1000 mg

J01CA04
AMOXICILLINUM

AMOXICILLINUM
COMPR. FILM.
1000mg 125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml SANDOZ GMBH

1000mg 125mg/5ml

AMOXICILLINUM

PULB. PT. SUSP. ORALA
OZONE LABORATORIES LTD. SANDOZ S.R.L. GULF PHARMACEUTICAL INDUSTRIES S.R.L. SANDOZ GMBH

AMOXICILINA 125 mg/5 ml AMOXICILINA SANDOZ 125 mg/5 ml PULBERE PENTRU SUSPENSIE ORALA JULPHAMOX OSPAMOX® 125 mg/5 ml

J01CA04
MOXILEN

AMOXICILLINUM AMOXICILLINUM
250mg 250mg 250mg 250mg 250mg 250mg 250mg

PULB. SUSP.
125mg/5ml MEDOCHEMIE LTD.

125mg/5ml 250mg
EUROPHARM SA SANDOZ SRL OZONE LABORATORIES LTD. ANTIBIOTICE SA ARENA GROUP SA MEDICO UNO PHARMACEUTICAL S.R.L. SANDOZ GMBH

J01CA04

CAPS.

AMOXICILINA AMOXICILINA SANDOZ 250 mg CAPSULE AMOXICILINA 250 mg AMOXICILINA ANTIBIOTICE 250 mg AMOXICILINA ARENA 250 mg AMOXICILINA MEDICO UNO 250 mg OSPAMOX 250 mg

J01CA04

AMOXICILLINUM

PULB. PT. SUSP. ORALA
250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml SANDOZ S.R.L. OZONE LABORATORIES LTD. E.I.P.I.CO. MED S.R.L. GULF PHARMACEUTICAL INDUSTRIES S.R.L. SANDOZ GMBH

250mg/5ml

AMOXICILINA SANDOZ 250 mg/ 5 ml PULBERE PENTRU SUSPENSIE ORALA AMOXICILINA 250 mg/5 ml E - MOX JULPHAMOX OSPAMOX 250 mg/5 ml

J01CA04 J01CA04

AMOXICILLINUM AMOXICILLINUM
500mg 500mg 500mg 500mg 500mg 500mg 500mg

PULB. SUSP.
250mg/5ml MEDOCHEMIE LTD.

250mg/5ml 500mg
ANTIBIOTICE SA ARENA GROUP SA OZONE LABORATORIES LTD. SANDOZ SRL E.I.P.I.CO. MED S.R.L. EUROPHARM SA MEDOCHEMIE LTD.

MOXILEN FORTE AMOXICILINA ANTIBIOTICE 500 mg AMOXICILINA ARENA 500 mg AMOXICILINA FORTE 500 mg AMOXICILINA SANDOZ 500 mg CAPSULE E - MOX EPHAMOX MOXILEN

CAPS.

J01CA04 J01CA04 J01CA04 J01CA04 J01CA04

AMOXICILLINUM
500mg 1000mg 250mg 500mg 750mg

COMPR. FILM.
SANDOZ GMBH

500mg 1000mg 250mg 500mg 750mg

OSPAMOX 500 mg

AMOXICILLINUM AMOXICILLINUM AMOXICILLINUM AMOXICILLINUM

COMPR. PT. DISPERSIE ORALA
ASTELLAS PHARMA EUROPE BV

DUOMOX 1000 mg DUOMOX 250 mg DUOMOX 500 mg DUOMOX 750 mg

COMPR. PT. DISPERSIE ORALA
ASTELLAS PHARMA EUROPE BV

COMPR. PT. DISPERSIE ORALA
ASTELLAS PHARMA EUROPE BV

COMPR. PT. DISPERSIE ORALA
ASTELLAS PHARMA EUROPE BV

81
J01CE02 J01CE02
OSPEN® 1000

J01CE02

PHENOXYMETHYLPENICILLINUM
COMPR.
1000000ui EUROPHARM SA

PHENOXYMETHYLPENICILLINUM PHENOXYMETHYLPENICILLINUM PHENOXYMETHYLPENICILLINUM PHENOXYMETHYLPENICILLINUM PHENOXYMETHYLPENICILLINUM
500000ui

1000000ui 1000000ui
SANDOZ GMBH

PENICILINA V 1 000 000 U.I.

COMPR. FILM.
1000000ui

J01CE02
OSPEN® 1500

COMPR. FILM.
1500000ui SANDOZ GMBH

1500000ui 400000ui/5ml
SANDOZ GMBH

J01CE02
OSPEN 400

SIROP
400000ui/5ml

J01CE02
OSPEN® 500

COMPR. FILM.
SANDOZ GMBH

500000ui

15 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

82
J01CE08
MOLDAMIN®

J01CE08

BENZATHINI BENZYLPENICILLINUM
PULB. PT. SUSP. INJ.
1200000ui ANTIBIOTICE SA

BENZATHINI BENZYLPENICILLINUM BENZATHINI BENZYLPENICILLINUM
600000ui

1200000ui 600000ui

J01CE08
MOLDAMIN®

PULB. PT. SUSP. INJ.
ANTIBIOTICE SA

83
J01CF04

J01CF04
OXACILLINUM

OXACILLINUM
CAPS.
250mg 250mg 250mg 250mg 250mg FARMACOM SA ANTIBIOTICE SA ARENA GROUP SA FARMEX COMPANY SRL SANDOZ SRL

250mg

OXACILINA OXACILINA 250 mg OXACILINA ARENA 250 mg OXACILINA FARMEX 250 mg OXACILINA SANDOZ 250 mg

J01CF04

OXACILLINUM
500mg 500mg 500mg 500mg 500mg 1g

CAPS.
ANTIBIOTICE SA ARENA GROUP SA OZONE LABORATORIES LTD. SANDOZ SRL EUROPHARM SA

500mg

OXACILINA 500 mg OXACILINA ARENA 500 mg OXACILINA FORTE 500 mg OXACILINA SANDOZ 500 mg OXALIN 500 mg

J01CF04

OXACILLINUM

PULB. PT. SOL. INJ./PERF.I.M./I.V.
ANTIBIOTICE SA

1g

OXACILINA ANTIBIOTICE 1 g

84

J01CR02
Prescriere limitata:

AMOXICILLINUM + ACIDUM CLAVULANICUM

Tratamentul de scurta durata a infectiilor bacteriene atunci cand este suspectata rezistenta la amoxicilina. Infectii la care este dovedita rezistenta la amoxicilina. A fost raportată hepatotoxicitate la acest medicament. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM
1000mg 1000mg 1062.5mg

COMPR. FILM.
LEK PHARMACEUTICALS D.D. MEDOCHEMIE LTD.

1000mg

AMOKSIKLAV 2 x 1000 mg MEDOCLAV 1000 mg

J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM

COMPR. FILM. ELIB. PREL.
BEECHAM GROUP PLC

1062.5mg 125mg+31.25/5m l 156.25mg/5ml

AUGMENTIN™ SR

PULB. PT. SUSP. ORALA
125mg+31.25/5ml 156.25mg/5ml 156.25mg/5ml MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D. SANDOZ GMBH

MEDOCLAV 156,25 mg/5 ml

J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SUSP. ORALA

AMOKSIKLAV 156,25mg/5ml BIOCLAVID 156.25mg/5ml

J01CR02 J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM

COMPR. DISP.
250/62,5mg ASTELLAS PHARMA EUROPE BV

250/62,5mg 250mg+125mg
MEDOCHEMIE LTD.

FORCID SOLUTAB 250/62,5 MEDOCLAV 375 mg

COMPR. FILM.
250mg+125mg

PULB. PT. SUSP. ORALA
250mg+62.5mg/5 ml 312.5mg/5ml 312.5mg/5ml 312.5mg/5ml MEDOCHEMIE LTD.

250mg+62.5mg/5 ml 312.5mg/5ml 312.5mg/5ml

MEDOCLAV FORTE 312,5mg/5ml

J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SUSP. ORALA
SANDOZ GMBH LEK PHARMACEUTICALS D.D. RANBAXY UK LIMITED

BIOCLAVID 312.5mg/5ml AMOKSIKLAV 312.5mg/5ml ENHANCIN 312,5 mg/5 ml

PULB. PT.SUSP. ORALA

J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SUSP. ORALA
400mg+57mg/5ml SMITHKLINE BEECHAM PLC

400mg+57mg/5m l 500/125mg

AUGMENTIN BIS

J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM

COMPR. DISP.
500/125mg ASTELLAS PHARMA EUROPE BV

FORCID SOLUTAB 500/125 AUGMENTIN 625 mg MEDOCLAV 625 mg

COMPR. FILM.
500mg+125mg 500mg+125mg BEECHAM GROUP PLC MEDOCHEMIE LTD.

500mg+125mg

J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM
625mg 625mg

COMPR. FILM.
LEK PHARMACEUTICALS D.D. SANDOZ GMBH

625mg

AMOKSIKLAV 2 x 625 mg BIOCLAVID 625 mg

J01CR02 J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SUSP. ORALA
642.90mg/5ml SMITHKLINE BEECHAM PLC

642.90mg/5ml 875mg+125mg

AUGMENTIN® ES FORCID SOLUTAB 875/125 AUGMENTIN 1 g

COMPR. DISP.
875mg+125mg ASTELLAS PHARMA EUROPE BV

COMPR. FILM.
875mg+125mg BEECHAM GROUP PLC

875mg+125mg

85
J01DB01 J01DB01
OSPEXIN 1000 mg

J01DB01
CEFALEXINUM

CEFALEXINUM
COMPR. FILM.
1000mg 125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml SANDOZ GMBH

1000mg 125mg/5ml

CEFALEXINUM

GRAN. PT. SUSP. ORALA
SANDOZ SRL ACTAVIS GROUP HF SANDOZ GMBH

CEFALEXIN SANDOZ 125 mg/5 ml GRANULE PENTRU SUSPENSIE ORALA KEFLEX® 125 mg/5 ml OSPEXIN® 125 mg/5 ml

J01DB01 J01DB01

CEFALEXINUM CEFALEXINUM
250mg 250mg 250mg 250mg 250mg

PULB. PT. SUSP. ORALA
OZONE LABORATORIES LTD.

125mg/5ml 250mg

CEFALEXIN 125 mg/5 ml CEFALEXIN 250 mg CEFALEXIN SANDOZ 250 mg CAPSULE CEFALEXINA 250 mg CEFALEXINA ARENA 250 mg CEFALEXINA MEDICO UNO 250 mg

CAPS.
OZONE LABORATORIES LTD. SANDOZ SRL ANTIBIOTICE SA ARENA GROUP SA MEDICO UNO PHARMACEUTICAL S.R.L.

16 / 153

DCI/DENUMIRE COMERCIALA
OSPEXIN® 250 mg SPORIDEX 250 mg

CONCENTRATIE
250mg 250mg 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml

FORMA FARM.

FIRMA
SANDOZ GMBH TERAPIA S.A.

PROTOCOL

J01DB01

CEFALEXINUM

GRAN. PT. SUSP. ORALA
SANDOZ SRL ACTAVIS GROUP HF SANDOZ GMBH

250mg/5ml

CEFALEXIN SANDOZ 250 mg/5 ml GRANULE PENTRU SUSPENSIE ORALA KEFLEX® 250 mg/5 ml OSPEXIN® 250 mg/5 ml

J01DB01 J01DB01

CEFALEXINUM CEFALEXINUM
500mg 500mg 500mg 500mg

PULB. PT. SUSP. ORALA
OZONE LABORATORIES LTD.

250mg/5ml 500mg

CEFALEXIN 250 mg/5 ml CEFALEXIN 500 mg CEFALEXINA 500 mg CEFALEXINA ARENA 500 mg SPORIDEX 500 mg

CAPS.
OZONE LABORATORIES LTD. ANTIBIOTICE SA ARENA GROUP SA TERAPIA S.A.

J01DB01

CEFALEXINUM
500mg 500mg

COMPR. FILM.
SANDOZ SRL SANDOZ GMBH

500mg

CEFALEXIN SANDOZ 500 mg COMPRIMATE FILMATE OSPEXIN 500 mg

86
J01DB05 J01DB05 J01DB05
CEXYL 250 mg CEXYL 1000 mg

J01DB05
CEFADROXILUM

CEFADROXILUM
COMPR. FILM.
1000mg 125mg/5ml SANDOZ S.R.L.

1000mg 125mg/5ml 250mg
SANDOZ S.R.L.

CEFADROXILUM CEFADROXILUM
250mg

GRAN. PT. SUSP. ORALA
SANDOZ S.R.L.

CEXYL 125 mg/5 ml

CAPS. GRAN. SUSP. ORALA
250mg/5ml SANDOZ S.R.L.

J01DB05 J01DB05

CEFADROXILUM CEFADROXILUM
500mg 500mg 500mg 500mg

250mg/5ml 500mg

CEXYL 250 mg/5 ml CEFADROXIL CEFADROXIL TERAPIA CEFORAN® 500 mg CEXYL 500 mg

CAPS.
OZONE LABORATORIES LTD. TERAPIA S.A. ANTIBIOTICE SA SANDOZ S.R.L.

J01DB05

CEFADROXILUM

GRAN. SUSP. ORALA
500mg/5ml SANDOZ S.R.L.

500mg/5ml

CEXYL 500 mg/5 ml

87
J01DC02
AXYCEF® 125

J01DC02
CEFUROXIMUM

CEFUROXIMUM
COMPR. ACOPERITE
125mg SANDOZ SRL

125mg 125mg

J01DC02 J01DC02

CEFUROXIMUM
125mg

COMPR. FILM.
GLAXOWELLCOME UK LTD.

ZINNAT® 125 mg

CEFUROXIMUM

GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml RANBAXY UK LIMITED GLAXO WELLCOME UK LTD.

125mg/5ml

CEROXIM 125mg/5ml ZINNAT

J01DC02 J01DC02 J01DC02
AXYCEF® 250

CEFUROXIMUM CEFUROXIMUM
250mg 250mg

PULB. PT. SUSP. ORALA
SANDOZ SRL

125mg/5ml 250mg

AXYCEF® 125 mg/5 ml CEROXIM 250 mg

COMPR.
RANBAXY U.K. LIMITED

CEFUROXIMUM CEFUROXIMUM
250mg

COMPR. ACOPERITE
SANDOZ SRL

250mg 250mg

J01DC02 J01DC02 J01DC02 J01DC02
AXYCEF® 500

COMPR. FILM.
GLAXOWELLCOME UK LTD.

ZINNAT® 250 mg

CEFUROXIMUM CEFUROXIMUM
500mg 500mg

GRAN. PT. SUSP. ORALA
250mg/5ml RANBAXY UK LIMITED

250mg/5ml 500mg

CEROXIM 250mg/5ml CEROXIM 500 mg

COMPR.
RANBAXY U.K. LIMITED

CEFUROXIMUM CEFUROXIMUM
500mg

COMPR. ACOPERITE
SANDOZ SRL

500mg 500mg

J01DC02

COMPR. FILM.
GLAXOWELLCOME UK LTD.

ZINNAT® 500 mg

88

J01DC04

CEFACLORUM

Reactii asemanatoare bolii serului au fost raportate la utilizarea acestui medicament, in special de catre copii. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01DC04

CEFACLORUM

GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml SANDOZ SRL ACTAVIS GROUP HF OZONE LABORATORIES LTD. TERAPIA S.A.

125mg/5ml

CECLODYNE 125 mg/5 ml CECLOR® 125 mg/5 ml CEFACLOR 125 mg/5ml VERCEF 125 mg/5 ml

J01DC04

CEFACLORUM

PULB. PT. SUSP. ORALA
HEMOFARM S.R.L. DAR AL DAWA PHARMA S.R.L

125mg/5ml

CEFAKLOR 125 mg/5 ml CLORACEF® 125

J01DC04

CEFACLORUM
250mg 250mg 250mg 250mg

CAPS.
SANDOZ SRL OZONE LABORATORIES LTD. DAR AL DAWA PHARMA S.R.L MEDOCHEMIE LTD.

250mg

CECLODYNE 250 mg CEFACLOR 250 mg CLORACEF® 250 MEDOCLOR 250

J01DC04

CEFACLORUM

GRAN. PT. SUSP. ORALA
250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 375mg SANDOZ SRL ACTAVIS GROUP HF OZONE LABORATORIES LTD.

250mg/5ml

CECLODYNE 250 mg/ 5 ml CECLOR® 250 mg/5 ml CEFACLOR 250 mg/5ml

J01DC04

CEFACLORUM

PULB. PT. SUSP. ORALA
HEXAL AG HEMOFARM S.R.L. DAR AL DAWA PHARMA S.R.L

250mg/5ml

CEC HEXAL FORTE 250mg/5ml CEFAKLOR 250 mg/5 ml CLORACEF® 250

J01DC04
CECLOR® MR

CEFACLORUM

COMPR. ELIB. PREL.
ACTAVIS GROUP HF

375mg

17 / 153

DCI/DENUMIRE COMERCIALA
CECLOZONE MR 375 mg

CONCENTRATIE
375mg 375mg

FORMA FARM.

FIRMA
OZONE LABORATORIES LTD.

PROTOCOL

J01DC04 J01DC04

CEFACLORUM CEFACLORUM
500mg 500mg 500mg 500mg 500mg

COMPR. FILM. ELIB. MODIF.
SANDOZ SRL

375mg 500mg

CECLODYNE® MR 375 mg CECLODYNE FORTE 500 mg CEFACLOR 500 mg CLORACEF® FORTE 500 MEDOCLOR 500

CAPS.
SANDOZ SRL OZONE LABORATORIES LTD. DAR AL DAWA PHARMA S.R.L MEDOCHEMIE LTD.

J01DC04
CECLOR® MR

CEFACLORUM CEFACLORUM
500mg 750mg 750mg 750mg

COMPR. ELIB. PREL.
ACTAVIS GROUP HF

500mg 500mg 750mg

J01DC04 J01DC04

COMPR. FILM. ELIB. MODIF.
SANDOZ SRL

CECLODYNE® MR 500 mg

CEFACLORUM

COMPR. ELIB. PREL.
ACTAVIS GROUP HF OZONE LABORATORIES LTD.

CECLOR® MR CECLOZONE MR 750 mg

J01DC04

CEFACLORUM

COMPR. FILM. ELIB. MODIF.
SANDOZ SRL

750mg

CECLODYNE® MR 750 mg

89
J01DD08
SUPRAX

J01DD08
CEFIXIMUM CEFIXIMUM

CEFIXIMUM
GRAN. PT. SUSP. ORALA
100mg/5ml GEDEON RICHTER LTD.

100mg/5ml 200mg

J01DD08 J01DD08
SUPRAX

CAPS.
200mg ANTIBIOTICE SA

EFICEF® 200 mg

CEFIXIMUM
200mg

COMPR. FILM.
GEDEON RICHTER LTD.

200mg

90

J01EE01

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01EE01
EPITRIM

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM SULFAMETHOXAZOLUM + TRIMETHOPRIMUM SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SUSP. ORALA
200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.

200mg/40mg /5ml 25mg/5mg/ml
EGIS PHARMACEUTICALS P.L.C.

J01EE01
SUMETROLIM

SIROP
25mg/5mg/ml

J01EE01
BISEPTRIM CO - TRIM ELL SUMETROLIM TAGREMIN

COMPR.
400mg/80mg 400mg/80mg 400mg/80mg 400mg/80mg EUROPHARM SA ARENA GROUP S.A. EGIS PHARMACEUTICALS P.L.C. ZENTIVA S.A.

400mg/80mg

91
J01FA01

J01FA01
ERYTHROMYCINUM

ERYTHROMYCINUM
COMPR.
200mg 200mg 200mg 200mg 200mg/5ml ARENA GROUP SA ANTIBIOTICE SA EUROPHARM SA SANDOZ S.R.L.

200mg

ERITROMAGIS 200 mg ERITROMICINA 200 mg ERITROMICINA EUROPHARM 200 mg ERITROMICINA SANDOZ 200 mg COMPRIMATE

J01FA01
ERITRO 200

ERYTHROMYCINUM

PULB. PT. SUSP. ORALA
LEK PHARMATECH SRL

200mg/5ml

92
J01FA09

J01FA09
CLARITHROMYCINUM

CLARITHROMYCINUM
GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml KRKA D.D. TERAPIA S.A. ABBOTT SPA SANDOZ S.R.L.

125mg/5ml

FROMILID® 125 mg/5 ml KLABAX 125 mg/5 ml KLACID® LEKOKLAR 125 mg/5 ml

J01FA09

CLARITHROMYCINUM
250mg 250mg 250mg 250mg 250mg 250mg 250mg

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT SPA MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

250mg

CLAR 250 CLARITROMICINA 250 mg FROMILID 250 KLABAX 250 mg KLACID® KLERIMED® 250 LEKOKLAR® 250 mg

J01FA09

CLARITHROMYCINUM

GRAN. PT. SUSP. ORALA
250mg/5ml 250mg/5ml TERAPIA S.A. SANDOZ SRL

250mg/5ml

KLABAX 250 mg/5 ml LEKOKLAR 250 mg/5 ml

J01FA09

CLARITHROMYCINUM
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

500mg

CLAR 500 CLARITROMICINA 500 mg FROMILID 500 KLABAX 500 mg KLERIMED® 500 LEKOKLAR® 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. MODIF.
TERAPIA S.A. LEK PHARMACEUTICALS D.D.

500mg

KLABAX MR 500 mg LEKOKLAR XL 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. PREL.
KRKA D.D. ABBOTT LABORATORIES LTD.

500mg

FROMILID® UNO KLACID SR

93
OFLOXACIN 200 mg OFLOXIN 200 ZANOCIN

J01MA01

OFLOXACINUM
COMPR. FILM.
200mg 200mg 200mg ANTIBIOTICE SA ZENTIVA AS RANBAXY UK LIMITED

J01MA01 OFLOXACINUM

200mg

18 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
400mg

FORMA FARM.

FIRMA

PROTOCOL

J01MA01 OFLOXACINUM
ZANOCIN® OD 400

COMPR. FILM. ELIB. PREL.
RANBAXY U.K. LIMITED

400mg

94
EUCIPRIN

J01MA02

CIPROFLOXACINUM
CAPS.
250mg EUROPHARM SA

J01MA02 CIPROFLOXACINUM J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN® 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg

250mg 250mg
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA

COMPR. FILM.

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 500 CIPRINOL 500 mg CIPRO QUIN® CIPROBAY® 500 CIPROCIN 500 mg CIPRODAR CIPROFLOXACINA ALKALOID 500 mg CIPROLEN® 500 mg CIPROLET 500 mg CIPROZONE FORTE 500 mg CUMINOL 500 mg SIFLOKS® 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO ANTIBIOTICE SA BAYER HEALTHCARE AG E.I.P.I.CO. MED S.R.L. DAR AL DAWA PHARMA S.R.L ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA ECZACIBASI ILAC SANAYI VE TICARET AS

500mg

J01MA02 CIPROFLOXACINUM
CIPRINOL 750 mg 750mg

COMPR. FILM.
KRKA D.D. NOVO MESTO

750mg

95

J01MA03

PEFLOXACINUM
COMPR. FILM.
400mg LAROPHARM S.R.L.

J01MA03 PEFLOXACINUM
PEFLOXACIN LAROPHARM

400mg

96

J01MA06
Prescriere limitata:

NORFLOXACINUM

Enterocolita bacteriana. Infectii de tract urinar. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01MA06 NORFLOXACINUM
EPINOR H - NORFLOXACIN 400 mg NOLICIN 400 mg NORFLOX - 400 NORFLOXACIN 400 mg NORFLOXACIN OZONE 400 mg NORFLOXACINA LPH 400 mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg

COMPR. FILM.
E.I.P.I.CO. MED S.R.L. AC HELCOR SRL KRKA D.D. NOVO MESTO LEK PHARMATECH SRL OZONE LABORATORIES LTD. OZONE LABORATORIES LTD. LABORMED PHARMA SA

400mg

97
NALIXID 500 mg

J01MB02

ACIDUM NALIDIXICUM
CAPS.
500mg ZENTIVA SA

J01MB02 ACIDUM NALIDIXICUM

500mg

98

J01XD01
Prescriere limitata:

METRONIDAZOLUM

Tratamentul infectiilor cu anaerobi. Tratamentul infectiilor cu protozoare sensibile la metronidazol. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01XD01 J01XD01
FLAGYL

METRONIDAZOLUM
250mg

COMPR.
ARENA GROUP SA

250mg 250mg
LABORATOIRE AVENTIS

METRONIDAZOL 250 mg (J01XD01)

METRONIDAZOLUM
250mg

COMPR. FILM. SUSP. ORALA
4% LABORATOIRE AVENTIS

J01XD01

METRONIDAZOLUM

4%

FLAGYL 4 % (J01XD01)

99

J01XD02
Prescriere limitata:

TINIDAZOLUM

Tratamentul infectiilor cu anaerobi. Tratamentul infectiilor cu protozoare sensibile la tinidazol. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01XD02

TINIDAZOLUM
500mg 500mg 500mg

COMPR. FILM.
PFIZER EUROPE MA EEIG ZENTIVA S.A. AC HELCOR SRL

500mg

FASIGYN (J01XD02) TINIZOL® 500 mg (J01XD02) TIPROGYN 500

100

J02AB02
Prescriere limitata:

KETOCONAZOLUM

Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade. Tratamentul candidozelor muco-cutanate cronice si candidozelor orofaringiene care nu pot fi tratate cu antifungice locale, la pacientii care prezinta rezistenta sau intoleranta la fluconazol si intraconazol Micoze sistemice la care alte forme de terapie antifungica nu au avut efect. A fost raportată hepatotoxicitate la ketoconazol. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AB02

KETOCONAZOLUM
200mg 200mg 200mg 200mg 200mg

COMPR.
ANTIBIOTICE SA MAGISTRA C & C AC HELCOR SRL JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOSTIN 200 mg NIZORAL NIZORAL 200 mg

101

J02AC01

FLUCONAZOLUM

19 / 153

DCI/DENUMIRE COMERCIALA Prescriere limitata: Candidoze genitale.

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Candidoze ale mucoaselor orofaringiene, esofargiene, bronhopulmonare non-invazive. Infectii cu candida ale pielii. Candidoze sistemice. Profilaxia candidozelor la pacientii cu risc aflati in tratament cu antibiotic. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC01

FLUCONAZOLUM
100mg 100mg 100mg 100mg 100mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

100mg

DIFLAZON 100 mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

J02AC01

FLUCONAZOLUM
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG OZONE LABORATORIES LTD. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL ZENTIVA AS GEDEON RICHTER PLC.

150mg

DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ® 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCORIC 150 mg FLUCOVIM 150 MYCOMAX 150 MYCOSYST® 150 mg

J02AC01

FLUCONAZOLUM
200mg 200mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL

200mg

DIFLAZON 200 mg FLUCONAZOLE TEVA 200 mg

J02AC01

FLUCONAZOLUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg/5ml

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG SLAVIA PHARM SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

50mg

DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ® 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg

J02AC01

FLUCONAZOLUM

PULB. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

50mg/5ml

DIFLUCAN® 50 mg/5 ml

102

J05AB01
Prescriere limitata:

ACICLOVIRUM

Herpes genital. Tratamentul episodic sau supresiv al herpesului genital recurent. Herpes cutanat initial moderat/sever. Tratamentul episodic sau supresiv al herpesului cutanat recurent (forme moderate/severe). Herpes zoster. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AB01

ACICLOVIRUM
200mg 200mg

CAPS.
SLAVIA PHARM SRL EUROPHARM SA

200mg

ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01

ACICLOVIRUM
200mg 200mg 200mg

COMPR.
TERAPIA SA ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg CLOVIRAL 200 mg ZOVIRAX

J05AB01

ACICLOVIRUM
200mg 200mg 250mg

COMPR. DISP.
OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM
400mg

PULB. PT. SOL. INJ./PERF.
KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01 J05AB01 J05AB01
ACIKLOVIR

CAPS.
ARENA GROUP S.A.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR.
EGIS PHARMACEUTICALS P.L.C.

400mg 400mg
A & G MED TRADING S.R.L.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR. FILM.

103
ROGLUTEN® 250 mg

L02BG01

AMINOGLUTETHIMIDUM
COMPR.
250mg ACTAVIS S.R.L.

L02BG01 AMINOGLUTETHIMIDUM

250mg

104

M01AB01

INDOMETACINUM
SUPOZ.
50mg MAGISTRA C & C

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale

M01AB01 INDOMETACINUM
INDOMETACIN 50 mg

50mg

105

M01AB05

DICLOFENACUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AB05 DICLOFENACUM
DICLOTARD® 100 mg REFEN® RETARD VOLTAREN® RETARD 100mg 100mg 100mg

COMPR. FILM. ELIB. PREL.
TERAPIA SA HEMOFARM S.R.L. NOVARTIS PHARMA GMBH

100mg

M01AB05 DICLOFENACUM
CLAFEN 100 mg DICLOFENAC 100 mg 100mg 100mg

SUPOZ.
ANTIBIOTICE SA SINTOFARM SA

100mg

20 / 153

DCI/DENUMIRE COMERCIALA
DICLOFENAC SODIC 100 mg DICLOGESIC 100 SUPOZITOARE EPIFENAC VOLTAREN®

CONCENTRATIE
100mg 100mg 100mg 100mg

FORMA FARM.

FIRMA
MAGISTRA C & C DAR AL DAWA PHARMA SRL E.I.P.I.CO. MED S.R.L. NOVARTIS PHARMA GMBH

PROTOCOL

M01AB05 DICLOFENACUM
TRATUL 120 120mg

SUPOZ.
GEROT PHARMAZEUTIKA GMBH

120mg 150mg
ALFA WASSERMANN SPA

M01AB05 DICLOFENACUM
DICLOREUM 150 mg 150mg 25mg 25mg 25mg 25mg

CAPS. ELIB. PREL. COMPR. FILM. GASTROREZ.
FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
RHEUMAVEK VOLTAREN® 25

25mg

M01AB05 DICLOFENACUM
EPIFENAC

COMPR. GASTROREZ.
E.I.P.I.CO. MED S.R.L.

25mg 25mg 25mg/ml

M01AB05 DICLOFENACUM
DICLOFENAC 25 mg

DRAJ. GASTROREZ.
ARENA GROUP SA

M01AB05 DICLOFENACUM
RHEUMAVEK VOLTAREN® 25mg/ml 25mg/ml

SOL. INJ.
FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
TRATUL® 30mg/ml 50mg 50mg 50mg 50mg

SOL. INJ.
GEROT PHARMAZEUTIKA GMBH

30mg/ml 50mg 50mg

M01AB05 DICLOFENACUM
TRATUL 50

CAPS. GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

M01AB05 DICLOFENACUM
CLAFEN 50 mg DICLOFENAC 50 mg VOLTAREN® 50

COMPR. FILM. GASTROREZ.
ANTIBIOTICE SA AC HELCOR PHARMA SRL NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
VOLTAREN RAPID® 50mg 50mg

DRAJ.
NOVARTIS PHARMA GMBH

50mg 50mg 50mg
NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
DICLOFENAC 50 mg

DRAJ. GASTROREZ.
ARENA GROUP SA

M01AB05 DICLOFENACUM
VOLTAREN® 50mg

SUPOZ. SUPOZ.
60mg 75mg GEROT PHARMAZEUTIKA GMBH

M01AB05 DICLOFENACUM
TRATUL 60

60mg 75mg 75mg
HEXAL AG HELP S.A. PHARMACEUTICALS

M01AB05 DICLOFENACUM
DICLAC® 75 ID

COMPR. ELIB. MODIF.
HEXAL AG

M01AB05 DICLOFENACUM
DICLAC VURDON 75mg 75mg

SOL. INJ.

M01AB05 DICLOFENACUM
ALMIRAL DICLOFENAC 75 mg DICLOFENAC AL I.M. 75mg/3ml 75mg/3ml 75mg/3ml

SOL. INJ.
MEDOCHEMIE LTD. TERAPIA SA ALIUD PHARMA GMBH & CO.KG

75mg/3ml

106
KETANOV 10 mg KETOROL

M01AB15

KETOROLACUM TROMETHAMIN
COMPR. FILM.
10mg 10mg TERAPIA S.A. DR. REDDY'S LABORATORIES

M01AB15 KETOROLACUM TROMETHAMIN

10mg

M01AB15 KETOROLACUM TROMETHAMIN
KETANOV KETOROL 30mg/ml 30mg/ml

SOL. INJ.
TERAPIA S.A. DR. REDDY'S LABORATORIES

30mg/ml

107

M01AB16

ACECLOFENACUM

Prescriere limitata: Tratamentul simptomatic al puseelor de poliartrita reumatoida, osteoartrita, spondilita anchilozanta, artroza sau afectiunilor musculo-scheletale acute. A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AB16 ACECLOFENACUM
AFLAMIL 100mg

COMPR. FILM.
GEDEON RICHTER PLC.

100mg

108

M01AC02

TENOXICAMUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AC02 TENOXICAMUM
TENOXICAM LPH 20 mg 20mg

CAPS.
LABORMED PHARMA SA

20mg 20mg
ARENA GROUP SA

M01AC02 TENOXICAMUM
TENOXICAM 20 mg 20mg

COMPR. COMPR. FILM.
20mg 20mg 20mg 20mg ANFARM HELLAS S.A. PHARMACEUTICALS ROCHE ROMANIA S.R.L.

M01AC02 TENOXICAMUM
NEO - ENDUSIX® TILCOTIL

20mg

M01AC02 TENOXICAMUM
NEO - ENDUSIX®

LIOF. + SOLV. PT. SOL. INJ.
ANFARM HELLAS S.A. PHARMACEUTICALS

20mg 20mg

M01AC02 TENOXICAMUM
TILCOTIL

LIOF. SI SOLV.PT.SOL.INJ
ROCHE ROMANIA S.R.L.

109

M01AC06

MELOXICAMUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AC06 MELOXICAMUM
CELOMIX MELARTRIN 15 mg MELOX 15 mg MELOXICAM 15 mg MELOXICAM LPH 15 mg MELOXICAM MCC 15 mg MELOXICAM SANDOZ 15 mg MOVALIS® 15 mg 15mg 15mg 15mg 15mg 15mg 15mg 15mg 15mg

COMPR.
ACTAVIS GROUP HF. TERAPIA SA MEDOCHEMIE LTD VIM SPECTRUM SRL LABORMED PHARMA SA MAGISTRA C & C SRL HEXAL AG BOEHRINGER INGELHEIM INT. GMBH

15mg

21 / 153

DCI/DENUMIRE COMERCIALA
RECOXA 15

CONCENTRATIE
15mg

FORMA FARM.

FIRMA
ZENTIVA AS

PROTOCOL

M01AC06 MELOXICAMUM
MELOXICAM 15 mg MOVALIS® 15 mg 15mg 15mg

SUPOZ.
MAGISTRA C & C BOEHRINGER INGELHEIM INT. GMBH

15mg

M01AC06 MELOXICAMUM
MOVALIS®

SOL. INJ.
15mg/1.5ml BOEHRINGER INGELHEIM INT. GMBH

15mg/1.5ml 7.5 mg
MEDOCHEMIE LTD

M01AC06 MELOXICAMUM
MELOX 7,5 mg 7.5 mg

COMPR. COMPR.
7.5mg 7.5mg 7.5mg 7.5mg 7.5mg VIM SPECTRUM SRL LABORMED PHARMA SA MAGISTRA C & C SRL HEXAL AG BOEHRINGER INGELHEIM INT. GMBH

M01AC06 MELOXICAMUM
MELOXICAM 7,5 mg MELOXICAM LPH 7,5 mg MELOXICAM MCC 7,5 mg MELOXICAM SANDOZ 7,5 mg MOVALIS® 7,5 mg

7.5mg

M01AC06 MELOXICAMUM
MELOXICAM 7,5 mg 7.5mg

SUPOZ.
MAGISTRA C & C

7.5mg

110

M01AE03

KETOPROFENUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AE03 KETOPROFENUM
RUBIFEN 100 mg 100 mg

COMPR. FILM.
ANTIBIOTICE SA

100 mg 100mg
TERAPIA SA

M01AE03 KETOPROFENUM
KETOPROFEN SR 100 mg 100mg

CAPS. ELIB. PREL. COMPR. FILM.
100mg 100mg 100mg 100mg LEK PHARMACEUTICALS D.D. AC HELCOR PHARMA SRL LAB. AVENTIS

M01AE03 KETOPROFENUM
KETONAL FORTE 100 mg KETOPROXIN 100 mg PROFENID® 100 mg

100mg

M01AE03 KETOPROFENUM
PROFENID® 100 mg

LIOF. + SOLV. PT. SOL. INJ.
LAB. AVENTIS

100mg 100mg

M01AE03 KETOPROFENUM
KETOMAG KETONAL 100 mg RUBIFEN® 100 mg 100mg 100mg 100mg

SUPOZ.
MAGISTRA C & C LEK PHARMACEUTICALS D.D. ANTIBIOTICE SA

M01AE03 KETOPROFENUM
KETONAL 100 mg/ 2 ml

SOL. INJ.
100mg/2ml 100mg/2ml LEK PHARMACEUTICALS D.D.

100mg/2ml 100mg/2ml 150mg
SANDOZ S.R.L.

M01AE03 KETOPROFENUM
KETOPROFEN 100mg/2ml

SOL. INJ./CONC. SOL. PERF.
TERAPIA SA

M01AE03 KETOPROFENUM
KETONAL® DUO 150 mg 150mg 150mg

CAPS. ELIB. PREL. COMPR. ELIB. PREL.
LEK PHARMACEUTICALS D.D.

M01AE03 KETOPROFENUM
KETONAL RETARD

150mg 200mg

M01AE03 KETOPROFENUM
KETALGON 200 mg KETONAL UNO KETOPROFEN SR 200 mg 200mg 200mg 200mg 200mg

CAPS. ELIB. PREL.
NOVIA FARM SOLUTIONS SRL SANDOZ S.R.L. TERAPIA SA

M01AE03 KETOPROFENUM
PROFENID® LP 200 mg

COMPR. FILM. ELIB. PREL.
LAB. AVENTIS

200mg 50mg

M01AE03 KETOPROFENUM
KETOPROXIN 50 mg 50mg

COMPR. FILM.
AC HELCOR PHARMA SRL

111
MYOLASTAN® 50 mg

M03BX07

TETRAZEPAMUM
COMPR. FILM.
50mg SANOFI-SYNTHELABO FRANCE

M03BX07 TETRAZEPAMUM

50mg

112

M04AA01

ALLOPURINOLUM *

NOTA: Doza trebuie ajustata in concordanta cu functia renala. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M04AA01 ALLOPURINOLUM
MILURIT 100 mg 100mg

COMPR.
EGIS PHARMACEUTICALS LTD.

100mg 300mg
EGIS PHARMACEUTICALS LTD.

M04AA01 ALLOPURINOLUM
MILURIT 300 mg 300mg

COMPR.

113
COLCHICINA

M04AC01

COLCHICINUM
COMPR.
1mg BIOFARM SA

M04AC01 COLCHICINUM

1mg

114

N02AD01

PENTAZOCINUM

Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCIului.

N02AD01 PENTAZOCINUM
FORTRAL FORTWIN® 30mg/ml 30mg/ml

SOL. INJ.
KRKA D.D. NOVO MESTO TERAPIA S.A.

30mg/ml

N02AD01 PENTAZOCINUM
FORTRAL 50 mg 50mg

COMPR.
KRKA D.D. NOVO MESTO

50mg

115

N02AX02
Prescriere limitata:

TRAMADOLUM

Durere severa, care nu raspunde la analgezice non-opioide. Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate. Se aplica tuturor denumirilor comerciale, formelor farmaceutice (mai putin formele injectabile) si concentratiilor corespunzatoare DCI-ului.

N02AX02 TRAMADOLUM
TRAMADOLOR® 100 ID 100mg 100mg 100mg 100mg

COMPR. ELIB. MODIF.
HEXAL AG

100mg 100mg

N02AX02 TRAMADOLUM
TRALGIT SR 100 TRAMADOL® RETARD

COMPR. ELIB. PREL.
ZENTIVA AS KRKA D.D.

N02AX02 TRAMADOLUM
TRAMAL RETARD 100 mg

COMPR. FILM. ELIB. PREL.
GRUNENTHAL GMBH

100mg

22 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
100mg 100mg

FORMA FARM.

FIRMA

PROTOCOL

N02AX02 TRAMADOLUM
MABRON TRADOLAN

SOL. INJ.
MEDOCHEMIE LTD. LANNACHER HEILMITTEL GMBH

100mg

Prescriere limitata:
TRADOLAN TRAMADOL TRAMAG 100 TRAMAL®

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM
100mg 100mg 100mg 100mg

SUPOZ.
LANNACHER HEILMITTEL GMBH KRKA D.D. MAGISTRA C & C GRUNENTHAL GMBH

100mg

N02AX02 TRAMADOLUM
TRALGIT 100

SOL. INJ.
100mg/2ml ZENTIVA A.S.

100mg/2ml

Prescriere limitata:
TRALGIT

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM
100mg/ml

PIC. ORALE, SOL.
ZENTIVA A.S.

100mg/ml 100mg/ml
LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM
TRADOLAN 100mg/ml 150mg 150mg 150mg 200mg 200mg 200mg

SOL. ORALA COMPR. ELIB. PREL.
ZENTIVA AS

N02AX02 TRAMADOLUM
TRALGIT SR 150

150mg 150mg

N02AX02 TRAMADOLUM
TRAMADOL RETARD 150 mg TRAMAL RETARD 150 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

N02AX02 TRAMADOLUM
TRALGIT SR 200

COMPR. ELIB. PREL.
ZENTIVA AS

200mg 200mg

N02AX02 TRAMADOLUM
TRAMADOL RETARD 200 mg TRAMAL RETARD 200 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

N02AX02 TRAMADOLUM
K-ALMA® MABRON 50 mg TRALGIT 50 TRAMACALM TRAMADOL TRAMADOL LPH 50 mg TRAMADOL AL 50 TRAMADOL ARENA TRAMAL® URGENDOL 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
ANTIBIOTICE SA MEDOCHEMIE LTD. ZENTIVA A.S. AC HELCOR SRL KRKA D.D. LABORMED PHARMA SA ALIUD® PHARMA GMBH & CO.KG ARENA GROUP S.A. GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg

N02AX02 TRAMADOLUM
TRAMADOL 50 mg TRAMADOL EEL TRAMAG 50 50mg 50mg 50mg

COMPR.
OZONE LABORATORIES LTD. BIO EEL SRL MAGISTRA C & C

50mg

N02AX02 TRAMADOLUM
TRADOLAN 50 mg 50mg

COMPR. FILM.
LANNACHER HEILMITTEL GMBH

50mg 50mg
LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM
TRADOLAN 50 mg 50mg

SOL. INJ.

Prescriere limitata:
TRALGIT 50 TRAMADOL TRAMADOL® AL 100 Fiole TRAMAL® 100 TRAMAL® 50 URGENDOL

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM
50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml

SOL. INJ.
ZENTIVA A.S. KRKA D.D. ALIUD® PHARMA GMBH & CO.KG GRUNENTHAL GMBH GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg/ml

Prescriere limitata:
TRAMADOL AL PICATURI

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM N02AX02 TRAMADOLUM
TRAMAL® 100mg/ml

PIC. ORALE, SOL.
ALIUD PHARMA GMBH & CO.KG

PICATURI ORALE-SOL.
GRUNENTHAL GMBH

100mg/ml

116

N02CC01
Prescriere limitata:

SUMATRIPTANUM *

Atacurile de migrena la pacientii care primesc sau au primit medicatie profilactica si la care crizele migrenoase nu au raspuns la tratamentul oral cu ergotamina sau alte medicamente antimigrenoase, sau la care aceste medicamente sunt contraindicate. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N02CC01 SUMATRIPTANUM
SUMIGRA 100 mg 100mg

COMPR.
SANDOZ S.R.L.

100mg 100mg
GLAXO WELLCOME UK LTD. ACTAVIS GROUP PTC EHF. DR. REDDY'S LABORATORIES

N02CC01 SUMATRIPTANUM
IMIGRAN® 100 SUMACTA 100 mg SUMATRIPTAN 100mg 100mg 100mg

COMPR. FILM.

N02CC01 SUMATRIPTANUM
SUMIGRA 50 mg 50mg

COMPR.
SANDOZ S.R.L.

50mg 50mg
GLAXO WELLCOME UK LTD. ACTAVIS GROUP PTC EHF. DR. REDDY'S LABORATORIES

N02CC01 SUMATRIPTANUM
IMIGRAN® 50 SUMACTA 50 mg SUMATRIPTAN 50mg 50mg 50mg

COMPR. FILM.

117
TIMONIL SIROP

N03AF01

CARBAMAZEPINUM
SUSP. ORALA
100mg/5ml DESITIN ARZNEIMITTEL GMBH

Protocol: N025G
100mg/5ml 150mg
DESITIN

N03AF01 CARBAMAZEPINUM N03AF01 CARBAMAZEPINUM
TIMONIL 150 RETARD 150mg

COMPR. RET. COMPR.
200mg 200mg 200mg SLAVIA PHARM SRL BIO EEL SRL OZONE LABORATORIES LTD.

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN CARBAMAZEPIN EEL CARBAMAZEPINA

200mg

23 / 153

DCI/DENUMIRE COMERCIALA
CARBAMAZEPINA ARENA 200 mg CARBAMAZEPINA LPH 200 mg CARBAVIM CARBEPSIL 200 FINLEPSIN NEUROTOP TAVER TEGRETOL® 200

CONCENTRATIE
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 300mg

FORMA FARM.

FIRMA
ARENA GROUP SA LABORMED PHARMA SA VIM SPECTRUM SRL AC HELCOR SRL AWD PHARMA GMBH & CO.KG GEROT PHARMAZEUTIKA GMBH MEDOCHEMIE LTD. NOVARTIS PHARMA GMBH

PROTOCOL

N03AF01 CARBAMAZEPINUM
TEGRETOL CR 200

COMPR. FILM. ELIB. PREL.
NOVARTIS PHARMA GMBH

200mg 300mg 300mg

N03AF01 CARBAMAZEPINUM
NEUROTOP® RETARD 300 mg

COMPR. ELIB. PREL.
GEROT PHARMAZEUTIKA GMBH

N03AF01 CARBAMAZEPINUM
TIMONIL 300 RETARD 300mg

COMPR. RET.
DESITIN

N03AF01 CARBAMAZEPINUM
CARBEPSIL 400 TEGRETOL® 400 400mg 400mg 400mg

COMPR.
AC HELCOR SRL NOVARTIS PHARMA GMBH

400mg

N03AF01 CARBAMAZEPINUM
TEGRETOL CR 400

COMPR. FILM. ELIB. PREL.
NOVARTIS PHARMA GMBH

400mg 400mg

N03AF01 CARBAMAZEPINUM
FINLEPSIN 400 RETARD 400mg 600mg

COMPR. RET.
AWD PHARMA GMBH & CO.KG

N03AF01 CARBAMAZEPINUM
NEUROTOP® RETARD 600 mg

COMPR. ELIB. PREL.
GEROT PHARMAZEUTIKA GMBH

600mg 600mg

N03AF01 CARBAMAZEPINUM
TIMONIL 600 RETARD 600mg 200mg

COMPR. RET.
DESITIN

N03AF01 CARBAMAZEPINUM
FINLEPSIN 200 RETARD

COMPR.FILM.ELIB.PREL
AWD PHARMA GMBH & CO.KG

200mg

118
GABAGAMMA 100 mg GABALEPT 100 mg

N03AX12

GABAPENTINUM
CAPS.
100mg 100mg WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O.

Protocol: N025G
100mg

N03AX12 GABAPENTINUM

N03AX12 GABAPENTINUM
GABAGAMMA 300 mg GABALEPT 300 mg GABARAN 300 mg 300mg 300mg 300mg

CAPS.
WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. RANBAXY UK LTD.

300mg

N03AX12 GABAPENTINUM
GABAGAMMA 400 mg GABALEPT 400 mg GABARAN 400 mg 400mg 400mg 400mg

CAPS.
WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. RANBAXY UK LTD.

400mg

N03AX12 GABAPENTINUM
GABARAN 600 mg 600mg

COMPR. FILM.
RANBAXY UK LTD.

600mg 800mg
RANBAXY UK LTD.

N03AX12 GABAPENTINUM
GABARAN 800 mg 800mg

COMPR. FILM.

119

N05AD01

HALOPERIDOLUM
SOL. INJ.
50mg/ml GEDEON RICHTER LTD.

N05AD01 HALOPERIDOLUM
HALOPERIDOL DECANOAT

50mg/ml 5mg
JANSSEN PHARMACEUTICA NV

N05AD01 HALOPERIDOLUM
HALDOL 5mg

COMPR. SOL. INJ.
5mg/ml GEDEON RICHTER LTD.

N05AD01 HALOPERIDOLUM
HALOPERIDOL 5 mg/ml

5mg/ml 2mg/ml
GEDEON RICHTER ROMANIA SA

N05AD01 HALOPERIDOLUM
HALOPERIDOL 2 mg/ml 2mg/ml 2mg/ml

PIC. ORALE-SOL. PICATURI ORALE-SOL.
TERAPIA SA

N05AD01 HALOPERIDOLUM
HALOPERIDOL

2mg/ml

120

N05BA01

DIAZEPAMUM

NOTA: Diazepamum este utilizat ca agent anxiolitic, anticonvulsivant si relaxant muscular de tip central. In tratamentul anxietatii se utilizeaza ca sedativ in anxietatea acuta de tip sever cat si in tratamentul agitatiei asociata cu delirium tremens. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N05BA01 DIAZEPAMUM
DIAZEPAM DIAZEPAM 10 mg 10mg 10mg

COMPR.
TERAPIA SA GEDEON RICHTER ROMANIA SA

10mg

N05BA01 DIAZEPAMUM
DIAZEPAM DESITIN® SOLUTIE RECTALA 10 mg

SOL. RECTALA
10mg/2.5ml DESITIN

10mg/2.5ml 10mg/2ml
TERAPIA SA

N05BA01 DIAZEPAMUM
DIAZEPAM 10 mg 10mg/2ml

SOL. INJ. SOL. RECTALA
5mg/2.5ml DESITIN

N05BA01 DIAZEPAMUM
DIAZEPAM DESITIN® SOLUTIE RECTALA 5 mg

5mg/2.5ml

121
MEDAZEPAM

N05BA03

MEDAZEPAMUM *
COMPR.
10 mg ARENA GROUP SA

N05BA03 MEDAZEPAMUM N05BA03 MEDAZEPAMUM
ANSILAN 10 mg 10mg

10 mg 10mg
LEK PHARMACEUTICALS D.D.

CAPS. COMPR.
10mg 10mg LABORMED PHARMA SA AWD PHARMA GMBH & CO.KG

N05BA03 MEDAZEPAMUM
MEDAZEPAM 10 mg RUDOTEL

10mg

122
ANXIAR® 1 mg

N05BA06

LORAZEPAMUM *
COMPR.
1 mg GEDEON RICHTER ROMANIA SA

N05BA06 LORAZEPAMUM

1 mg

123

N05BA08

BROMAZEPAMUM *
COMPR.
1.5mg LABORMED PHARMA SA

N05BA08 BROMAZEPAMUM
BROMAZEPAM LPH 1,5 mg

1.5mg

24 / 153

DCI/DENUMIRE COMERCIALA
CALMEPAM®

CONCENTRATIE
1.5mg

FORMA FARM.

FIRMA
GLAXOSMITHKLINE (GSK) SRL

PROTOCOL

N05BA08 BROMAZEPAMUM
BROMAZEPAM LPH 3 mg CALMEPAM® LEXOTAN LEXOTANIL 3mg 3mg 3mg 3mg

COMPR.
LABORMED PHARMA SA GLAXOSMITHKLINE (GSK) SRL ROCHE ROMANIA S.R.L. TERAPIA S.A.

3mg

124

N05BA12
Prescriere limitata:

ALPRAZOLAMUM *

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii moderate sau severe si al anxietatii asociate cu depresia. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N05BA12 ALPRAZOLAMUM
XANAX 0,25 mg 0,25mg

COMPR.
PFIZER EUROPE MA EEIG

0,25mg 0,5mg
PFIZER EUROPE MA EEIG

N05BA12 ALPRAZOLAMUM
XANAX 0,5 mg 0,5mg

COMPR. COMPR.
0.25mg 0.25mg 0.25mg LABORMED PHARMA SA EGIS PHARMACEUTICALS PLC GEDEON RICHTER ROMANIA SA

N05BA12 ALPRAZOLAMUM
ALPRAZOLAM LPH® 0,25 mg FRONTIN 0,25 mg PRAZOLEX® 0,25 mg

0.25mg

N05BA12 ALPRAZOLAMUM
ALPRAZOLAM LPH® 0,5 mg FRONTIN 0,5 mg PRAZOLEX® 0,5 mg 0.5mg 0.5mg 0.5mg 0.5mg

COMPR.
LABORMED PHARMA SA EGIS PHARMACEUTICALS PLC GEDEON RICHTER ROMANIA SA

0.5mg

N05BA12 ALPRAZOLAMUM
NEUROL® SR 0,5

COMPR. ELIB. PREL.
ZENTIVA AS

0.5mg 1mg

N05BA12 ALPRAZOLAMUM
ALPRAZOLAM LPH® 1 mg FRONTIN PRAZOLEX® 1 mg XANAX 1 mg 1mg 1mg 1mg 1mg 1mg

COMPR.
LABORMED PHARMA SA EGIS PHARMACEUTICALS PLC GEDEON RICHTER ROMANIA SA PFIZER EUROPE MA EEIG

N05BA12 ALPRAZOLAMUM
NEUROL® SR 1

COMPR. ELIB. PREL.
ZENTIVA AS

1mg 2mg

N05BA12 ALPRAZOLAMUM
XANAX 2 mg 2mg 2mg

COMPR.
PFIZER EUROPE MA EEIG

N05BA12 ALPRAZOLAMUM
NEUROL® SR 2

COMPR. ELIB. PREL.
ZENTIVA AS

2mg

125

N05CD02

NITRAZEPAMUM

Cod restrictie 3007: Tratamentul de scurta durata al insomniei. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N05CD02 NITRAZEPAMUM
NITRAZEPAM LPH® 2,5 mg 2.5mg

COMPR.
LABORMED PHARMA SA

2.5mg 5mg
GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA

N05CD02 NITRAZEPAMUM
NITRAZEPAM 5 mg NITRAZEPAM LPH® 5 mg 5mg 5mg

COMPR.

N05CD02 NITRAZEPAMUM
NITRAZEPAM 5 mg NITRAZEPAM LPH® 5 mg 5mg 5mg

COMPR.
GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA

5mg

126

N05CF01

ZOPICLONUM *

Cod restrictie 3007: Pentru tratamentul de scurta durata al insomniei. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N05CF01 ZOPICLONUM
ALS-ZOPICLON 7,5 mg IMOVANE 7,5 mg 7.5mg 7.5mg

COMPR. FILM.
ALSIFCOM INTERMED SRL SANOFI AVENTIS

7.5mg

127

N05CF02

ZOLPIDEMUM *

Cod restrictie 3007: Pentru tratamentul de scurta durata al insomniei. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N05CF02 ZOLPIDEMUM
HYPNOGEN 10 mg LADINOX SANVAL® 10 mg ZOLPIDEM 10 mg ZOLPIDEM ANTIBIOTICE 10 mg 10mg 10mg 10mg 10mg 10mg

COMPR. FILM.
ZENTIVA AS GEDEON RICHTER ROMANIA S.A. LEK PHARMACEUTICALS D.D. LABORMED PHARMA SA ANTIBIOTICE S.A.

10mg

128

N06AA04
Prescriere limitata:

CLOMIPRAMINUM *

Tratamentul simptomatic al depresiei in special atunci cand este necesara sedarea. Tratamentul starilor fobice si obsesiv-compulsive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N06AA04 CLOMIPRAMINUM
ANAFRANIL® 10 mg 10mg

DRAJ.
NOVARTIS PHARMA GMBH

10mg 25mg
NOVARTIS PHARMA GMBH

N06AA04 CLOMIPRAMINUM
ANAFRANIL® 25 mg 25mg

DRAJ.

129

N06AA09

AMITRIPTYLINUM *
CAPS. RET.
25mg DESITIN

N06AA09 AMITRIPTYLINUM
AMITRIPTILIN 25 R. DESITIN

25mg 25mg
ARENA GROUP S.A.

N06AA09 AMITRIPTYLINUM
AMITRIPTILINA ARENA 25 mg 25mg

COMPR. FILM. CAPS. RET.
50mg DESITIN

N06AA09 AMITRIPTYLINUM
AMITRIPTILIN 50 R. DESITIN

50mg

130
DOXEPIN 25 mg

N06AA12

DOXEPINUM *
DRAJ.
25mg TERAPIA SA

N06AA12 DOXEPINUM

25mg

131

N06AB03

FLUOXETINUM *

25 / 153

DCI/DENUMIRE COMERCIALA CONCENTRATIE FORMA FARM. FIRMA Prescriere limitata: Tratamentul depresiilor cu sau fara anxietate in special cand componenta de sedare nu este necesara. Tratamentul bulimiei nervoase. Tratamentul tulburarilor obsesiv compulsive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

PROTOCOL

N06AB03 FLUOXETINUM
FLUOXETINE 20 mg FLUOXIN FLURAN MAGRILAN 20 mg 20mg 20mg 20mg 20mg

CAPS.
DR. REDDY'S LABORATORIES VIM SPECTRUM SRL RANBAXY U.K. LIMITED MEDOCHEMIE LTD.

20mg

N06AB03 FLUOXETINUM
PROZAC 20 mg 20mg

COMPR. DISP.
ELI LILLY SA

20mg

132
CITALORAN 10 mg LINISAN 10 mg

N06AB04

CITALOPRAMUM **
COMPR. FILM.
10mg 10mg RANBAXY UK LIMITED GEDEON RICHTER ROMANIA S.A.

Protocol: N008F
10mg

N06AB04 CITALOPRAMUM

N06AB04 CITALOPRAMUM
CITALORAN 20mg LINISAN 20 mg 20mg 20mg

COMPR. FILM.
RANBAXY UK LIMITED GEDEON RICHTER ROMANIA S.A.

20mg

N06AB04 CITALOPRAMUM
CITALORAN 40 mg LINISAN 40 mg 40mg 40mg

COMPR. FILM.
RANBAXY UK LIMITED GEDEON RICHTER ROMANIA S.A.

40mg

133

N06AB05
Prescriere limitata:

PAROXETINUM *

Tratamentul tulburarilor depresive majore. Tratamentul tulburarilor obsesiv-compulsive. Tratamentul atacurilor de panica. Tratamentul anxietatii. Tratamentul fobiei sociale. Tratamentul bolii de stres posttraumatic. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N06AB05 PAROXETINUM
ARKETIS 20mg

COMPR.
MEDOCHEMIE LTD.

20mg 20mg
ALSIFCOM INTERMED SRL HEXAL AG ACTAVIS GROUP HF. GEDEON RICHTER PLC. SMITHKLINE BEECHAM PLC

N06AB05 PAROXETINUM
ALS-PAROXETIN 20 mg PALUXETIL 20 mg PAXETEN 20 mg REXETIN SEROXAT 20 mg 20mg 20mg 20mg 20mg 20mg

COMPR. FILM.

N06AB05 PAROXETINUM
PALUXETIL 40 mg 40mg

COMPR. FILM.
HEXAL AG

40mg

134

N06AB06
Prescriere limitata:

SERTRALINUM *

Tratamentul tulburarilor depresive inclusiv cu componenta anxioasa. Tratamentul tulburari obsesiv-compulsive. Tratamentul atacurilor de panica. Tratamentul fobiei sociale. Tratamentul bolii de stres posttraumatic. Eficienta tratamentului in boala de stres posttraumatic a fost demonstrata doar pentru sexul feminin. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N06AB06 SERTRALINUM
ALS-SERTRALINA 100 mg ASENTRA® SERLIFT 100 mg SERTRALIN SANDOZ 100 mg SERTRALINA 100 mg SERTRALINA DR. REDDY'S 100 mg STIMULOTON® 100 mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg

COMPR. FILM.
ALSIFCOM INTERMED SRL KRKA D.D. TERAPIA S.A. HEXAL AG ARENA GROUP S.A. DR. REDDY'S LABORATORIES EGIS PHARMACEUTICALS LTD.

100mg

N06AB06 SERTRALINUM
ZOLOFT® 20mg/ml

SOL. ORALA
PFIZER EUROPE MA EEIG

20mg/ml 50mg
ALSIFCOM INTERMED SRL KRKA D.D. TERAPIA S.A. OZONE LABORATORIES LTD. HEXAL AG ARENA GROUP SA DR. REDDY'S LABORATORIES EGIS PHARMACEUTICALS LTD. PFIZER EUROPE MA EEIG

N06AB06 SERTRALINUM
ALS-SERTRALINA 50 mg ASENTRA® SERLIFT 50 mg SERTRALIN 50 mg SERTRALIN SANDOZ 50 mg SERTRALINA 50 mg SERTRALINA DR. REDDY'S 50 mg STIMULOTON® 50 mg ZOLOFT 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

COMPR. FILM.

135

N06AB08
Prescriere limitata:

FLUVOXAMINUM *

Tratamentul tulburarilor depresive majore. Tratamentul tulburarilor obsesiv-compulsive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N06AB08 FLUVOXAMINUM
FEVARIN® 100 FLUVOXAMINE TEVA 100 mg 100mg 100mg

COMPR. FILM.
SOLVAY PHARMACEUTICALS BV TEVA PHARMACEUTICALS SRL

100mg

N06AB08 FLUVOXAMINUM
FEVARIN® 50 FLUVOXAMINE TEVA 50 mg 50mg 50mg

COMPR. FILM.
SOLVAY PHARMACEUTICALS BV TEVA PHARMACEUTICALS SRL

50mg

136
MIANSERIN 10

N06AX03

MIANSERINUM *
COMPR. FILM.
10mg REMEDICA LTD.

N06AX03 MIANSERINUM N06AX03 MIANSERINUM
MIANSERIN 10 mg 10mg

10mg 10mg
TERAPIA SA

DRAJ.

26 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
30mg

FORMA FARM.

FIRMA

PROTOCOL

N06AX03 MIANSERINUM
MIANSERIN 30

COMPR. FILM.
REMEDICA LTD.

30mg 30mg
TERAPIA SA

N06AX03 MIANSERINUM
MIANSERIN 30 mg 30mg

DRAJ.

137

N06AX11

MIRTAZAPINUM *

Prescriere limitata: Tratamentul episoadelor depresive majore. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N06AX11 MIRTAZAPINUM
REMERON® SOLTAB 15 mg 15mg

COMPR. DISP.
ORGANON NV

15mg 15mg
ZENTIVA AS KRKA D.D.

N06AX11 MIRTAZAPINUM
ESPRITAL® 15 MIRZATEN® 15 mg 15mg 15mg

COMPR. FILM.

N06AX11 MIRTAZAPINUM
REMERON® SOLTAB 30 mg 30mg

COMPR. DISP.
ORGANON NV

30mg 30mg
ZENTIVA AS TEVA PHARMACEUTICALS SRL KRKA D.D. ACTAVIS GROUP HF.

N06AX11 MIRTAZAPINUM
ESPRITAL® 30 MIRTAZAPINE-TEVA 30 mg MIRZATEN® 30 mg PHARMATAZ 30 mg 30mg 30mg 30mg 30mg

COMPR. FILM.

N06AX11 MIRTAZAPINUM
REMERON® SOLTAB 45 mg 45mg

COMPR. DISP.
ORGANON NV

45mg 45mg
ZENTIVA AS KRKA D.D.

N06AX11 MIRTAZAPINUM
ESPRITAL® 45 MIRZATEN® 45 mg 45mg 45mg

COMPR. FILM.

138
EFECTIN ER 150 mg VELAXIN 150 mg

N06AX16

VENLAFAXINUM **
CAPS. ELIB. PREL.
150mg 150mg WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

Protocol: N013F
150mg

N06AX16 VENLAFAXINUM

N06AX16 VENLAFAXINUM
VELAXIN 37,5 mg VENLAFAXINA LPH 37,5 mg 37.5mg 37.5mg

COMPR.
EGIS PHARMACEUTICALS PLC LABORMED PHARMA SA

37.5mg

N06AX16 VENLAFAXINUM
EFECTIN ER 75 mg VELAXIN 75 mg 75mg 75mg

CAPS. ELIB. PREL.
WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

75mg

N06AX16 VENLAFAXINUM
VELAXIN 75 mg VENLAFAXINA LPH 75 mg 75mg 75mg

COMPR.
EGIS PHARMACEUTICALS PLC LABORMED PHARMA SA

75mg

139
MIOSTIN 0,5 mg/ml

N07AA01

NEOSTIGMINI BROMIDUM
SOL. INJ.
0.5mg/ml ZENTIVA S.A.

N07AA01 NEOSTIGMINI BROMIDUM N07AA01 NEOSTIGMINI BROMIDUM
NEOSTIGMINA LPH 15 mg 15mg

0.5mg/ml 15mg
LABORMED PHARMA SA

COMPR.

140

P01AB01
Prescriere limitata:

METRONIDAZOLUM

Tratamentul infectiilor cu anaerobi. Tratamentul infectiilor cu protozoare sensibile la metronidazol.

P01AB01 METRONIDAZOLUM
METRONIDAZOL 250 mg (P01AB01) METRONIDAZOL 250 mg (P01AB1) 250mg 250mg

COMPR.
ZENTIVA SA ARENA GROUP SA

250mg

P01AB01 METRONIDAZOLUM
FLAGYL 250mg

COMPR. FILM.
LABORATOIRE AVENTIS

250mg 4%
LABORATOIRE AVENTIS

P01AB01 METRONIDAZOLUM
FLAGYL 4% (P01AB01) 4%

SUSP. ORALA

141

P01AB02
Prescriere limitata:

TINIDAZOLUM

Tratamentul infectiilor cu anaerobi. Tratamentul infectiilor cu protozoare sensibile la metronidazol.

P01AB02 TINIDAZOLUM
FASIGYN (P01AB02) TINIZOL® 500 mg (P01AB02) TIPROGYN 500 500mg 500mg 500mg

COMPR. FILM.
PFIZER EUROPE MA EEIG ZENTIVA S.A. AC HELCOR SRL

500mg

P01AB02 TINIDAZOLUM
FASIGYN (P01AB02) TINIZOL® 500 mg (J01XD02) TIPROGYN 500 500mg 500mg 500mg

COMPR. FILM.
PFIZER EUROPE MA EEIG ZENTIVA S.A. AC HELCOR SRL

500mg

142
ZENTEL 0,4 g/10 ml

P02CA03

ALBENDAZOLUM
SUSP. ORALA
0.4g/10ml GLAXOSMITHKLINE EXPORT LTD.

P02CA03 ALBENDAZOLUM P02CA03 ALBENDAZOLUM
DUADOR 200 mg ZENTEL 200 mg 200mg 200mg

0.4g/10ml 200mg
GEDEON RICHTER ROMANIA SA GLAXOSMITHKLINE EXPORT LTD.

COMPR. FILM.

P02CA03 ALBENDAZOLUM
ESKAZOLE 400mg

COMPR.
GLAXO SMITHKLINE EXPORT LTD.

400mg 400mg
BIOFARM S.A.

P02CA03 ALBENDAZOLUM
ALBENDAZOL BIOFARM 400 mg 400mg

SUSP. ORALA COMPR.FILM
200mg OZONE LABORATORIES LTD.

P02CA03 ALBENDAZOLUM
ALBENDAZOL

200mg

143
DECARIS 150 mg

P02CE01

LEVAMISOLUM
COMPR.
150mg GEDEON RICHTER ROMANIA SA

P02CE01 LEVAMISOLUM P02CE01 LEVAMISOLUM
DECARIS 50 mg 50mg

150mg 50mg
GEDEON RICHTER ROMANIA SA

COMPR.

27 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

144

R03AC02

SALBUTAMOLUM
SUSP. INHAL. PRESURIZATA
100µg/doza 100µg/doza 100µg/doza CIPLA (UK) LIMITED IVAX - PHARMACEUTICALS S.R.O. GLAXOWELLCOME UK LTD.

R03AC02 SALBUTAMOLUM
ASTHALIN INHALER ECOSAL Easi-Breath VENTOLIN 100 INHALER CFC-FREE

100µg/doza

R03AC02 SALBUTAMOLUM
VENTOLIN® 5mg/ml

SOL. INHAL.
GLAXOWELLCOME UK LTD.

5mg/ml

145

R03BA01

BECLOMETASONUM *
AEROSOL SOL. INHAL.
100µg/doza 100µg/doza IVAX - PHARMACEUTICALS S.R.O. IVAX - PHARMACEUTICALS S.R.O.

R03BA01 BECLOMETASONUM
ECOBEC 100 µg CFC FREE ECOBEC EASI - BREATHE 100 µg CFC FREE

100µg/doza

R03BA01 BECLOMETASONUM
RINOCLENIL 100

SPRAY NAZ.,SUSP.
100µg/doza 250µg/doza 250µg/doza 250µg/doza 250µg/doza 50µg/doza CHIESI FARMACEUTICI S.P.A.

100µg/doza 250µg/doza

R03BA01 BECLOMETASONUM
ECOBEC 250 µg CFC FREE ECOBEC EASI - BREATHE 250 µg CFC FREE

AEROSOL SOL. INHAL.
IVAX - PHARMACEUTICALS S.R.O. IVAX - PHARMACEUTICALS S.R.O.

R03BA01 BECLOMETASONUM
BECLOFORTE® CFC-Free

SOL. DE INHALAT PRESURIZATA
GLAXO WELLCOME UK LTD.

250µg/doza 250µg/doza 50µg/doza

R03BA01 BECLOMETASONUM
CLENIL® JET 250 µg

SOL. INHALAT PRESURIZATA
CHIESI FARMACEUTICI SPA GLAXO WELLCOME UK LTD.

R03BA01 BECLOMETASONUM
BECOTIDE® CFC-Free

SOL. DE INHALAT PRESURIZATA

146
FRENOLYN 200

R03BA02

BUDESONIDUM *
PULB. INHAL.
200 µg/doza MEDOCHEMIE ROMANIA SRL

R03BA02 BUDESONIDUM R03BA02 BUDESONIDUM
PULMICORT TURBUHALER 200 µg/doza

200 µg/doza 200µg/doza
ASTRAZENECA AB

PULB. INHAL.
200µg/doza

R03BA02 BUDESONIDUM
FRENOLYN 400

PULB. INHAL.
400 µg/doza MEDOCHEMIE ROMANIA SRL

400 µg/doza

147

R03BB01

IPRATROPII BROMIDUM *
AEROSOL
20µg/doza CIPLA (UK) LIMITED

R03BB01 IPRATROPII BROMIDUM
IPRAVENT 20 - INHALER

20µg/doza

148
SALBUTAMOL T

R03CC02

SALBUTAMOLUM
SOL. ORALA
0.04% TIS FARMACEUTIC SA

R03CC02 SALBUTAMOLUM R03CC02 SALBUTAMOLUM
VENTOLIN® 0.5mg/ml

0.04% 0.5mg/ml
GLAXO WELLCOME UK LTD.

SOL. INJ. SIROP
2mg/5ml 2mg/5ml E.I.P.I.CO. MED S.R.L. GLAXOWELLCOME UK LTD.

R03CC02 SALBUTAMOLUM
SALBUTAMOL EIPICO 2mg/5ml VENTOLIN®

2mg/5ml

R03CC02 SALBUTAMOLUM
SALBUTAMOL 2mg/5ml

SOL. ORALA
TERAPIA S.A.

2mg/5ml

149

R03DA04

THEOPHYLLINUM

Datorita efectelor variabile ale alimentelor asupra absorbtiei teofilinei, pacientii care folosesc un anumit preparat nu trebuie sa il schimbe cu un altul fara o monitorizare adecvata. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

R03DA04 THEOPHYLLINUM
TEOFILINA SR 100 mg THEO SR 100 100mg 100mg

CAPS. ELIB. PREL.
TERAPIA SA GLAXOSMITHKLINE (GSK) SRL

100mg

R03DA04 THEOPHYLLINUM
TEOFILINA SR 200 mg TEOTARD® 200 THEO SR 200 200mg 200mg 200mg

CAPS. ELIB. PREL.
TERAPIA SA KRKA D.D. GLAXOSMITHKLINE (GSK) SRL

200mg

R03DA04 THEOPHYLLINUM
TEOFILINA SR 300 mg THEO SR 300 300mg 300mg

CAPS. ELIB. PREL.
TERAPIA SA GLAXOSMITHKLINE (GSK) SRL

300mg

R03DA04 THEOPHYLLINUM
TEOTARD® 350 350mg

CAPS. ELIB. PREL.
KRKA D.D.

350mg 50mg
TERAPIA SA

R03DA04 THEOPHYLLINUM
TEOFILINA SR 50 mg 50mg

CAPS. ELIB. PREL.

150

R05DA04

CODEINUM
COMPR.
15mg 15mg 15mg 15mg 15mg 15mg 15mg SLAVIA PHARM SRL OZONE LABORATORIES LTD. LABORMED PHARMA SA BIO EEL SRL MAGISTRA C & C FARMACOM SA SINTOFARM SA

R05DA04 CODEINUM
CODEINA FOSFAT CODEINA FOSFAT 15 mg CODEINA FOSFAT LPH 15 mg CODEINA FOSFORICA CODEINA FOSFORICA 15 mg FARMACOD FOSFAT DE CODEINA 15 mg

15mg

151
CLORFENIRAMIN

R06AB04

CHLORPHENAMINUM
COMPR.
4mg LABORMED PHARMA SA

R06AB04 CHLORPHENAMINUM

4mg

152
CELERG

R06AE07

CETIRIZINUM
COMPR. FILM.
10 mg AC HELCOR PHARMA SRL

R06AE07 CETIRIZINUM R06AE07 CETIRIZINUM
LETIZEN® 10 mg 10mg

10 mg 10mg
KRKA D.D.

COMPR. FILM. SOL. ORALA
1mg/ml 10mg/ml KRKA D.D.

R06AE07 CETIRIZINUM
LETIZEN

1mg/ml 10mg/ml

R06AE07 CETIRIZINUM
ZYRTEC®

PICATURI ORALE-SOL.
U.C.B. GMBH

28 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

153
KETOF 1 mg

R06AX17

KETOTIFENUM
CAPS.
1mg HEXAL AG

R06AX17 KETOTIFENUM R06AX17 KETOTIFENUM
H - KETOTIFEN KETOTIFEN KETOTIFEN LPH® 1 mg 1mg 1mg 1mg

1mg 1mg
AC HELCOR SRL MAGISTRA C & C LABORMED PHARMA SA

COMPR.

R06AX17 KETOTIFENUM
FRENASMA KETOF 1 mg/5 ml 1mg/5ml 1mg/5ml

SIROP
FARAN LABORATORIES S.A. HEXAL AG

1mg/5ml

154
CIPLOX

S01AX13

CIPROFLOXACINUM
UNG. OFT.
0.3% CIPLA (UK) LIMITED

S01AX13 CIPROFLOXACINUM

0.3%

155

S01BC03

DICLOFENACUM
PICATURI OFT.-SOL.
0.1% 0.1% 0.1% DAR AL DAWA PHARMA S.R.L. UNIMED PHARMA LTD. NOVARTIS PHARMA GMBH

S01BC03 DICLOFENACUM
DICLOGESIC 0,1% PICATURI OFTALMICE, SOLUTIE UNICLOPHEN® 0,1% VOLTAREN OPHTHA CD

0.1%

S01BC03 DICLOFENACUM
DICLOFENAC RPH 1mg/ml

PIC. OFT.-SOL.
ROMPHARM COMPANY SRL

1mg/ml 1mg/ml
HELP S.A. PHARMACEUTICALS

S01BC03 DICLOFENACUM
VURDON 1mg/ml

PIC.OFT.-SOL.

156

S01CA05

COMBINATII (BETHAMETASONUM+ANTIINFECTIOASE)
UNG. OFT.
0,2g+0,5g FARMILA FARMACEUTICI

S01CA05 COMBINATII (BETHAMETASONUM+ANTIINFECTIOASE)
BETABIOPTAL

0,2g+0,5g

S01CA05 COMBINATII (BETHAMETASONUM+ANTIINFECTIOASE)
BETABIOPTAL 0,2g+0,5g

PICATURI OFT.SUSP.
FARMILA FARMACEUTICI MILANO SPA

0,2g+0,5g

29 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA B - MEDICAMENTE CU NIVEL DE COMPENSARE 50% DIN PREŢUL DE REFERINŢĂ 157 A02BC02 PANTOPRAZOLUM
A02BC02 PANTOPRAZOLUM
CONTROLOC 20 mg 20mg

COMPR. FILM. GASTROREZ.
ALTANA PHARMA AG

20mg

Prescriere limitata: Mentinerea rezultatelor terapiei refluxului gastro-esofagian Prescriere limitata: Boala de reflux gastro-esofagian Prescriere limitata: Profilaxia ulcerului gastro-duodenal asociat tratamentului cu antiinflamatoare nesteroidiene pe termen lung la pacientii la pacientii cu factori de risc gastrointestinal. Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiei de 20 mg.

A02BC02 PANTOPRAZOLUM
CONTROLOC 40mg 40mg

COMPR. FILM. GASTROREZ.
ALTANA PHARMA AG

40mg

Prescriere limitata: Boala de reflux gastro-esofagian. Prescriere limitata: Sindromul Zollinger-Ellison Prescriere limitata: Tratamentul ulcerului gastric si duodenal. Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiiei de 40mg.

A02BC02 PANTOPRAZOLUM
CONTROLOC 40mg LIOFILIZAT PENTRU SOLUTIE INJECTABILA 40mg

LIOF. PT. SOL. INJ.
ALTANA PHARMA AG

40mg

158
NEXIUM 40 mg

A02BC05

ESOMEPRAZOLUM
COMPR. FILM. GASTROREZ.
40mg ASTRAZENECA AB

A02BC05 ESOMEPRAZOLUM

40mg

Prescriere limitata: Terapia refluxului gastro-esofagian. Prescriere limitata: Sindromul Zollinger-Ellison. Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiei de 40 mg.

A02BC05 ESOMEPRAZOLUM
NEXIUM® 40mg 20mg

LIOF. PT. SOL. INJ./PERF.
ASTRAZENECA AB

40mg 20mg

A02BC05 ESOMEPRAZOLUM
NEXIUM 20 mg

COMPR. FILM. GASTROREZ.
ASTRAZENECA AB

Prescriere limitata: Tratamentul ulcerului gastric si duodenal. Prescriere limitata: Mentinerea rezultatelor terapiei refluxului gastro-esofagian. Prescriere limitata: Profilaxia ulcerului gastro-duodenal asociat tratamentului cu antiinflamatoare nesteroidiene pe termen lung la pacientii cu factori de risc gastrointestinali. Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiei de 20 mg.

159
GASTROFAIT SUCRALAN® VENTER

A02BX02

SUCRALFATUM
COMPR.
1g 1g 1g E.I.P.I.CO. MED S.R.L. LANNACHER HEILMITTEL GMBH KRKA D.D.

A02BX02 SUCRALFATUM

1g

160
DE - NOL

A02BX05

BISMUTHI SUBCITRAS
COMPR. FILM.
120mg ASTELLAS PHARMA EUROPE B.V.

A02BX05 BISMUTHI SUBCITRAS

120mg

161
SPASMOMEN®

A03AB06

OTILONIUM BROMIDUM
COMPR. FILM.
40mg A. MENARINI IND. FARM. RIUNITE SRL

A03AB06 OTILONIUM BROMIDUM

40mg

162
FORTRANS®

A06AD15

MACROGOLUM *(2)
PULB. PT. SOL. ORALA
BEAUFOUR IPSEN INT.

A06AD15 MACROGOLUM

163
NORMIX 200 mg

A07AA11

RIFAXIMINUM
COMPR. FILM.
200mg ALFA WASSERMANN SPA

A07AA11 RIFAXIMINUM

200mg

164

A07EA06
Prescriere limitata:

BUDESONIDUM **
CAPS. GASTROREZ.
3mg DR. FALK PHARMA GMBH

Inducerea remisiunii formelor usoare/moderate de boala Crohn cu afectare ileala sau / si de colon ascendent.

A07EA06 BUDESONIDUM
BUDENOFALK

3mg

165
HIDRASEC 100 mg

A07XA04

RACECADOTRILUM
CAPS.
100mg 10mg 30mg LAB. FOURNIER SA

A07XA04 RACECADOTRILUM A07XA04 RACECADOTRILUM
HIDRASEC 10 mg

100mg 10mg 30mg

PULB. PT. SOL. ORALA
LAB. FOURNIER SA

A07XA04 RACECADOTRILUM
HIDRASEC 30 mg

PULB. PT. SOL. ORALA
LAB. FOURNIER SA

166
LINDAXA 10 REDUCTIL 10mg

A08AA10

SIBUTRAMINUM ****
CAPS.
10mg 10mg ZENTIVA A.S. ABBOTT GMBH&CO.KG

Protocol: A003E
10mg

A08AA10 SIBUTRAMINUM

A08AA10 SIBUTRAMINUM
LINDAXA 15 REDUCTIL 15 mg 15mg 15mg

CAPS.
ZENTIVA A.S. ABBOTT GMBH&CO.KG

15mg

167
XENICAL 120mg

A08AB01

ORLISTATUM ****
CAPS.
120mg ROCHE REGISTRATION LTD.

Protocol: A001E
120mg

A08AB01 ORLISTATUM

168
ACOMPLIA 20mg

A08AX01

RIMONABANTUM ****
COMPR. FILM.
20mg SANOFI AVENTIS

Protocol: A031E
20mg

A08AX01 RIMONABANTUM

169
ALPHA D3 0,25 µg

A11CC03

ALFACALCIDOLUM
CAPS. MOI
0.25µg TEVA PHARMACEUTICALS SRL

A11CC03 ALFACALCIDOLUM A11CC03 ALFACALCIDOLUM
ALPHA D3 0.50 µg 0.50µg

0.25µg 0.50µg
TEVA PHARMACEUTICALS S.R.L.

CAPS. MOI

30 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

170

A16AX01

ACIDUM TIOCTICUM (ALFA-LIPOICUM) **#
SOL. PERF.
12mg/ml 12mg/ml 30mg/ml WORWAG PHARMA GMBH & CO. KG WORWAG PHARMA GMBH & CO. KG

Protocol: A021E
12mg/ml

A16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM)
THIOGAMMA® TURBO-SE THIOGAMMA® TURBO-SET

A16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM)
THIOGAMMA® 600 INJEKT

CONC. PT. SOL. PERF.
WORWAG PHARMA GMBH & CO. KG

30mg/ml 600mg

A16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM)
THIOGAMMA® 600 oral 600mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG

171
FRAGMIN 10000 UI/ml

B01AB04

DALTEPARINUM **#
SOL. INJ.
10000ui/ml PFIZER EUROPE MA EEIG

Protocol: B008D
10000ui/ml 15000ui/0.6ml
PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM B01AB04 DALTEPARINUM
FRAGMIN15000 UI/0,6 ml

SOL. INJ.
15000ui/0.6ml

B01AB04 DALTEPARINUM
FRAGMIN 2500 UI/0,2 ml

SOL. INJ.
2500ui/0.2ml PFIZER EUROPE MA EEIG

2500ui/0.2ml 5000ui/0.2ml
PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN 5000 UI/0,2 ml

SOL. INJ.
5000ui/0.2ml

B01AB04 DALTEPARINUM
FRAGMIN 7500 UI/0,3 ml

SOL. INJ.
7500ui/0.3ml PFIZER EUROPE MA EEIG

7500ui/0.3ml

172

B01AB05

ENOXAPARINUM **#
SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

Protocol: B008D
2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

173

B01AB06

NADROPARINUM **#
SOL. INJ.
11400 uiAXa/0.6ml GLAXO GROUP LTD.

Protocol: B008D
11400 uiAXa/0.6ml 15200 uiAXa/0.8ml
GLAXO GROUP LTD.

B01AB06 NADROPARINUM
FRAXODI 11400 UI anti-factor Xa/0,6ml

B01AB06 NADROPARINUM
FRAXODI 15200 UI anti-factor Xa/0,8ml

SOL. INJ.
15200 uiAXa/0.8ml

B01AB06 NADROPARINUM
FRAXIPARINE® 2850 UI anti-factor Xa/0,3 ml

SOL. INJ.
2850 ui AFXa/0.3ml GLAXO GROUP LTD.

2850 ui AFXa/0.3ml

B01AB06 NADROPARINUM
FRAXIPARINE® 3800 UI anti-factor Xa/0,4 ml

SOL. INJ.
3800 ui AFXa/0.4ml GLAXO GROUP LTD.

3800 ui AFXa/0.4ml

B01AB06 NADROPARINUM
FRAXIPARINE® 5700 UI anti-factor Xa/0,6 ml

SOL. INJ.
5700 ui AFXa/0.6ml GLAXO GROUP LTD.

5700 ui AFXa/0.6ml

B01AB06 NADROPARINUM
FRAXIPARINE® 7600 UI anti-factor Xa/0,8 ml

SOL. INJ.
7600 ui AXa/0.8ml GLAXO GROUP LTD.

7600 ui AXa/0.8ml

174

B01AB08

REVIPARINUM **#
SOL. INJ.
1432ui/0.25ml ABBOTT GMBH&CO.KG

Protocol: B008D
1432ui/0.25ml 3436ui/0.6ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 1432UI/0,25 ml

B01AB08 REVIPARINUM
CLIVARIN® 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml

175

B01AB10

TINZAPARINUM **#
SOL. INJ. 10000u ANTIF. Xa/ml

Protocol: B008D

B01AB10 TINZAPARINUM

31 / 153

DCI/DENUMIRE COMERCIALA
INNOHEP

CONCENTRATIE
10000u ANTIF. Xa/ml

FORMA FARM.

FIRMA
LEO PHARMACEUTICAL PRODUCTS

PROTOCOL

B01AB10 TINZAPARINUM
INNOHEP

SOL. INJ.
20000u ANTIF. Xa/ml LEO PHARMACEUTICAL PRODUCTS

20000u ANTIF. Xa/ml

176
VESSEL DUE F

B01AB11

SULODEXIDUM **
CAPS. MOI
250ULS ALFA WASSERMANN SPA

Protocol: B014I
250ULS 600ULS/2ml
ALFA WASSERMANN SPA

B01AB11 SULODEXIDUM B01AB11 SULODEXIDUM
VESSEL DUE F

SOL. INJ.
600ULS/2ml

177
PLAVIX 75mg

B01AC04

CLOPIDOGRELUM **
COMPR. FILM.
75mg SANOFI PHARMA - BRISTOL MYERS SQUIBB

Protocol: B009I;B010I
75mg

B01AC04 CLOPIDOGRELUM

Cod restrictie 1719: Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de episoade ischiemice cererbrovasculare conform protocolului de prescriere. Cod restrictie 1722: Preventia recurentei infarctului de miocard sau a anginei instabile la pacienţii cu istoric de evenimente ischiemice cardiace simptomatice conform protocolului de prescriere. Cod restrictie 3008: Tratamentul antiagregant al ateromatozei extensive (carotidiene, coronariene si perfierice).

178

B01AC30

COMBINATII (DIPYRIDAMOLUM+ACIDUM ACETYLSALICYLICUM) **
CAPS. ELIB. MODIF.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Protocol: B010I

B01AC30 COMBINATII (DIPYRIDAMOLUM+ACIDUM ACETYLSALICYLICUM)
AGGRENOX

179
ARIXTRA 10mg/0.8ml

B01AX05

FONDAPARINUX SODIUM **#
SOL. INJ. IN SERINGA PREUMPLUTA
10mg/0.8ml 2.5mg/0.5ml 5mg/0.4ml 7.5mg/0.6ml GLAXO GROUP LTD.

Protocol: B008D
10mg/0.8ml 2.5mg/0.5ml 5mg/0.4ml 7.5mg/0.6ml

B01AX05 FONDAPARINUX SODIUM B01AX05 FONDAPARINUX SODIUM
ARIXTRA 2.5mg/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA
GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD.

B01AX05 FONDAPARINUX SODIUM
ARIXTRA 5mg/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B01AX05 FONDAPARINUX SODIUM
ARIXTRA 7.5mg/0.6ml

180

B03AC02

COMPLEX DE HIDROXID DE FER (III) SUCROZA
SOL. INJ./PERF.
20mg/ml VIFOR FRANCE S.A.

B03AC02 COMPLEX DE HIDROXID DE FER (III) SUCROZA
VENOFER®

20mg/ml

Cod restrictie 2070: Anemie feriprivă, la pacienţii care au prezentat o reacţie de hipersensibilitate documentată la fier polimaltozat şi la care este indicată administrarea continuă intravenoasă.

181
AFLEN®

B01AC18

TRIFLUSALUM
CAPS.
300mg ZENTIVA S.A.

B01AC18 TRIFLUSALUM

300mg

182
MEXITIL® 200 mg

C01BB02

MEXILETINUM
CAPS.
200mg BOEHRINGER INGELHEIM INT. GMBH

C01BB02 MEXILETINUM

200mg

183
CORLENTOR 5mg

C01EB17

IVABRADINUM **
COMPR. FILM.
5mg LES LAB. SERVIER

Protocol: C003I
5mg 7.5mg
LES LAB. SERVIER

C01EB17 IVABRADINUM C01EB17 IVABRADINUM
CORLENTOR 7,5mg 7.5mg

COMPR. FILM.

184

C02AC05

MOXONIDINUM

Prescriere limitata: Hipertensiune arteriala esentiala la pacienţii care primesc tratament antihipertensiv concomitent. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C02AC05 MOXONIDINUM
MOXOGAMMA 0,2 mg PHYSIOTENS 0,2 0.2mg 0.2mg

COMPR. FILM.
WORWAG PHARMA GMBH SOLVAY PHARMACEUTICALS GMBH

0.2mg

C02AC05 MOXONIDINUM
MOXOGAMMA 0,3 mg 0.3mg

COMPR. FILM.
WORWAG PHARMA GMBH

0.3mg 0.4mg
WORWAG PHARMA GMBH SOLVAY PHARMACEUTICALS GMBH

C02AC05 MOXONIDINUM
MOXOGAMMA 0,4 mg PHYSIOTENS 0,4 0.4mg 0.4mg

COMPR. FILM.

185
TENAXUM

C02AC06

RILMENIDINUM
COMPR.
1mg LES LABORATOIRES SERVIER INDUSTRIE

C02AC06 RILMENIDINUM

1mg

186
MINIPRESS® 1 mg

C02CA01

PRAZOSINUM
COMPR.
1mg PFIZER EUROPE MA EEIG

C02CA01 PRAZOSINUM C02CA01 PRAZOSINUM
MINIPRESS® 2 mg 2mg

1mg 2mg
PFIZER EUROPE MA EEIG

COMPR.

187

C03DA04
Prescriere limitata:

EPLERENONUM *#

Insuficienţă cardiacă cu o fracţie de ejecţie a ventriculului stâng de 40% sau mai puţin, apărută la 3-14 zile de la un infarct miocardic acut. Tratmentul cu eplerenone trebuie început la maximum 14 zile de la data aparitiei infarctului miocardic acut. Data infarctului miocardic acut şi data iniţierii tratamentului cu eplerenone trebuie documentate în fişa pacientului. Electroliţii serici trebuie să fie verificaţi periodic. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C03DA04 EPLERENONUM
INSPRA 25 mg 25mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

25mg 50mg

C03DA04 EPLERENONUM

COMPR. FILM.

32 / 153

DCI/DENUMIRE COMERCIALA
INSPRA 50 mg

CONCENTRATIE
50mg

FORMA FARM.

FIRMA
PFIZER EUROPE MA EEIG

PROTOCOL

188

C04AE02

NICERGOLINUM
COMPR. FILM.
10mg LABORMED PHARMA SA

C04AE02 NICERGOLINUM
NICERGOLINA LPH 10 mg

10mg 10mg
HEXAL AG SINTOFARM SA

C04AE02 NICERGOLINUM
NICERIUM® 10 SINERGOLIN 10 10mg 10mg 15mg 30mg

DRAJ.

C04AE02 NICERGOLINUM
NICERIUM® 15

CAPS. ELIB. MODIF.
HEXAL AG

15mg 30mg 30mg

C04AE02 NICERGOLINUM
NICERIUM® 30 UNO

CAPS. ELIB. MODIF.
HEXAL AG

C04AE02 NICERGOLINUM
NICERGOLINA LPH 30 mg SERMION 30mg 30mg

COMPR. FILM.
LABORMED PHARMA SA PFIZER EUROPE MA EEIG

C04AE02 NICERGOLINUM
SINERGOLIN 30 30mg

DRAJ.
SINTOFARM SA

30mg 5mg
LABORMED PHARMA SA

C04AE02 NICERGOLINUM
NICERGOLINA LPH 5 mg 5mg

COMPR. FILM.

189
VINCAMINA

C04AX07

VINCAMINUM
DRAJ.
10mg BIOFARM SA

C04AX07 VINCAMINUM C04AX07 VINCAMINUM
VINCAMIL 20mg

10mg 20mg
FARMACEUTICI ECOBI S.A.S

COMPR. CAPS. ELIB. PREL.
30mg GLAXOSMITHKLINE (GSK) SRL

C04AX07 VINCAMINUM
OXYBRAL SR 30 mg

30mg

190
GINGIUM 120m

C04AXN1

GINKGO BILOBA **
COMPR. FILM.
120mg HEXAL AG

Protocol: C001I
120mg 40mg
HEXAL AG DR. WILLMAR SCHWABE GMBH & CO KG

C04AXN1 GINKGO BILOBA C04AXN1 GINKGO BILOBA
GINGIUM 40mg TEBOKAN 40mg 40mg

COMPR. FILM.

C04AXN1 GINKGO BILOBA
BILOBIL FORTE 80mg

CAPS.
KRKA D.D. NOVO MESTO

80mg 80mg
HEXAL AG

C04AXN1 GINKGO BILOBA
GINGIUM 80mg 80mg

COMPR. FILM.

191
DETRALEX®

C05CA53

DIOSMINUM (COMBINATII) **
COMPR. FILM.
500mg LES LAB. SERVIER IND.

Protocol: B016I
500mg

C05CA53 DIOSMINUM (COMBINATII)

192
NEBILET®

C07AB12

NEBIVOLOLUM
COMPR.
5mg BERLIN CHEMIE AG MENARINI GROUP

C07AB12 NEBIVOLOLUM

5mg

193

C07BB07

COMBINATII (BISOPROLOLUM+HYDROCHLOROTHIAZIDUM)
COMPR. FILM.

C07BB07 COMBINATII (BISOPROLOLUM+HYDROCHLOROTHIAZIDU M)
LODOZ 10 mg LODOZ 2,5 mg LODOZ 5 mg

MERCK KGAA MERCK KGAA MERCK KGAA

194

C07EBN1

COMBINATII (METOPROLOLUM+FELODIPINUM)
COMPR. ELIB. PREL.
50mg+5mg ASTRAZENECA AB

C07EBN1 COMBINATII (METOPROLOLUM+FELODIPINUM)
LOGIMAX®

50mg+5mg

195
LACIPIL 4 mg

C08CA09

LACIDIPINUM
COMPR. FILM.
4mg GLAXO OPERATIONS UK LTD.

C08CA09 LACIDIPINUM

4mg

196
LERIDIP

C08CA13

LERCANIDIPINUM
COMPR. FILM.
10mg BERLIN CHEMIE AG MENARINI GROUP

C08CA13 LERCANIDIPINUM C08CA13 LERCANIDIPINUM
LERIDIP 20 20mg

10mg 20mg
BERLIN CHEMIE AG MENARINI GROUP

COMPR. FILM.

197

C09AA04

PERINDOPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09AA04 PERINDOPRILUM
PRESTARIUM 10 mg 10 mg

COMPR. FILM.
LES LAB. SERVIER IND.

10 mg 4mg
LES LAB. SERVIER IND.

C09AA04 PERINDOPRILUM
PRESTARIUM® 4 mg 4mg

COMPR. COMPR. FILM.
5mg LES LAB. SERVIER IND.

C09AA04 PERINDOPRILUM
PRESTARIUM 5 mg

5mg 8mg
LES LAB. SERVIER IND.

C09AA04 PERINDOPRILUM
PRESTARIUM® 8 mg 8mg

COMPR.

198

C09AA07

BENAZEPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09AA07 BENAZEPRILUM
BENAZEPRIL STADA 10 mg CIBACEN® 10 mg 10mg 10mg

COMPR. FILM.
STADA ARZNEIMITTEL AG NOVARTIS PHARMA GMBH

10mg

33 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
20mg 20mg

FORMA FARM.

FIRMA

PROTOCOL

C09AA07 BENAZEPRILUM
BENAZEPRIL STADA 20 mg CIBACEN® 20 mg

COMPR. FILM.
STADA ARZNEIMITTEL AG NOVARTIS PHARMA GMBH

20mg

C09AA07 BENAZEPRILUM
BENAZEPRIL STADA 5 mg CIBACEN® 5 mg 5mg 5mg

COMPR. FILM.
STADA ARZNEIMITTEL AG NOVARTIS PHARMA GMBH

5mg

199

C09AA10

TRANDOLAPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09AA10 TRANDOLAPRILUM
GOPTEN® 0,5 mg 0.5mg

CAPS.
ABBOTT GMBH&CO.KG

0.5mg 2mg
ABBOTT GMBH&CO.KG

C09AA10 TRANDOLAPRILUM
GOPTEN® 2 mg 2mg

CAPS. CAPS.
4mg ABBOTT GMBH&CO.KG

C09AA10 TRANDOLAPRILUM
GOPTEN® 4 mg

4mg

200

C09AA15

ZOFENOPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero.

C09AA15 ZOFENOPRILUM
ZOMEN® 30 mg 30mg

COMPR. FILM.
BERLIN CHEMIE AG

30mg 7.5mg
BERLIN CHEMIE AG

C09AA15 ZOFENOPRILUM
ZOMEN® 7,5 mg 7.5mg

COMPR. FILM.

201

C09BA04

COMBINATII (PERINDOPRILUM+INDAPAMIDUM)

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09BA04 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)
NOLIPREL®

COMPR.
2mg+0.625mg LES LAB. SERVIER IND.

2mg+0.625mg

C09BA04 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)
NOLIPREL FORTE® PRESTARIUM PLUS

COMPR.
4mg+1.25mg 4mg+1.25mg LES LAB. SERVIER IND. LES LAB. SERVIER IND.

4mg+1.25mg

202

C09BA06

COMBINATII (QUINAPRILUM+HYDROCHLOROTHIAZIDUM)

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09BA06 COMBINATII (QUINAPRILUM+HYDROCHLOROTHIAZIDUM)
ACCUZIDE

COMPR. FILM.
PFIZER EUROPE MA EEIG

10mg/12.5mg

10mg/12.5mg

C09BA06 COMBINATII (QUINAPRILUM+HYDROCHLOROTHIAZIDUM)
ACUZIDE FORTE

COMPR. FILM.
PFIZER EUROPE MA EEIG

20mg/12.5mg

20mg/12.5mg

203

C09BA09

COMBINATII (FOSINOPRILUM+HYDROCHLOROTHIAZIDUM)

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09BA09 COMBINATII (FOSINOPRILUM+HYDROCHLOROTHIAZIDU M)
FOSINOZIDE 20 mg/12,5 mg

COMPR.

20mg/12.5mg

20mg/12.5mg

BRISTOL MYERS SQUIBB KFT

204

C09BB02

COMBINATII (NITRENDIPINUM+ENALAPRILUM)

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09BB02 COMBINATII (NITRENDIPINUM+ENALAPRILUM)
ENEAS

COMPR.
10mg+20mg VITA CIENTIFICA SL

10mg+20mg

205

C09BB10

COMBINATII (VERAPAMILUM+TRANDOLAPRILUM)

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09BB10 COMBINATII (VERAPAMILUM+TRANDOLAPRILUM)
TARKA

COMPR.FILM.ELIB.MODIF.
180mg/2mg ABBOTT GMBH&CO.KG

180mg/2mg

206

C09CA03
Prescriere limitata:

VALSARTANUM

Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei. Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09CA03 VALSARTANUM
DIOVAN 160 mg 160mg

COMPR. FILM.
NOVARTIS PHARMA GMBH

160mg 80mg
NOVARTIS PHARMA GMBH

C09CA03 VALSARTANUM
DIOVAN 80 mg 80mg

COMPR. FILM.

207

C09CA04
Prescriere limitata:

IRBESARTANUM

Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei. Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

34 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
150mg

FORMA FARM.

FIRMA

PROTOCOL

C09CA04 IRBESARTANUM
APROVEL 150mg

COMPR. FILM.
SANOFI PHARMA - BRISTOL MYERS SQUIBB

150mg 300mg
SANOFI PHARMA - BRISTOL MYERS SQUIBB

C09CA04 IRBESARTANUM
APROVEL 300mg 300mg

COMPR. FILM.

208

C09CA06
Prescriere limitata:

CANDESARTANUM CILEXETIL

Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei. Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09CA06 CANDESARTANUM CILEXETIL
ATACAND 16mg

COMPR.
ASTRAZENECA AB

16mg 8mg
ASTRAZENECA AB

C09CA06 CANDESARTANUM CILEXETIL
ATACAND 8mg

COMPR.

209

C09CA07
Prescriere limitata:

TELMISARTANUM

Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei. Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09CA07 TELMISARTANUM
MICARDIS 40 mg PRITOR 40 mg 40mg 40mg

COMPR.
BOEHRINGER INGELHEIM INT. GMBH BAYER HEALTHCARE AG

40mg

C09CA07 TELMISARTANUM
MICARDIS 80 mg PRITOR 80 mg 80mg 80mg

COMPR.
BOEHRINGER INGELHEIM INT. GMBH BAYER HEALTHCARE AG

80mg

210

C09DA01
Prescriere limitata:

COMBINATII (LOSARTANUM+HYDROCHLOROTHIAZIDUM)

Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei. Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09DA01 COMBINATII (LOSARTANUM+HYDROCHLOROTHIAZIDUM)
HYZAAR® 50 mg/12,5 mg

COMPR. FILM.
MERCK SHARP & DOHME ROMANIA S.R.L.

50mg+12.5mg

50mg+12.5mg

211

C09DA03
Prescriere limitata:

COMBINATII (VALSARTANUM+HYDROCHLOROTHIAZIDUM)

Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei. Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09DA03 COMBINATII (VALSARTANUM+HYDROCHLOROTHIAZIDUM )
CO-DIOVAN 80 mg/12,5 mg

COMPR. FILM.

80mg/12.5mg

80mg/12.5mg

NOVARTIS PHARMA GMBH

212

C09DA04
Prescriere limitata:

COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZIDUM)

Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei. Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZID UM)
COAPROVEL 150mg/12.5mg

COMPR.

150mg/12.5mg

150mg/12.5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZID UM)
COAPROVEL 300mg/12.5mg

COMPR.

300mg/12.5mg

300mg/12.5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

213

C09DA07
Prescriere limitata:

COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZIDUM)

Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei. Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09DA07 COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZID UM)
MICARDISPLUS 80/12.5mg

COMPR.

80/12.5mg

80/12.5mg

BOEHRINGER INGELHEIM INT. GMBH

C09DA07 COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZID UM)
PRITOR PLUS 80mg/12,5mg

COMPR.

80mg/12.5mg

80mg/12.5mg

BAYER HEALTHCARE AG

214

C09DB01
Prescriere limitata:

COMBINATII ( VALSARTANUM+AMLODIPINUM)

Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei. Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09DB01 COMBINATII ( VALSARTANUM+AMLODIPINUM)
EXFORGE 10mg/160mg

COMPR. FILM.
10mg/160mg NOVARTIS EUROPHARM LTD.

10mg/160mg

C09DB01 COMBINATII ( VALSARTANUM+AMLODIPINUM)
EXFORGE 5mg/160mg

COMPR. FILM.
5mg/160mg NOVARTIS EUROPHARM LTD.

5mg/160mg

C09DB01 COMBINATII ( VALSARTANUM+AMLODIPINUM)
EXFORGE 5mg/80mg

COMPR. FILM.
5mg/80mg NOVARTIS EUROPHARM LTD.

5mg/80mg

215

C10AA04

FLUVASTATINUM

Protocol: CE01E

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

35 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
20mg

FORMA FARM.

FIRMA

PROTOCOL

C10AA04 FLUVASTATINUM
LESCOL® 20

CAPS.
NOVARTIS PHARMA GMBH

20mg 40mg
NOVARTIS PHARMA GMBH

C10AA04 FLUVASTATINUM
LESCOL® 40 40mg 80mg

CAPS. COMPR. ELIB. PREL.
NOVARTIS PHARMA GMBH

C10AA04 FLUVASTATINUM
LESCOL® XL

80mg

216

C10AA05

ATORVASTATINUM

Protocol: CE01E

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10AA05 ATORVASTATINUM
SORTIS 10 mg 10mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

10mg 20mg
PFIZER EUROPE MA EEIG

C10AA05 ATORVASTATINUM
SORTIS 20 mg 20mg

COMPR. FILM. COMPR. FILM.
40mg PFIZER EUROPE MA EEIG

C10AA05 ATORVASTATINUM
SORTIS 40 mg

40mg 80mg
PFIZER EUROPE MA EEIG

C10AA05 ATORVASTATINUM
SORTIS 80 mg 80mg

COMPR. FILM.

217

C10AA07

ROSUVASTATINUM

Protocol: CE01E

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10AA07 ROSUVASTATINUM
CRESTOR 10 mg 10mg

COMPR. FILM.
ASTRAZENECA UK LTD.

10mg 20mg
ASTRAZENECA UK LTD.

C10AA07 ROSUVASTATINUM
CRESTOR 20 mg 20mg

COMPR. FILM. COMPR. FILM.
40mg ASTRAZENECA UK LTD.

C10AA07 ROSUVASTATINUM
CRESTOR 40 mg

40mg 5mg
ASTRAZENECA UK LTD.

C10AA07 ROSUVASTATINUM
CRESTOR 5 mg 5mg

COMPR. FILM.

218

C10AB02

BEZAFIBRATUM

Protocol: CE01E

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10AB02 BEZAFIBRATUM
REGADRIN® B 200mg

DRAJ.
BERLIN CHEMIE AG MENARINI GROUP

200mg

219

C10AB08

CIPROFIBRATUM

Protocol: CE01E

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10AB08 CIPROFIBRATUM
LIPANOR® 100 mg 100mg

CAPS.
SANOFI-AVENTIS FRANCE

100mg

220
OMACOR®

C10AX06

ACID OMEGA-3-ESTERI ETILICI 90 **
CAPS. MOI
1000mg PRONOVA BIOCARE AS

Protocol: C004I
1000mg

C10AX06 ACID OMEGA-3-ESTERI ETILICI 90

221

C10AX09
Prescriere limitata:

EZETIMIBUM

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Cod restrictie 2649: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(a) boală coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155 mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Cod restrictie 2650: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(b) diabet zaharat. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155 mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Cod restrictie 2651: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(c) boala vasculara periferica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155 mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib.

36 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Cod restrictie 2652: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(d) hipercolesterolemie familiala heterozigota. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Cod restrictie 2653: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(e) boala cerebrovasculara simptomatica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Cod restrictie 2667: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(f) istoric familial de boala coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Cod restrictie 2668: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(g) HTA. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Cod restrictie 1989: Pacienti care indeplinesc criteriile de eligibilitate pentru prescrierea de hipolipemiante (in concordanta cu criteriile stabilite in Protocoalele de prescriere in vederea decontarii) atunci cand tratamentul cu un inhibitor de HMG CoA reductaza (statine) este contraindicat Cod restrictie 2669: Pacienti care indeplinesc criteriile de eligibilitate pentru prescrierea de hipolipemiante (in concordanta cu criteriile stabilite in Protocoalele de prescriere in vederea decontarii) atunci cand tratamentul cu un inhibitor de HMG CoA reductaza (statin) trebuie intrerupt sau redus la mai putin de 20 mg/zi datorita aparitiei efectelor secundare urmatoare: (i) Mialgie severa (simptome mulsculare fara cresterea CK) care survine pe perioada tratamentului cu statine; sau (ii) Miozita (cresterea importanta a CK, cu sau fara simptomatologie musculara) demonstrata prin valori de doua ori mai mari decat limita superioara a normalului la o singura determinare sau o tendinta de crestere la determinari consecutive, neexplicate de alte cauze; sau (iii) Persistenta unor valori crescute ale transaminazelor, neexplicata de alte cauze (mai mult de trei ori decat valoarea limita maxima a normalului) in timpul tratamentului cu o statina Cod restrictie 1991: Homozygous sitosterolaemia; Cod restrictie 2438: Pacienti cu hipercolesterolemie familiala (homozigota) care sunt eligibili pentru tratamentul cu hipolipemiante (in concordanta cu Protocolul de prescriere in vederea decontarii), in combinatie cu un inhibitor de HMG CoA reductase (statin). Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10AX09 EZETIMIBUM
EZETROL® 10mg

COMPR.
MERCK SHARP & DOHME ROMANIA SRL

10mg

222

C10BA02

COMBINATII (EZETIMIBUM + SIMVASTATINUM)

Cod restrictie 2654: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(a) boală coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Cod restrictie 2655: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(b) diabet zaharat. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Cod restrictie 2656: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(c) boala vasculara periferica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib.

37 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Cod restrictie 2657: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(d) hipercolesterolemie familiala heterozigota. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Cod restrictie 2658: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(e) boala cerebrovasculara simptomatica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Cod restrictie 2678: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(f) istoric familial de boala coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetimib. Cod restrictie 2679:Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol nu este controlat adecvat cu o statină şi care au:(g) HTA. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetimib. Cod restrictie 2431: Pacientii cu hipercolesterolemie familiala (heterozigota) care sunt eligibili pentru tratament cu hipo-lipemiante (in concordanta cu criteriile stabilite prin Protocolul de prescriere in vederea decontarii). Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10BA02 COMBINATII (EZETIMIBUM + SIMVASTATINUM)
INEGY® 10 mg/10 mg

COMPR.
10mg/10mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/10mg

C10BA02 COMBINATII (EZETIMIBUM + SIMVASTATINUM)
INEGY® 10 mg/20 mg

COMPR.
10mg/20mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/20mg

C10BA02 COMBINATII (EZETIMIBUM + SIMVASTATINUM)
INEGY® 10 mg/40 mg

COMPR.
10mg/40mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/40mg

C10BA02 COMBINATII (EZETIMIBUM + SIMVASTATINUM)
INEGY® 10 mg/80 mg

COMPR.
10mg/80mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/80mg

223

C10BX03
Prescriere limitata:

COMBINATII (ATORVASTATINUM + AMLODIPINUM)

Protocol: CE01E

Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor hipolipemiante in vederea decontarii, si:(a) care primesc in mod curent tratament cu un blocant de canale de calciu. Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor hipolipemiante in vederea decontarii, si:(b) al caror nivel al tensiunii arteriale si/sau angina pectorala sunt insuficient controlate cu alte clase de antihipertensive si/sau medicamente anti-angina si la care terapia adjuvanta cu blocanti ai canalelor de calciu ar fi adecvata; Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor hipolipemiante in vederea decontarii, si (c) care nu tolereaza efectele secundare ale altor clase de antihipertensive si/sau medicamente anti-angina si la care inlocuirea terapiei cu un blocant de canale de calciu ar fi indicata. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C10BX03 COMBINATII (ATORVASTATINUM + AMLODIPINUM)
CADUET 10mg/10mg

COMPR. FILM.
10mg/10mg PFIZER EUROPE MA EEIG

10mg/10mg

C10BX03 COMBINATII (ATORVASTATINUM + AMLODIPINUM)
CADUET 5mg/10mg

COMPR. FILM.
5mg/10mg PFIZER EUROPE MA EEIG

5mg/10mg

224
PIMAFUCIN

D01AA02

NATAMYCINUM
CREMA
20mg/g ASTELLAS EUROPE B.V.

D01AA02 NATAMYCINUM

20mg/g

226

D01BA02

TERBINAFINUM

Prescriere limitata: Tratamentul de prima intentie al onicomicozelor proximale sau extinse la care tratamentul topic a esuat. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

D01BA02 TERBINAFINUM
LAMISIL® TERBINARAN TERBISIL® 250 mg 250mg 250mg 250mg

COMPR.
NOVARTIS PHARMA GMBH RANBAXY UK LIMITED GEDEON RICHTER LTD.

250mg

227

D05AX02

CALCIPOTRIOLUM *
CREMA 50µg/g

D05AX02 CALCIPOTRIOLUM

38 / 153

DCI/DENUMIRE COMERCIALA
DAIVONEX

CONCENTRATIE
50µg/g

FORMA FARM.

FIRMA
LEO PHARMACEUTICAL PRODUCTS

PROTOCOL

D05AX02 CALCIPOTRIOLUM
DAIVONEX UNGUENT 50µg/g

UNGUENT
LEO PHARMACEUTICAL PRODUCTS

50µg/g 50µg/ml
LEO PHARMACEUTICAL PRODUCTS

D05AX02 CALCIPOTRIOLUM
DAIVONEX SOLUTIE CUTANATA PENTRU SCALP 50µg/ml

SOL. CUT. UNGUENT
0.005% LEK PHARMACEUTICALS D.D.

D05AX02 CALCIPOTRIOLUM
SOREL® unguent 0,005%

0.005%

228

D05AX52

COMBINATII (CALCIPOTRIOLUM+BETAMETHASONUM) *
UNGUENT
LEO PHARMACEUTICAL PRODUCTS

D05AX52 COMBINATII (CALCIPOTRIOLUM+BETAMETHASONUM)
DAIVOBET® UNGUENT

230
FUCIDIN®

D06AX01

ACIDUM FUSIDICUM
CREMA
2% LEO PHARMACEUTICAL PRODUCTS

D06AX01 ACIDUM FUSIDICUM D06AX01 ACIDUM FUSIDICUM
FUCIDIN® 2%

2,00% 2,00%
LEO PHARMACEUTICAL PRODUCTS

UNGUENT

231
BANEOCIN®

D06AXN1

COMBINATII (NEOMYCINUM+BACITRACINUM)
PULB. CUT.
SANDOZ GMBH

D06AXN1 COMBINATII (NEOMYCINUM+BACITRACINUM) D06AXN1 COMBINATII (NEOMYCINUM+BACITRACINUM)
BANEOCIN® NEOBACIN

UNGUENT
SANDOZ GMBH DAR AL DAWA PHARMA SRL

232
DERMAZIN® 1%

D06BA01

SULFADIAZINUM
CREMA
1% LEK PHARMACEUTICALS D.D.

D06BA01 SULFADIAZINUM

1,00%

233
WARTEC 1,5 mg/g

D06BB04

PODOPHYLLOTOXINUM *
CREMA
1,5 mg/g STIEFEL LABORATORIES (UK) LTD.

D06BB04 PODOPHYLLOTOXINUM D06BB04 PODOPHYLLOTOXINUM
CONDYLINE 5mg/ml

1,5 mg/g 5mg/ml
ASTELLAS PHARMA EUROPE B.V.

SOL. CUT.

Prescriere limitata:

Pentru tratamentul verucilor.

235

D07AB02

HYDROCORTISONUM BUTYRATUM
CREMA
0.1% 0.1% ASTELLAS PHARMA EUROPE BV ASTELLAS PHARMA EUROPE B.V.

Protocol: D001L
0.1%

D07AB02 HYDROCORTISONUM BUTYRATUM
LOCOID® crema 0,1% LOCOID® LIPOCREAM 0,1%

D07AB02 HYDROCORTISONUM BUTYRATUM
LOCOID CRELO® 0,1% 0.1%

EMULSIE CUT.
ASTELLAS PHARMA EUROPE BV

0.1% 0.1%
ASTELLAS PHARMA EUROPE B.V.

D07AB02 HYDROCORTISONUM BUTYRATUM
LOCOID® 0.1%

SOL. CUT.

236
ELOCOM

D07AC13

MOMETASONUM
CREMA
1mg/g SCHERING PLOUGH EUROPE

Protocol: D001L
1mg/g 1mg/g
SCHERING PLOUGH EUROPE

D07AC13 MOMETASONUM D07AC13 MOMETASONUM
ELOCOM 1mg/g

SOL. CUT. UNGUENT
1mg/g SCHERING PLOUGH EUROPE

D07AC13 MOMETASONUM
ELOCOM

1mg/g

237
ADVANTAN® MILK

D07AC14

METHYLPREDNISOLONUM ACEPONAT
EMULSIE CUT.
0.1% INTENDIS GMBH

Protocol: D001L
0.1% 1mg/g

D07AC14 METHYLPREDNISOLONUM ACEPONAT D07AC14 METHYLPREDNISOLONUM ACEPONAT
ADVANTAN 1mg/g

CREMA
INTENDIS GmbH

D07AC14 METHYLPREDNISOLONUM ACEPONAT
ADVANTAN 1mg/g

UNGUENT
INTENDIS GmbH

1mg/g

238
CUTIVATE

D07AC17

FLUTICASONUM
CREMA
0.05% GLAXO WELLCOME UK LIMITED

Protocol: D001L
0.05% 0.005%
GLAXO WELLCOME UK LIMITED

D07AC17 FLUTICASONUM D07AC17 FLUTICASONUM
CUTIVATE 0.005%

UNGUENT

239
DERMOVATE

D07AD01

CLOBETASOLUM *
CREMA
0.05% GLAXOWELLCOME UK LTD.

Protocol: D001L
0.05% 0.05%
GLAXO WELLCOME UK LTD.

D07AD01 CLOBETASOLUM D07AD01 CLOBETASOLUM
DERMOVATE® 0.05%

SOL. CUT. UNGUENT
0.05% 0.05% OZONE LABORATORIES LTD. GLAXOWELLCOME UK LTD.

D07AD01 CLOBETASOLUM
DERMIONE DERMOVATE

0.05%

240

D07CA01

COMBINATII (HYDROCORTISONUM+ANTIINFECTIOASE)
CREMA
LEO PHARMACEUTICAL PRODUCTS ASTELLAS PHARMA EUROPE B.V.

Protocol: D001L

D07CA01 COMBINATII (HYDROCORTISONUM+ANTIINFECTIOASE)
FUCIDIN® H PIMAFUCORT

D07CA01 COMBINATII (HYDROCORTISONUM+ANTIINFECTIOASE)
PIMAFUCORT

UNGUENT
ASTELLAS PHARMA EUROPE B.V.

241

D07CC01

COMBINATII (BETAMETHASONUM+ANTIINFECTIOASE)
CREMA
LEO PHARMACEUTICAL PRODUCTS

Protocol: D001L

D07CC01 COMBINATII (BETAMETHASONUM+ANTIINFECTIOASE)
FUCICORT®

39 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

242

D07XC03

COMBINATII (MOMETASONUM + AC. SALICILICUM)
UNGUENT
SCHERING PLOUGH EUROPE

Protocol: D001L

D07XC03 COMBINATII (MOMETASONUM + AC. SALICILICUM)
ELOSALIC

243

D10AD54

COMBINATII (ISOTRETINOINUM + ERITROMICINUM)
GEL
0,05%/0,2% STIEFEL LABORATORIES (UK) LTD.

D10AD54 COMBINATII (ISOTRETINOINUM + ERITROMICINUM)
ISOTREXIN GEL

0,05%/0,2%

244
SKINOREN

D10AX03

ACIDUM AZELAICUM
CREMA
200mg/g INTENDIS GmbH

D10AX03 ACIDUM AZELAICUM D10AX03 ACIDUM AZELAICUM
SKINOREN® 15% 15%

200mg/g 15%
INTENDIS GMBH

GEL

245

D10BA01

ISOTRETINOINUM **

Cod restrictie 1354: Acnee chistica severa care nu raspunde la alte tipuri de tratamente. Acest medicament poate cauza defecte la nastere. Isotretinoin a fost incriminat pentru cauzarea frecventa a altor efecte toxice cu potential sever. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

D10BA01 ISOTRETINOINUM
ROACCUTANE 10 mg SOTRET 10 mg 10mg 10mg

CAPS. MOI
ROCHE ROMANIA SRL RANBAXY U.K. LIMITED

10mg

D10BA01 ISOTRETINOINUM
SOTRET 20 mg 20mg

CAPS. MOI
RANBAXY U.K. LIMITED

20mg

246
PIMAFUCIN®

G01AA02

NATAMYCINUM
OVULE
100mg ASTELLAS PHARMA EUROPE B.V.

G01AA02 NATAMYCINUM

100mg

247
MACMIROR COMPLEX

G01AA51

COMBINATII
CREMA VAG.
10g/400000UI POLICHEM SA

G01AA51 COMBINATII G01AA51 COMBINATII
MACMIROR COMPLEX

10g/400000UI 500mg/200000UI
POLICHEM SA LAB. INNOTECH INT.

CAPS. MOI VAG.
500mg/200000UI

G01AA51 COMBINATII
POLYGYNAX

CAPS. MOI VAG.

248
LOMEXIN 600 mg

G01AF12

FENTICONAZOLUM
CAPS. MOI VAG.
600mg RECORDATI SPA

G01AF12 FENTICONAZOLUM

600mg

249
GYNOFORT 2%

G01AF15

BUTOCONAZOLUM
CREMA VAG.
GEDEON RICHTER LTD.

G01AF15 BUTOCONAZOLUM

251
MACMIROR

G01AX05

NIFURATELUM
DRAJ.
200mg POLICHEM SA

G01AX05 NIFURATELUM

200mg

252
DOSTINEX

G02CB03

CABERGOLINUM *
COMPR.
0.5mg PFIZER EUROPE MA EEG

Protocol: G001C
0.5mg

G02CB03 CABERGOLINUM

Prescriere limitata: Prevenirea aparitiei lactatiei in lauzie. Cod restrictie 2659: Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicala Cod restrictie 2660: Hiperprolactinemia patologica pentru care a fost utilizat tratament chirurgical dar cu rezultate incomplete

253
EXLUTON®

G03AC02

LYNESTRENOLUM *
COMPR.
0.5mg ORGANON NV

G03AC02 LYNESTRENOLUM

0.5mg

254
MIRENA 20 µg/24 h

G03AC03

LEVONORGESTRELUM ***#
DISPOZITIV INTRAUTERIN
52mg SCHERING OY (SCHERING AG)

Protocol: G005N
52mg

G03AC03 LEVONORGESTRELUM

255
OVESTIN

G03CA04

ESTRIOLUM *
CREMA VAG.
0.1% ORGANON NV

G03CA04 ESTRIOLUM G03CA04 ESTRIOLUM
OVESTIN 0.5mg

0.1% 0.5mg
ORGANON NV

OVULE

256
COLPOTROPHINE®

G03CA09

PROMESTRIENUM *
CAPS. MOI VAG.
10mg LAB. THERAMEX

G03CA09 PROMESTRIENUM G03CA09 PROMESTRIENUM
COLPOTROPHINE® 1%

10mg 1%
LAB. THERAMEX

CREMA VAG.

257

G03DA04

PROGESTERONUM *
CAPS. MOI
100mg LAB. BESINS INTERNATIONAL

G03DA04 PROGESTERONUM
UTROGESTAN® 100 mg

100mg 1%
ANTIBIOTICE SA LAB. BESINS INTERNATIONAL

G03DA04 PROGESTERONUM
MASTOPROFEN 1% PROGESTOGEL 1% 1%

GEL

258
DUPHASTON®

G03DB01

DYDROGESTERONUM *
COMPR. FILM.
10mg SOLVAY PHARMACEUTICALS BV

G03DB01 DYDROGESTERONUM

10mg

259
ORGAMETRIL

G03DC03

LYNESTRENOLUM *
COMPR.
5mg ORGANON NV

G03DC03 LYNESTRENOLUM

5mg

260

G03DC05

TIBOLONUM **

Protocol: G007N

40 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
2,5mg

FORMA FARM.

FIRMA

PROTOCOL

G03DC05 TIBOLONUM
LADYBON

COMPR.
ZENTIVA A.S.

2,5mg 2.5mg
ORGANON NV

G03DC05 TIBOLONUM
LIVIAL® 2,5 mg 2.5mg

COMPR.

261
ACTIVELLE 1mg/0,5mg

G03FA01

COMBINATII **
COMPR. FILM.
1mg/0,5mg NOVO NORDISK A/S

Protocol: G002N
1mg/0,5mg

G03FA01 COMBINATII

262
FEMOSTON® conti 1/5

G03FA14

COMBINATII **
COMPR. FILM.
SOLVAY PHARMACEUTICALS BV

Protocol: G002N

G03FA14 COMBINATII

263
KLIMODIEN

G03FA15

ESTRADIOLUMVALERAT+DIENOGEST **
DRAJ.
SCHERING AG

Protocol: G002N

G03FA15 ESTRADIOLUMVALERAT+DIENOGEST

264
ANGELIQ

G03FA17

COMBINATII **
COMPR. FILM.
SCHERING AG

Protocol: G002N

G03FA17 COMBINATII

265
CYCLO PROGINOVA®

G03FB01

COMBINATII **
DRAJ.
SCHERING AG

Protocol: G002N

G03FB01 COMBINATII

266
NOVOFEM

G03FB05

COMBINATII **
COMPR. FILM.
NOVO NORDISK A/S

Protocol: G002N

G03FB05 COMBINATII

267
FEMOSTON 2/10

G03FB08

COMBINATII **
COMPR. FILM.
SOLVAY PHARMACEUTICALS BV

Protocol: G002N

G03FB08 COMBINATII G03FB08 COMBINATII
FEMOSTON 2/10

COMPR. FILM.
SOLVAY PHARMACEUTICALS BV

268

G03GA05
Prescriere limitata:

FOLITROPINUM ALFA ****#

Protocol: G003N

Infertilitate anovulatorie.

NOTA: Cu excepţia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fără efect (sarcina nu a fost obţinuta). Femeile care au urmat tratament pentru inducerea ovulaţiei cu alte clase de medicamente si nu au obţinut o sarcina necesita evaluare laparoscopică pentru a exclude alte cauze care împiedica apariţia unei sarcini. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

G03GA05 FOLITROPINUM ALFA
GONAL - f 150 UI 150UI 75UI

PULB. + SOLV. PT. SOL. INJ.
SERONO EUROPE LTD.

150UI 75UI

G03GA05 FOLITROPINUM ALFA
GONAL - f 75 UI

PULB. + SOLV. PT. SOL. INJ.
SERONO EUROPE LTD.

Prescriere limitata:

Infertilitate anovulatorie

269

G03GA06
Prescriere limitata:

FOLLITROPINUM BETA ****#

Protocol: G008N

Infertilitate anovulatorie.

NOTA: Cu excepţia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fără efect (sarcina nu a fost obţinuta). Femeile care au urmat tratament pentru inducerea ovulaţiei cu alte clase de medicamente si nu au obţinut o sarcina necesita evaluare laparoscopică pentru a exclude alte cauze care împiedica apariţia unei sarcini. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

G03GA06 FOLLITROPINUM BETA
PUREGON 100UI/0,5ml

SOL. INJ.
100UI/0.5ml N. V. ORGANON

100UI/0.5ml 300UI/0.36ml
N. V. ORGANON

G03GA06 FOLLITROPINUM BETA
PUREGON 300UI/0,36 ml

SOL. INJ.
300UI/0.36ml

G03GA06 FOLLITROPINUM BETA
PUREGON 50UI/0,5ml

SOL. INJ.
50UI/0.5ml N. V. ORGANON

50UI/0.5ml 600UI/0.72ml
N. V. ORGANON

G03GA06 FOLLITROPINUM BETA
PUREGON 600UI/0,72 ml

SOL. INJ.
600UI/0.72ml 100UI/ml 50UI/ml

G03GA06 FOLLITROPINUM BETA
PUREGON 100UI

PULB+SOLV. PT. SOL. INJ.
ORGANON NV

100UI/ml 50UI/ml

G03GA06 FOLLITROPINUM BETA
PUREGON 50UI

PULB+SOLV. PT. SOL. INJ
ORGANON NV

271
CLOSTILBEGYT OVA - MIT

G03GB02

CLOMIFENUM
COMPR.
50mg 50mg EGIS PHARMACEUTICALS PLC REMEDICA LTD.

G03GB02 CLOMIFENUM

50mg

Prescriere limitata:

Infertilitate anovulatorie

272
EVISTA 60mg

G03XC01

RALOXIFENUM
COMPR. FILM.
60mg ELI LILLY NEDERLAND BV

G03XC01 RALOXIFENUM

60mg

Cod restrictie 3006: Monoterapie cu medicamente antiresorbtive pentru tratamentul si profilaxia osteoporozei sexoidoprive la femei pana la varsta de 60 ani. NOTA: Agentii antiresorbtivi utilizati in tratamentul osteoporozei instalate sunt: ALENDRONATE SODIUM, RISEDRONAT SODIUM, RALOXIFEN HYDROCHLORIDE, IBANDRONATE, ZOLENDRONATE SI STRONTIUM RANELATE (agent antiresorbtiv si formator osos)..

273
DRIPTANE® 5 mg

G04BD04

OXYBUTYNINUM
COMPR.
5mg LAB. FOURNIER SA

G04BD04 OXYBUTYNINUM
Prescriere limitata: Hipereactivitate a detrusorului

5mg

274
DETRUSITOL SR 4 mg

G04BD07

TOLTERODINUM **#
CAPS. ELIB. PREL.
4mg PFIZER EUROPE MA EEIG

Protocol: G010N
4mg

G04BD07 TOLTERODINUM

275
VESICARE 10 mg

G04BD08

SOLIFENACINUM SUCCINATE **#
COMPR. FILM.
10mg ASTELLAS PHARMA EUROPE B.V.

Protocol: G009N
10mg

G04BD08 SOLIFENACINUM SUCCINATE

41 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
5mg

FORMA FARM.

FIRMA

PROTOCOL

G04BD08 SOLIFENACINUM SUCCINATE
VESICARE 5 mg

COMPR. FILM.
ASTELLAS PHARMA EUROPE B.V.

5mg

276
INKONTAN 15 mg

G04BD09

TROSPIUM
COMPR. FILM.
15mg

G04BD09 TROSPIUM G04BD09 TROSPIUM
INKONTAN 30 mg 30mg

15mg
PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H.

COMPR. FILM.

30mg
PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H.

277
ALFURAN MR 10 mg XATRAL SR 10 mg

G04CA01

ALFUZOSINUM
COMPR. ELIB. PREL.
10mg 10mg 5mg TERAPIA S.A. SANOFI-SYNTHELABO FRANCE

G04CA01 ALFUZOSINUM

10mg

G04CA01 ALFUZOSINUM
XATRAL® LP 5 mg

COMPR. FILM. ELIB. PREL.
SANOFI-SYNTHELABO FRANCE

5mg

278

G04CA02

TAMSULOSINUM

Prescriere limitata: Tratamentul hiperplaziei benigne de prostata. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

G04CA02 TAMSULOSINUM
TAMSOL 0,4 mg TAMSULOSIN ACTAVIS 0,4mg 0,4mg 0.4mg

CAPS. ELIB. MODIF.
GEDEON RICHTER ROMANIA ACTAVIS GROUP HF.

0,4mg

G04CA02 TAMSULOSINUM
FOKUSIN

CAPS. ELIB. MODIF.
ZENTIVA AS

0.4mg 0.4mg

G04CA02 TAMSULOSINUM
CONTIFLO MR TANYZ 0.4mg 0.4mg 0.4mg

CAPS. ELIB. PREL.
RANBAXY UK LTD. KRKA D.D. NOVO MESTO

G04CA02 TAMSULOSINUM
OMNIC TOCAS® 0,4

COMPR. FILM. ELIB. PREL.
ASTELLAS PHARMA EUROPE B.V.

0.4mg

279

G04CB01

FINASTERIDUM *

Prescriere limitata: Tratamentul hiperplaziei benigne de prostata. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

G04CB01 FINASTERIDUM
MOSTRAFIN PROSCAR 5 mg TAREDOX 5 mg 5mg 5mg 5mg

COMPR. FILM.
PLIVA LJUBLIJANA D.O.O. MERCK SHARP & DOHME ROMANIA S.R.L. DR. REDDY'S LABORATORIES

5mg

G04CB01 FINASTERIDUM
MOSTRAFIN PROSCAR 5 mg TAREDOX 5 mg 5mg 5mg 5mg

COMPR. FILM.
PLIVA LJUBLIJANA D.O.O. MERCK SHARP & DOHME ROMANIA S.R.L. DR. REDDY'S LABORATORIES

5mg

G04CB01 FINASTERIDUM
FINASTERID SANDOZ 5 mg 5 mg

COMPR. FILM.
HEXAL AG

5 mg

280

G04CB02

DUTASTERIDUM *

Prescriere limitata: Tratamentul hiperplaziei benigne de prostata. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

G04CB02 DUTASTERIDUM
AVODART® 0.5mg

CAPS. MOI
GLAXO GROUP LTD.

0.5mg

281
SYNACHTEN DEPOT

H01AA02

TETRACOSACTIDUM
SUSP. INJ.
1mg/ml NOVARTIS PHARMA GMBH

H01AA02 TETRACOSACTIDUM

1mg/ml

282

H01AC01

SOMATROPINUM ***#
SOL. INJ.
10mg/1.5ml NOVO NORDISK A/S

Protocol: H009E
10mg/1.5ml 10mg/2ml
IPSEN LIMITED

H01AC01 SOMATROPINUM
NORDITROPIN SIMPLEX x 10mg/1,5ml

H01AC01 SOMATROPINUM
NUTROPINAq 10 mg/2 ml 10mg/2ml

SOL. INJ. SOL. INJ.
3,3mg/ml 4mg (12ui) 5.3mg/ml (16ui) SANDOZ GMBH

H01AC01 SOMATROPINUM
OMNITROPE 3,3mg/ml

3,3mg/ml 4mg (12ui) 5.3mg/ml (16ui) 5mg/1.5ml
NOVO NORDISK A/S

H01AC01 SOMATROPINUM
ZOMACTON

LIOF. + SOLV. PT. SOL. INJ.
FERING GMBH PFIZER EUROPE MA EEIG

H01AC01 SOMATROPINUM
GENOTROPIN® 16 ui (5,3 mg)

PULB. + SOLV. PT. SOL. INJ. SOL. INJ.
5mg/1.5ml

H01AC01 SOMATROPINUM
NORDITROPIN SIMPLEXx 5 mg/1,5 ml

283

H01CC01

GANIRELIXUM ***#
SOL. INJ.
0.25mg/0.5ml N. V. ORGANON

Protocol: G004N
0.25mg/0.5ml

H01CC01 GANIRELIXUM
ORGALUTRAN 0.25mg/0.5ml

284
CETROTIDE 0,25 mg

H01CC02

CETRORELIXUM ***#
LIOF. + SOLV. PT. SOL. INJ.
0.25mg 3mg SERONO EUROPE LTD.

Protocol: H004E
0.25mg 3mg

H01CC02 CETRORELIXUM H01CC02 CETRORELIXUM
CETROTIDE 3 mg

LIOF. + SOLV. PT. SOL. INJ.
SERONO EUROPE LTD.

285
ASTONIN H

H02AA02

FLUDROCORTISONUM
COMPR.
0.1mg MERCK KGAA

H02AA02 FLUDROCORTISONUM

0.1mg

286
DIPROPHOS®

H02AB01

BETAMETHASONUM
SUSP. INJ. I.M.
7mg/ml SCHERING PLOUGH EUROPE

H02AB01 BETAMETHASONUM

7mg/ml

287

H02AB06

PREDNISOLONUM
LIOF. + SOLV. PT. SOL. INJ.
250mg MERCK KGAA

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 250

250mg 50mg

H02AB06 PREDNISOLONUM

LIOF. + SOLV. PT. SOL. INJ.

42 / 153

DCI/DENUMIRE COMERCIALA
SOLU - DECORTIN H 50

CONCENTRATIE
50mg

FORMA FARM.

FIRMA
MERCK KGAA

PROTOCOL

288
THYROZOL® 10 mg

H03BB02

THIAMAZOLUM
COMPR. FILM.
10mg MERCK KGAA

H03BB02 THIAMAZOLUM H03BB02 THIAMAZOLUM
THYROZOL® 20 mg 20mg

10mg 20mg
MERCK KGAA

COMPR. FILM. COMPR. FILM.
5mg MERCK KGAA

H03BB02 THIAMAZOLUM
THYROZOL® 5 mg

5mg

289
TONOCALCIN 100 UI

H05BA01

CALCITONINUM (SOMON)
SOL. INJ.
100UI ALFA WASSERMANN SPA

H05BA01 CALCITONINUM (SOMON) H05BA01 CALCITONINUM (SOMON)
NYLEX 100 UI/doza

100UI 100ui/doza
PHARMACEUTICAL IND. PROEL EPAM. G.CORONIS SA

SPRAY NAZ.,SOL.
100UI/doza

H05BA01 CALCITONINUM (SOMON)
NYLEX® 100UI/ml

SOL. INJ.
PROEL E.P. CORONIS SA

100UI/ml 200UI/doza

H05BA01 CALCITONINUM (SOMON)
MIACALCIC® NASAL 200 NYLEX®

SPRAY NAZAL - SOL.
200ui/doza 200UI/doza NOVARTIS PHARMA GMBH PROEL E.P. CORONIS SA

H05BA01 CALCITONINUM (SOMON)
MIACALCIC® 50ui/ml

SOL. INJ.
NOVARTIS PHARMA GMBH

50ui/ml

290
J01CR01
AMPIPLUS® 1,5 g

J01CR01
AMPICILLINUM + SULBACTAM

AMPICILLINUM + SULBACTAM
PULB. PT. SOL. INJ.
1g+500mg ANTIBIOTICE SA

1g+500mg

291
J01CR04
UNASYN

J01CR04
SULTAMICILLINUM SULTAMICILLINUM

SULTAMICILLINUM
PULB. PT. SUSP. ORALA
250mg/5ml PFIZER EUROPE MA EEIG

250mg/5ml 375mg

J01CR04
UNASYN

COMPR. FILM.
375mg PFIZER EUROPE MA EEIG

292
J01DC10 J01DC10 J01DC10 J01DC10
CEFZIL 125 mg/5 ml

J01DC10
CEFPROZILUM CEFPROZILUM

CEFPROZILUM
PULB. PT. SUSP. ORALA
125mg/5ml BRISTOL-MYERS SQUIBB KFT.

125mg/5ml 250mg

COMPR. FILM.
250mg 250mg/5ml BRISTOL-MYERS SQUIBB KFT.

CEFZIL 250 mg

CEFPROZILUM CEFPROZILUM
500mg

PULB. PT. SUSP. ORALA
BRISTOL-MYERS SQUIBB KFT.

250mg/5ml 500mg

CEFZIL 250 mg/5 ml CEFZIL 500 mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB KFT.

293
J01DD14
CEDAX

J01DD14
CEFTIBUTENUM

CEFTIBUTENUM
PULB. PT. SUSP. ORALA
36mg/ml SCHERING PLOUGH EUROPE

36mg/ml 400mg

J01DD14
CEDAX

CEFTIBUTENUM
400mg

CAPS.
SCHERING PLOUGH EUROPE

294
J01FA02 J01FA02

J01FA02
SPIRAMYCINUM

SPIRAMYCINUM
COMPR. FILM.
1.5 M ui LAB. AVENTIS

1.5 M ui 3M ui
LAB. AVENTIS

ROVAMYCINE® 1,5 Mil. UI

SPIRAMYCINUM
3M ui

COMPR. FILM.

ROVAMYCINE® 3 Mil. UI

295
J01FA10 J01FA10 J01FA10 J01FA10 J01FA10 J01FA10 J01FA10

J01FA10
AZITHROMYCINUM AZITHROMYCINUM

AZITHROMYCINUM
PULB. PT. SUSP. ORALA
100mg/5ml SANDOZ SRL

100mg/5ml 125mg

AZITROMICINA SANDOZ 100 mg/5 ml SUMAMED 125 mg

COMPR. FILM.
125mg 200 mg/5 ml 200mg/5ml 200mg/5ml PLIVA LJUBLJANA D.O.O.

AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM
250mg

PULB. PT. SUSP. ORALA
SANDOZ SRL

200 mg/5 ml 200mg/5ml 200mg/5ml 250mg

AZITROMICINA SANDOZ 200 mg/5 ml AZITROX 200 mg/5 ml SUMAMED FORTE AZATRIL 250 mg

PULB. + SOLV. SUSP. ORALA
ECZACIBASI PHARMACEUTICALS S.R.L. PLIVA LJUBLIJANA D.O.O. BALKANPHARMA RAZGRAD AD

PULB. PT. SUSP. ORALA CAPS. COMPR. FILM.
250mg 250mg SANDOZ S.R.L. ZENTIVA AS

AZITHROMYCINUM

250mg

AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE AZITROX® 250

J01FA10

AZITHROMYCINUM
500mg 500mg 500mg 500mg 500mg 2g

COMPR. FILM.
SANDOZ S.R.L. ZENTIVA AS ECZACIBASI PHARMACEUTICALS S.R.L. PLIVA LJUBLJANA D.O.O. OZONE LABORATORIES LTD.

500mg

AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE AZITROX® 500 AZRO® 500 mg SUMAMED 500 mg ZITROCIN 500 mg

J01FA10
ZMAX 2 g

AZITHROMYCINUM

GRAN. ELIB. PREL. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

2g

296

J01FF01
Prescriere limitata:

CLINDAMYCINUM

Infectii cu coci Gram pozitivi care nu pot fi tratate eficient cu peniciline. Infectii severe cu germeni anaerobi. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01FF01 J01FF01

CLINDAMYCINUM
150mg

CAPS.
PFIZER EUROPE MA EEIG

150mg 300mg
PFIZER EUROPE MA EEIG

DALACIN C 150 mg

CLINDAMYCINUM
300mg

CAPS.

DALACIN C 300 mg

43 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

297
TAVANIC®

J01MA12

LEVOFLOXACINUM
COMPR. FILM.
500mg AVENTIS PHARMA DEUTSCHLAND GMBH

J01MA12 LEVOFLOXACINUM

500mg

298
AVELOX® 400 mg

J01MA14

MOXIFLOXACINUM
COMPR. FILM.
400mg BAYER HEALTHCARE AG

J01MA14 MOXIFLOXACINUM

400mg

299
J02AC02
ITRACONAZOL 100 mg OMICRAL 100 mg ORUNGAL

J02AC02
ITRACONAZOLUM

ITRACONAZOLUM *
CAPS.
100mg 100mg 100mg TERAPIA S.A. MEDICO UNO PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV

100mg

300
J05AB11
VALTREX 500 mg

J05AB11
VALACYCLOVIRUM

VALACYCLOVIRUM *
COMPR. FILM.
500mg THE WELLCOME FOUNDATION LTD.

500mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in decurs de 72 de ore de la debutul rash-ului Herpes zoster oftalmic. Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe).

301

J05ABN1
Prescriere limitata:

BRIVUDINUM *#
COMPR.
125mg BERLIN CHEMIE AG MENARINI GROUP

Tratamentul pacientilor cu herpes zoster in decurs de 72 de ore de la debutul rash-ului.

J05ABN1 BRIVUDINUM
BRIVAL®

125mg

302
L01AA01
ENDOXAN® 50 mg

L01AA01
CYCLOPHOSPHAMIDUM

CYCLOPHOSPHAMIDUM *
DRAJ.
50mg BAXTER ONCOLOGY GMBH

50mg

305

L02AE04
Prescriere limitata:

TRIPTORELINUM ***#

Protocol: L013E

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic. Tratamentul pubertatii precoce. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului

L02AE04 L02AE04 L02AE04

TRIPTORELINUM
0.1mg 11.25mg 3.75mg

LIOF. + SOLV. PT. SOL. INJ.
BEAUFOUR IPSEN PHARMA

0.1mg 11.25mg 3.75mg

DIPHERELINE 0,1 mg

TRIPTORELINUM TRIPTORELINUM

LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.
BEAUFOUR IPSEN PHARMA

DIPHERELINE® 11,25 mg DIPHERELINE® 3,75 mg

LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.
BEAUFOUR IPSEN PHARMA

306
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

307

M01AC01

PIROXICAMUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AC01 PIROXICAMUM
FLAMEXIN N - PIROXICAM MEDUMAN 20 mg PIROXICAM 20 mg PIROXICAM LPH 20 mg PIROXSAL 20mg 20mg 20mg 20mg 20mg

COMPR.
CHIESI FARMACEUTICI SPA MEDUMAN S.A. ARENA GROUP SA LABORMED PHARMA SA SLAVIA PHARM SRL

20mg

M01AC01 PIROXICAMUM
FLAMEXIN 20mg

COMPR. EFF.
CHIESI FARMACEUTICI S.P.A.

20mg 20mg
SINTOFARM SA

M01AC01 PIROXICAMUM
PIROXICAM 20 mg 20mg

SUPOZ. SOL. INJ.
20mg/ml 20mg/ml 20mg/plic PFIZER EUROPE MA EEIG EGIS PHARMACEUTICALS PLC

M01AC01 PIROXICAMUM
FELDENE® 20 mg/ml HOTEMIN

20mg/ml

M01AC01 PIROXICAMUM
FLAMEXIN®

PULB. PT. SOL. ORALA
CHIESI FARMACEUTICI SPA

20mg/plic 40mg

M01AC01 PIROXICAMUM
PIROXICAM 40 mg 40mg

SUPOZ.
ANTIBIOTICE SA

308

M01AC05

LORNOXICAMUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AC05 LORNOXICAMUM
XEFO® 4 mg 4mg

COMPR. FILM.
NYCOMED AUSTRIA GMBH

4mg 8mg
NYCOMED AUSTRIA GMBH

M01AC05 LORNOXICAMUM
XEFO® 8 mg 8mg 8mg/2ml

COMPR. FILM. PULB. + SOLV. PT. SOL. INJ.
NYCOMED AUSTRIA GMBH

M01AC05 LORNOXICAMUM
XEFO 8 mg/ 2 ml

8mg/2ml

309

M01AE17

DEXKETOPROFENUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AE17 DEXKETOPROFENUM
TADOR 25mg 50mg/2ml

COMPR. FILM.
BERLIN CHEMIE AG MENARINI GROUP

25mg 50mg/2ml

M01AE17 DEXKETOPROFENUM
TADOR INJECT

SOL. INJ./CONC. PT. SOL. PERF.

MENARINI INTERNATIONAL OPERATIONS S.A.

310

M01AH01

CELECOXIBUM

Prescriere limitata: Tratamentul simptomatic antiinflamator la pacientii cu intoleranta la AINS neselective. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AH01 CELECOXIBUM

CAPS.

100mg

44 / 153

DCI/DENUMIRE COMERCIALA
CELEBREX 100 mg

CONCENTRATIE
100mg

FORMA FARM.

FIRMA
PFIZER EUROPE MA EEIG

PROTOCOL

M01AH01 CELECOXIBUM
CELEBREX 200 mg 200mg

CAPS.
PFIZER EUROPE MA EEIG

200mg

311

M01AH05

ETORICOXIBUM

Prescriere limitata: Tratamentul simptomatic antiinflamator la pacientii cu intoleranta la AINS neselective. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AH05 ETORICOXIBUM
ARCOXIA® 120 mg 120mg

COMPR. FILM.
MERCK SHARP & DOHME ROMANIA S.R.L.

120mg 60mg
MERCK SHARP & DOHME ROMANIA S.R.L.

M01AH05 ETORICOXIBUM
ARCOXIA® 60 mg 60mg

COMPR. FILM. COMPR. FILM.
90mg MERCK SHARP & DOHME ROMANIA S.R.L.

M01AH05 ETORICOXIBUM
ARCOXIA® 90 mg

90mg

312
DONA®

M01AX05

GLUCOSAMINUM
PULB. PT. SOL. ORALA
150mg/plic ROTTAPHARM SPA

M01AX05 GLUCOSAMINUM

150mg/plic

313

M01AX17

NIMESULIDUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AX17 NIMESULIDUM
APONIL AULIN® 100 mg COXTRAL LEMESIL NIMESULID LPH 100 mg NIMESULID 100 mg NIMESULID ARENA 100 mg NIMESULID SLAVIA NISE 100 mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg

COMPR.
MEDOCHEMIE LTD CSC PHARMACEUTICALS HANDELS GMBH ZENTIVA AS ANFARM HELLAS S.A. PHARMACEUTICALS LABORMED PHARMA SA MAGISTRA C & C ARENA GROUP S.A. SLAVIA PHARM SRL DR. REDDY'S LABORATORIES

100mg

M01AX17 NIMESULIDUM
SULIDAMOR

PULB. PT. SUSP. ORALA
FARMACEUTICI DAMOR SPA

100mg 100mg/plic

M01AX17 NIMESULIDUM
AULIN® NIMESIL

GRAN. PT. SUSP. ORALA
100mg/plic 100mg/plic CSC PHARMACEUTICALS HANDELS GMBH LAB. GUIDOTTI SPA

314
LIORESAL®

M03BX01

BACLOFENUM
COMPR.
10mg NOVARTIS PHARMA GMBH

M03BX01 BACLOFENUM M03BX01 BACLOFENUM
LIORESAL® 25mg

10mg 25mg
NOVARTIS PHARMA GMBH

COMPR.

315

M05BA04

ACIDUM ALENDRONICUM *

Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold). Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile. Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M05BA04 ACIDUM ALENDRONICUM
FOSAMAX 10 mg 10mg

COMPR.
MERCK SHARP & DOHME S.R.L.

10mg 70mg
MERCK SHARP & DOHME S.R.L.

M05BA04 ACIDUM ALENDRONICUM
FOSAMAX 70 mg 70mg

COMPR.

316

M05BA06

ACIDUM IBANDRONICUM *

Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold). Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile. Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M05BA06 ACIDUM IBANDRONICUM
BONVIVA 150mg 150mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

150mg

317

M05BA07

ACIDUM RISEDRONICUM *

Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold). Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile. Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M05BA07 ACIDUM RISEDRONICUM
ACTONEL® SAPTAMANAL 35mg

COMPR. FILM.
AVENTIS PHARMA AB

35mg

318
OSSEOR 2 g

M05BX03

STRONTIUM RANELATUM *
GRAN. PT. SUSP. ORALA
2g LES LAB. SERVIER

M05BX03 STRONTIUM RANELATUM

2g

319

M05BB03

COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM) *

Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold). Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile. Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M05BB03 COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM)
FOSAVANCE 70mg/2800UI

COMPR.
70mg/2800UI MERCK SHARP & DOHME LTD.

70mg/2800UI

320

N02AA05
Prescriere limitata:

OXYCODONUM *#

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide. Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni. Risc inalt de aparitie a dependentei. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N02AA05 OXYCODONUM

COMPR. FILM. ELIB. MODIF.

10 mg

45 / 153

DCI/DENUMIRE COMERCIALA
OXYCONTIN® 10 mg

CONCENTRATIE
10 mg 20 mg 40 mg 80mg

FORMA FARM.

FIRMA
MUNDIPHARMA GMBH

PROTOCOL

N02AA05 OXYCODONUM
OXYCONTIN® 20 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

20 mg 40 mg 80mg

N02AA05 OXYCODONUM
OXYCONTIN® 40 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

N02AA05 OXYCODONUM
OXYCONTIN® 80 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

321

N02AA08

DIHYDROCODEINUM *
COMPR. ELIB. PREL.
120mg 60mg 90mg MUNDIPHARMA GMBH

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 120 mg

120mg 60mg 90mg

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 60 mg

COMPR. ELIB. PREL.
MUNDIPHARMA GMBH

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 90 mg

COMPR. ELIB. PREL.
MUNDIPHARMA GMBH

322

N02AX52
Prescriere limitata:

COMBINATII (TRAMADOLUM+PARACETAMOLUM)

Durere severa, care nu raspunde la analgezice non-opioide. Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX52 COMBINATII (TRAMADOLUM+PARACETAMOLUM)
ZALDIAR®

COMPR. FILM.
37,5mg+325mg GRUNENTHAL GMBH

37,5mg+325mg

323
RIVOTRIL

N03AE01

CLONAZEPAMUM
COMPR.
0.5mg ROCHE ROMANIA S.R.L.

N03AE01 CLONAZEPAMUM N03AE01 CLONAZEPAMUM
RIVOTRIL® 2mg

0.5mg 2mg
ROCHE ROMANIA S.R.L.

COMPR.

324
LYRICA 150 mg

N03AX16

PREGABALINUM **#
CAPS.
150mg PFIZER LTD.

Protocol: N025G;N032G
150mg 300mg
PFIZER LTD.

N03AX16 PREGABALINUM N03AX16 PREGABALINUM
LYRICA 300 mg 300mg

CAPS. CAPS.
75mg PFIZER LTD.

N03AX16 PREGABALINUM
LYRICA 75 mg

75mg

326

N04BC05

PRAMIPEXOLUM *

Prescriere limitata: Tratamentul simptomatic al sindromului idiopatic al picioarelor nelinistite, forme moderate/severe. La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,18 mg 0.18mg

COMPR. COMPR.
0.7mg

0.18mg
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,7 mg

0.7mg
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

327

N04BXN1

PIRIBEDILUM **
DRAJ. ELIB. PREL.
50mg LES LAB. SERVIER IND.

N04BXN1 PIRIBEDILUM
PRONORAN® 50 mg LP

50mg

328
N05AL03 N05AL03
TIAPRIDAL® 100 mg

N05AL03
TIAPRIDUM

TIAPRIDUM
COMPR.
100mg SANOFI-SYNTHELABO FRANCE

100mg 100mg/2ml
SANOFI-AVENTIS FRANCE

TIAPRIDUM

SOL. INJ.
100mg/2ml

TIAPRIDAL 100 mg/2 ml

329

N05BE01

BUSPIRONUM

Prescriere limitata: Pentru tratamentul de scurta durata al anxietatii. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N05BE01 BUSPIRONUM
SPITOMIN 10 mg STRESSIGAL 10mg 10mg

COMPR.
EGIS PHARMACEUTICALS PLC ANFARM HELLAS S.A. PHARMACEUTICALS

10mg

N05BE01 BUSPIRONUM
SPITOMIN 5 mg 5mg

COMPR.
EGIS PHARMACEUTICALS PLC

5mg

330
LUDIOMIL® 10 mg

N06AA21

MAPROTILINUM *
COMPR. FILM.
10mg NOVARTIS PHARMA GMBH

N06AA21 MAPROTILINUM N06AA21 MAPROTILINUM
LUDIOMIL® 25 mg 25mg

10mg 25mg
NOVARTIS PHARMA GMBH

COMPR. FILM.

331
CIPRALEX 10 mg

N06AB10

ESCITALOPRAMUM **
COMPR. FILM.
10mg H. LUNDBECK A/S

Protocol: N009F
10mg 5mg
H. LUNDBECK A/S

N06AB10 ESCITALOPRAMUM N06AB10 ESCITALOPRAMUM
CIPRALEX 5 mg 5mg

COMPR. FILM.

332
TRITTICO AC 150 mg

N06AX05

TRAZODONUM **
COMPR. ELIB. PREL.
150mg ANGELINI FRANCESCO SPA

Protocol: N010F
150mg

N06AX05 TRAZODONUM

333
COAXIL®

N06AX14

TIANEPTINUM **
DRAJ.
12.5mg LES LAB. SERVIER IND.

Protocol: N011F
12.5mg

N06AX14 TIANEPTINUM

334
IXEL

N06AX17

MILNACIPRANUM **
CAPS.
25mg PIERRE FABRE MEDICAMENT

Protocol: N002F
25mg 50mg
PIERRE FABRE MEDICAMENT

N06AX17 MILNACIPRANUM N06AX17 MILNACIPRANUM
IXEL 50mg

CAPS.

46 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

335
CYMBALTA 30mg

N06AX21

DULOXETINUM **
CAPS. GASTROREZ.
30mg ELI LILLY NEDERLAND BV

Protocol: N014F
30mg 100mg/50ml
ELI LILLY NEDERLAND BV

N06AX21 DULOXETINUM N06AX21 DULOXETINUM
CYMBALTA 60mg 60mg

SOL. PERF.

336

N06AXN1

BUPROPIONUM **#
COMPR. FILM. ELIB. PREL.
150mg GLAXO WELLCOME UK LTD.

N06AXN1 BUPROPIONUM
WELLBUTRIN SR 150 mg

150mg

337
PRAMISTAR

N06BX16

PRAMIRACETAMUM **#
COMPR. FILM.
600mg F.I.R.M.A. S.p.a. (MENARINI GROUP)

N06BX16 PRAMIRACETAMUM

600mg

338
CAVINTON® FORTE

N06BX18

VINPOCETINUM
COMPR.
10mg GEDEON RICHTER LTD.

N06BX18 VINPOCETINUM N06BX18 VINPOCETINUM
VIMPOCETIN 5 mg 5mg

10mg 5mg
VIM SPECTRUM SRL

CAPS. COMPR.
5mg GEDEON RICHTER LTD.

N06BX18 VINPOCETINUM
CAVINTON®

5mg

339
BETASERC® 16 mg

N07CA01

BETAHISTINUM
COMPR.
16mg SOLVAY PHARMACEUTICALS BV

N07CA01 BETAHISTINUM N07CA01 BETAHISTINUM
BETASERC® 24 mg 24mg

16mg 24mg
SOLVAY PHARMACEUTICALS BV

COMPR. COMPR.
80mg A & G MED TRADING S.R.L.

N07CA01 BETAHISTINUM
URUTAL 8 mg

80mg 8mg
SOLVAY PHARMACEUTICALS BV PRODOTTI FORMENTI ACTAVIS GROUP HF.

N07CA01 BETAHISTINUM
BETASERC® 8 mg MICROSER VESTIBO 8 mg 8mg 8mg 8mg

COMPR.

340

N07CA52

COMBINATII (CINNARIZINUM+DIMENHIDRATUM)
COMPR.
HENNIG ARZNEIMITTEL GMBH & CO.KG

N07CA52 COMBINATII (CINNARIZINUM+DIMENHIDRATUM)
ARLEVERT

341

N07XN01

HIDROLIZAT DE PROTEINA DIN CREIER DE PORCINA **
SOL. INJ./PERF.
215.2mg/ml EBEWE PHARMA GMBH NFG. KG

Protocol: N026F

N07XN01 HIDROLIZAT DE PROTEINA DIN CREIER DE PORCINA
CEREBROLYSIN®

215.2mg/ml

342
PLAQUENIL®

P01BA02

HYDROXYCHLOROQUINUM
COMPR. FILM.
200mg SANOFI-SYNTHELABO LTD.

P01BA02 HYDROXYCHLOROQUINUM

200mg

343
BEROTEC N - 100 µg

R03AC04

FENOTEROLUM
SOL. DE INHALAT PRESURIZATA
100µg/doza BOEHRINGER INGELHEIM INT. GMBH

R03AC04 FENOTEROLUM

100µg/doza

344

R01AD05
Prescriere limitata:

BUDESONIDUM *
SPRAY NAZAL SUSP.
32µg/doza ASTRAZENECA AB

Profilaxia si tratamentul rinitei alergice.

R01AD05 BUDESONIDUM
RHINOCORT® AQUA

32µg/doza 50µg/doza

R01AD05 BUDESONIDUM
TAFEN NASAL

SPRAY NAZ.,SUSP.
50µg/doza LEK PHARMACEUTICALS D.D.

345
FLIXONASE®

R01AD08

FLUTICASONUM *
SPRAY NAZAL SUSP.
50µg/doza GLAXOWELLCOME UK LTD.

R01AD08 FLUTICASONUM
Prescriere limitata: Profilaxia si tratamentul rinitei alergice

50µg/doza

346
NASONEX

R01AD09

MOMETASONUM *
SPRAY NAZAL SUSP.
50µg/doza SCHERING PLOUGH EUROPE

R01AD09 MOMETASONUM
Prescriere limitata: Prescriere limitata: Profilaxia si tratamentul rinitei alergice. Tratamentul polipozelor nazale a adultului.

50µg/doza

347

R03AK03

COMBINATII (FENOTEROLUM + IPRATROPIUM) *
AEROSOL SOL. INHAL.
0,020mg+0,050mg BOEHRINGER INGELHEIM INT. GMBH

R03AK03 COMBINATII (FENOTEROLUM + IPRATROPIUM)
BERODUAL® N

0,020mg+0,050m g

348

R03AK06
Prescriere limitata:

COMBINATII (SALMETEROLUM+FLUTICASONUM) *

Tratament simptomatic al bolii pulmonare cronice obstructive (BPOC) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)
SERETIDE® 25/125 µg INHALER CFC FREE

AEROSOL SUSP. INHAL.
25mg/125mg GLAXOWELLCOME UK LTD.

25mg/125mg

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)
SERETIDE® 25/250 µg INHALER CFC FREE

AEROSOL SUSP. INHAL.
25mg/250mg GLAXOWELLCOME UK LTD.

25mg/250mg

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)
SERETIDE® 25/50 µg INHALER CFC FREE

AEROSOL SUSP. INHAL.
25mg/50mg GLAXOWELLCOME UK LTD.

25mg/50mg

47 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)
SERETIDE DISKUS 50/100

PULB. INHAL.
50mg/100mg GLAXO WELLCOME UK LIMITED

50mg/100mg

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)
SERETIDE DISKUS 50/250

PULB. INHAL.
50mg/250mg GLAXOWELLCOME UK LTD.

50mg/250mg

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)
SERETIDE DISKUS 50/500

PULB. INHAL.
50mg/500mg GLAXOWELLCOME UK LTD.

50mg/500mg

349

R03AK07
Prescriere limitata:

COMBINATII (BUDESONIDUM+FORMOTEROLUM) *

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

R03AK07 COMBINATII (BUDESONIDUM+FORMOTEROLUM)
SYMBIOCORT® TURBUHALER® 160/4,5 µg

PULB. INHAL.
160/4.5µg ASTRAZENECA AB

160/4.5µg

R03AK07 COMBINATII (BUDESONIDUM+FORMOTEROLUM)
SYMBIOCORT® TURBUHALER® 320/9 µg 320/9µg

PULB. INHAL.
ASTRAZENECA AB

320/9µg

R03AK07 COMBINATII (BUDESONIDUM+FORMOTEROLUM)
SYMBIOCORT® TURBUHALER® 80/4,5 µg 80/4.5µg

PULB. INHAL.
ASTRAZENECA AB

80/4.5µg

350

R03BA05

FLUTICASONUM *

Prescriere limitata: Tratamentul de control al astmului bronsic persistent. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

R03BA05 FLUTICASONUM
FLIXOTIDE® NEBULES® 0,5 mg/2 ml

SUSP. INHAL.
0.5mg/2ml 125µg/doza GLAXO WELLCOME UK LTD.

0.5mg/2ml 125µg/doza 2mg/2ml
GLAXO WELLCOME UK LTD.

R03BA05 FLUTICASONUM
FLIXOTIDE 125 INHALER CFC - Free

SUSP. INHAL. PRESURIZATA
GLAXO WELLCOME UK LTD.

R03BA05 FLUTICASONUM
FLIXOTIDE® NEBULES® 2 mg/2 ml 2mg/2ml

SUSP. INHAL. SUSP. INHAL. PRESURIZATA
50µg/doza GLAXO WELLCOME UK LTD.

R03BA05 FLUTICASONUM
FLIXOTIDE® 50 INHALER CFC - Free

50µg/doza

352

R03BA08

CICLESONIDUM *

Prescriere limitata: Tratamentul de fond al astmului bronsic persistent. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

R03BA08 CICLESONIDUM
ALVESCO 160 INHALER

SOL. DE INHALAT PRESURIZATA
160µg/doza 80µg/doza ALTANA PHARMA AG

160µg/doza 80µg/doza

R03BA08 CICLESONIDUM
ALVESCO 80 INHALER

SOL. DE INHALAT PRESURIZATA
ALTANA PHARMA AG

353
SPIRIVA® 18 µg

R03BB04

TIOTROPIUM *
CAPS. CU PULB.INHAL.
18µg

R03BB04 TIOTROPIUM
Prescriere limitata:

18µg

BOEHRINGER INGELHEIM PHARMA GMBH&CO.KG

Pentru tratamentul de intretinere pe termen lung al bronhospasmului si dispneei associate bolii pulmonare obstructive cronice

354
MIOFILIN 100 mg

R03DA05

AMINOPHYLLINUM
CAPS.
100mg ZENTIVA SA

R03DA05 AMINOPHYLLINUM R03DA05 AMINOPHYLLINUM
AMINOFILINA EEL 100mg

100mg 100mg
BIO EEL SRL

COMPR. COMPR.
200mg ARENA GROUP SA

R03DA05 AMINOPHYLLINUM
AMINOFILINA 200 mg

200mg 24mg/ml
ZENTIVA S.A.

R03DA05 AMINOPHYLLINUM
MIOFILIN 24mg/ml

SOL. INJ.

355
SINGULAIR®

R03DC03

MONTELUKASTUM *
COMPR. FILM.
10mg MERCK SHARP & DOHME ROMANIA S.R.L.

R03DC03 MONTELUKASTUM
Prescriere limitata:

10mg

Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu durata scurta de actiune.

R03DC03 MONTELUKASTUM
SINGULAIR 4mg

COMPR. MAST.
MERCK SHARP & DOHME S.R.L.

4mg

Prescriere limitata:

Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu durata scurta de actiune. Cod restrictie 2617: Tratament astmului bronsic persistent la copii cu varste cuprinse intre 2 si 5 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.

R03DC03 MONTELUKASTUM
SINGULAIR® 4mg/plic

GRANULE
MERCK SHARP & DOHME ROMANIA S.R.L.

4mg/plic

Prescriere limitata:

Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu durata scurta de actiune. Cod restrictie 2617: Tratament astmului bronsic persistent la copii cu varste cuprinse intre 2 si 5 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.

R03DC03 MONTELUKASTUM
SINGULAIR® 5mg

COMPR. MAST.
MERCK SHARP & DOHME ROMANIA S.R.L.

5mg

Prescriere limitata:

Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu durata scurta de actiune. Cod restrictie 2617: Tratament astmului bronsic persistent la copii cu varste cuprinse intre 6 si 14 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.

356
EURESPAL®

R03DX03

FENSPIRIDUM
SIROP
0.2% LES LAB. SERVIER IND.

R03DX03 FENSPIRIDUM R03DX03 FENSPIRIDUM

0.2% 80mg

COMPR. FILM.

48 / 153

DCI/DENUMIRE COMERCIALA
EURESPAL 80 mg

CONCENTRATIE
80mg

FORMA FARM.

FIRMA
LES LAB. SERVIER IND.

PROTOCOL

357
ERDOMED® 175

R05CB15

ERDOSTEINUM
PULB. PT. SUSP. ORALA
175mg/5ml CSC PHARMACEUTICALS HANDELS GMBH

R05CB15 ERDOSTEINUM R05CB15 ERDOSTEINUM
ERDOMED 300mg

175mg/5ml 300mg

CAPS.
MEDICOM INTERNATIONAL SRO

358
HUMEX TUSSIN SIROP

R05DA09

DEXTROMETHORPHANUM
SIROP
0.1% 0.1% LAB. URGO SA GLOBAL PHARMACEUTICALS S.R.L.

R05DA09 DEXTROMETHORPHANUM

0.1%

R05DA09 DEXTROMETHORPHANUM
HUMEX 0.13%

SIROP
LAB. URGO SA

0.13% 10mg
EUROPHARM SA

R05DA09 DEXTROMETHORPHANUM
TUSSIN 10mg

COMPR. SIROP
15mg/5ml BIOFARM SA

R05DA09 DEXTROMETHORPHANUM
ROFEDEX

15mg/5ml 20mg
EUROPHARM SA

R05DA09 DEXTROMETHORPHANUM
TUSSIN FORTE 20mg

COMPR. SOL. ORALA
3.75mg/5ml WYETH WHITEHALL EXPORT GMBH

R05DA09 DEXTROMETHORPHANUM
ROBITUSSIN JUNIOR

3.75mg/5ml 7.5mg/5ml
WYETH WHITEHALL EXPORT GMBH

R05DA09 DEXTROMETHORPHANUM
ROBITUSSIN ANTITUSSICUM

SOL. ORALA
7.5mg/5ml

359
XYZAL®

R06AE09

LEVOCETIRIZINUM
COMPR. FILM.
5mg U.C.B. GMBH

R06AE09 LEVOCETIRIZINUM R06AE09 LEVOCETIRIZINUM
XYZAL 5mg/ml

5mg 5mg/ml
U.C.B. GMBH

PIC. ORALE, SOL.

360
ALTIVA 120 mg TELFAST® 120 mg

R06AX26

FEXOFENADINUM
COMPR. FILM.
120mg 120mg RANBAXY UK LTD. AVENTIS PHARMA DEUTSCHLAND GMBH

R06AX26 FEXOFENADINUM

120mg

R06AX26 FEXOFENADINUM
ALTIVA 180 mg TELFAST® 180 mg 180mg 180mg

COMPR. FILM.
RANBAXY UK LTD. AVENTIS PHARMA DEUTSCHLAND GMBH

180mg

R06AX26 FEXOFENADINUM
TELFAST® 30 mg 30mg

COMPR. FILM.
AVENTIS PHARMA DEUTSCHLAND GMBH

30mg

361
AERIUS 0.5mg/ml

R06AX27

DESLORATADINUM
SIROP
0.5mg/ml SP EUROPE

R06AX27 DESLORATADINUM R06AX27 DESLORATADINUM
AERIUS 5mg 5mg

0.5mg/ml 5mg
SP EUROPE

COMPR. FILM.

362
OPHTAGRAM® 0,3%

S01AA11

GENTAMICINUM
PICATURI OFT.-SOL.
0.3% LAB. CHAUVIN

S01AA11 GENTAMICINUM S01AA11 GENTAMICINUM
GENTICOL 0.3%

0.3% 0.3%

SOL. OFT.
S.I.F.I. SPA

S01AA11 GENTAMICINUM
GENTICOL OPHTAGRAM® 0,3% 0.3% 0.3%

UNG. OFT.
S.I.F.I. SPA LAB. CHAUVIN

0.3%

S01AA11 GENTAMICINUM
GENTAMICIN SULPHATE 0.3%

PIC. OFT., SOL
E.I.P.I.CO. MED S.R.L.

0.3%

363
TOBREX®

S01AA12

TOBRAMYCINUM
UNG. OFT.
0.3% ALCON COUVREUR NV

S01AA12 TOBRAMYCINUM S01AA12 TOBRAMYCINUM
TOBISOL 0.3%

0.3% 0.3%
E.I.P.I.CO. MED S.R.L.

PIC. OFT., SOL. PIC. OFT.,SOL.
3mg/ml ALCON COUVREUR NV

S01AA12 TOBRAMYCINUM
TOBREX

3mg/ml

364
NETTACIN®

S01AA23

NETILMICINUM
PICATURI OFT.-SOL.
0.3% S.I.F.I. SPA

S01AA23 NETILMICINUM S01AA23 NETILMICINUM
NETTAVISC 3mg/g 3mg/g

0.3% 3mg/g

UNG. OFT.
S.I.F.I. SPA

S01AA23 NETILMICINUM
NETTACIN® 0.3%

PIC. OFT., SOL
S.I.F.I. SPA

0.3%

365
FLOXAL®

S01AX11

OFLOXACINUM
PICATURI OFT.-SOL.
0.3%

S01AX11 OFLOXACINUM S01AX11 OFLOXACINUM
FLOXAL® 0.3%

0.3% 0.3%

DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

UNG. OFT.

DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

366
MAXIDEX®

S01BA01

DEXAMETHASONUM
PICATURI OFT.-SUSP.
0.1% ALCON COUVREUR NV

S01BA01 DEXAMETHASONUM

0.1%

367
OPHTAMESONE

S01BA06

BETAMETHASONUM
SOL. OFT.
0.1% DAR AL DAWA PHARMA S.R.L

S01BA06 BETAMETHASONUM

0.1%

368

S01CA01

COMBINATII (NETILMICINUM + DEXAMETHASONUM)

49 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

S01CA01 COMBINATII (NETILMICINUM + DEXAMETHASONUM)
NETILDEX

PIC. OFT.,SOL.
S.I.F.I. SPA

S01CA01 COMBINATII (NETILMICINUM + DEXAMETHASONUM)
NETILDEX

PIC. OFT.SOL. UNIDOZA
S.I.F.I. SPA

369

S01CA01

COMBINATII (TOBRAMYCINUM + DEXAMETHASONUM)
UNG. OFT.
1mg+3mg ALCON COUVREUR NV

S01CA01 COMBINATII (TOBRAMYCINUM + DEXAMETHASONUM)
TOBRADEX®

1mg+3mg

S01CA01 COMBINATII (TOBRAMYCINUM + DEXAMETHASONUM)
TOBRADEX® 1mg+3mg

PICATURI OFT.-SUSP.
ALCON COUVREUR NV

1mg+3mg

370

S01CA01

COMBINATII (CHLORAMPHENICOLUM + DEXAMETHASONUM)
PICATURI OFT.-SOL.
5mg/ml+1mg/ml NOVARTIS PHARMA GMBH

S01CA01 COMBINATII (CHLORAMPHENICOLUM + DEXAMETHASONUM)
SPERSADEX COMP

5mg/ml+1mg/ml

371
OPATANOL 1mg/ml

S01GX09

OLOPATADINUM
PIC. OFT., SOL.
1mg/ml ALCON LABORATORIES LTD.

S01GX09 OLOPATADINUM

1mg/ml

372
OCULOTECT

S01XA02

RETINOLUM
GEL OFT.
10mg/g NOVARTIS PHARMA GMBH

S01XA02 RETINOLUM

10mg/g

1219
CARBIMAZOLE 5

H03BB01

CARBIMAZOLUM
COMPR. FILM.
5mg REMEDICA LTD.

H03BB01 CARBIMAZOLUM

5mg

50 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G1 INSUFICIENTA CARDIACA CRONICA (CLASA III SAU IV NYHA). 373 B01AA07 ACENOCUMAROLUM
B01AA07 ACENOCUMAROLUM
TROMBOSTOP 2 mg 2mg

COMPR.
TERAPIA SA

2mg 4mg
NOVARTIS PHARMA GMBH

B01AA07 ACENOCUMAROLUM
SINTROM® 4mg

COMPR.

374

C01AA05

DIGOXINUM
SOL. ORALA
0.05mg/ml THE WELLCOME FOUNDATION LTD.

C01AA05 DIGOXINUM
LANOXIN SOLUTIE ORALA

0.05mg/ml 0.25mg
ZENTIVA S.A.

C01AA05 DIGOXINUM
DIGOXIN 0,25 mg 0.25mg

COMPR. SOL. INJ.
0.5mg/ml ZENTIVA S.A.

C01AA05 DIGOXINUM
DIGOXIN 0,5 mg/2 ml

0.5mg/ml

375
NEFRIX 25 mg

C03AA03

HYDROCHLOROTHIAZIDUM
COMPR.
25mg ZENTIVA SA

C03AA03 HYDROCHLOROTHIAZIDUM

25mg

376

C03CA01

FUROSEMIDUM

Electroliţii serici trebuie să fie verificaţi periodic. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C03CA01 FUROSEMIDUM
FUROSEMID 20 mg/2 ml 10mg/ml

SOL. INJ.
ZENTIVA SA

10mg/ml 40mg
ARENA GROUP S.A. BIO EEL SRL LABORMED PHARMA SA MAGISTRA C & C SRL SLAVIA PHARM SRL ZENTIVA SA

C03CA01 FUROSEMIDUM
FUROSEMID ARENA 40 mg FUROSEMID EEL FUROSEMID LPH 40 mg FUROSEMID MCC 40 mg FUROSEMID SLAVIA FUROSEMID ZENTIVA 40mg 40mg 40mg 40mg 40mg 40mg

COMPR.

377

C03DA01

SPIRONOLACTONUM

Electroliţii serici trebuie să fie verificaţi periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C03DA01 SPIRONOLACTONUM
VEROSPIRON 100mg

CAPS.
GEDEON RICHTER LTD.

100mg 25mg
BIO EEL SRL

C03DA01 SPIRONOLACTONUM
SPIRONOLACTONA 25 mg 25mg

COMPR. COMPR. FILM.
25mg 25mg AC HELCOR PHARMA SRL TERAPIA SA

C03DA01 SPIRONOLACTONUM
ALSPIRON 25 mg SPIRONOLACTONA 25 mg

25mg

C03DA01 SPIRONOLACTONUM
VEROSPIRON 50mg

CAPS.
GEDEON RICHTER LTD.

50mg 50mg
AC HELCOR PHARMA SRL

C03DA01 SPIRONOLACTONUM
ALSPIRON 50 mg 50mg

COMPR. FILM.

378

C07AB02

METOPROLOLUM
COMPR.
100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 190mg AC HELCOR PHARMA SRL KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH OZONE LABORATORIES LTD. ALIUD® PHARMA GMBH & CO.KG LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L. TERAPIA SA SLOVAKOFARMA

C07AB02 METOPROLOLUM
BETAPROL 100 mg BLOXAN EGILOK 100 mg METOPRO TAD 100 METOPROLOL 100 mg METOPROLOL AL 100 METOPROLOL LPH 100 mg METOPROLOL MEDICO UNO 100 mg METOPROLOL TERAPIA 100 mg VASOCARDIN® 100

100mg

C07AB02 METOPROLOLUM
METOPROLOL RETARD 100 mg

COMPR. ELIB. PREL.
TERAPIA S.A.

100mg 100mg 190mg 1mg/ml

C07AB02 METOPROLOLUM
BETALOC® ZOC 100 mg

COMPR. FILM. ELIB. PREL.
ASTRAZENECA AB

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 190 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

C07AB02 METOPROLOLUM
BETALOC 1mg/ml 200mg

SOL. INJ.
ASTRAZENECA AB

C07AB02 METOPROLOLUM
VASOCARDIN® SR 200

COMPR. ELIB. PREL.
ZENTIVA AS

200mg 25mg

C07AB02 METOPROLOLUM
EGILOK 25 mg METOPROLOL 25 mg METOPROLOL LPH 25 mg METOPROLOL MEDICO UNO 25 mg 25mg 25mg 25mg 25mg 47.5mg

COMPR.
EGIS PHARMACEUTICALS P.L.C. ARENA GROUP S.A. LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L.

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 47,5 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

47.5mg 50mg

C07AB02 METOPROLOLUM
BETAPROL 50 mg EGILOK 50 mg METOPRO TAD 50 METOPROLOL 50 mg METOPROLOL AL 50 METOPROLOL LPH 50 mg METOPROLOL MEDICO UNO 50 mg METOPROLOL TERAPIA 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

COMPR.
AC HELCOR PHARMA SRL EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH OZONE LABORATORIES LTD. ALIUD PHARMA GMBH & CO.KG LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L. TERAPIA SA

51 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
50mg 95mg

FORMA FARM.

FIRMA

PROTOCOL

C07AB02 METOPROLOLUM
BETALOC® ZOC 50 mg

COMPR. FILM. ELIB. PREL.
ASTRAZENECA AB

50mg 95mg

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 95 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

379
CONCOR COR 2,5 mg

C07AB07

BISOPROLOLUM
COMPR. FILM.
2.5mg MERCK KGAA

C07AB07 BISOPROLOLUM

2.5mg

380
NEBILET®

C07AB12

NEBIVOLOLUM **
COMPR.
5mg BERLIN CHEMIE AG MENARINI GROUP

C07AB12 NEBIVOLOLUM

5mg

381
CARVEDILOL SANDOZ

C07AG02

CARVEDILOLUM
COMPR.
12,5 mg HEXAL AG

C07AG02 CARVEDILOLUM C07AG02 CARVEDILOLUM
ATRAM 12,5 CARVEDILOL 12,5 mg CARVEDILOL HELCOR 12,5 mg CARVEDILOL LPH 12,5 mg CARVEDILOL TEVA 12,5 mg CORYOL® DILATREND® 12,5 mg TALLITON® 12,5 mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg

12,5 mg 12.5mg
ZENTIVA AS VIM SPECTRUM SRL AC HELCOR PHARMA SRL LABORMED PHARMA SA TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. EGIS PHARMACEUTICALS LTD.

COMPR.

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 12,5 mg 12.5mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG

12.5mg 25mg
ZENTIVA AS AC HELCOR PHARMA SRL LABORMED PHARMA SA HEXAL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. EGIS PHARMACEUTICALS LTD.

C07AG02 CARVEDILOLUM
ATRAM 25 CARVEDILOL HELCOR 25 mg CARVEDILOL LPH 25 mg CARVEDILOL SANDOZ CARVEDILOL TEVA 25 mg CORYOL® DILATREND® 25 mg TALLITON® 25 mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg

COMPR.

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 25 mg 25mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG

25mg 3.125mg
KRKA D.D.

C07AG02 CARVEDILOLUM
CORYOL® 3,125 mg 3.125mg

COMPR. COMPR.
6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg ZENTIVA AS VIM SPECTRUM SRL LABORMED PHARMA SA HEXAL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. EGIS PHARMACEUTICALS LTD.

C07AG02 CARVEDILOLUM
ATRAM 6,25 CARVEDILOL 6,25 mg CARVEDILOL LPH 6,25 mg CARVEDILOL SANDOZ CARVEDILOL TEVA 6,25 mg CORYOL® DILATREND® 6,25 mg TALLITON 6,25 mg

6.25mg

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 6,25 mg 6.25mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG

6.25mg

382

C09AA01

CAPTOPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09AA01 CAPTOPRILUM
CAPTOPRIL MCC 12,5 mg 12,5mg

COMPR.
MAGISTRA C & C

12,5mg 12.5mg
EGIS PHARMACEUTICALS LTD.

C09AA01 CAPTOPRILUM
CAPTOPRIL 12,5 mg 12.5mg

COMPR. COMPR.
25mg 25mg 25mg 25mg 25mg 25mg AC HELCOR PHARMA SRL SINTOFARM SA BIO EEL SRL EGIS PHARMACEUTICALS LTD. LABORMED PHARMA SA MAGISTRA C & C

C09AA01 CAPTOPRILUM
CAPTOPRIL - AC 25 mg CAPTOPRIL SINTOFARM 25 mg CAPTOPRIL 25 EEL CAPTOPRIL 25 mg CAPTOPRIL LPH 25 mg CAPTOPRIL MCC 25 mg

25mg

C09AA01 CAPTOPRILUM
CAPTOPRIL 50 mg 50 mg

COMPR.
ARENA GROUP SA

50 mg 50mg
AC HELCOR PHARMA SRL BIO EEL SRL EGIS PHARMACEUTICALS LTD. LABORMED PHARMA SA MAGISTRA C & C

C09AA01 CAPTOPRILUM
CAPTOPRIL - AC 50 mg CAPTOPRIL 50 EEL CAPTOPRIL 50 mg CAPTOPRIL LPH 50 mg CAPTOPRIL MCC 50 mg 50mg 50mg 50mg 50mg 50mg

COMPR.

383

C09AA02

ENALAPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09AA02 ENALAPRILUM
ENAP®

SOL. INJ.
1.25mg/ml KRKA D.D.

1.25mg/ml 10mg
GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH E.I.P.I.CO. MED S.R.L. MAGISTRA C & C

C09AA02 ENALAPRILUM
EDNYT® 10 mg ENAHEXAL® 10 mg ENALA TAD 10 ENALAP ENALAPRIL 10 mg 10mg 10mg 10mg 10mg 10mg

COMPR.

52 / 153

DCI/DENUMIRE COMERCIALA
ENALAPRIL AL 10 ENALAPRIL FABIOL 10 mg ENALAPRIL LPH 10 mg ENALAPRIL SANDOZ 10 mg ENALAPRIL TERAPIA 10 mg ENAM 10 mg ENAP 10 mg RENITEC 10 mg

CONCENTRATIE
10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

FORMA FARM.

FIRMA
ALIUD® PHARMA GMBH & CO.KG FABIOL SA LABORMED PHARMA SA SANDOZ SRL TERAPIA SA REPREZENTANTA DR. REDDY'S LABORATORIES LTD. KRKA D.D. NOVO MESTO MERCK SHARP & DOHME ROMANIA S.R.L.

PROTOCOL

C09AA02 ENALAPRILUM
EDNYT® 2,5 mg 2.5mg

COMPR.
GEDEON RICHTER LTD.

2.5mg 20mg
GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH OZONE LABORATORIES LTD. MAGISTRA C & C ALIUD® PHARMA GMBH & CO.KG FABIOL SA LABORMED PHARMA SA SANDOZ SRL TERAPIA SA KRKA D.D. NOVO MESTO MERCK SHARP & DOHME ROMANIA S.R.L.

C09AA02 ENALAPRILUM
EDNYT® 20 mg ENAHEXAL® 20 mg ENALA TAD 20 ENALAPRIL ENALAPRIL 20 mg ENALAPRIL AL 20 ENALAPRIL FABIOL 20 mg ENALAPRIL LPH 20 mg ENALAPRIL SANDOZ 20 mg ENALAPRIL TERAPIA 20 mg ENAP 20 mg RENITEC 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR.

C09AA02 ENALAPRILUM
EDNYT® 5 mg ENAHEXAL® 5 mg ENALA TAD 5 ENALAPRIL 5 mg ENALAPRIL AL 5 ENALAPRIL LPH® 5 mg ENALAPRIL SANDOZ 5 mg ENAP 5 mg RENITEC 5 mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.
GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH OZONE LABORATORIES LTD. ALIUD® PHARMA GMBH & CO.KG LABORMED PHARMA SA SANDOZ SRL KRKA D.D. NOVO MESTO MERCK SHARP & DOHME ROMANIA S.R.L.

5mg

384

C09AA03

LISINOPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09AA03 LISINOPRILUM
LISIGAMMA 10 mg LISINOPRIL 10 MEDO LISINOPRIL ANTIBIOTICE 10 mg LISINOPRIL SANDOZ 10 mg LISIREN 10 mg MEDAPRIL 10 RANOLIP SINOPRYL® 10 TONOLYSIN 10 mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

COMPR.
WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL ANTIBIOTICE SA HEXAL AG AC HELCOR SRL MEDOCHEMIE LTD. RANBAXY U.K. LIMITED ECZACIBASI PHARMACEUTICALS S.R.L. GEDEON RICHTER LTD.

10mg

C09AA03 LISINOPRILUM
TONOLYSIN 2,5 mg 2.5mg

COMPR.
GEDEON RICHTER LTD.

2.5mg 20mg
WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL ANTIBIOTICE SA HEXAL AG AC HELCOR SRL MEDOCHEMIE LTD. RANBAXY U.K. LIMITED GEDEON RICHTER LTD.

C09AA03 LISINOPRILUM
LISIGAMMA 20 mg LISINOPRIL 20 MEDO LISINOPRIL ANTIBIOTICE 20 mg LISINOPRIL SANDOZ 20 mg LISIREN 20 mg MEDAPRIL 20 RANOLIP TONOLYSIN 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR.

C09AA03 LISINOPRILUM
LISINOPRIL ANTIBIOTICE 40 mg 40mg

COMPR.
ANTIBIOTICE SA

40mg 5mg
WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL HEXAL AG MEDOCHEMIE LTD. RANBAXY U.K. LIMITED GEDEON RICHTER LTD.

C09AA03 LISINOPRILUM
LISIGAMMA 5 mg LISINOPRIL 5 MEDO LISINOPRIL SANDOZ 5 mg MEDAPRIL 5 RANOLIP TONOLYSIN 5 mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.

385

C09AA05

RAMIPRILUM

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in utero. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C09AA05 RAMIPRILUM
RAMIRAN 1,25 mg 1.25mg

COMPR. FILM.
RANBAXY U.K. LIMITED

1.25mg 10 mg
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

C09AA05 RAMIPRILUM
EMREN 10 mg VIVACE 10 mg 10 mg 10 mg

COMPR.

C09AA05 RAMIPRILUM
AMPRIL 10 mg PIRAMIL 10 mg RAMIGAMMA 10 mg RAMIPRIL-AC 10 mg TRITACE 10 ZENRA 10 10mg 10mg 10mg 10mg 10mg 10mg

COMPR.
KRKA D.D. NOVO MESTO SANDOZ SRL WORWAG PHARMA GMBH & CO. KG AC HELCOR PHARMA SRL SANOFI - AVENTIS DEUTSCHLAND GMBH ZENTIVA S.A.

10mg

C09AA05 RAMIPRILUM
RAMIRAN 10 mg 10mg

COMPR. FILM.
RANBAXY U.K. LIMITED

10mg 2,5 mg

C09AA05 RAMIPRILUM

COMPR.

53 / 153

DCI/DENUMIRE COMERCIALA
EMREN 2,5 mg VIVACE 2,5 mg

CONCENTRATIE
2,5 mg 2,5 mg

FORMA FARM.

FIRMA
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

PROTOCOL

C09AA05 RAMIPRILUM
AMPRIL 2,5 mg PIRAMIL 2,5 mg RAMIPRIL-AC 2,5 mg TRITACE® 2,5 ZENRA 2,5 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg

COMPR.
KRKA D.D. NOVO MESTO SANDOZ SRL AC HELCOR PHARMA SRL AVENTIS PHARMA DEUTSCHLAND GMBH ZENTIVA S.A.

2.5mg

C09AA05 RAMIPRILUM
RAMIRAN 2,5 mg 2.5mg

COMPR. FILM.
RANBAXY U.K. LIMITED

2.5mg 5 mg
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

C09AA05 RAMIPRILUM
EMREN 5 mg VIVACE 5 mg 5 mg 5 mg

COMPR.

C09AA05 RAMIPRILUM
AMPRIL 5 mg PIRAMIL 5 mg RAMIGAMMA 5 mg RAMIPRIL-AC 5 mg TRITACE® 5 ZENRA 5 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.
KRKA D.D. NOVO MESTO SANDOZ SRL WORWAG PHARMA GMBH & CO. KG AC HELCOR PHARMA SRL AVENTIS PHARMA DEUTSCHLAND GMBH ZENTIVA S.A.

5mg

C09AA05 RAMIPRILUM
RAMIRAN 5 mg 5mg

COMPR. FILM.
RANBAXY U.K. LIMITED

5mg

386
DIOVAN 160 mg

C09CA03

VALSARTANUM **
COMPR. FILM.
160mg NOVARTIS PHARMA GMBH

Protocol: C005I
160mg 80mg
NOVARTIS PHARMA GMBH

C09CA03 VALSARTANUM C09CA03 VALSARTANUM
DIOVAN 80 mg 80mg

COMPR. FILM.

387
ATACAND

C09CA06

CANDESARTANUM CILEXETIL **
COMPR.
16mg ASTRAZENECA AB

Protocol: C005I
16mg 8mg

C09CA06 CANDESARTANUM CILEXETIL C09CA06 CANDESARTANUM CILEXETIL
ATACAND 8mg

COMPR.
ASTRAZENECA AB

SUBLISTA C1-G2 BOLNAVI CU PROTEZE VALVULARE SI VASCULARE. 388 B01AA07 ACENOCUMAROLUM *
B01AA07 ACENOCUMAROLUM
TROMBOSTOP 2 mg 2mg

Protocol: BB01I
2mg
TERAPIA SA

COMPR. COMPR.
4mg NOVARTIS PHARMA GMBH

B01AA07 ACENOCUMAROLUM
SINTROM®

4mg

SUBLISTA C1-G3 BOLNAVI CU PROCEDURI INTERVENTIONALE PERCUTANE, NUMAI DUPA IMPLANTAREA UNEI PROTEZE ENDOVASCULARE (STENT). 389 B01AC04 CLOPIDOGRELUM ***
B01AC04 CLOPIDOGRELUM
PLAVIX 75mg 75mg

COMPR. FILM.
SANOFI PHARMA - BRISTOL MYERS SQUIBB

75mg

54 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G4 HEPATITELE CRONICE DE ETIOLOGIE VIRALA B, C SI D. 390 B03XA01 EPOETINUM ALFA **
B03XA01 EPOETINUM ALFA
EPREX® 10000 UI

Protocol: LB01B;LB02B
Protocol: B013K
10000ui/ml

SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 1000 UI/0,5 ml EPREX® 1000 UI

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

1000UI/0.5ml

B03XA01 EPOETINUM ALFA
EPOPHAR 2000 U.I. 2000UI

SOL. INJ.
GULF PHARMACEUTICAL IND. S.R.L.

2000UI 2000ui/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/0,5 ml EPREX® 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPREX® 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA
EPREX® 40 000 UI 40 000UI

SOL. INJ.
JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA
EPOPHAR 4000 U.I. 4000UI

SOL. INJ. SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/0,4 ml EPREX® 4000 UI

4000ui/0.4ml

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml RENAMED FARMA S.R.L.

4000UI/1ml

391

B03XA01

EPOETINUM BETA **
SOL. INJ. IN SERINGA PREUMPLUTA
10000UI/0,6ml 1000UI/0,3ml 2000UI/0,3ml 30000 UI/0,6ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L

Protocol: B013K

B03XA01 EPOETINUM BETA
NEORECORMON 10000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 1000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA
NEORECORMON 2000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 30000UI/0,6ml

30000 UI/0,6ml

B03XA01 EPOETINUM BETA
NEORECORMON 4000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 5000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 500 UI

392
J05AB04 J05AB04
COPEGUS® REBETOL 200 mg

J05AB04
RIBAVIRINUM

RIBAVIRINUM ****
CAPS.
200mg SP EUROPE

Protocol: J002N
200mg 200mg
ROCHE ROMANIA SRL

RIBAVIRINUM
200mg

COMPR. FILM.

393
J05AF05 J05AF05 J05AF05
EPIVIR 150mg ZEFFIX 100 mg

J05AF05
LAMIVUDINUM

LAMIVUDINUM ****
COMPR. FILM.
100mg GLAXO GROUP LTD.

Protocol: J005N
100mg 10mg/ml
GLAXO GROUP LTD.

LAMIVUDINUM
10mg/ml

SOL. ORALA COMPR. FILM.
150mg GLAXO GROUP LTD.

EPIVIR 10mg/ml

LAMIVUDINUM LAMIVUDINUM
5mg/ml

150mg 5mg/ml
GLAXO GROUP LTD.

J05AF05

SOL. ORALA

ZEFFIX 5 mg/ml

395
J05AF10 J05AF10
BARACLUDE 0,5mg

J05AF10
ENTECAVIRUM

ENTECAVIRUM ****
COMPR. FILM.
0,5mg BRISTOL-MYERS SQUIBB PHARMA EEIG

Protocol: J008N
0,5mg 1mg
BRISTOL-MYERS SQUIBB PHARMA EEIG

ENTECAVIRUM
1mg

COMPR. FILM.

BARACLUDE 1mg

396
L03AA02
NEUPOGEN®

L03AA02
FILGRASTIMUM (G-CSF) FILGRASTIMUM (G-CSF)

FILGRASTIMUM (G-CSF) **
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

Protocol: B013K
30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

L03AA02
NEUPOGEN®

SOL. INJ.
48MU/0.5ml

397

L03AB04

INTERFERONUM ALFA 2a ****

Protocol: J007N

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB04
ROFERON A

INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a

SOL. INJ.
18Mui/0.6ml ROCHE ROMANIA S.R.L.

18Mui/0.6ml 3Mui/0.5ml
ROCHE ROMANIA S.R.L.

L03AB04
ROFERON A

SOL. INJ.
3Mui/0.5ml

L03AB04
ROFERON A

SOL. INJ.
4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5ml 9Mui/0.5ml
ROCHE ROMANIA S.R.L.

L03AB04
ROFERON A

SOL. INJ.
9Mui/0.5ml

L03AB04
ROFERON A

SOL. INJ.
3Mui/0.5ml ROCHE ROMANIA S.R.L.

3Mui/0.5ml 4.5Mui/0.5ml

L03AB04

SOL. INJ.

55 / 153

DCI/DENUMIRE COMERCIALA
ROFERON A

CONCENTRATIE
4.5Mui/0.5ml

FORMA FARM.

FIRMA
ROCHE ROMANIA S.R.L.

PROTOCOL

L03AB04
ROFERON A

INTERFERONUM ALFA 2a

SOL. INJ.
9Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5ml

398

L03AB05

INTERFERONUM ALFA 2b ****

Protocol: J006N

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB05 L03AB05

INTERFERONUM ALFA 2b INTERFERONUM ALFA 2b

SOL. INJ. PEN MULTIDOZA
18 milioane U.I. 30 milioane U.I. 60 milioane U.I. 30 milioane U.I. 60 milioane U.I. SP EUROPE

18 milioane U.I. 30 milioane U.I.

INTRON A 18 milioane U.I. INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

SOL. INJ. PEN MULTIDOZA
SP EUROPE SP EUROPE

L03AB05

INTERFERONUM ALFA 2b

SOL. INJ. PEN MULTIDOZA
SP EUROPE SP EUROPE

60 milioane U.I.

INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

399

L03AB10

PEGINTERFERON alfa-2b ****

Protocol: J003N

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB10 L03AB10 L03AB10 L03AB10

PEGINTERFERON alfa-2b
100µg 120µg 150µg 50µg

PULB. + SOLV. PT. SOL. INJ.
SP EUROPE

100µg 120µg 150µg 50µg

PEGINTRON 100 µg

PEGINTERFERON alfa-2b PEGINTERFERON alfa-2b PEGINTERFERON alfa-2b

PULB. + SOLV. PT. SOL. INJ.
SP EUROPE

PEGINTRON 120 µg PEGINTRON 150 µg PEGINTRON 50 µg

PULB. + SOLV. PT. SOL. INJ.
SP EUROPE

PULB. + SOLV. PT. SOL. INJ.
SP EUROPE

400

L03AB11

PEGINTERFERON alfa-2a ****

Protocol: J004N

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB11 L03AB11

PEGINTERFERON alfa-2a
135µg/ml

SOL. INJ.
ROCHE REGISTRATION LTD.

135µg/ml 180µg/0.5ml

PEGASYS 135 µg/ml

PEGINTERFERON alfa-2a

SOL. INJ. IN SERINGA PREUMPLUTA
180µg/0.5ml ROCHE REGISTRATION LTD.

PEGASYS 180 µg/0,5ml

401
VIREGYT®- K

N04BB01

AMANTADINUM **
CAPS.
100mg EGIS PHARMACEUTICALS LTD.

N04BB01 AMANTADINUM

100mg

SUBLISTA C1-G5 HEPATITA AUTOIMUNA. 402 H02AB04 METHYLPREDNISOLONUM
H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 125 mg 125mg 125mg/2ml

LIOF. PT. SOL. INJ.
HEMOFARM S.R.L.

125mg 125mg/2ml 16mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg

COMPR. LIOF. PT. SOL. INJ.
20mg 250mg/4ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg

20mg 250mg/4ml 32mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg

COMPR. LIOF. PT. SOL. INJ.
40mg 40mg/1ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg

40mg 40mg/1ml 4mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg 4mg

COMPR. LIOF. PT. SOL. INJ.
500mg 500mg/7.8ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg

500mg 500mg/7.8ml

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.
PFIZER EUROPE MA EEIG

403

H02AB06

PREDNISOLONUM
LIOF. + SOLV. PT. SOL. INJ.
250mg 50mg MERCK KGAA

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 250

250mg 50mg

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 50

LIOF. + SOLV. PT. SOL. INJ.
MERCK KGAA

404
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

SUBLISTA C1-G06 CIROZA BILIARA PRIMARA, COLANGITA SCLEROZANTA PRIMITIVA, HEPATITA CRONICA SI CIROZE DE ALTE ETIOLOGII CU COLESTAZA. 405 A05AA02 ACIDUM URSODEOXYCHOLICUM
A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOFALK (R) URSOFALK® URSOSAN 250mg 250mg 250mg

CAPS.
DR. FALK PHARMA GMBH DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

300mg

56 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G7 CIROZA HEPATICA. 406 A06AD11 LACTULOSUM *
A06AD11 LACTULOSUM
DUPHALAC® 66.7% 66.7% 670mg/ml

LICHID ORAL
SOLVAY PHARMACEUTICALS BV ALIUD PHARMA GMBH & CO.KG FRESENIUS KABI AUSTRIA GMBH

66.7%

A06AD11 LACTULOSUM
LACTULOSE AL SIROP

A06AD11 LACTULOSUM
LAEVOLAC 670mg/ml

A06AD11 LACTULOSUM
LACTULOSE AL SIROP 66.7%

SIROP
ALIUD PHARMA GMBH & CO.KG

66.7% 670mg/ml
FRESENIUS KABI AUSTRIA GMBH

A06AD11 LACTULOSUM
LAEVOLAC 670mg/ml 670mg/ml

SOL. ORALA SIROP
66.7% ALIUD PHARMA GMBH & CO.KG

A06AD11 LACTULOSUM
LACTULOSE AL SIROP

66.7% 670mg/ml
FRESENIUS KABI AUSTRIA GMBH

A06AD11 LACTULOSUM
LAEVOLAC 670mg/ml 670mg/ml

SOL. ORALA LICHID ORAL
66.7% SOLVAY PHARMACEUTICALS BV

A06AD11 LACTULOSUM
DUPHALAC®

66.7% 65%
E.I.P.I.CO. MED S.R.L.

A06AD11 LACTULOSUM
LACTULOSE 65%

SIROP

407
NORMIX 200 mg

A07AA11

RIFAXIMINUM *
COMPR. FILM.
200mg ALFA WASSERMANN SPA

A07AA11 RIFAXIMINUM

200mg

408
EPREX® 10000 UI

B03XA01

EPOETINUM ALFA **
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

Protocol: B013K
10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA
EPOKINE 1000 UI/0,5 ml EPREX® 1000 UI

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOPHAR 2000 U.I. 2000UI

SOL. INJ.
GULF PHARMACEUTICAL IND. S.R.L.

2000UI 2000ui/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/0,5 ml EPREX® 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPREX® 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA
EPREX® 40 000 UI 40 000UI

SOL. INJ.
JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA
EPOPHAR 4000 U.I. 4000UI

SOL. INJ. SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/0,4 ml EPREX® 4000 UI

4000ui/0.4ml

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml RENAMED FARMA S.R.L.

4000UI/1ml

409

B03XA01

EPOETINUM BETA **
SOL. INJ. IN SERINGA PREUMPLUTA
10000UI/0,6ml 1000UI/0,3ml 2000UI/0,3ml 30000 UI/0,6ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L

Protocol: B013K

B03XA01 EPOETINUM BETA
NEORECORMON 10000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 1000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA
NEORECORMON 2000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 30000UI/0,6ml

30000 UI/0,6ml

B03XA01 EPOETINUM BETA
NEORECORMON 4000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 5000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 500 UI

410

C03CA01

FUROSEMIDUM

Electroliţii serici trebuie să fie verificaţi periodic. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C03CA01 FUROSEMIDUM
FUROSEMID 20 mg/2 ml 10mg/ml

SOL. INJ.
ZENTIVA SA

10mg/ml 40mg
ARENA GROUP S.A. BIO EEL SRL LABORMED PHARMA SA MAGISTRA C & C SRL SLAVIA PHARM SRL ZENTIVA SA

C03CA01 FUROSEMIDUM
FUROSEMID ARENA 40 mg FUROSEMID EEL FUROSEMID LPH 40 mg FUROSEMID MCC 40 mg FUROSEMID SLAVIA FUROSEMID ZENTIVA 40mg 40mg 40mg 40mg 40mg 40mg

COMPR.

411

C03DA01

SPIRONOLACTONUM

Electroliţii serici trebuie să fie verificaţi periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

C03DA01 SPIRONOLACTONUM

CAPS.

100mg

57 / 153

DCI/DENUMIRE COMERCIALA
VEROSPIRON

CONCENTRATIE
100mg

FORMA FARM.

FIRMA
GEDEON RICHTER LTD.

PROTOCOL

C03DA01 SPIRONOLACTONUM
SPIRONOLACTONA 25 mg 25mg

COMPR.
BIO EEL SRL

25mg 25mg
AC HELCOR PHARMA SRL TERAPIA SA

C03DA01 SPIRONOLACTONUM
ALSPIRON 25 mg SPIRONOLACTONA 25 mg 25mg 25mg

COMPR. FILM.

C03DA01 SPIRONOLACTONUM
VEROSPIRON 50mg

CAPS.
GEDEON RICHTER LTD.

50mg 50mg
AC HELCOR PHARMA SRL

C03DA01 SPIRONOLACTONUM
ALSPIRON 50 mg 50mg

COMPR. FILM.

412

H02AB06

PREDNISOLONUM
LIOF. + SOLV. PT. SOL. INJ.
250mg 50mg MERCK KGAA

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 250

250mg 50mg

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 50

LIOF. + SOLV. PT. SOL. INJ.
MERCK KGAA

413
J05AB04 J05AB04
COPEGUS® REBETOL 200 mg

J05AB04
RIBAVIRINUM

RIBAVIRINUM ****
CAPS.
200mg SP EUROPE

200mg 200mg
ROCHE ROMANIA SRL

RIBAVIRINUM
200mg

COMPR. FILM.

414
J05AF05 J05AF05 J05AF05
EPIVIR 150mg ZEFFIX 100 mg

J05AF05
LAMIVUDINUM

LAMIVUDINUM ****
COMPR. FILM.
100mg GLAXO GROUP LTD.

100mg 10mg/ml
GLAXO GROUP LTD.

LAMIVUDINUM
10mg/ml

SOL. ORALA COMPR. FILM.
150mg GLAXO GROUP LTD.

EPIVIR 10mg/ml

LAMIVUDINUM LAMIVUDINUM
5mg/ml

150mg 5mg/ml
GLAXO GROUP LTD.

J05AF05

SOL. ORALA

ZEFFIX 5 mg/ml

416
J05AF10 J05AF10
BARACLUDE 0,5mg

J05AF10
ENTECAVIRUM

ENTECAVIRUM ****
COMPR. FILM.
0,5mg BRISTOL-MYERS SQUIBB PHARMA EEIG

0,5mg 1mg
BRISTOL-MYERS SQUIBB PHARMA EEIG

ENTECAVIRUM
1mg

COMPR. FILM.

BARACLUDE 1mg

417
L03AA02
NEUPOGEN®

L03AA02
FILGRASTIMUM (G-CSF) FILGRASTIMUM (G-CSF)

FILGRASTIMUM (G-CSF) **
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

Protocol: B013K
30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

L03AA02
NEUPOGEN®

SOL. INJ.
48MU/0.5ml

418

L03AB04

INTERFERONUM ALFA 2a ****

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB04
ROFERON A

INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a

SOL. INJ.
18Mui/0.6ml ROCHE ROMANIA S.R.L.

18Mui/0.6ml 3Mui/0.5ml
ROCHE ROMANIA S.R.L.

L03AB04
ROFERON A

SOL. INJ.
3Mui/0.5ml

L03AB04
ROFERON A

SOL. INJ.
4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5ml 9Mui/0.5ml
ROCHE ROMANIA S.R.L.

L03AB04
ROFERON A

SOL. INJ.
9Mui/0.5ml

L03AB04
ROFERON A

SOL. INJ.
3Mui/0.5ml ROCHE ROMANIA S.R.L.

3Mui/0.5ml 4.5Mui/0.5ml
ROCHE ROMANIA S.R.L.

L03AB04
ROFERON A

SOL. INJ.
4.5Mui/0.5ml

L03AB04
ROFERON A

SOL. INJ.
9Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5ml

419

L03AB05

INTERFERONUM ALFA 2b ****

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB05 L03AB05

INTERFERONUM ALFA 2b INTERFERONUM ALFA 2b

SOL. INJ. PEN MULTIDOZA
18 milioane U.I. 30 milioane U.I. 60 milioane U.I. 30 milioane U.I. 60 milioane U.I. SP EUROPE

18 milioane U.I. 30 milioane U.I.

INTRON A 18 milioane U.I. INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

SOL. INJ. PEN MULTIDOZA
SP EUROPE SP EUROPE

L03AB05

INTERFERONUM ALFA 2b

SOL. INJ. PEN MULTIDOZA
SP EUROPE SP EUROPE

60 milioane U.I.

INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

420

L03AB10

PEGINTERFERON alfa-2b ****

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB10 L03AB10 L03AB10

PEGINTERFERON alfa-2b
100µg 120µg 150µg

PULB. + SOLV. PT. SOL. INJ.
SP EUROPE

100µg 120µg 150µg

PEGINTRON 100 µg

PEGINTERFERON alfa-2b PEGINTERFERON alfa-2b

PULB. + SOLV. PT. SOL. INJ.
SP EUROPE

PEGINTRON 120 µg PEGINTRON 150 µg

PULB. + SOLV. PT. SOL. INJ.
SP EUROPE

58 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
50µg

FORMA FARM.

FIRMA

PROTOCOL

L03AB10

PEGINTERFERON alfa-2b

PULB. + SOLV. PT. SOL. INJ.
SP EUROPE

50µg

PEGINTRON 50 µg

421

L03AB11

PEGINTERFERON alfa-2a ****

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB11 L03AB11

PEGINTERFERON alfa-2a
135µg/ml

SOL. INJ.
ROCHE REGISTRATION LTD.

135µg/ml 180µg/0.5ml

PEGASYS 135 µg/ml

PEGINTERFERON alfa-2a

SOL. INJ. IN SERINGA PREUMPLUTA
180µg/0.5ml ROCHE REGISTRATION LTD.

PEGASYS 180 µg/0,5ml

422
VIREGYT®- K

N04BB01

AMANTADINUM **
CAPS.
100mg EGIS PHARMACEUTICALS LTD.

N04BB01 AMANTADINUM

100mg

59 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Protocol: N030C SUBLISTA C1-G10 LEUCEMII, LIMFOAME, APLAZIE MEDULARA, GAMAPATII MONOCLONALE MALIGNE, MIELOPROLIFERARI CRONICE SI TUMORI MALIGNE, SINDROAME MIELODISPLAZICE. 423 A04AA01 ONDANSETRONUM ** Protocol: A004C
A04AA01 ONDANSETRONUM
OSETRON 4 mg OSETRON 8 mg 2mg/ml 2mg/ml

SOL. INJ.
DR. REDDY'S LABORATORIES DR. REDDY'S LABORATORIES

2mg/ml

A04AA01 ONDANSETRONUM
EMESET 4 mg/2 ml EMESET 8 mg/4 ml 2mg/ml 2mg/ml

SOL. INJ./PERF.
CIPLA (UK) LIMITED CIPLA (UK) LIMITED

2mg/ml

A04AA01 ONDANSETRONUM
OSETRON 4 mg SETRONON 4 mg ZOFRAN 4 mg 4mg 4mg 4mg 4mg

COMPR. FILM.
DR. REDDY'S LABORATORIES PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

4mg

A04AA01 ONDANSETRONUM
ONDARAN MD 4mg

COMPR. ORODISPERSABILE
RANBAXY UK LTD.

4mg 4mg/2ml

A04AA01 ONDANSETRONUM
ZOFRAN 4mg/2ml 4mg/2ml

SOL. INJ.
GLAXO WELLCOME UK LIMITED

A04AA01 ONDANSETRONUM
SETRONON 4 mg/2 ml 4mg/2ml

SOL. INJ./PERF.
PLIVA LJUBLJANA D.O.O.

4mg/2ml 8mg
DR. REDDY'S LABORATORIES (UK) LTD PLIVA LJUBLJANA D.O.O.

A04AA01 ONDANSETRONUM
OSETRON 8 mg SETRONON 8 mg 8mg 8mg 8mg

COMPR. FILM.

A04AA01 ONDANSETRONUM
ONDARAN MD 8 mg

COMPR. ORODISPERSABILE
RANBAXY UK LIMITED

8mg 8mg/4ml

A04AA01 ONDANSETRONUM
ZOFRAN 8mg/4ml 8mg/4ml

SOL. INJ.
GLAXO WELLCOME UK LIMITED

A04AA01 ONDANSETRONUM
OSETRON 4 mg SETRONON 4 mg ZOFRAN 4 mg 4mg 4mg 4mg 4mg

COMPR. FILM.
DR. REDDY'S LABORATORIES PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

4mg

A04AA01 ONDANSETRONUM
ONDARAN MD 4mg

COMPR. ORODISPERSABILE
RANBAXY UK LTD.

4mg 8mg

A04AA01 ONDANSETRONUM
OSETRON 8 mg SETRONON 8 mg 8mg 8mg 8mg

COMPR. FILM.
DR. REDDY'S LABORATORIES (UK) LTD PLIVA LJUBLJANA D.O.O.

A04AA01 ONDANSETRONUM
ONDARAN MD 8 mg

COMPR. ORODISPERSABILE
RANBAXY UK LIMITED

8mg 8mg/4 ml

A04AA01 ONDANSETRONUM
SETRONON 8 mg/4 ml 8mg/4 ml

SOL. INJ./PERF.
PLIVA LJUBLJANA D.O.O.

424
KYTRIL® 1 mg

A04AA02

GRANISETRONUM **
COMPR. FILM.
1mg ROCHE ROMANIA S.R.L.

Protocol: A004C
1mg 2mg
F. HOFFMANN LA ROCHE LTD.

A04AA02 GRANISETRONUM A04AA02 GRANISETRONUM
KYTRIL 2mg

COMPR. FILM. SOL. INJ.
3mg/3ml ROCHE ROMANIA SRL

A04AA02 GRANISETRONUM
KYTRIL

3mg/3ml 2mg
F. HOFFMANN LA ROCHE LTD.

A04AA02 GRANISETRONUM
KYTRIL 2mg

COMPR. FILM.

425
ALOXI

A04AA05

PALONOSETRONUM **
SOL. INJ.
250 µg/5ml HELSINN BIREX PHARMACEUTICALS LTD.

Protocol: A002C;A004C
250 µg/5ml

A04AA05 PALONOSETRONUM

426
EPREX® 10000 UI

B03XA01

EPOETINUM ALFA ***
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

Protocol: L022B
10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA
EPOKINE 1000 UI/0,5 ml EPREX® 1000 UI

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOPHAR 2000 U.I. 2000UI

SOL. INJ.
GULF PHARMACEUTICAL IND. S.R.L.

2000UI 2000ui/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/0,5 ml EPREX® 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPREX® 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA
EPREX® 40 000 UI 40 000UI

SOL. INJ.
JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA
EPOPHAR 4000 U.I. 4000UI

SOL. INJ. SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/0,4 ml EPREX® 4000 UI

4000ui/0.4ml

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml RENAMED FARMA S.R.L.

4000UI/1ml

427

B03XA01

EPOETINUM BETA ***
SOL. INJ. IN SERINGA PREUMPLUTA
10000UI/0,6ml 1000UI/0,3ml ROCHE REGISTRATION L ROCHE REGISTRATION L

Protocol: L022B

B03XA01 EPOETINUM BETA
NEORECORMON 10000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 1000 UI

SOL. INJ. IN SERINGA PREUMPLUTA

60 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
2000UI/0,3ml 30000 UI/0,6ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml

FORMA FARM.

FIRMA
ROCHE REGISTRATION L

PROTOCOL

B03XA01 EPOETINUM BETA
NEORECORMON 2000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA
NEORECORMON 30000UI/0,6ml

30000 UI/0,6ml

B03XA01 EPOETINUM BETA
NEORECORMON 4000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 5000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 500 UI

428
ARANESP 10µg/0.4ml

B03XA02

DARBEPOETINUM ALFA ***
SOL. INJ. IN SERINGA PREUMPLUTA
10µg/0.4ml 100µg/0.5ml 15µg/0.375ml 150µg/0.3ml 20µg/0.5ml 30µg/0.3ml 300µg/0.6ml 40µg/0.4ml 50µg/0.5ml 500µg/ml 60µg/0.3ml 80µg/0.4ml AMGEN EUROPE BV

Protocol: L022B
10µg/0.4ml 100µg/0.5ml 15µg/0.375ml 150µg/0.3ml 20µg/0.5ml 30µg/0.3ml 300µg/0.6ml 40µg/0.4ml 50µg/0.5ml 500µg/ml 60µg/0.3ml 80µg/0.4ml

B03XA02 DARBEPOETINUM ALFA B03XA02 DARBEPOETINUM ALFA
ARANESP 100µg/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA
ARANESP 15µg/0.375ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA
ARANESP 150µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 20µg/0.5ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 30µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 300µg/0.6ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 40µg/0.4ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 50µg/0.5ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 500µg/ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 60µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 80µg/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA

429
ANDROCUR

G03HA01

CYPROTERONUM **
COMPR.
50mg SCHERING AG

G03HA01 CYPROTERONUM
Cod restrictie 1014: Cancer de prostata in stadiu avansat;

50mg

G03HA01 CYPROTERONUM
ANDROCUR 50mg SCHERING AG

430

H02AB02

DEXAMETHASONUM
SOL. INJ.
8mg E.I.P.I.CO. MED S.R.L.

H02AB02 DEXAMETHASONUM
DEXAMETHASONE SODIUM PHOSPHATE

8mg 8mg/2ml
MEDOCHEMIE LTD.

H02AB02 DEXAMETHASONUM
DEXAMED 8mg/2ml

SOL. INJ.

431
J02AC02
ITRACONAZOL 100 mg OMICRAL 100 mg ORUNGAL

J02AC02
ITRACONAZOLUM

ITRACONAZOLUM
CAPS.
100mg 100mg 100mg TERAPIA S.A. MEDICO UNO PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV

100mg

432
J02AC03
VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM **
COMPR. FILM.
200mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg
PFIZER LTD.

J02AC03
VFEND 200mg

VORICONAZOLUM
200mg

PULB. PT. SOL. PERF.
PFIZER LTD.

J02AC03 J02AC03
VFEND 50mg

VORICONAZOLUM
40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LTD.

VFEND 40 mg/ml

VORICONAZOLUM
50mg

COMPR. FILM.

433
J02AC04
NOXAFIL SP 40mg/ml

J02AC04
POSACONAZOLUM

POSACONAZOLUM **
SUSP. ORALA
40mg/ml SP EUROPE

40mg/ml

Prescriere limitata: Prescriere limitata:

Profilaxia si infectiilor fungice invazive la pacientii aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care prezinta risc inalt de a dezvolta infectii fungice masive; Profilaxia si infectiilor fungice invazive la pacientii in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de a dezvolta infectii fungice masive.

434
J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 70mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 70mg

CASPOFUNGINUM

PULB. PT. CONC. PT. SOL. PERF.
MERCK SHARP & DOHME LTD

CANCIDAS 70 mg

435
L01XX35
THROMBOREDUCTIN

L01XX35
ANAGRELIDUM

ANAGRELIDUM ***
CAPS.
0.5mg

Protocol: L015D
0.5mg
ORPHA-DEVEL HANDELS UND VERTRIEBS GMBH

436
L04AA01 L04AA01
EQUORAL® 100 mg

L04AA01
CICLOSPORINUM

CICLOSPORINUM *
CAPS. MOI
100mg IVAX - PHARMACEUTICALS S.R.O.

100mg 100mg/ml

CICLOSPORINUM

SOL. ORALA

61 / 153

DCI/DENUMIRE COMERCIALA
EQUORAL® SANDIMMUN NEORAL®

CONCENTRATIE
100mg/ml 100mg/ml

FORMA FARM.

FIRMA
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

PROTOCOL

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

437

N02AA01
Prescriere limitata:

MORPHYNUM

Durere severa, invalidanta, asociata cu diagnosticul de cancer. Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide. Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni. Risc inalt de aparitie a dependentei. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI

N02AA01 MORPHYNUM
MST CONTINUS® 100 mg 100mg 100mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

100mg 100mg 10mg

N02AA01 MORPHYNUM
VENDAL® RETARD 100 mg

COMPR. FILM. ELIB. PREL.
LANNACHER HEILMITTEL GMBH

N02AA01 MORPHYNUM
SEVREDOL 10 mg 10mg 10mg 10mg 200mg

COMPR. FILM.
MUNDIPHARMA GMBH

N02AA01 MORPHYNUM
MST CONTINUS® 10 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

10mg 10mg 200mg 20mg

N02AA01 MORPHYNUM
VENDAL® RETARD 10 mg

COMPR. FILM. ELIB. PREL.
LANNACHER HEILMITTEL GMBH

N02AA01 MORPHYNUM
MST CONTINUS® 200 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

N02AA01 MORPHYNUM
SEVREDOL 20 mg 20mg

COMPR. FILM.
MUNDIPHARMA GMBH

N02AA01 MORPHYNUM
MORFINA 20 mg/ml 20mg/ml 30mg 30mg 60mg 60mg

SOL. INJ.
ZENTIVA S.A.

20mg/ml 30mg 30mg 60mg 60mg

N02AA01 MORPHYNUM
MST CONTINUS® 30 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

N02AA01 MORPHYNUM
VENDAL® RETARD 30 mg

COMPR. FILM. ELIB. PREL.
LANNACHER HEILMITTEL GMBH

N02AA01 MORPHYNUM
MST CONTINUS® 60 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

N02AA01 MORPHYNUM
VENDAL® RETARD 60 mg

COMPR. FILM. ELIB. PREL.
LANNACHER HEILMITTEL GMBH

438

N02AA05
Prescriere limitata:

OXYCODONUM

Durere severa, invalidanta, asociata cu diagnosticul de cancer. Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide. Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni. Risc inalt de aparitie a dependentei. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI

N02AA05 OXYCODONUM
OXYCONTIN® 10 mg 10 mg 20 mg 40 mg 80mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

10 mg 20 mg 40 mg 80mg

N02AA05 OXYCODONUM
OXYCONTIN® 20 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

N02AA05 OXYCODONUM
OXYCONTIN® 40 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

N02AA05 OXYCODONUM
OXYCONTIN® 80 mg

COMPR. FILM. ELIB. MODIF.
MUNDIPHARMA GMBH

439

N02AA08

DIHYDROCODEINUM
COMPR. ELIB. PREL.
120mg 60mg 90mg MUNDIPHARMA GMBH

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 120 mg

120mg 60mg 90mg

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 60 mg

COMPR. ELIB. PREL.
MUNDIPHARMA GMBH

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 90 mg

COMPR. ELIB. PREL.
MUNDIPHARMA GMBH

440
MIALGIN® 100 mg/2 ml

N02AB02

PETHIDINUM
SOL. INJ.
50mg/ml ZENTIVA SA

N02AB02 PETHIDINUM

50mg/ml

441

N02AB03
Prescriere limitata:

FENTANYLUM **

Durere severa, invalidanta, asociata cu diagnosticul de cancer. Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide. Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

N02AB03 FENTANYLUM
FENTANYL SANDOZ 100 µg/h 100µg/h

PLASTURE TRANSDERMIC
SANDOZ S.R.L.

100µg/h 16.8mg/42.0cmp 25µg/h 4.2mg/10.5cmp 50µg/h 75µg/h

N02AB03 FENTANYLUM
DUROGESIC 100 µg/h

PLASTURE TRANSDERM.
16.8mg/42.0cmp 25µg/h 4.2mg/10.5cmp 50µg/h JANSSEN PHARMACEUTICA NV SANDOZ S.R.L.

N02AB03 FENTANYLUM
FENTANYL SANDOZ 25 µg/h

PLASTURE TRANSDERMIC PLASTURE TRANSDERM.
JANSSEN PHARMACEUTICA NV SANDOZ S.R.L.

N02AB03 FENTANYLUM
DUROGESIC 25 µg/h

N02AB03 FENTANYLUM
FENTANYL SANDOZ 50 µg/h

PLASTURE TRANSDERMIC PLASTURE TRANSDERMIC

N02AB03 FENTANYLUM

62 / 153

DCI/DENUMIRE COMERCIALA
FENTANYL SANDOZ 75 µg/h

CONCENTRATIE
75µg/h

FORMA FARM.

FIRMA
SANDOZ S.R.L.

PROTOCOL

N02AB03 FENTANYLUM
DUROGESIC 50 µg/h

PLASTURE TRANSDERM.
8.4mg/21.0cmp JANSSEN PHARMACEUTICA NV

8.4mg/21.0cmp

442

N02AX02
Prescriere limitata:

TRAMADOLUM

Durere severa, care nu raspunde la analgezice non-opioide. Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate. Se aplica tuturor denumirilor comerciale, formelor farmaceutice (mai putin formelor injenctabile) si concentratiilor corespunzatoare DCI-ului.

N02AX02 TRAMADOLUM
TRAMADOLOR® 100 ID 100mg 100mg 100mg 100mg

COMPR. ELIB. MODIF.
HEXAL AG

100mg 100mg

N02AX02 TRAMADOLUM
TRALGIT SR 100 TRAMADOL® RETARD

COMPR. ELIB. PREL.
ZENTIVA AS KRKA D.D.

N02AX02 TRAMADOLUM
TRAMAL RETARD 100 mg

COMPR. FILM. ELIB. PREL.
GRUNENTHAL GMBH

100mg 100mg

N02AX02 TRAMADOLUM
MABRON TRADOLAN 100mg 100mg

SOL. INJ.
MEDOCHEMIE LTD. LANNACHER HEILMITTEL GMBH

Prescriere limitata:
TRADOLAN TRAMADOL TRAMAG 100 TRAMAL®

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM
100mg 100mg 100mg 100mg

SUPOZ.
LANNACHER HEILMITTEL GMBH KRKA D.D. MAGISTRA C & C GRUNENTHAL GMBH

100mg

N02AX02 TRAMADOLUM
TRALGIT 100

SOL. INJ.
100mg/2ml ZENTIVA A.S.

100mg/2ml

Prescriere limitata:
TRALGIT

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM
100mg/ml

PIC. ORALE, SOL.
ZENTIVA A.S.

100mg/ml 100mg/ml
LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM
TRADOLAN 100mg/ml 150mg 150mg 150mg 200mg 200mg 200mg

SOL. ORALA COMPR. ELIB. PREL.
ZENTIVA AS

N02AX02 TRAMADOLUM
TRALGIT SR 150

150mg 150mg

N02AX02 TRAMADOLUM
TRAMADOL RETARD 150 mg TRAMAL RETARD 150 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

N02AX02 TRAMADOLUM
TRALGIT SR 200

COMPR. ELIB. PREL.
ZENTIVA AS

200mg 200mg

N02AX02 TRAMADOLUM
TRAMADOL RETARD 200 mg TRAMAL RETARD 200 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

N02AX02 TRAMADOLUM
K-ALMA® MABRON 50 mg TRALGIT 50 TRAMACALM TRAMADOL TRAMADOL LPH 50 mg TRAMADOL AL 50 TRAMADOL ARENA TRAMAL® URGENDOL 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
ANTIBIOTICE SA MEDOCHEMIE LTD. ZENTIVA A.S. AC HELCOR SRL KRKA D.D. LABORMED PHARMA SA ALIUD® PHARMA GMBH & CO.KG ARENA GROUP S.A. GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg

N02AX02 TRAMADOLUM
TRAMADOL 50 mg TRAMADOL EEL TRAMAG 50 50mg 50mg 50mg

COMPR.
OZONE LABORATORIES LTD. BIO EEL SRL MAGISTRA C & C

50mg

N02AX02 TRAMADOLUM
TRADOLAN 50 mg 50mg

COMPR. FILM.
LANNACHER HEILMITTEL GMBH

50mg 50mg
LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM
TRADOLAN 50 mg 50mg

SOL. INJ.

Prescriere limitata:
TRALGIT 50 TRAMADOL TRAMADOL® AL 100 Fiole TRAMAL® 100 TRAMAL® 50 URGENDOL

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM
50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml

SOL. INJ.
ZENTIVA A.S. KRKA D.D. ALIUD® PHARMA GMBH & CO.KG GRUNENTHAL GMBH GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg/ml

Prescriere limitata:
TRAMADOL AL PICATURI

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM N02AX02 TRAMADOLUM
TRAMAL® 100mg/ml

PIC. ORALE, SOL.
ALIUD PHARMA GMBH & CO.KG

PICATURI ORALE-SOL.
GRUNENTHAL GMBH

100mg/ml

443

N07BC02
Risc inalt de aparitie a dependentei.

METHADONUM
COMPR.
2.5mg ZENTIVA S.A.

N07BC02 METHADONUM
SINTALGON 2,5 mg

2.5mg

444

R05DA04

CODEINUM
COMPR.
15mg 15mg 15mg 15mg 15mg SLAVIA PHARM SRL OZONE LABORATORIES LTD. LABORMED PHARMA SA BIO EEL SRL MAGISTRA C & C

R05DA04 CODEINUM
CODEINA FOSFAT CODEINA FOSFAT 15 mg CODEINA FOSFAT LPH 15 mg CODEINA FOSFORICA CODEINA FOSFORICA 15 mg

15mg

63 / 153

DCI/DENUMIRE COMERCIALA
FARMACOD FOSFAT DE CODEINA 15 mg

CONCENTRATIE
15mg 15mg

FORMA FARM.

FIRMA
FARMACOM SA SINTOFARM SA

PROTOCOL

445
DESFERAL

V03AC01

DEFEROXAMINUM **(3)
LIOF. PT. SOL. INJ./PERF.
500mg NOVARTIS PHARMA GMBH

Protocol: V001D
500mg

V03AC01 DEFEROXAMINUM

446
EXJADE 125mg

V03AC03

DEFERASIROXUM ***
COMPR. DISP.
125mg NOVARTIS EUROPHARM LTD.

Protocol: V002D
125mg 250mg
NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM V03AC03 DEFERASIROXUM
EXJADE 250mg 250mg

COMPR. DISP. COMPR. DISP.
500mg NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM
EXJADE 500mg

500mg

64 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G11 EPILEPSIE. 447 N03AA02
N03AA02 PHENOBARBITALUM
FENOBARBITAL 100 mg

Protocol: NG01G
PHENOBARBITALUM
COMPR.
100 mg ZENTIVA SA

100 mg

Prescriere limitata:
FENOBARBITAL 100 mg

Epilepsie

N03AA02 PHENOBARBITALUM
100mg

COMPR.
SC ARENA GROUP SA

100mg

Prescriere limitata:
FENOBARBITAL 200 mg/ 2 ml

Epilepsie

N03AA02 PHENOBARBITALUM
10%

SOL. INJ.
ZENTIVA S.A

10%

448
FENITOIN 100 mg

N03AB02

PHENYTOINUM
COMPR.
100mg GEDEON RICHTER ROMANIA SA

N03AB02 PHENYTOINUM N03AB02 PHENYTOINUM
PHENHYDAN®SOLUTIE INJECTABILA 50mg/ml

100mg 50mg/ml
DESITIN

SOL. INJ.

449
RIVOTRIL

N03AE01

CLONAZEPAMUM
COMPR.
0.5mg ROCHE ROMANIA S.R.L.

N03AE01 CLONAZEPAMUM N03AE01 CLONAZEPAMUM
RIVOTRIL® 2mg

0.5mg 2mg
ROCHE ROMANIA S.R.L.

COMPR.

450
TIMONIL SIROP

N03AF01

CARBAMAZEPINUM
SUSP. ORALA
100mg/5ml DESITIN ARZNEIMITTEL GMBH

N03AF01 CARBAMAZEPINUM N03AF01 CARBAMAZEPINUM
TIMONIL 150 RETARD 150mg

100mg/5ml 150mg
DESITIN

COMPR. RET. COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 300mg SLAVIA PHARM SRL BIO EEL SRL OZONE LABORATORIES LTD. ARENA GROUP SA LABORMED PHARMA SA VIM SPECTRUM SRL AC HELCOR SRL AWD PHARMA GMBH & CO.KG GEROT PHARMAZEUTIKA GMBH MEDOCHEMIE LTD. NOVARTIS PHARMA GMBH

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN CARBAMAZEPIN EEL CARBAMAZEPINA CARBAMAZEPINA ARENA 200 mg CARBAMAZEPINA LPH 200 mg CARBAVIM CARBEPSIL 200 FINLEPSIN NEUROTOP TAVER TEGRETOL® 200

200mg

N03AF01 CARBAMAZEPINUM
TEGRETOL CR 200

COMPR. FILM. ELIB. PREL.
NOVARTIS PHARMA GMBH

200mg 300mg 300mg

N03AF01 CARBAMAZEPINUM
NEUROTOP® RETARD 300 mg

COMPR. ELIB. PREL.
GEROT PHARMAZEUTIKA GMBH

N03AF01 CARBAMAZEPINUM
TIMONIL 300 RETARD 300mg

COMPR. RET.
DESITIN

N03AF01 CARBAMAZEPINUM
CARBEPSIL 400 TEGRETOL® 400 400mg 400mg 400mg

COMPR.
AC HELCOR SRL NOVARTIS PHARMA GMBH

400mg

N03AF01 CARBAMAZEPINUM
TEGRETOL CR 400

COMPR. FILM. ELIB. PREL.
NOVARTIS PHARMA GMBH

400mg 400mg

N03AF01 CARBAMAZEPINUM
FINLEPSIN 400 RETARD 400mg 600mg

COMPR. RET.
AWD PHARMA GMBH & CO.KG

N03AF01 CARBAMAZEPINUM
NEUROTOP® RETARD 600 mg

COMPR. ELIB. PREL.
GEROT PHARMAZEUTIKA GMBH

600mg 600mg

N03AF01 CARBAMAZEPINUM
TIMONIL 600 RETARD 600mg 200mg

COMPR. RET.
DESITIN

N03AF01 CARBAMAZEPINUM
FINLEPSIN 200 RETARD

COMPR.FILM.ELIB.PREL
AWD PHARMA GMBH & CO.KG

200mg

451

N03AF02

OXCARBAZEPINUM

Cod restrictie 1587: Tratamentul crizelor epileptice partiale si al crizelor primare cu contractii tonico-clonice generalizate, care nu pot fi suficient controlate cu alte medicamente anti-epileptice Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

N03AF02 OXCARBAZEPINUM
TRILEPTAL® 300 mg 300mg

COMPR. FILM.
NOVARTIS PHARMA GMBH

300mg 600mg
NOVARTIS PHARMA GMBH

N03AF02 OXCARBAZEPINUM
TRILEPTAL® 600 mg 600mg

COMPR. FILM.

452

N03AG01

ACIDUM VALPROICUM + SARURI

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL LONG 1000 mg 1000mg

MINICOMPR. ELIB. PREL.
DESITIN ARZNEIMITTEL GMBH

1000mg 150mg

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL LONG 150 mg 150mg 150mg 150mg

CAPS. ELIB. PREL.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
CONVULEX® 150 mg

CAPS. MOI GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

150mg 150mg 200mg

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL 150

COMPR. FILM. GASTROREZ.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
PETILIN 200mg 200mg

COMPR. FILM.
REMEDICA LTD.

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE 200 mg

COMPR. FILM. GASTROREZ.
SANOFI-AVENTIS FRANCE

200mg 300mg

N03AG01 ACIDUM VALPROICUM + SARURI

CAPS. ELIB. PREL.

65 / 153

DCI/DENUMIRE COMERCIALA
ORFIRIL LONG 300 mg

CONCENTRATIE
300mg 300mg 300mg

FORMA FARM.

FIRMA
DESITIN ARZNEIMITTEL GMBH

PROTOCOL

N03AG01 ACIDUM VALPROICUM + SARURI
CONVULEX® 300 mg

CAPS. MOI GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

300mg 300mg 300mg/5ml

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL 300

COMPR. FILM. GASTROREZ.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL SIROP

SIROP
300mg/5ml 400mg/4ml DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE® 400 mg/4 ml LIOFILIZAT SI SOLVENT PENTRU SOLUTIE INJECTABILA i.v.

LIOF. + SOLV. PT. SOL.
SANOFI-AVENTIS FRANCE

400mg/4ml

N03AG01 ACIDUM VALPROICUM + SARURI
CONVULEX® 500 mg 500mg 500mg

CAPS. MOI GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

500mg 500mg 50mg/ml

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL LONG 500 mg

MINICOMPR. ELIB. PREL.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
CONVULEX® 50mg/ml

SIROP
GEROT PHARMAZEUTIKA GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE

SIROP
57.64mg/ml 600mg 300mg 500mg SANOFI - AVENTIS FRANCE

57.64mg/ml 600mg 300mg 500mg

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL 600

COMPR. FILM. GASTROREZ.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE CHRONO 300 mg

COMPR. FILM. ELIB. PREL. DIVIZ.
SANOFI-AVENTIS FRANCE

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE® CHRONO 500 mg

COMPR. FILM. ELIB. PREL. DIVIZ.
SANOFI-AVENTIS FRANCE

453

N03AX09

LAMOTRIGINUM **

Cod restrictie 1426: Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

N03AX09 LAMOTRIGINUM
EPIMIL 100 mg EPIZOL 100 mg LAMICTAL 100 mg LAMOLEP 100 mg LAMOTIRAN 100 mg LAMOTRIX 100 mg PLEXXO® 100 mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg

SOL. INJ.
IVAX PHARMCEUTICALS S.R.O. KRKA D.D. NOVO MESTO THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH

0.1mg/ml

N03AX09 LAMOTRIGINUM
LAMOTRIGIN STADA 100 mg LAMOTRIN 100 mg 100mg 100mg

COMPR. DISP.
STADA ARZNEIMITTEL AG ACTAVIS GROUP HF.

100mg

N03AX09 LAMOTRIGINUM
LAMOTIRAN 200 mg LAMOTRIX 200 mg 200mg 200mg

COMPR.
RANBAXY UK LTD. MEDOCHEMIE LTD.

200mg

N03AX09 LAMOTRIGINUM
EPIMIL 25mg EPIZOL 25 mg LAMICTAL 25 mg LAMOLEP 25 mg LAMOTIRAN 25 mg LAMOTRIX 25 mg PLEXXO® 25 mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg

COMPR.
IVAX PHARMCEUTICALS S.R.O. KRKA D.D. NOVO MESTO THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH

25mg

N03AX09 LAMOTRIGINUM
LAMOTRIGIN STADA 25 mg LAMOTRIN 25 mg 25mg 25mg 25mg 2mg

COMPR. DISP.
STADA ARZNEIMITTEL AG ACTAVIS GROUP HF.

25mg

N03AX09 LAMOTRIGINUM
LAMICTAL 25 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

25mg 2mg 50mg

N03AX09 LAMOTRIGINUM
LAMICTAL® 2 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

N03AX09 LAMOTRIGINUM
EPIMIL 50 mg EPIZOL 50 mg LAMICTAL 50 mg LAMOLEP 50 mg LAMOTIRAN 50 mg LAMOTRIX 50 mg PLEXXO® 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

COMPR.
IVAX PHARMCEUTICALS S.R.O. KRKA D.D. NOVO MESTO THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH

N03AX09 LAMOTRIGINUM
LAMOTRIGIN STADA 50 mg LAMOTRIN 50 mg 50mg 50mg 5mg

COMPR. DISP.
STADA ARZNEIMITTEL AG ACTAVIS GROUP HF.

50mg

N03AX09 LAMOTRIGINUM
LAMICTAL 5 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

5mg

454

N03AX11

TOPIRAMATUM **

Cod restrictie 2797: Tratamentul crizelor epileptice partiale, crizelor primare cu contractii tonico-clonice generalizate, crizelor din sindromul Lennox-Gastaut, insuficient controlate prin administrarea altor merdicamente antiepileptice. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

N03AX11 TOPIRAMATUM
TOPAMAX 100 mg TOPRAN 100 mg 100mg 100mg

COMPR. FILM.
JOHNSON & JOHNSON D.O.O. TERAPIA S.A.

100mg

N03AX11 TOPIRAMATUM
TOPAMAX 200 mg TOPRAN 200 mg 200mg 200mg

COMPR. FILM.
JOHNSON & JOHNSON D.O.O. TERAPIA S.A.

200mg

N03AX11 TOPIRAMATUM
TOPAMAX 25 mg TOPRAN 25 mg 25mg 25mg

COMPR. FILM.
JOHNSON & JOHNSON D.O.O. TERAPIA S.A.

25mg

N03AX11 TOPIRAMATUM

COMPR. FILM.

50mg

66 / 153

DCI/DENUMIRE COMERCIALA
TOPAMAX 50 mg TOPRAN 50 mg

CONCENTRATIE
50mg 50mg

FORMA FARM.

FIRMA
JOHNSON & JOHNSON D.O.O. TERAPIA S.A.

PROTOCOL

455

N03AX12

GABAPENTINUM ***

Cod restrictie 2664: Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.

N03AX12 GABAPENTINUM
GABAGAMMA 100 mg GABALEPT 100 mg 100mg 100mg

CAPS.
WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O.

100mg

N03AX12 GABAPENTINUM
GABAGAMMA 300 mg GABALEPT 300 mg GABARAN 300 mg 300mg 300mg 300mg

CAPS.
WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. RANBAXY UK LTD.

300mg

N03AX12 GABAPENTINUM
GABAGAMMA 400 mg GABALEPT 400 mg GABARAN 400 mg 400mg 400mg 400mg

CAPS.
WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. RANBAXY UK LTD.

400mg

N03AX12 GABAPENTINUM
GABARAN 600 mg 600mg

COMPR. FILM.
RANBAXY UK LTD.

600mg 800mg
RANBAXY UK LTD.

N03AX12 GABAPENTINUM
GABARAN 800 mg 800mg

COMPR. FILM.

456

N03AX14
Prescriere limitata:

LEVETIRACETAMUM **

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat reactii adverse in antecedente la alte antiepileptice. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat interactiuni medicamentoase cu alte medicamente compensate adecvate. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde transferul la alt medicament compensat adecvat este posibil sa genereze consecinte clinice adverse. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N03AX14 LEVETIRACETAMUM
KEPPRA 1000 mg 1000mg

COMPR. FILM.
UCB PHARMA SA

1000mg 100mg/ml
UCB PHARMA SA

N03AX14 LEVETIRACETAMUM
KEPPRA 100 mg/ml 100mg/ml

SOL. ORALA COMPR. FILM.
500mg UCB PHARMA LTD

N03AX14 LEVETIRACETAMUM
KEPPRA 500 mg

500mg 1000mg
UCB PHARMA SA

N03AX14 LEVETIRACETAMUM
KEPPRA 1000 mg 1000mg

COMPR. FILM. COMPR. FILM.
500mg UCB PHARMA LTD

N03AX14 LEVETIRACETAMUM
KEPPRA 500 mg

500mg

457

N03AX16
Prescriere limitata:

PREGABALINUM ***
CAPS.
150mg PFIZER LTD.

Tratamentul adjuvant al epilepsiei la adulţii cu convulsii parţiale, cu sau fără generalizare secundară.

N03AX16 PREGABALINUM
LYRICA 150 mg

150mg 300mg
PFIZER LTD.

N03AX16 PREGABALINUM
LYRICA 300 mg 300mg

CAPS. CAPS.
75mg PFIZER LTD.

N03AX16 PREGABALINUM
LYRICA 75 mg

75mg

67 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G12 BOALA PARKINSON. 458 N04AA01 TRIHEXYPHENIDYLUM
N04AA01 TRIHEXYPHENIDYLUM
ROMPARKIN® 2 mg 2mg

COMPR.
TERAPIA SA

2mg

460
MADOPAR HBS

N04BA02

COMBINATII (LEVODOPUM + CARBIDOPUM) **
CAPS. ELIB. MODIF.
100mg+25mg ROCHE ROMANIA S.R.L.

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM) N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)
MADOPAR 250 MADOPAR® 250

100mg+25mg 200mg+50mg

COMPR.
200mg+50mg 200mg+50mg ROCHE ROMANIA SRL TERAPIA SA

Cod restrictie 1257: Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu inhibitor al decarboxylazei

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)
ISICOM 250 mg/25 mg

COMPR.
250mg/25mg DESITIN ARZNEIMITTEL GMBH

250mg/25mg 250mg+25mg
TEVA PHARMACEUTICALS SRL REMEDICA LTD. LEK PHARMACEUTICALS D.D. FARAN LABORATORIES S.A.

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)
CARBIDOPA / LEVODOPA TEVA 25/250 CREDANIL 25/250 NAKOM ZIMOX

COMPR.
250mg+25mg 250mg+25mg 250mg+25mg 250mg+25mg

461

N04BA02

COMBINATII (LEVODOPUM + BENSERAZIDUM) **

Cod restrictie 1257: Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu inhibitor al decarboxylazei. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)
MADOPAR HBS

CAPS. ELIB. MODIF.
100mg+25mg ROCHE ROMANIA S.R.L.

100mg+25mg

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)
MADOPAR 250 MADOPAR® 250

COMPR.
200mg+50mg 200mg+50mg ROCHE ROMANIA SRL TERAPIA SA

200mg+50mg

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)
ISICOM 250 mg/25 mg

COMPR.
250mg/25mg DESITIN ARZNEIMITTEL GMBH

250mg/25mg

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)
CARBIDOPA / LEVODOPA TEVA 25/250 CREDANIL 25/250 NAKOM ZIMOX

COMPR.
250mg+25mg 250mg+25mg 250mg+25mg 250mg+25mg TEVA PHARMACEUTICALS SRL REMEDICA LTD. LEK PHARMACEUTICALS D.D. FARAN LABORATORIES S.A.

250mg+25mg

462

N04BA03

COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPONUM) ***

Cod restrictie 2059: Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei de actiune a unei doze Cod restrictie 2060: Boala Parkinson la pacienti stabilizati sub tratamentul cu inhibitor de decarboxylase-levodopa in asociere cu entacapone

N04BA03 COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPONU M)
STALEVO 100 mg/25 mg/200 mg

COMPR. FILM.

100mg/25mg/200 mg
ORION CORPORATION

100mg/25mg/200 mg

N04BA03 COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPONU M)
STALEVO 150 mg/37,5 mg/200 mg

COMPR. FILM.

150mg/37.5mg/2 00mg
ORION CORPORATION

150mg/37.5mg/20 0mg

N04BA03 COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPONU M)
STALEVO 50 mg/12,5 mg/200 mg

COMPR. FILM.

50mg/12.5mg/20 0mg
ORION CORPORATION

50mg/12.5mg/200 mg

463
VIREGYT®- K

N04BB01

AMANTADINUM **
CAPS.
100mg EGIS PHARMACEUTICALS LTD.

N04BB01 AMANTADINUM

100mg

464
BROCRIPTIN

N04BC01

BROMOCRIPTINUM
DRAJ.
2.5mg BIOFARM SA

N04BC01 BROMOCRIPTINUM
Prescriere limitata: Boala Parkinson

2.5mg

465
REQUIP 0,25 mg REQUIP 1 mg REQUIP 2 mg REQUIP 5 mg

N04BC04

ROPINIROLUM **
COMPR. FILM.
SMITHKLINE BEECHAM PLC T/A SMITHKLINE BEECHAM PLC T/A SMITHKLINE BEECHAM PLC T/A SMITHKLINE BEECHAM PLC T/A

N04BC04 ROPINIROLUM

466

N04BC05

PRAMIPEXOLUM **

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,18 mg 0.18mg

COMPR. COMPR.

0.18mg
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

N04BC05 PRAMIPEXOLUM

0.7mg

68 / 153

DCI/DENUMIRE COMERCIALA
MIRAPEXIN 0,7 mg

CONCENTRATIE
0.7mg

FORMA FARM.

FIRMA
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

PROTOCOL

467

N04BC09
Prescriere limitata:

ROTIGOTINUM ***

Monoterapie (fără levodopa), pentru tratarea semnelor şi simptomelor bolii Parkinson idiopatice, în stadiu incipient. Tratament in asociere cu levodopa in perioada de evoluţie şi în stadiile avansate ale bolii Parkinson, când efectul medicamentului levodopa diminuează sau devine inconstant şi apar fluctuaţii ale efectului terapeutic (fluctuaţii apărute către sfârşitul intervalului dintre doze sau fluctuaţii de tip on-off). Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N04BC09 ROTIGOTINUM
NEUPRO 2mg/24h 2mg/24h 4mg/24h 6mg/24h 8mg/24h

PLASTURE TRANSDERMIC
SCHWARZ PHARMA LTD

2mg/24h 4mg/24h 6mg/24h 8mg/24h

N04BC09 ROTIGOTINUM
NEUPRO 4mg/24h

PLASTURE TRANSDERMIC
SCHWARZ PHARMA LTD

N04BC09 ROTIGOTINUM
NEUPRO 6mg/24h

PLASTURE TRANSDERMIC
SCHWARZ PHARMA LTD

N04BC09 ROTIGOTINUM
NEUPRO 8mg/24h

PLASTURE TRANSDERMIC
SCHWARZ PHARMA LTD

468

N04BD01

SELEGILINUM

Prescriere limitata: Stadiu tardiv al bolii Parkinson ca tratament complementar la pacientii tratati cu levodopa combinat cu inhibitor al decarboxylazei. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N04BD01 SELEGILINUM
ALS-SELEGILINA 5 mg JUMEX 5 mg SELEGOS 5mg 5mg 5mg

COMPR.
ALSIFCOM INTERMED SRL CHINOIN PRIVATE CO. LTD. MEDOCHEMIE LTD.

5mg

469

N04BD02
Prescriere limitata:

RASAGILINUM ***

Tratamentul bolii Parkinson idiopatică (BP) ca monoterapie (fără levodopa). Tratament adjuvant (în asociere cu levodopa) la pacienţii cu fluctuaţii de sfârşit de doză. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N04BD02 RASAGILINUM
AZILECT 1mg 1mg

COMPR.
TEVA PHARMA GMBH

1mg

470
COMTAN 200mg

N04BX02

ENTACAPONUM ***
COMPR. FILM.
200mg NOVARTIS EUROPHARM LTD.

N04BX02 ENTACAPONUM

200mg

Cod restrictie 2067: Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei de actiune a unei doze

471

N05AH02

CLOZAPINUM **

Prescriere limitata: Tulburari psihotice aparute in cursul bolii Parkinson in situatia in care terapia standard a esuat. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N05AH02 CLOZAPINUM
LEPONEX® 100 mg 100mg

COMPR.
NOVARTIS PHARMA GMBH

100mg 25mg
NOVARTIS PHARMA GMBH

N05AH02 CLOZAPINUM
LEPONEX® 25 mg 25mg

COMPR.

SUBLISTA C1-G13 MIASTENIA GRAVIS. 472 H02AB07 PREDNISONUM
H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg 5mg 5mg 5mg 5mg 5mg

COMPR.
MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

5mg

473
L01BA01

L01BA01
METHOTREXATUM

METHOTREXATUM (4) AZATHIOPRINUM
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

474
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

50mg

475
MIOSTIN 0,5 mg/ml

N07AA01

NEOSTIGMINI BROMIDUM
SOL. INJ.
0.5mg/ml ZENTIVA S.A.

N07AA01 NEOSTIGMINI BROMIDUM N07AA01 NEOSTIGMINI BROMIDUM
NEOSTIGMINA LPH 15 mg 15mg

0.5mg/ml 15mg
LABORMED PHARMA SA

COMPR.

476
MESTINON 60 mg

N07AA02

PYRIDOSTIGMINI BROMIDUM
DRAJ.
60mg ICN POLFA RZESZOW S.A.

N07AA02 PYRIDOSTIGMINI BROMIDUM

60mg

69 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G14 SCLEROZA MULTIPLA. 477 H02AB04 METHYLPREDNISOLONUM
H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 125 mg 125mg 125mg/2ml

LIOF. PT. SOL. INJ.
HEMOFARM S.R.L.

125mg 125mg/2ml 16mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg

COMPR. LIOF. PT. SOL. INJ.
20mg 250mg/4ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg

20mg 250mg/4ml 32mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg

COMPR. LIOF. PT. SOL. INJ.
40mg 40mg/1ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg

40mg 40mg/1ml 4mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg 4mg

COMPR. LIOF. PT. SOL. INJ.
500mg 500mg/7.8ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg

500mg 500mg/7.8ml

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.
PFIZER EUROPE MA EEIG

478

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

480
L01DB07 L01DB07 L01DB07
ONKOTRONE

L01DB07
MITOXANTRONUM

MITOXANTRONUM ***
CONC. PT. SOL. PERF.
2 mg/ml TEVA PHARMACEUTICALS SRL

Protocol: L001G
2 mg/ml 20mg/10ml
WYETH LEDERLE PHARMA GMBH

MITOXANTRONE TEVA 2 mg/ml

MITOXANTRONUM MITOXANTRONUM
2mg/ml

SOL. PERF.
20mg/10ml

NOVANTRONE

CONC. PT. SOL. INJ.
BAXTER ONCOLOGY GMBH

2mg/ml

481
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

70 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G15 BOLI PSIHICE (SCHIZOFRENIE, TULBURARI SCHIZOTIPALE SI DELIRANTE, TULBURARI AFECTIVE MAJORE, TULBURARI PSIHOTICE ACUTE SI BOLI PSIHICE COPII, AUTISM). 482 N03AG01 ACIDUM VALPROICUM + SARURI
S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL LONG 1000 mg 1000mg

MINICOMPR. ELIB. PREL.
DESITIN ARZNEIMITTEL GMBH

1000mg 150mg

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL LONG 150 mg 150mg 150mg 150mg

CAPS. ELIB. PREL.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
CONVULEX® 150 mg

CAPS. MOI GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

150mg 150mg 200mg

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL 150

COMPR. FILM. GASTROREZ.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
PETILIN 200mg 200mg

COMPR. FILM.
REMEDICA LTD.

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE 200 mg

COMPR. FILM. GASTROREZ.
SANOFI-AVENTIS FRANCE

200mg 300mg

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL LONG 300 mg 300mg 300mg 300mg

CAPS. ELIB. PREL.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
CONVULEX® 300 mg

CAPS. MOI GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

300mg 300mg 300mg/5ml

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL 300

COMPR. FILM. GASTROREZ.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL SIROP

SIROP
300mg/5ml 400mg/4ml DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE® 400 mg/4 ml LIOFILIZAT SI SOLVENT PENTRU SOLUTIE INJECTABILA i.v.

LIOF. + SOLV. PT. SOL.
SANOFI-AVENTIS FRANCE

400mg/4ml

N03AG01 ACIDUM VALPROICUM + SARURI
CONVULEX® 500 mg 500mg 500mg

CAPS. MOI GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

500mg 500mg 50mg/ml

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL LONG 500 mg

MINICOMPR. ELIB. PREL.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
CONVULEX® 50mg/ml

SIROP
GEROT PHARMAZEUTIKA GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE

SIROP
57.64mg/ml 600mg 300mg 500mg SANOFI - AVENTIS FRANCE

57.64mg/ml 600mg 300mg 500mg

N03AG01 ACIDUM VALPROICUM + SARURI
ORFIRIL 600

COMPR. FILM. GASTROREZ.
DESITIN ARZNEIMITTEL GMBH

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE CHRONO 300 mg

COMPR. FILM. ELIB. PREL. DIVIZ.
SANOFI-AVENTIS FRANCE

N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE® CHRONO 500 mg

COMPR. FILM. ELIB. PREL. DIVIZ.
SANOFI-AVENTIS FRANCE

483
EPIMIL 100 mg EPIZOL 100 mg LAMICTAL 100 mg LAMOLEP 100 mg LAMOTIRAN 100 mg LAMOTRIX 100 mg PLEXXO® 100 mg

N03AX09

LAMOTRIGINUM **
COMPR.
100mg 100mg 100mg 100mg 100mg 100mg 100mg IVAX PHARMCEUTICALS S.R.O. KRKA D.D. NOVO MESTO THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH

Protocol: N012F
100mg

N03AX09 LAMOTRIGINUM

N03AX09 LAMOTRIGINUM
LAMOTRIGIN STADA 100 mg LAMOTRIN 100 mg 100mg 100mg

COMPR. DISP.
STADA ARZNEIMITTEL AG ACTAVIS GROUP HF.

100mg

N03AX09 LAMOTRIGINUM
LAMOTIRAN 200 mg LAMOTRIX 200 mg 200mg 200mg

COMPR.
RANBAXY UK LTD. MEDOCHEMIE LTD.

200mg

N03AX09 LAMOTRIGINUM
EPIMIL 25mg EPIZOL 25 mg LAMICTAL 25 mg LAMOLEP 25 mg LAMOTIRAN 25 mg LAMOTRIX 25 mg PLEXXO® 25 mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg

COMPR.
IVAX PHARMCEUTICALS S.R.O. KRKA D.D. NOVO MESTO THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH

25mg

N03AX09 LAMOTRIGINUM
LAMOTRIGIN STADA 25 mg LAMOTRIN 25 mg 25mg 25mg 25mg 2mg

COMPR. DISP.
STADA ARZNEIMITTEL AG ACTAVIS GROUP HF.

25mg

N03AX09 LAMOTRIGINUM
LAMICTAL 25 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

25mg 2mg 50mg

N03AX09 LAMOTRIGINUM
LAMICTAL® 2 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

N03AX09 LAMOTRIGINUM
EPIMIL 50 mg EPIZOL 50 mg LAMICTAL 50 mg LAMOLEP 50 mg LAMOTIRAN 50 mg LAMOTRIX 50 mg PLEXXO® 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

COMPR.
IVAX PHARMCEUTICALS S.R.O. KRKA D.D. NOVO MESTO THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH

N03AX09 LAMOTRIGINUM
LAMOTRIGIN STADA 50 mg 50mg

COMPR. DISP.
STADA ARZNEIMITTEL AG

50mg

71 / 153

DCI/DENUMIRE COMERCIALA
LAMOTRIN 50 mg

CONCENTRATIE
50mg 5mg

FORMA FARM.

FIRMA
ACTAVIS GROUP HF.

PROTOCOL

N03AX09 LAMOTRIGINUM
LAMICTAL 5 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

5mg

484
ROMPARKIN® 2 mg

N04AA01

TRIHEXYPHENIDYLUM
COMPR.
2mg TERAPIA SA

N04AA01 TRIHEXYPHENIDYLUM

2mg

485

N05AD01

HALOPERIDOLUM
SOL. INJ.
50mg/ml GEDEON RICHTER LTD.

N05AD01 HALOPERIDOLUM
HALOPERIDOL DECANOAT

50mg/ml 5mg
JANSSEN PHARMACEUTICA NV

N05AD01 HALOPERIDOLUM
HALDOL 5mg

COMPR. SOL. INJ.
5mg/ml GEDEON RICHTER LTD.

N05AD01 HALOPERIDOLUM
HALOPERIDOL 5 mg/ml

5mg/ml 2mg/ml
GEDEON RICHTER ROMANIA SA

N05AD01 HALOPERIDOLUM
HALOPERIDOL 2 mg/ml 2mg/ml 2mg/ml

PIC. ORALE-SOL. PICATURI ORALE-SOL.
TERAPIA SA

N05AD01 HALOPERIDOLUM
HALOPERIDOL

2mg/ml

486
SERDOLECT 12 mg

N05AE03

SERTINDOL **
COMPR. FILM.
12mg H. LUNDBECK A/S

Protocol: N017F
12mg 16mg
H. LUNDBECK A/S

N05AE03 SERTINDOL N05AE03 SERTINDOL
SERDOLECT 16 mg 16mg

COMPR. FILM. COMPR. FILM.
20mg H. LUNDBECK A/S

N05AE03 SERTINDOL
SERDOLECT 20 mg

20mg 4mg
H. LUNDBECK A/S

N05AE03 SERTINDOL
SERDOLECT 4 mg 4mg

COMPR. FILM.

487
ZELDOX® 20 mg/ml

N05AE04

ZIPRASIDONUM **
LIOF. PT. SOL. INJ. + SOLV.
20mg/ml PFIZER EUROPE MA EEIG

Protocol: N018F
20mg/ml 40mg
PFIZER EUROPE MA EEIG

N05AE04 ZIPRASIDONUM N05AE04 ZIPRASIDONUM
ZELDOX® 40 mg 40mg

CAPS. CAPS.
60mg PFIZER EUROPE MA EEIG

N05AE04 ZIPRASIDONUM
ZELDOX® 60 mg

60mg 80mg
PFIZER EUROPE MA EEIG

N05AE04 ZIPRASIDONUM
ZELDOX® 80 mg 80mg

CAPS.

488
FLUANXOL DEPOT

N05AF01

FLUPENTIXOLUM **
SOL. INJ.
20mg/ml H. LUNDBECK A/S

Protocol: N015F
20mg/ml

N05AF01 FLUPENTIXOLUM

489
CLOPIXOL® 10 mg

N05AF05

ZUCLOPENTHIXOLUM **
COMPR. FILM.
10mg H. LUNDBECK A/S

Protocol: N019F
10mg 200mg/ml
H. LUNDBECK A/S

N05AF05 ZUCLOPENTHIXOLUM N05AF05 ZUCLOPENTHIXOLUM
CLOPIXOL® DEPOT 200mg/ml

SOL. INJ. COMPR. FILM.
25mg H. LUNDBECK A/S

N05AF05 ZUCLOPENTHIXOLUM
CLOPIXOL® 25 mg

25mg 50mg/ml
H. LUNDBECK A/S

N05AF05 ZUCLOPENTHIXOLUM
CLOPIXOL ACUPHASE® 50mg/ml

SOL. INJ. PIC. ORALE-SOL.
20mg/ml H. LUNDBECK A/S

N05AF05 ZUCLOPENTHIXOLUM
CLOPIXOL 20 mg/ml

20mg/ml

490
LEPONEX® 100 mg

N05AH02

CLOZAPINUM **
COMPR.
100mg NOVARTIS PHARMA GMBH

Protocol: N016F
100mg 25mg
NOVARTIS PHARMA GMBH

N05AH02 CLOZAPINUM N05AH02 CLOZAPINUM
LEPONEX® 25 mg 25mg

COMPR.

491
ZYPREXA 10 mg

N05AH03

OLANZAPINUM **
COMPR. FILM.
10mg 10mg 15mg 20mg ELI LILLY NEDERLAND BV

Protocol: N003F
10mg 10mg 15mg 20mg 5mg
ELI LILLY NEDERLAND BV

N05AH03 OLANZAPINUM N05AH03 OLANZAPINUM
ZYPREXA 10 mg

PULB. PT. SOL. INJ.
ELI LILLY NEDERLAND BV

N05AH03 OLANZAPINUM
ZYPREXA VELOTAB 15 mg

COMPR. ORODISPERSABILE
ELI LILLY NEDERLAND BV

N05AH03 OLANZAPINUM
ZYPREXA VELOTAB 20 mg

COMPR. ORODISPERSABILE
ELI LILLY NEDERLAND BV

N05AH03 OLANZAPINUM
ZYPREXA 5 mg 5mg

COMPR. FILM.

492
SEROQUEL 100mg

N05AH04

QUETIAPINUM **
COMPR. FILM.
100mg ASTRAZENECA UK LTD.

Protocol: N005F
100mg 200mg
ASTRAZENECA UK LTD.

N05AH04 QUETIAPINUM N05AH04 QUETIAPINUM
SEROQUEL 200 mg 200mg 200mg

COMPR. FILM. COMPR. FILM. ELIB. PREL.
ASTRAZENECA UK LTD.

N05AH04 QUETIAPINUM
SEROQUEL XR 200 mg

200mg 300mg

N05AH04 QUETIAPINUM
SEROQUEL® 300 mg 300mg 300mg

COMPR. FILM.
ASTRAZENECA UK LTD.

N05AH04 QUETIAPINUM
SEROQUEL XR 300 mg

COMPR. FILM. ELIB. PREL.
ASTRAZENECA UK LTD.

300mg

493
N05AL01
EGLONYL® 200 mg

N05AL01
SULPIRIDUM

SULPIRIDUM
COMPR.
200mg SANOFI-SYNTHELABO FRANCE

200mg

72 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
50mg

FORMA FARM.

FIRMA

PROTOCOL

N05AL01 N05AL01

SULPIRIDUM SULPIRIDUM
50mg/ml

CAPS.
SANOFI-SYNTHELABO FRANCE

50mg 50mg/ml
SANOFI-AVENTIS FRANCE

EGLONYL® 50 mg EGLONYL 100 mg/2 ml

SOL. INJ.

494
N05AL05 N05AL05
SOLIAN 200 mg

N05AL05
AMISULPRIDUM

AMISULPRIDUM **
COMPR. DIVIZ.
200mg SANOFI-AVENTIS FRANCE

Protocol: N006F
200mg 400mg
SANOFI-AVENTIS FRANCE

AMISULPRIDUM
400mg

COMPR. FILM.

SOLIAN® 400 mg

495
RISSET 1 mg

N05AX08

RISPERIDONUM **
COMPR. FILM.
1 mg PLIVA LJUBLJANA D.O.O.

Protocol: N004F
1 mg 1mg
EGIS PHARMACEUTICALS P.L.C. ZENTIVA AS ARENA GROUP S.A. TEVA PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV KRKA D.D. NOVO MESTO

N05AX08 RISPERIDONUM N05AX08 RISPERIDONUM
RILEPTID 1 mg RISPEN 1 RISPERIDONA 1 mg RISPERIDONE TEVA 1 mg RISPOLEPT® 1 mg TORENDO 1 mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg

COMPR. FILM.

N05AX08 RISPERIDONUM
RISPOLEPT QUICKLET TORENDO Q-TAB 1 mg

COMPR. ORODISPERSABILE
JANSSEN PHARMACEUTICA NV KRKA D.D. NOVO MESTO

1mg

N05AX08 RISPERIDONUM
RISPOLEPT 1mg/ml

SOL. ORALA
JANSSEN PHARMACEUTICA NV

1mg/ml 2 mg
ZENTIVA AS PLIVA LJUBLJANA D.O.O.

N05AX08 RISPERIDONUM
RISPEN 2 RISSET 2 mg 2 mg 2 mg 25mg

COMPR. FILM.

N05AX08 RISPERIDONUM
RISPOLEPT CONSTA® 25 mg

PULB. + SOLV. PT. SOL. INJ.
JANSSEN PHARMACEUTICA NV

25mg 2mg

N05AX08 RISPERIDONUM
RILEPTID 2 mg RISON 2 mg RISPERIDONA 2 mg RISPERIDONE TEVA 2 mg RISPOLEPT® 2 mg TORENDO 2 mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 37.5mg

COMPR. FILM.
EGIS PHARMACEUTICALS P.L.C. ACTAVIS GROUP HF. ARENA GROUP S.A. TEVA PHARMACEUTICALS SRL JANSSEN PHARMACEUTICA NV KRKA D.D. NOVO MESTO

N05AX08 RISPERIDONUM
RISPOLEPT QUICKLET TORENDO Q-TAB 2 mg

COMPR. ORODISPERSABILE
JANSSEN PHARMACEUTICA NV KRKA D.D. NOVO MESTO

2mg

N05AX08 RISPERIDONUM
RISPOLEPT CONSTA® 37,5 mg

PULB. + SOLV. PT. SOL. INJ.
JANSSEN PHARMACEUTICA NV

37.5mg 3mg

N05AX08 RISPERIDONUM
RILEPTID 3 mg RISON 3 mg RISPEN 3 RISPERIDONA 3 mg RISPERIDONE TEVA 3 mg RISPOLEPT® 3 mg RISSET 3 mg TORENDO 3 mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg

COMPR. FILM.
EGIS PHARMACEUTICALS P.L.C. ACTAVIS GROUP HF. ZENTIVA AS ARENA GROUP S.A. TEVA PHARMACEUTICALS SRL JANSSEN PHARMACEUTICA NV PLIVA LJUBLJANA D.O.O. KRKA D.D. NOVO MESTO

N05AX08 RISPERIDONUM
RISPEN 4 4 mg

COMPR. FILM.
ZENTIVA AS

4 mg 4mg
EGIS PHARMACEUTICALS P.L.C. ACTAVIS GROUP HF. ARENA GROUP S.A. TEVA PHARMACEUTICALS SRL JANSSEN PHARMACEUTICA NV PLIVA LJUBLJANA D.O.O. KRKA D.D. NOVO MESTO

N05AX08 RISPERIDONUM
RILEPTID 4 mg RISON 4 mg RISPERIDONA 4 mg RISPERIDONE TEVA 4 mg RISPOLEPT® 4 mg RISSET 4 mg TORENDO 4 mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg 50mg

COMPR. FILM.

N05AX08 RISPERIDONUM
RISPOLEPT CONSTA® 50 mg

PULB. + SOLV. PT. SOL. INJ.
JANSSEN PHARMACEUTICA NV

50mg

496
ABILIFY 10mg

N05AX12

ARIPIPRAZOLUM **
COMPR.
10mg OTSUKA PHARMACEUTICAL EUROPE LTD.

Protocol: N007F
10mg 15mg
OTSUKA PHARMACEUTICAL EUROPE LTD.

N05AX12 ARIPIPRAZOLUM N05AX12 ARIPIPRAZOLUM
ABILIFY 15mg 15mg

COMPR.

498
CITALORAN 10 mg LINISAN 10 mg

N06AB04

CITALOPRAMUM **
COMPR. FILM.
10mg 10mg RANBAXY UK LIMITED GEDEON RICHTER ROMANIA S.A.

Protocol: N008F
10mg

N06AB04 CITALOPRAMUM

N06AB04 CITALOPRAMUM
CITALORAN 20mg LINISAN 20 mg 20mg 20mg

COMPR. FILM.
RANBAXY UK LIMITED GEDEON RICHTER ROMANIA S.A.

20mg

N06AB04 CITALOPRAMUM
CITALORAN 40 mg LINISAN 40 mg 40mg 40mg

COMPR. FILM.
RANBAXY UK LIMITED GEDEON RICHTER ROMANIA S.A.

40mg

499
CIPRALEX 10 mg

N06AB10

ESCITALOPRAMUM **
COMPR. FILM.
10mg H. LUNDBECK A/S

Protocol: N009F
10mg 5mg
H. LUNDBECK A/S

N06AB10 ESCITALOPRAMUM N06AB10 ESCITALOPRAMUM
CIPRALEX 5 mg 5mg

COMPR. FILM.

73 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

500
TRITTICO AC 150 mg

N06AX05

TRAZODONUM **
COMPR. ELIB. PREL.
150mg ANGELINI FRANCESCO SPA

Protocol: N010F
150mg

N06AX05 TRAZODONUM

501
COAXIL®

N06AX14

TIANEPTINUM **
DRAJ.
12.5mg LES LAB. SERVIER IND.

Protocol: N011F
12.5mg

N06AX14 TIANEPTINUM

502
EFECTIN ER 150 mg VELAXIN 150 mg

N06AX16

VENLAFAXINUM **
CAPS. ELIB. PREL.
150mg 150mg WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

Protocol: N013F
150mg

N06AX16 VENLAFAXINUM

N06AX16 VENLAFAXINUM
VELAXIN 37,5 mg VENLAFAXINA LPH 37,5 mg 37.5mg 37.5mg

COMPR.
EGIS PHARMACEUTICALS PLC LABORMED PHARMA SA

37.5mg

N06AX16 VENLAFAXINUM
EFECTIN ER 75 mg VELAXIN 75 mg 75mg 75mg

CAPS. ELIB. PREL.
WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

75mg

N06AX16 VENLAFAXINUM
VELAXIN 75 mg VENLAFAXINA LPH 75 mg 75mg 75mg

COMPR.
EGIS PHARMACEUTICALS PLC LABORMED PHARMA SA

75mg

503
IXEL

N06AX17

MILNACIPRANUM **
CAPS.
25mg PIERRE FABRE MEDICAMENT

Protocol: N002F
25mg 50mg
PIERRE FABRE MEDICAMENT

N06AX17 MILNACIPRANUM N06AX17 MILNACIPRANUM
IXEL 50mg

CAPS.

504
CYMBALTA 30mg

N06AX21

DULOXETINUM **
CAPS. GASTROREZ.
30mg 60mg ELI LILLY NEDERLAND BV

Protocol: N014F
30mg 60mg

N06AX21 DULOXETINUM N06AX21 DULOXETINUM
CYMBALTA 60mg

CAPS. GASTROREZ.
ELI LILLY NEDERLAND BV

SUBLISTA C1-G16 DEMENTE (DEGENERATIVE, VASCULARE, MIXTE). 505 N06DA02 DONEPEZILUM ***
N06DA02 DONEPEZILUM
ARICEPT® 10 mg 10mg 10mg

Protocol: N020G
10mg
PFIZER EUROPE MA EEIG

COMPR. FILM. COMPR. ORODISPERSABILE
PFIZER EUROPE MA EEIG

N06DA02 DONEPEZILUM
ARICEPT EVESS

10mg 5mg

N06DA02 DONEPEZILUM
ARICEPT® 5 mg 5mg 5mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

N06DA02 DONEPEZILUM
ARICEPT EVESS

COMPR. ORODISPERSABILE
PFIZER EUROPE MA EEIG

5mg

506
EXELON 1.5mg

N06DA03

RIVASTIGMINUM ***
CAPS.
1.5mg NOVARTIS EUROPHARM LTD.

Protocol: N021G
1.5mg 3mg
NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM N06DA03 RIVASTIGMINUM
EXELON 3mg 3mg

CAPS. CAPS.
4.5mg 4.6mg/24h NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM
EXELON 4.5mg

4.5mg 4.6mg/24h 6mg
NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM
EXELON 4.6mg/24h

PLASTURE TRANSDERMIC
NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM
EXELON 6mg 6mg

CAPS. PLASTURE TRANSDERMIC
9.5mg/24h NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM
EXELON 9.5mg/24h

9.5mg/24h

507
REMINYL® 12 mg

N06DA04

GALANTAMINUM ***
COMPR. FILM.
12mg JANSSEN-PHARMACEUTICA NV

Protocol: N022G
12mg 16mg
JANSSEN PHARMACEUTICA NV

N06DA04 GALANTAMINUM N06DA04 GALANTAMINUM
REMINYL 16 mg 16mg

CAPS. ELIB. PREL. CAPS. ELIB. PREL.
24mg JANSSEN PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL 24 mg

24mg 4mg
JANSSEN-PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL® 4 mg 4mg

COMPR. FILM. SOL. ORALA
4mg/ml JANSSEN-PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL® 4 mg/ml

4mg/ml 8mg
JANSSEN PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL 8 mg 8mg

CAPS. ELIB. PREL. COMPR. FILM.
8mg JANSSEN-PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL® 8 mg

8mg

508
EBIXA® 10 mg

N06DX01

MEMANTINUM ***
COMPR. FILM.
10mg H. LUNDBECK A/S

Protocol: N001F
10mg 10mg/g
H. LUNDBECK A/S

N06DX01 MEMANTINUM N06DX01 MEMANTINUM
EBIXA® 10 mg/g 10mg/g

PIC. ORALE, SOL.

74 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G17 COLAGENOZE MAJORE (LUPUS ERITEMATOS SISTEMIC, SCLERODERMIE, POLI/DERMATOMIOZITA, VASCULITE SISTEMICE). 509 H02AB04 METHYLPREDNISOLONUM (5)
H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg

Protocol: L045M

COMPR.
PFIZER EUROPE MA EEIG

16mg 32mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg

COMPR. COMPR.
4mg PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg

4mg

510
L01AA01 L01AA01 L01AA01 L01AA01
ENDOXAN® 1 g

L01AA01
CYCLOPHOSPHAMIDUM

CYCLOPHOSPHAMIDUM *
PULB. PT. SOL. INJ./PERF.
1g 200mg 500mg BAXTER ONCOLOGY GMBH

1g 200mg 500mg 50mg

CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM
50mg

PULB. PT. SOL. PERF./INJ. I.V.
ACTAVIS S.R.L.

ENDOXAN 200 mg ENDOXAN® 500 mg ENDOXAN® 50 mg

PULB. PT. SOL. INJ./PERF.
BAXTER ONCOLOGY GMBH

DRAJ.
BAXTER ONCOLOGY GMBH

511
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

512
PLAQUENIL®

P01BA02

HYDROXYCHLOROQUINUM
COMPR. FILM.
200mg SANOFI-SYNTHELABO LTD.

P01BA02 HYDROXYCHLOROQUINUM

200mg

75 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G18 POLIARTRITA REUMATOIDA, ARTROPATIA PSORIAZICA, SI ARTRITA JUVENILA. 513 A07EC01 SULFASALAZINUM
A07EC01 SULFASALAZINUM
SALAZIDIN 500mg 500mg

COMPR. FILM.
AC HELCOR SRL

500mg 500mg

A07EC01 SULFASALAZINUM
SULFASALAZIN EN

COMPR. FILM. GASTROREZ.
KRKA D.D. NOVO MESTO

514
DIPROPHOS®

H02AB01

BETAMETHASONUM
SUSP. INJ. I.M.
7mg/ml SCHERING PLOUGH EUROPE

H02AB01 BETAMETHASONUM

7mg/ml

515
MEDROL A 16

H02AB04

METHYLPREDNISOLONUM (5)
COMPR.
16mg PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg

16mg 32mg
PFIZER EUROPE MA EEIG

COMPR. COMPR.
4mg PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg

4mg

516
L01BA01

L01BA01
METHOTREXATUM

METHOTREXATUM (4) CICLOSPORINUM *

517

L04AA01
Prescriere limitata:

Terapie de mentinere ulterioara initierii si stabilizarii tratamentului cu ciclosporina, la pacientii cu poliartrita reumatoida severa pentru care agentii antireumatici clasici cu actiune lenta (inclusiv methotrexat) sunt ineficienti sau inadecvati. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA01 L04AA01

CICLOSPORINUM
100mg

CAPS. MOI
IVAX - PHARMACEUTICALS S.R.O.

100mg 100mg/ml
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

EQUORAL® 100 mg

CICLOSPORINUM
100mg/ml 100mg/ml

SOL. ORALA

EQUORAL® SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

518

L04AA13

LEFLUNOMIDUM **

Cod restrictie 2643: Tratamentul iniţial al poliartritei reumatoide active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente şi/sau Cod restrictie 2681: Tratamentul iniţial al poliartritei reumatoide active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente şi/sau Leflunomide este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitată timp de doi ani după întreruperea tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA13
ARAVA 100mg

LEFLUNOMIDUM
100mg

COMPR. FILM.
SANOFI- AVENTIS DEUTSCHLAND GMBH

100mg 10mg
SANOFI- AVENTIS DEUTSCHLAND GMBH

L04AA13
ARAVA 10mg

LEFLUNOMIDUM
10mg

COMPR. FILM. COMPR. FILM.
20mg SANOFI- AVENTIS DEUTSCHLAND GMBH

L04AA13
ARAVA 20mg

LEFLUNOMIDUM

20mg

519
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

520

M01AB05

DICLOFENACUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AB05 DICLOFENACUM
DICLOTARD® 100 mg REFEN® RETARD VOLTAREN® RETARD 100mg 100mg 100mg

COMPR. FILM. ELIB. PREL.
TERAPIA SA HEMOFARM S.R.L. NOVARTIS PHARMA GMBH

100mg

M01AB05 DICLOFENACUM
CLAFEN 100 mg DICLOFENAC 100 mg DICLOFENAC SODIC 100 mg DICLOGESIC 100 SUPOZITOARE EPIFENAC VOLTAREN® 100mg 100mg 100mg 100mg 100mg 100mg

SUPOZ.
ANTIBIOTICE SA SINTOFARM SA MAGISTRA C & C DAR AL DAWA PHARMA SRL E.I.P.I.CO. MED S.R.L. NOVARTIS PHARMA GMBH

100mg

M01AB05 DICLOFENACUM
TRATUL 120 120mg

SUPOZ.
GEROT PHARMAZEUTIKA GMBH

120mg 150mg
ALFA WASSERMANN SPA

M01AB05 DICLOFENACUM
DICLOREUM 150 mg 150mg 25mg 25mg 25mg 25mg

CAPS. ELIB. PREL. COMPR. FILM. GASTROREZ.
FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
RHEUMAVEK VOLTAREN® 25

25mg

M01AB05 DICLOFENACUM
EPIFENAC

COMPR. GASTROREZ.
E.I.P.I.CO. MED S.R.L.

25mg 25mg 25mg/ml

M01AB05 DICLOFENACUM
DICLOFENAC 25 mg

DRAJ. GASTROREZ.
ARENA GROUP SA

M01AB05 DICLOFENACUM
RHEUMAVEK VOLTAREN® 25mg/ml 25mg/ml

SOL. INJ.
FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM

SOL. INJ.

30mg/ml

76 / 153

DCI/DENUMIRE COMERCIALA
TRATUL®

CONCENTRATIE
30mg/ml 50mg 50mg 50mg 50mg

FORMA FARM.

FIRMA
GEROT PHARMAZEUTIKA GMBH

PROTOCOL

M01AB05 DICLOFENACUM
TRATUL 50

CAPS. GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

50mg 50mg

M01AB05 DICLOFENACUM
CLAFEN 50 mg DICLOFENAC 50 mg VOLTAREN® 50

COMPR. FILM. GASTROREZ.
ANTIBIOTICE SA TERAPIA SA NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
VOLTAREN RAPID® 50mg 50mg

DRAJ.
NOVARTIS PHARMA GMBH

50mg 50mg 50mg
NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
DICLOFENAC 50 mg

DRAJ. GASTROREZ.
ARENA GROUP SA

M01AB05 DICLOFENACUM
VOLTAREN® 50mg

SUPOZ. SUPOZ.
60mg 75mg GEROT PHARMAZEUTIKA GMBH

M01AB05 DICLOFENACUM
TRATUL 60

60mg 75mg 75mg
HEXAL AG HELP S.A. PHARMACEUTICALS

M01AB05 DICLOFENACUM
DICLAC® 75 ID

COMPR. ELIB. MODIF.
HEXAL AG

M01AB05 DICLOFENACUM
DICLAC VURDON 75mg 75mg

SOL. INJ.

M01AB05 DICLOFENACUM
ALMIRAL DICLOFENAC 75 mg DICLOFENAC AL I.M. 75mg/3ml 75mg/3ml 75mg/3ml

SOL. INJ.
MEDOCHEMIE LTD. TERAPIA SA ALIUD PHARMA GMBH & CO.KG

75mg/3ml

521
PLAQUENIL®

P01BA02

HYDROXYCHLOROQUINUM
COMPR. FILM.
200mg SANOFI-SYNTHELABO LTD.

P01BA02 HYDROXYCHLOROQUINUM

200mg

77 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G19 SPONDILITA ANKILOZANTA. 522 A07EC01 SULFASALAZINUM
A07EC01 SULFASALAZINUM
SALAZIDIN 500mg 500mg

COMPR. FILM.
AC HELCOR SRL

500mg 500mg

A07EC01 SULFASALAZINUM
SULFASALAZIN EN

COMPR. FILM. GASTROREZ.
KRKA D.D. NOVO MESTO

523
DIPROPHOS®

H02AB01

BETAMETHASONUM
SUSP. INJ. I.M.
7mg/ml SCHERING PLOUGH EUROPE

H02AB01 BETAMETHASONUM

7mg/ml

524

M01AB05

DICLOFENACUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AB05 DICLOFENACUM
DICLOTARD® 100 mg REFEN® RETARD VOLTAREN® RETARD 100mg 100mg 100mg

COMPR. FILM. ELIB. PREL.
TERAPIA SA HEMOFARM S.R.L. NOVARTIS PHARMA GMBH

100mg

M01AB05 DICLOFENACUM
CLAFEN 100 mg DICLOFENAC 100 mg DICLOFENAC SODIC 100 mg DICLOGESIC 100 SUPOZITOARE EPIFENAC VOLTAREN® 100mg 100mg 100mg 100mg 100mg 100mg

SUPOZ.
ANTIBIOTICE SA SINTOFARM SA MAGISTRA C & C DAR AL DAWA PHARMA SRL E.I.P.I.CO. MED S.R.L. NOVARTIS PHARMA GMBH

100mg

M01AB05 DICLOFENACUM
TRATUL 120 120mg

SUPOZ.
GEROT PHARMAZEUTIKA GMBH

120mg 150mg
ALFA WASSERMANN SPA

M01AB05 DICLOFENACUM
DICLOREUM 150 mg 150mg 25mg 25mg 25mg 25mg

CAPS. ELIB. PREL. COMPR. FILM. GASTROREZ.
FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
RHEUMAVEK VOLTAREN® 25

25mg

M01AB05 DICLOFENACUM
EPIFENAC

COMPR. GASTROREZ.
E.I.P.I.CO. MED S.R.L.

25mg 25mg 25mg/ml

M01AB05 DICLOFENACUM
DICLOFENAC 25 mg

DRAJ. GASTROREZ.
ARENA GROUP SA

M01AB05 DICLOFENACUM
RHEUMAVEK VOLTAREN® 25mg/ml 25mg/ml

SOL. INJ.
FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
TRATUL® 30mg/ml 50mg 50mg 50mg 50mg

SOL. INJ.
GEROT PHARMAZEUTIKA GMBH

30mg/ml 50mg 50mg

M01AB05 DICLOFENACUM
TRATUL 50

CAPS. GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

M01AB05 DICLOFENACUM
CLAFEN 50 mg DICLOFENAC 50 mg VOLTAREN® 50

COMPR. FILM. GASTROREZ.
ANTIBIOTICE SA AC HELCOR PHARMA SRL NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
VOLTAREN RAPID® 50mg 50mg

DRAJ.
NOVARTIS PHARMA GMBH

50mg 50mg 50mg
NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
DICLOFENAC 50 mg

DRAJ. GASTROREZ.
ARENA GROUP SA

M01AB05 DICLOFENACUM
VOLTAREN® 50mg

SUPOZ. SUPOZ.
60mg 75mg GEROT PHARMAZEUTIKA GMBH

M01AB05 DICLOFENACUM
TRATUL 60

60mg 75mg 75mg
HEXAL AG HELP S.A. PHARMACEUTICALS

M01AB05 DICLOFENACUM
DICLAC® 75 ID

COMPR. ELIB. MODIF.
HEXAL AG

M01AB05 DICLOFENACUM
DICLAC VURDON 75mg 75mg

SOL. INJ.

M01AB05 DICLOFENACUM
ALMIRAL DICLOFENAC 75 mg DICLOFENAC AL I.M. 75mg/3ml 75mg/3ml 75mg/3ml

SOL. INJ.
MEDOCHEMIE LTD. TERAPIA SA ALIUD PHARMA GMBH & CO.KG

75mg/3ml

78 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G22 BOLI ENDOCRINE (GUSA ENDEMICA, INSUFICIENTA SUPRARENALA CRONICA, DIABETUL INSIPID, MIXEDEMUL ADULTULUI, TUMORI HIPOFIZARE CU EXPANSIUNE SUPRASELARA SI TUMORI NEUROENDOCRINE). 525 G02CB03 CABERGOLINUM **
G02CB03 CABERGOLINUM
DOSTINEX 0.5mg

Protocol: G001C

COMPR.
PFIZER EUROPE MA EEG

0.5mg 0.5mg
PFIZER EUROPE MA EEG

G02CB03 CABERGOLINUM
DOSTINEX 0.5mg

COMPR.

Prescriere limitata: Prevenirea aparitiei lactatiei in lauzie din motive medicale Cod restrictie 2659: Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicala Cod restrictie 2660: Hiperprolactinemia patologica pentru care a fost utilizat tratament chirurgical dar cu rezultate incomplete

526
SOMAVERT 10 mg

H01AX01

PEGVISOMANTUM ****
LIOF. + SOLV. PT. SOL. INJ.
10mg 20mg PFIZER LTD.

Protocol: H012E
10mg 20mg

H01AX01 PEGVISOMANTUM H01AX01 PEGVISOMANTUM
SOMAVERT 20 mg

LIOF. + SOLV. PT. SOL. INJ.
PFIZER LTD.

527
MINIRIN 0,2 mg

H01BA02

DESMOPRESSINUM
COMPR.
0.2mg FERRING AB

H01BA02 DESMOPRESSINUM
Cod restrictie 1678: Diabet insipid.

0.2mg

H01BA02 DESMOPRESSINUM
MINIRIN 0,2 mg 0.2mg FERRING AB

528
SANDOSTATIN®

H01CB02

OCTREOTIDUM ****
COMPR.
0.1mg/ml NOVARTIS PHARMA GMBH

Protocol: H008E
100mg 10mg

H01CB02 OCTREOTIDUM H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 10 mg 10mg

PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB. PRELUNG.
NOVARTIS PHARMA GMBH

H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 20 mg 20mg

PULB. + SOLV. PT. SUSP. INJ. (I.M.) CU ELIB. PRELU
NOVARTIS PHARMA GMBH

20mg

H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 30 mg 30mg

PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB. PRELUNG.
NOVARTIS PHARMA GMBH

30mg

529

H01CB03

LANREOTIDUM ****
LIOF. PT. SOL. INJ. + SOLV.
30mg BEAUFOUR IPSEN PHARMA

Protocol: H005E;H006C
30mg

H01CB03 LANREOTIDUM
SOMATULINE® PR 30 mg

530
ASTONIN H

H02AA02

FLUDROCORTISONUM
COMPR.
0.1mg MERCK KGAA

H02AA02 FLUDROCORTISONUM

0.1mg

531

H02AB06

PREDNISOLONUM
LIOF. + SOLV. PT. SOL. INJ.
250mg 50mg MERCK KGAA

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 250

250mg 50mg

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 50

LIOF. + SOLV. PT. SOL. INJ.
MERCK KGAA

532

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

533

H02AB09

HYDROCORTISONUM
LIOF. + SOLV. PT. SOL. INJ.
100mg 100mg HEMOFARM S.R.L. E.I.P.I.CO. MED S.R.L.

H02AB09 HYDROCORTISONUM
HYDROCORTISONE 100 mg HYDROCORTISONE SUCCINAT SODIC

100mg

H02AB09 HYDROCORTISONUM
HIDROCORTIZON HEMISUCCINAT 25mg/5ml 500mg

SOL. INJ. I.V.
ZENTIVA S.A.

25mg/5ml 500mg

H02AB09 HYDROCORTISONUM
HYDROCORTISONE 500 mg

LIOF. PT. SOL. INJ. + SOLV.
HEMOFARM S.R.L.

534

H03AA01

LEVOTHYROXINUM
COMPR.
100µg 100µg MERCK KGAA BERLIN CHEMIE AG MENARINI GROUP

H03AA01 LEVOTHYROXINUM
EUTHYROX® 100 L-THYROXIN 100 BERLIN - CHEMIE

100µg

H03AA01 LEVOTHYROXINUM
EUTHYROX® 200 200µg

COMPR.
MERCK KGAA

200µg 25µg
MERCK KGAA

H03AA01 LEVOTHYROXINUM
EUTHYROX® 25 25µg

COMPR. COMPR.
50µg 50µg MERCK KGAA BERLIN CHEMIE AG MENARINI GROUP

H03AA01 LEVOTHYROXINUM
EUTHYROX® 50 L-THYROXIN 50

50µg

535
JODID 100

H03CA01

KALII IODIDUM
COMPR.
100µg MERCK KGAA

H03CA01 KALII IODIDUM H03CA01 KALII IODIDUM
JODID 200 200µg

100µg 200µg
MERCK KGAA

COMPR.

536

G02CB01

BROMOCRIPTINUM
DRAJ. 2.5mg

G02CB01 BROMOCRIPTINUM

79 / 153

DCI/DENUMIRE COMERCIALA
BROCRIPTIN

CONCENTRATIE
2.5mg

FORMA FARM.

FIRMA
BIOFARM SA

PROTOCOL

Prescriere limitata: Prescriere limitata:

Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicala Hiperprolactinemia patologica pentru care tratamentul chirurgical utilizat a dus la rezultate incomplete;

SUBLISTA C1-G23 BOALA WILSON. 537 M01CC01 PENICILLAMINUM **(4)
M01CC01 PENICILLAMINUM

80 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G25 BOALA CRONICA DE RINICHI – FAZA PREDIALIZA. 538 A11CC07 PARICALCITOLUM **
A11CC07 PARICALCITOLUM
ZEMPLAR 5 µg/ml

Protocol: A005E
5 µg/ml
ABBOTT LABORATORIES S.A.

SOL. INJ.

539

B03AC02

COMPLEX DE HIDROXID DE FER (III) SUCROZA **
SOL. INJ./PERF.
20mg/ml VIFOR FRANCE S.A.

Protocol: A010N
20mg/ml

B03AC02 COMPLEX DE HIDROXID DE FER (III) SUCROZA
VENOFER®

540
EPREX® 10000 UI

B03XA01

EPOETINUM ALFA **
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

Protocol: B010N
10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA
EPOKINE 1000 UI/0,5 ml EPREX® 1000 UI

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOPHAR 2000 U.I. 2000UI

SOL. INJ.
GULF PHARMACEUTICAL IND. S.R.L.

2000UI 2000ui/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/0,5 ml EPREX® 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPREX® 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA
EPREX® 40 000 UI 40 000UI

SOL. INJ.
JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA
EPOPHAR 4000 U.I. 4000UI

SOL. INJ. SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/0,4 ml EPREX® 4000 UI

4000ui/0.4ml

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml RENAMED FARMA S.R.L.

4000UI/1ml

541

B03XA01

EPOETINUM BETA **
SOL. INJ. IN SERINGA PREUMPLUTA
10000UI/0,6ml 1000UI/0,3ml 2000UI/0,3ml 30000 UI/0,6ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L

Protocol: B009N

B03XA01 EPOETINUM BETA
NEORECORMON 10000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 1000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA
NEORECORMON 2000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 30000UI/0,6ml

30000 UI/0,6ml

B03XA01 EPOETINUM BETA
NEORECORMON 4000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 5000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 500 UI

542
ARANESP 10µg/0.4ml

B03XA02

DARBEPOETINUM ALFA **
SOL. INJ. IN SERINGA PREUMPLUTA
10µg/0.4ml 100µg/0.5ml 15µg/0.375ml 150µg/0.3ml 20µg/0.5ml 30µg/0.3ml 300µg/0.6ml 40µg/0.4ml 50µg/0.5ml 500µg/ml 60µg/0.3ml 80µg/0.4ml AMGEN EUROPE BV

Protocol: B011N
10µg/0.4ml 100µg/0.5ml 15µg/0.375ml 150µg/0.3ml 20µg/0.5ml 30µg/0.3ml 300µg/0.6ml 40µg/0.4ml 50µg/0.5ml 500µg/ml 60µg/0.3ml 80µg/0.4ml

B03XA02 DARBEPOETINUM ALFA B03XA02 DARBEPOETINUM ALFA
ARANESP 100µg/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA
ARANESP 15µg/0.375ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA
ARANESP 150µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 20µg/0.5ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 30µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 300µg/0.6ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 40µg/0.4ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 50µg/0.5ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 500µg/ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 60µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 80µg/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA

544
APROVEL 150mg

C09CA04

IRBESARTANUM **
COMPR. FILM.
150mg SANOFI PHARMA - BRISTOL MYERS SQUIBB

Protocol: C008N
150mg 300mg
SANOFI PHARMA - BRISTOL MYERS SQUIBB

C09CA04 IRBESARTANUM C09CA04 IRBESARTANUM
APROVEL 300mg 300mg

COMPR. FILM.

545

H02AB07

PREDNISONUM
COMPR. 5mg

Protocol: H002N

H02AB07 PREDNISONUM

81 / 153

DCI/DENUMIRE COMERCIALA
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

CONCENTRATIE
5mg 5mg 5mg 5mg 5mg

FORMA FARM.

FIRMA
MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

PROTOCOL

546
L01AA01
ENDOXAN® 50 mg

L01AA01
CYCLOPHOSPHAMIDUM

CYCLOPHOSPHAMIDUM
DRAJ.
50mg BAXTER ONCOLOGY GMBH

Protocol: L027N
50mg

547

L04AA01

CICLOSPORINUM *

Protocol: L028N

Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA01 L04AA01

CICLOSPORINUM
100mg

CAPS. MOI
IVAX - PHARMACEUTICALS S.R.O.

100mg 100mg/ml
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

EQUORAL® 100 mg

CICLOSPORINUM
100mg/ml 100mg/ml

SOL. ORALA

EQUORAL® SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

548
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

Protocol: L029N
50mg

549

V06DDN1

AMINOACIZI INCLUSIV COMBINATII CU POLIPEPTIDE **
COMPR. FILM.
FRESENIUS KABI DEUTSCHLAND GMBH

Protocol: V004N

V06DDN1 AMINOACIZI INCLUSIV COMBINATII CU POLIPEPTIDE
KETOSTERIL®

82 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G26 GLAUCOM. 550 S01EC03
S01EC03 DORZOLAMIDUM
TRUSOPT

DORZOLAMIDUM
SOL. OFT.
20mg/ml MERCK SHARP & DOHME S.R.L.

20mg/ml

551
AZOPT 10mg/ml

S01EC04

BRINZOLAMIDUM
PICATURI OFT.-SUSP.
10mg/ml ALCON LABORATORIES LTD.

S01EC04 BRINZOLAMIDUM

10mg/ml

552
TIMO-COMOD® TIMOLOL 0,25%

S01ED01

TIMOLOLUM
PICATURI OFT.-SOL.
0.25% 0.25% 0.5% 0.5% 0.5% URSAPHARM ARZNEIMITTEL GMBH&CO.KG E.I.P.I.CO. MED S.R.L.

S01ED01 TIMOLOLUM

0.25%

S01ED01 TIMOLOLUM
TIMO-COMOD® TIMO-GAL® TIMOLOL 0,5%

PICATURI OFT.-SOL.
URSAPHARM ARZNEIMITTEL GMBH&CO.KG TERAPIA SA E.I.P.I.CO. MED S.R.L.

0.5%

S01ED01 TIMOLOLUM
NYOLOL GEL 1mg/g

GEL OFT.
NOVARTIS PHARMA GMBH

1mg/g 2.5mg/ml
MERCK SHARP & DOHME ROMANIA S.R.L.

S01ED01 TIMOLOLUM
TIMOPTIC 2.5mg/ml 2.5mg/ml

PIC. OFT.-SOL. PICATURI OFT.-SOL.
CHAUVIN ANKERPHARM GMBH

S01ED01 TIMOLOLUM
ARUTIMOL 0,25%

2.5mg/ml 5mg/ml

S01ED01 TIMOLOLUM
TIMOPTIC 5mg/ml 5mg/ml

PIC. OFT.-SOL.
MERCK SHARP & DOHME ROMANIA S.R.L.

S01ED01 TIMOLOLUM
ARUTIMOL 0,5%

PICATURI OFT.-SOL.
CHAUVIN ANKERPHARM GMBH

5mg/ml 2.5mg/ml

S01ED01 TIMOLOLUM
TIMOLOL RPH 0,25% 2.5mg/ml

PIC. OFT., SOL.
ROMPHARM COMPANY SRL

S01ED01 TIMOLOLUM
TIMABAK 2,5 mg/ml 2.5mg/ml

PIC. OFT.,SOL.
LABORATOIRES THEA

2.5mg/ml 5mg/ml
LABORATORIES THEA ROMPHARM COMPANY SRL

S01ED01 TIMOLOLUM
TIMABAK 5 mg/ml TIMOLOL RPH 0,5% 5mg/ml 5mg/ml

PIC. OFT.,SOL.

553
BETOPTIC - S

S01ED02

BETAXOLOLUM
PICATURI OFT.-SUSP.
0.25% ALCON COUVREUR NV

S01ED02 BETAXOLOLUM S01ED02 BETAXOLOLUM
BETAX 5mg/ml 5mg/ml

0.25% 5mg/ml

PIC. OFT.-SOL.
ROMPHARM SRL

S01ED02 BETAXOLOLUM
BETOPTIC

PIC.OFTALMICE,SOL.
ALCON COUVREUR NV

5mg/ml 5mg/ml

S01ED02 BETAXOLOLUM
BETAXOLOL 5mg/ml

PIC. OFT., SOL.
TERAPIA SA

554
CARTEOL 2%

S01ED05

CARTEOLOLUM
PICATURI OFT.-SOL.
20mg/ml 20mg/ml 2% S.I.F.I. SPA

S01ED05 CARTEOLOLUM S01ED05 CARTEOLOLUM
FORTINOL EP 2%

20mg/ml 20mg/ml 2%

PIC. OFTALMICE CU ELIB. PREL. PICATURI OFT.-SOL.
S.I.F.I. SPA

DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

S01ED05 CARTEOLOLUM
CARTEOL 2%

555

S01ED51

COMBINATII (BIMATOPROSTUM + TIMOLOLUM)
PIC. OFT.,SOL.
300µg/ml+5mg/ml ALLERGAN PHARMACEUTICALS IRELAND

S01ED51 COMBINATII (BIMATOPROSTUM + TIMOLOLUM)
GANFORT

300µg/ml+5mg/m l

556
COSOPT

S01ED51

COMBINATII (DORZOLAMIDUM+TIMOLOLUM)
PIC. OFT.-SOL.
MERCK SHARP & DOHME FARA CONCENTRATIE

S01ED51 COMBINATII (DORZOLAMIDUM+TIMOLOLUM)

557

S01ED51

COMBINATII (LATANOPROSTUM+TIMOLOLUM)
SOL. OFT.
FARA CONCENTRATIE PFIZER EUROPE MA EEI

S01ED51 COMBINATII (LATANOPROSTUM+TIMOLOLUM)
XALCOM (R)

558
XALATAN®

S01EE01

LATANOPROSTUM
PICATURI OFT.-SOL.
0.005% PFIZER EUROPE MA EEIG

S01EE01 LATANOPROSTUM

5,00%

559
LUMIGAN 0,3mg/ml

S01EE03

BIMATOPROSTUM
PIC. OFT.,SOL.
0,3mg/ml ALLERGAN PHARMACEUTICALS IRELAND

S01EE03 BIMATOPROSTUM

0,3mg/ml

561
TRAVATAN 40µg/ml

S01EE04

TRAVOPROSTUM
PICATURI OFT.SOL.
40µg/ml ALCON LABORATORIES LTD.

S01EE04 TRAVOPROSTUM

40µg/ml

83 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G27 PEMFIGUS. 562 H02AB02
H02AB02 DEXAMETHASONUM
DEXAMETHASONE SODIUM PHOSPHATE

DEXAMETHASONUM
SOL. INJ.
8mg E.I.P.I.CO. MED S.R.L.

8mg 8mg/2ml
MEDOCHEMIE LTD.

H02AB02 DEXAMETHASONUM
DEXAMED 8mg/2ml

SOL. INJ.

563

H02AB04

METHYLPREDNISOLONUM
COMPR.
32mg PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM
MEDROL 32

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg 4mg

COMPR.
PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg

COMPR.
PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.
500mg/7.8ml 125mg/2ml 250mg/4ml 40mg/1ml PFIZER EUROPE MA EEI PFIZER EUROPE MA EEI PFIZER EUROPE MA EEI PFIZER EUROPE MA EEI

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ LIOF. SI SOLV.PT.SOL.INJ LIOF. SI SOLV.PT.SOL.INJ LIOF. PT. SOL. INJ.
125mg HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 125 mg

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg 40mg

LIOF. PT. SOL. INJ.
HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg 20mg

LIOF. PT. SOL. INJ.
HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg 500mg

LIOF. PT. SOL. INJ.
HEMOFARM S.R.L.

564

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

565
J04BA02

J04BA02
DAPSONUM

DAPSONUM (4) CYCLOPHOSPHAMIDUM
PULB. PT. SOL. INJ./PERF.
1g 200mg 500mg BAXTER ONCOLOGY GMBH

566
L01AA01 L01AA01 L01AA01 L01AA01
ENDOXAN® 1 g

L01AA01
CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM

1g 200mg 500mg 50mg

PULB. PT. SOL. PERF./INJ. I.V.
ACTAVIS S.R.L.

ENDOXAN 200 mg ENDOXAN® 500 mg ENDOXAN® 50 mg

PULB. PT. SOL. INJ./PERF.
BAXTER ONCOLOGY GMBH

DRAJ.
50mg BAXTER ONCOLOGY GMBH

568

L04AA01

CICLOSPORINUM *

Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA01 L04AA01

CICLOSPORINUM
100mg

CAPS. MOI
IVAX - PHARMACEUTICALS S.R.O.

100mg 100mg/ml
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

EQUORAL® 100 mg

CICLOSPORINUM
100mg/ml 100mg/ml

SOL. ORALA

EQUORAL® SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

569
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

SUBLISTA C1-G29 BOALA GAUCHER. 570 A16AB02 IMIGLUCERASUM ****
A16AB02 IMIGLUCERASUM
CEREZYME 200U 200U 400U

Protocol: A008E
200U 400U
GENZYME EUROPE BV

PULB. PT.CONC. PT.SOL. PERF. PULB. PT.CONC. PT.SOL. PERF.
GENZYME EUROPE BV

A16AB02 IMIGLUCERASUM
CEREZYME 400U

571

A16AX06
Prescriere limitata:

MIGLUSTATUM ****
CAPS.
100mg ACTELION REGISTRATION LTD.

Tratamentul pe cale orală al bolii Gaucher de tip I, uşoară până la moderată.numai la pacienţii care nu pot fi supuşi terapiei de substituţie enzimatică

A16AX06 MIGLUSTATUM
ZAVESCA

100mg

84 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G30 BOLI VENERICE (SIFILIS, GONOREE, INFECTIA CU CHLAMIDIA). 572 J01AA02 DOXYCYCLINUM
J01AA02 DOXYCYCLINUM
100mg 100mg 100mg

CAPS.
EUROPHARM SA ANTIBIOTICE SA SANDOZ SRL

100mg

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02 J01AA02

DOXYCYCLINUM
100mg

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V.

100mg 100mg
ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

UNIDOX SOLUTAB

DOXYCYCLINUM
100mg 100mg 100mg

CAPS.

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02 J01AA02

DOXYCYCLINUM
100mg

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V.

100mg 100mg
ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

UNIDOX SOLUTAB

DOXYCYCLINUM
100mg 100mg 100mg

CAPS.

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02

DOXYCYCLINUM
100mg

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V.

100mg

UNIDOX SOLUTAB

573
J01AA07

J01AA07
TETRACYCLINUM

TETRACYCLINUM
CAPS.
250mg 250mg ANTIBIOTICE SA SANDOZ SRL

250mg

TETRACICLINA 250 mg TETRACICLINA SANDOZ 250 mg

574
J01CE02 J01CE02
OSPEN® 1000

J01CE02

PHENOXYMETHYLPENICILLINUM
COMPR.
1000000ui EUROPHARM SA

PHENOXYMETHYLPENICILLINUM PHENOXYMETHYLPENICILLINUM PHENOXYMETHYLPENICILLINUM PHENOXYMETHYLPENICILLINUM PHENOXYMETHYLPENICILLINUM
500000ui

1000000ui 1000000ui
SANDOZ GMBH

PENICILINA V 1 000 000 U.I.

COMPR. FILM.
1000000ui

J01CE02
OSPEN® 1500

COMPR. FILM.
1500000ui SANDOZ GMBH

1500000ui 400000ui/5ml
SANDOZ GMBH

J01CE02
OSPEN 400

SIROP
400000ui/5ml

J01CE02
OSPEN® 500

COMPR. FILM.
SANDOZ GMBH

500000ui

575
J01CE01 J01CE01 J01CE01 J01CE01
PENICILINA G SODICA

J01CE01
BENZYLPENICILLINUM BENZYLPENICILLINUM BENZYLPENICILLINUM

BENZYLPENICILLINUM
PULB. PT. SOL. INJ.
1 000 000ui 1000000ui 400 000ui 400000ui ANTIBIOTICE SA

1 000 000ui 1000000ui 400 000ui 400000ui

PULB. PT. SOL. INJ.
ANTIBIOTICE SA ANTIBIOTICE SA

PENICILINA G POTASICA PENICILINA G SODICA

PULB. PT. SOL. INJ. PULB. PT. SOL. INJ.
ANTIBIOTICE SA

BENZYLPENICILLINUM

PENICILINA G POTASICA

576
J01CE08
MOLDAMIN®

J01CE08

BENZATHINI BENZYLPENICILLINUM
PULB. PT. SUSP. INJ.
1200000ui ANTIBIOTICE SA

BENZATHINI BENZYLPENICILLINUM BENZATHINI BENZYLPENICILLINUM
600000ui

1200000ui 600000ui

J01CE08
MOLDAMIN®

PULB. PT. SUSP. INJ.
ANTIBIOTICE SA

577
J01DD08
SUPRAX

J01DD08
CEFIXIMUM CEFIXIMUM

CEFIXIMUM
GRAN. PT. SUSP. ORALA
100mg/5ml GEDEON RICHTER LTD.

100mg/5ml 200mg

J01DD08 J01DD08
SUPRAX

CAPS.
200mg ANTIBIOTICE SA

EFICEF® 200 mg

CEFIXIMUM
200mg

COMPR. FILM.
GEDEON RICHTER LTD.

200mg

578
J01FA01

J01FA01
ERYTHROMYCINUM

ERYTHROMYCINUM
COMPR.
200mg 200mg 200mg 200mg 200mg/5ml ARENA GROUP SA ANTIBIOTICE SA EUROPHARM SA SANDOZ S.R.L.

200mg

ERITROMAGIS 200 mg ERITROMICINA 200 mg ERITROMICINA EUROPHARM 200 mg ERITROMICINA SANDOZ 200 mg COMPRIMATE

J01FA01
ERITRO 200

ERYTHROMYCINUM

PULB. PT. SUSP. ORALA
LEK PHARMATECH SRL

200mg/5ml

579

J01FA10

AZITHROMYCINUM

Prescriere limitata: Infectii genitale necomplicate cu Chlamydia trachomatis. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01FA10 J01FA10 J01FA10 J01FA10 J01FA10 J01FA10

AZITHROMYCINUM AZITHROMYCINUM
125mg

PULB. PT. SUSP. ORALA
100mg/5ml SANDOZ SRL

100mg/5ml 125mg

AZITROMICINA SANDOZ 100 mg/5 ml SUMAMED 125 mg

COMPR. FILM.
PLIVA LJUBLJANA D.O.O.

AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM
250mg

PULB. PT. SUSP. ORALA
200 mg/5 ml 200mg/5ml 200mg/5ml SANDOZ SRL

200 mg/5 ml 200mg/5ml 200mg/5ml 250mg

AZITROMICINA SANDOZ 200 mg/5 ml AZITROX 200 mg/5 ml SUMAMED FORTE AZATRIL 250 mg

PULB. + SOLV. SUSP. ORALA
ECZACIBASI PHARMACEUTICALS S.R.L. PLIVA LJUBLIJANA D.O.O. BALKANPHARMA RAZGRAD AD

PULB. PT. SUSP. ORALA CAPS.

85 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
250mg 250mg 500mg

FORMA FARM.

FIRMA

PROTOCOL

J01FA10

AZITHROMYCINUM

COMPR. FILM.
SANDOZ S.R.L. ZENTIVA AS

250mg

AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE AZITROX® 250

J01FA10
SUMAMED®

AZITHROMYCINUM AZITHROMYCINUM
500mg 500mg 500mg 500mg 500mg 2g

LIOF. PT. SOL. PERF.
PLIVA LJUBLJANA D.O.O.

500mg 500mg

J01FA10

COMPR. FILM.
SANDOZ S.R.L. ZENTIVA AS ECZACIBASI PHARMACEUTICALS S.R.L. PLIVA LJUBLJANA D.O.O. OZONE LABORATORIES LTD.

AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE AZITROX® 500 AZRO® 500 mg SUMAMED 500 mg ZITROCIN 500 mg

J01FA10
ZMAX 2 g

AZITHROMYCINUM

GRAN. ELIB. PREL. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

2g

580

J01MA02

CIPROFLOXACINUM

Prescriere limitata: Gonoreea. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN® 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg

COMPR. FILM.
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA

250mg

J01MA02 CIPROFLOXACINUM
CIPRINOL® CIPROFLOXACINA 100 mg/10 ml

CONC. PT. SOL. PERF.
100mg/10ml 100mg/10ml KRKA D.D. SICOMED SA

100mg/10ml

J01MA02 CIPROFLOXACINUM
CIPRINOL

SOL. PERF.
100mg/50ml KRKA D.D. NOVO MESTO

100mg/50ml 200mg/100ml
KRKA D.D. NOVO MESTO BAYER HEALTHCARE AG

J01MA02 CIPROFLOXACINUM
CIPRINOL CIPROBAY® 200

SOL. PERF.
200mg/100ml 200mg/100ml

J01MA02 CIPROFLOXACINUM
EUCIPRIN 250mg

CAPS.
EUROPHARM SA

250mg 250mg
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN® 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg

COMPR. FILM.

J01MA02 CIPROFLOXACINUM
CIPROBAY® 400 UFEXIL 2mg/ml 2mg/ml

SOL. PERF.
BAYER HEALTHCARE AG DEMO SA

2mg/ml

J01MA02 CIPROFLOXACINUM
CIPRINOL®

SOL. PERF.
400mg/200ml KRKA D.D.

400mg/200ml 500mg
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO ANTIBIOTICE SA BAYER HEALTHCARE AG E.I.P.I.CO. MED S.R.L. DAR AL DAWA PHARMA S.R.L ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA ECZACIBASI ILAC SANAYI VE TICARET AS

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 500 CIPRINOL 500 mg CIPRO QUIN® CIPROBAY® 500 CIPROCIN 500 mg CIPRODAR CIPROFLOXACINA ALKALOID 500 mg CIPROLEN® 500 mg CIPROLET 500 mg CIPROZONE FORTE 500 mg CUMINOL 500 mg SIFLOKS® 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.

J01MA02 CIPROFLOXACINUM
CIPRINOL 750 mg 750mg

COMPR. FILM.
KRKA D.D. NOVO MESTO

750mg

SUBLISTA C1-G31A BOALA CRONICA INFLAMATORIE INTESTINALA. 582 L04AA12 INFLIXIMABUM ****
L04AA12 INFLIXIMABUM
100mg

Protocol: L034K
100mg

PULB. PT. CONC. PT. SOL. PERF.
CENTOCOR B.V.

REMICADE 100 mg

583
L04AA17
HUMIRA 40 mg

L04AA17
ADALIMUMABUM

ADALIMUMABUM ****
SOL. INJ. IN SERINGA PREUMPLUTA
40mg ABBOTT LABORATORIES LTD.

40mg

86 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G31B POLIARTRITA REUMATOIDA. 584 L01XC02 RITUXIMABUM ****
L01XC02 RITUXIMABUM
10mg/ml 10mg/ml

Protocol: L043M
10mg/ml

CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

MABTHERA 100 mg MABTHERA 500 mg

585
L04AA11
ENBREL 25mg

L04AA11
ETANERCEPTUM

ETANERCEPTUM ****
PULB. + SOLV. PT. SOL. INJ.
25mg WYETH EUROPA LIMITED

25mg 50mg 25mg 50mg 25mg 50mg

L04AA11 L04AA11
ENBREL 25mg

ETANERCEPTUM
50mg 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg 25mg

PULB. + SOLV. PT. SOL. INJ.
WYETH EUROPA LIMITED

L04AA11 L04AA11
ENBREL 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

L04AA11
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

586
L04AA12
REMICADE 100 mg

L04AA12
INFLIXIMABUM

INFLIXIMABUM ****
PULB. PT. CONC. PT. SOL. PERF.
100mg CENTOCOR B.V.

100mg

587
L04AA17
HUMIRA 40 mg

L04AA17
ADALIMUMABUM

ADALIMUMABUM ****
SOL. INJ. IN SERINGA PREUMPLUTA
40mg ABBOTT LABORATORIES LTD.

40mg

SUBLISTA C1-G31C ARTROPATIA PSORIAZICA. 589 L04AA11 ETANERCEPTUM ****
L04AA11
ENBREL 25mg

Protocol: L040M
25mg 50mg 25mg 50mg 25mg 50mg

ETANERCEPTUM
25mg

PULB. + SOLV. PT. SOL. INJ.
WYETH EUROPA LIMITED

L04AA11 L04AA11
ENBREL 25mg

ETANERCEPTUM
50mg 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg 25mg

PULB. + SOLV. PT. SOL. INJ.
WYETH EUROPA LIMITED

L04AA11 L04AA11
ENBREL 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

L04AA11
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

590
L04AA12
REMICADE 100 mg

L04AA12
INFLIXIMABUM

INFLIXIMABUM ****
PULB. PT. CONC. PT. SOL. PERF.
100mg CENTOCOR B.V.

100mg

591
L04AA17
HUMIRA 40 mg

L04AA17
ADALIMUMABUM

ADALIMUMABUM ****
SOL. INJ. IN SERINGA PREUMPLUTA
40mg ABBOTT LABORATORIES LTD.

40mg

SUBLISTA C1-G31D SPONDILITA ANKILOZANTA. 592 L04AA11 ETANERCEPTUM ****
L04AA11
ENBREL 25mg

Protocol: L041M
25mg 50mg 25mg 50mg 25mg 50mg

ETANERCEPTUM
25mg

PULB. + SOLV. PT. SOL. INJ.
WYETH EUROPA LIMITED

L04AA11 L04AA11
ENBREL 25mg

ETANERCEPTUM
50mg 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg 25mg

PULB. + SOLV. PT. SOL. INJ.
WYETH EUROPA LIMITED

L04AA11 L04AA11
ENBREL 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

L04AA11
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

593
L04AA12
REMICADE 100 mg

L04AA12
INFLIXIMABUM

INFLIXIMABUM ****
PULB. PT. CONC. PT. SOL. PERF.
100mg CENTOCOR B.V.

100mg

594
L04AA17
HUMIRA 40 mg

L04AA17
ADALIMUMABUM

ADALIMUMABUM ****
SOL. INJ. IN SERINGA PREUMPLUTA
40mg ABBOTT LABORATORIES LTD.

40mg

87 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G31E ARTRITA JUVENILA. 595 L04AA11 ETANERCEPTUM ****
L04AA11
ENBREL 25mg

Protocol: L039M
25mg 50mg 25mg 50mg 25mg 50mg

ETANERCEPTUM
25mg

PULB. + SOLV. PT. SOL. INJ.
WYETH EUROPA LIMITED

L04AA11 L04AA11
ENBREL 25mg

ETANERCEPTUM
50mg 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg 25mg

PULB. + SOLV. PT. SOL. INJ.
WYETH EUROPA LIMITED

L04AA11 L04AA11
ENBREL 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

L04AA11
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

SUBLISTA C1-G31F PSORIAZIS CRONIC SEVER (PLACI). 596 L04AA11 ETANERCEPTUM ****
L04AA11
ENBREL 25mg

Protocol: L044L
25mg 50mg 25mg 50mg 25mg 50mg

ETANERCEPTUM
25mg

PULB. + SOLV. PT. SOL. INJ.
WYETH EUROPA LIMITED

L04AA11 L04AA11
ENBREL 25mg

ETANERCEPTUM
50mg 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg 25mg

PULB. + SOLV. PT. SOL. INJ.
WYETH EUROPA LIMITED

L04AA11 L04AA11
ENBREL 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

L04AA11
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

597
L04AA12
REMICADE 100 mg

L04AA12
INFLIXIMABUM

INFLIXIMABUM ****
PULB. PT. CONC. PT. SOL. PERF.
100mg CENTOCOR B.V.

100mg

598
L04AA21
RAPTIVA 100mg/ml

L04AA21
EFALIZUMABUM

EFALIZUMABUM ****
PULB+SOLV.PT.SOL.INJ
100mg/ml SERONO EUROPE LTD.

100mg/ml

599
L04AA17
HUMIRA 40 mg

L04AA17
ADALIMUMABUM

ADALIMUMABUM ****
SOL. INJ. IN SERINGA PREUMPLUTA
40mg ABBOTT LABORATORIES LTD.

40mg

88 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P1: PROGRAMUL NATIONAL DE BOLI TRANSMISIBILE. A ) SUBPROGRAMUL DE TRATAMENT SI MONITORIZARE A PERSOANELOR CU INFECTIE HIV /SIDA SI TRATAMENTUL POSTEXPUNERE 600 J05AE01 SAQUINAVIRUM
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AE01 J05AE01

SAQUINAVIRUM
200mg

CAPS.
ROCHE REGISTRATION LTD.

200mg 500mg
ROCHE REGISTRATION LTD.

INVIRASE 200mg

SAQUINAVIRUM
500mg

COMPR. FILM.

INVIRASE 500 mg

601

J05AE02

INDINAVIRUM

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AE02 J05AE02

INDINAVIRUM
200mg

CAPS.
MERCK SHARP & DOHME LTD.

200mg 400mg
MERCK SHARP & DOHME LTD.

CRIXIVAN 200mg

INDINAVIRUM
400mg

CAPS.

CRIXIVAN 400mg

602

J05AE03

RITONAVIRUM **

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AE03

RITONAVIRUM
100mg

CAPS. MOI
ABBOTT LABORATORIES LTD.

100mg

NORVIR 100 mg

603

J05AE04

NELFINAVIRUM

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AE04 J05AE04

NELFINAVIRUM
250mg 50mg/g

COMPR. FILM.
ROCHE REGISTRATION LTD.

250mg 50mg/g

VIRACEPT 250 mg

NELFINAVIRUM

PULB. PT. SOL. ORALA
ROCHE REGISTRATION LTD.

VIRACEPT 50 mg/g

605

J05AE06

LOPINAVIRUM+RITONAVIRUM **

Prescriere limitata: Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AE06 J05AE06 J05AE06

LOPINAVIRUM+RITONAVIRUM LOPINAVIRUM+RITONAVIRUM LOPINAVIRUM+RITONAVIRUM

CAPS. MOI
133.3mg/33.3mg ABBOTT LABORATORIES LTD.

133.3mg/33.3mg 200mg/50mg
ABBOTT LABORATORIES LTD.

KALETRA 133,3mg/33,3mg KALETRA 200mg/50mg

COMPR. FILM.
200mg/50mg

SOL. ORALA
80mg/ml+20mg/ml ABBOTT LABORATORIES LTD.

80mg/ml+20mg/ ml

KALETRA 80mg/ml+20mg/ml

606
J05AE07
TELZIR 700mg

J05AE07
FOSAMPRENAVIRUM

FOSAMPRENAVIRUM **
COMPR. FILM.
700mg GLAXO GROUP LTD.

700mg

607

J05AE08

ATAZANAVIRUM

Prescriere limitata: Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AE08 J05AE08

ATAZANAVIRUM
150mg

CAPS.
BRISTOL-MYERS SQUIBB PHARMA EEIG

150mg 200mg
BRISTOL-MYERS SQUIBB PHARMA EEIG

REYATAZ 150 mg

ATAZANAVIRUM
200mg

CAPS.

REYATAZ 200 mg

608

J05AE09
Prescriere limitata:

TIPRANAVIRUM **

Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000 copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii trebuie sa fi avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1 inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AE09

TIPRANAVIRUM
250mg

CAPS. MOI

250mg
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

APTIVUS 250mg

609

J05AE10
Prescriere limitata:

DARUNAVIRUM **

Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000 copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii trebuie sa fi avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1 inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AE10

DARUNAVIRUM
300mg

COMPR. FILM.
JANSSEN-CILAG INTERNATIONAL NV

300mg

PREZISTA 300mg

610

J05AF01

ZIDOVUDINUM

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AF01
RETROVIR®

ZIDOVUDINUM
100mg

CAPS.
THE WELLCOME FOUNDATION LTD.

100mg 1%
THE WELLCOME FOUNDATION LTD.

J05AF01
RETROVIR®

ZIDOVUDINUM
1%

SOL. ORALA

611

J05AF02

DIDANOSINUM

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AF02 J05AF02

DIDANOSINUM
125mg 200mg

CAPS. GASTROREZ.
BRISTOL MYERS SQUIBB KFT

125mg 200mg

VIDEX EC 125 mg

DIDANOSINUM

CAPS. GASTROREZ.
BRISTOL MYERS SQUIBB KFT

VIDEX EC 200 mg

89 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
250mg 400mg

FORMA FARM.

FIRMA

PROTOCOL

J05AF02 J05AF02

DIDANOSINUM DIDANOSINUM

CAPS. GASTROREZ.
BRISTOL MYERS SQUIBB KFT

250mg 400mg

VIDEX EC 250 mg VIDEX EC 400 mg

CAPS. GASTROREZ.
BRISTOL MYERS SQUIBB KFT

612

J05AF04

STAVUDINUM

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AF04
ZERIT 15 mg

STAVUDINUM
15mg

CAPS.
BRISTOL-MYERS SQUIBB PHARMA EEIG

15mg 20mg
BRISTOL-MYERS SQUIBB PHARMA EEIG

J05AF04
ZERIT 20 mg

STAVUDINUM
20mg

CAPS. CAPS.
30mg BRISTOL-MYERS SQUIBB PHARMA EEIG

J05AF04
ZERIT 30 mg

STAVUDINUM STAVUDINUM
40mg

30mg 40mg
BRISTOL-MYERS SQUIBB PHARMA EEIG

J05AF04
ZERIT 40 mg

CAPS.

613
J05AF05 J05AF05 J05AF05
EPIVIR 150mg ZEFFIX 100 mg

J05AF05
LAMIVUDINUM

LAMIVUDINUM
COMPR. FILM.
100mg GLAXO GROUP LTD.

100mg 10mg/ml
GLAXO GROUP LTD.

LAMIVUDINUM
10mg/ml

SOL. ORALA COMPR. FILM.
150mg GLAXO GROUP LTD.

EPIVIR 10mg/ml

LAMIVUDINUM LAMIVUDINUM
5mg/ml

150mg 5mg/ml
GLAXO GROUP LTD.

J05AF05

SOL. ORALA

ZEFFIX 5 mg/ml

614

J05AF06

ABACAVIRUM

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AF06 J05AF06

ABACAVIRUM
20mg/ml

SOL. ORALA
GLAXO GROUP LTD.

20mg/ml 300mg
GLAXO GROUP LTD.

ZIAGEN 20 mg/ml

ABACAVIRUM
300mg

COMPR. FILM.

ZIAGEN 300 mg

615

J05AF07

TENOFOVIRUM DISOPROXIL FUMARATE

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AF07

TENOFOVIRUM DISOPROXIL FUMARATE
245mg

COMPR. FILM.
GILEAD SCIENCE INTERNATIONAL LIMITED

245mg

VIREAD 245mg

616

J05AF09

EMTRICITABINUM

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AF09

EMTRICITABINUM
200mg

CAPS.
GILEAD SCIENCE INTERNATIONAL LIMITED

200mg

EMTRIVA 200mg

617

J05AG01

NEVIRAPINUM

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AG01 J05AG01

NEVIRAPINUM
200mg

COMPR.
BOEHRINGER INGELHEIM INT. GMBH

200mg 50mg/5ml
BOEHRINGER INGELHEIM INT. GMBH

VIRAMUNE 200mg

NEVIRAPINUM
50mg/5ml

SUSP. ORALA

VIRAMUNE 50mg/ml

618

J05AG03

EFAVIRENZUM

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AG03 J05AG03 J05AG03 J05AG03

EFAVIRENZUM
100mg

CAPS.
MERCK SHARP & DOHME LTD.

100mg 50mg
MERCK SHARP & DOHME LTD.

STOCRIN 100 mg

EFAVIRENZUM
50mg

CAPS. COMPR. FILM.
50mg MERCK SHARP & DOHME LTD.

STOCRIN 50 mg

EFAVIRENZUM EFAVIRENZUM
600mg

50mg 600mg
MERCK SHARP & DOHME LTD.

STOCRIN 50 mg STOCRIN 600 mg

COMPR. FILM.

619

J05AR01

ZIDOVUDINUM+LAMIVUDINUM **

Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AR01

ZIDOVUDINUM+LAMIVUDINUM

COMPR. FILM.
150mg/300mg GLAXO GROUP LTD.

150mg/300mg

COMBIVIR 150mg/300mg

620

J05AR02
Prescriere limitata:

ABACAVIRUM+LAMIVUDINUM **

Tratamentul infectiei HIV la pacientii in varsta de peste 12 ani si cu greutate corporala > de 40 kg. cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AR02

ABACAVIRUM+LAMIVUDINUM

COMPR. FILM.
600mg/300mg GLAXO GROUP LTD.

600mg/300mg

KIVEXA 600mg/300mg

621

J05AR04
Prescriere limitata:

ABACAVIRUM+LAMIVUDINUM+ZIDOVUDINUM **

Tratamentul infectiei HIV la pacientii in varsta de peste 12 ani si cu greutate corporala > de 40 kg. cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AR04

ABACAVIRUM+LAMIVUDINUM+ZIDOVUDINUM

COMPR. FILM.

300mg/150mg/30 0mg

90 / 153

DCI/DENUMIRE COMERCIALA
TRIZIVIR 300mg/150mg/300mg

CONCENTRATIE

FORMA FARM.

FIRMA
GLAXO GROUP LTD.

PROTOCOL

300mg/150mg/300 mg

622

J05AX07
Prescriere limitata:

ENFUVIRTIDUM **

Tratmentul combinat al infectiei HIV la pacienti experimentati cu esec la tratament caracterizat prin:evidenta replicarii virale in timpul terapiei antiretrovirale continue sau intolerantei la medicamentele ARV anterior administrate. Pacientii au avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1 inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J05AX07

ENFUVIRTIDUM
90mg/ml

PULB. + SOLV. PT. SOL. INJ.
ROCHE REGISTRATION LTD.

90mg/ml

FUZEON 90mg/ml

623
NORMIX 200 mg

A07AA11

RIFAXIMINUM
COMPR. FILM.
200mg ALFA WASSERMANN SPA

A07AA11 RIFAXIMINUM

200mg

624
MICONAL ECOBI

D01AC02

MICONAZOLUM
CREMA
20mg/g FARMACEUTICI ECOBI S.A.S

D01AC02 MICONAZOLUM D01AC02 MICONAZOLUM
MEDACTER MICONAZOL NITRAT 2% 2% 2%

20mg/g 2%
FARAN LABORATORIES S.A. SLAVIA PHARM SRL

CREMA

D01AC02 MICONAZOLUM
DERMOZOL 2%

GEL
PHARCO IMPEX 93 S.R.L.

2%

625
ACICLOVIR HYPERION ACIKLOVIR CREMA

D06BB03

ACICLOVIRUM
CREMA
50mg/g 50mg/g HYPERION S.A. A & G MED TRADING S.R.L.

D06BB03 ACICLOVIRUM

50mg/g

D06BB03 ACICLOVIRUM
ACICLOVIR ACICLOVIR 5% CLOVIRAL® 5% ZOVIRAX 5% 5% 5% 5%

CREMA
OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SA ANTIBIOTICE SA THE WELLCOME FOUNDATION LTD.

5%

626
MICONAL ECOBI

G01AF04

MICONAZOLUM
CAPS. MOI VAG.
1.2g FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM G01AF04 MICONAZOLUM
MYCOHEAL 200 200mg

1.2g 200mg
DAR AL DAWA PHARMA S.R.L

SUPOZ. VAG. CREMA VAG.
20mg/g FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM
MICONAL ECOBI

20mg/g 2mg/ml
FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM
MICONAL ECOBI 2mg/ml

SOL. VAGINALA OVULE
50mg FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM
MICONAL ECOBI

50mg 2%
FARAN LABORATORIES S.A. DAR AL DAWA PHARMA S.R.L.

G01AF04 MICONAZOLUM
MEDACTER MYCOHEAL 2% 2%

CREMA VAG.

627
J01CF04

J01CF04
OXACILLINUM

OXACILLINUM
CAPS.
250mg 250mg 250mg 250mg 250mg FARMACOM SA ANTIBIOTICE SA ARENA GROUP SA FARMEX COMPANY SRL SANDOZ SRL

250mg

OXACILINA OXACILINA 250 mg OXACILINA ARENA 250 mg OXACILINA FARMEX 250 mg OXACILINA SANDOZ 250 mg

J01CF04

OXACILLINUM
500mg 500mg 500mg 500mg 500mg 500mg 1g 250mg

CAPS.
ANTIBIOTICE SA ARENA GROUP SA OZONE LABORATORIES LTD. SANDOZ SRL EUROPHARM SA

500mg

OXACILINA 500 mg OXACILINA ARENA 500 mg OXACILINA FORTE 500 mg OXACILINA SANDOZ 500 mg OXALIN 500 mg

J01CF04 J01CF04 J01CF04

OXACILLINUM OXACILLINUM OXACILLINUM

PULB. PT. SOL. INJ./PERF. I.M./I.V.
ANTIBIOTICE SA

500mg 1g 250mg

OXACILINA ANTIBIOTICE 500 mg OXACILINA ANTIBIOTICE 1 g OXACILINA ANTIBIOTICE 250 mg

PULB. PT. SOL. INJ./PERF.I.M./I.V.
ANTIBIOTICE SA

PULB. PT. SOL. INJ./PERF.I.M./I.V.
ANTIBIOTICE SA

628
J01CR01
AMPIPLUS® 1,5 g

J01CR01
AMPICILLINUM + SULBACTAM

AMPICILLINUM + SULBACTAM
PULB. PT. SOL. INJ.
1g+500mg ANTIBIOTICE SA

1g+500mg

629

J01CR02
Prescriere limitata:

AMOXICILLINUM + ACIDUM CLAVULANICUM

Tratamentul de scurta durata la infectiilor bacteriene atunci cand este suspectata rezistenta la amoxicilina. Infectii la care este dovedita rezistenta la amoxicilina. A fost raportată hepatotoxicitate la acest medicament. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01CR02 J01CR02 J01CR02 J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM
1.2g

PULB. PT. SOL. INJ./PERF.
ANTIBIOTICE SA

1.2g 1000mg

AMOXIPLUS 1,2 g

AMOXICILLINUM + ACIDUM CLAVULANICUM
1000mg

COMPR. FILM.
MEDOCHEMIE LTD.

MEDOCLAV 1000 mg

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM
1062.5mg

PULB. PT. SOL. INJ./PERF.
1000mg+200mg BEECHAM GROUP PLC

1000mg+200mg 1062.5mg 125mg+31.25/5m l

AUGMENTIN INTRAVENOS 1.2g AUGMENTIN™ SR

COMPR. FILM. ELIB. PREL.
BEECHAM GROUP PLC

AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SUSP. ORALA

91 / 153

DCI/DENUMIRE COMERCIALA
MEDOCLAV 156,25 mg/5 ml

CONCENTRATIE

FORMA FARM.

FIRMA
MEDOCHEMIE LTD.

PROTOCOL

125mg+31.25/5ml 156.25mg/5ml 156.25mg/5ml 2000mg+200mg

J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SUSP. ORALA
LEK PHARMACEUTICALS D.D. SANDOZ GMBH

156.25mg/5ml

AMOKSIKLAV 156,25mg/5ml BIOCLAVID 156.25mg/5ml

J01CR02 J01CR02 J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SOL. PERF.
BEECHAM GROUP PLC

2000mg+200mg 250/62,5mg

AUGMENTIN INTRAVENOS 2,2g FORCID SOLUTAB 250/62,5 MEDOCLAV 375 mg

COMPR. DISP.
250/62,5mg ASTELLAS PHARMA EUROPE BV

COMPR. FILM.
250mg+125mg MEDOCHEMIE LTD.

250mg+125mg 250mg+62.5mg/5 ml 312.5mg/5ml 312.5mg/5ml

PULB. PT. SUSP. ORALA
250mg+62.5mg/5 ml 312.5mg/5ml 312.5mg/5ml 312.5mg/5ml MEDOCHEMIE LTD.

MEDOCLAV FORTE 312,5mg/5ml

J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SUSP. ORALA
SANDOZ GMBH LEK PHARMACEUTICALS D.D. RANBAXY UK LIMITED

BIOCLAVID 312.5mg/5ml AMOKSIKLAV 312.5mg/5ml ENHANCIN 312,5 mg/5 ml

PULB. PT.SUSP. ORALA

J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SUSP. ORALA
400mg+57mg/5ml SMITHKLINE BEECHAM PLC

400mg+57mg/5m l 500/125mg

AUGMENTIN BIS

J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM

COMPR. DISP.
500/125mg ASTELLAS PHARMA EUROPE BV

FORCID SOLUTAB 500/125 AUGMENTIN 625 mg MEDOCLAV 625 mg

COMPR. FILM.
500mg+125mg 500mg+125mg 600mg BEECHAM GROUP PLC MEDOCHEMIE LTD.

500mg+125mg

J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM
625mg 625mg 625mg

PULB. PT. SOL. INJ./PERF.
ANTIBIOTICE SA

600mg 625mg

AMOXIPLUS 600 mg AMOKSIKLAV 2 x 625 mg BIOCLAVID 625 mg ENHANCIN 625 mg

COMPR. FILM.
LEK PHARMACEUTICALS D.D. SANDOZ GMBH RANBAXY UK LIMITED

J01CR02 J01CR02 J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM AMOXICILLINUM + ACIDUM CLAVULANICUM

PULB. PT. SUSP. ORALA
642.90mg/5ml SMITHKLINE BEECHAM PLC

642.90mg/5ml 875mg+125mg

AUGMENTIN® ES FORCID SOLUTAB 875/125 AUGMENTIN 1 g

COMPR. DISP.
875mg+125mg ASTELLAS PHARMA EUROPE BV

COMPR. FILM.
875mg+125mg BEECHAM GROUP PLC

875mg+125mg

630
J01CR05
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

PIPERACILLINUM + TAZOBACTAMUM

631
J01CR50

J01CR50

COMBINATII (CEFOPERAZONUM+SULBACTAM)
PULB. PT. SOL. INJ.
1g+1g PFIZER EUROPE MA EEIG

COMBINATII (CEFOPERAZONUM+SULBACTAM)

1g+1g

SULPERAZON® 2 g

632
J01DD04 J01DD04
NOVOSEF 0,5 g i.v.

J01DD04
CEFTRIAXONUM

CEFTRIAXONUM
PULB. PT. SOL. INJ.
0.5g 1g 1g 1g 1g 1g 250mg 250mg 2g 2g 2g ECZACIBASI PHARMACEUTICALS S.R.L.

0.5g 1g

CEFTRIAXONUM

PULB. PT. SOL. INJ.
LEK PHARMACEUTICALS D.D. ECZACIBASI PHARMACEUTICALS S.R.L. ECZACIBASI PHARMACEUTICALS S.R.L.

LENDACIN 1 g NOVOSEF 1 g i.m. NOVOSEF 1 g i.v.

J01DD04

CEFTRIAXONUM

PULB. PT. SOL. INJ./PERF.
ANTIBIOTICE SA OZONE LABORATORIES LTD.

1g

CEFORT 1 g CEFTRIAXON 1 g

J01DD04 J01DD04 J01DD04

CEFTRIAXONUM CEFTRIAXONUM CEFTRIAXONUM

PULB. PT. SOL. INJ.
LEK PHARMACEUTICALS D.D.

250mg 250mg 2g

LENDACIN 250 mg CEFORT 250 mg CEFORT 2 g MEDAXONE 2 g

PULB. PT. SOL. INJ./PERF.
ANTIBIOTICE SA

PULB. PT. SOL. INJ./PERF.
ANTIBIOTICE SA MEDOCHEMIE LTD.

J01DD04
ROCEPHIN®

CEFTRIAXONUM CEFTRIAXONUM
500mg 0.5g 500mg 0.5g

PULB. PT. SOL. PERF.
ROCHE ROMANIA S.R.L.

2g 500mg 0.5g 500mg 0.5g

J01DD04 J01DD04 J01DD04 J01DD04

PULB. PT. SOL. INJ./PERF.
ANTIBIOTICE SA

CEFORT 500 mg

CEFTRIAXONUM CEFTRIAXONUM CEFTRIAXONUM

PULB. PT. SOL. INJ.
ECZACIBASI PHARMACEUTICALS S.R.L.

NOVOSEF 0,5 g i.v. CEFORT 500 mg NOVOSEF 0,5 g i.m.

PULB. PT. SOL. INJ./PERF.
ANTIBIOTICE SA

PULB. + SOLV. PT. SOL. INJ./PERF.
ECZACIBASI PHARMACEUTICALS S.R.L.

633
J01DD08
SUPRAX

J01DD08
CEFIXIMUM CEFIXIMUM

CEFIXIMUM
GRAN. PT. SUSP. ORALA
100mg/5ml GEDEON RICHTER LTD.

100mg/5ml 200mg

J01DD08 J01DD08
SUPRAX

CAPS.
200mg ANTIBIOTICE SA

EFICEF® 200 mg

CEFIXIMUM
200mg

COMPR. FILM.
GEDEON RICHTER LTD.

200mg

92 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

634
J01DD12
LYZONE 1 g MEDOCEF 1 g

J01DD12
CEFOPERAZONUM

CEFOPERAZONUM
PULB. PT. SOL. INJ.
1g 1g MEDICAROM GROUP S.R.L. MEDOCHEMIE LTD.

1g

J01DD12
LYZONE 2 g MEDOCEF 2 g

CEFOPERAZONUM
2g 2g

PULB. PT. SOL. INJ.
MEDICAROM GROUP S.R.L. MEDOCHEMIE LTD.

2g

J01DD12 J01DD12
CEFOZON 1 g

CEFOPERAZONUM
500mg 1g

PULB. PT. SOL. INJ.
E.I.P.I.CO. MED S.R.L.

500mg 1g

CEFOZON 500 mg

CEFOPERAZONUM

PULB. PT. SOL. INJ./PERF.I.M./I.V.
E.I.P.I.CO. MED S.R.L.

635
J01DE02
CEFROM® 1 g

J01DE02
CEFPIROMUM

CEFPIROMUM
PULB. PT. SOL. INJ./PERF.
1g LAB. AVENTIS

1g 2g

J01DE02
CEFROM® 2 g

CEFPIROMUM
2g

PULB. PT. SOL. INJ./PERF.
LAB. AVENTIS

636
J01DH02 J01DH02
MERONEM IV 1 g

J01DH02
MEROPENEMUM

MEROPENEMUM
PULB. PT. SOL. INJ. I.V./PERF.
1g 500mg ASTRAZENECA UK LTD.

1g 500mg

MEROPENEMUM

PULB. PT. SOL. INJ. I.V./PERF.
ASTRAZENECA UK LTD.

MERONEM IV 500 mg

637
J01DH51
TIENAM I.V.

J01DH51
IMIPENEMUM + CILASTATINUM

IMIPENEMUM + CILASTATINUM
PULB. PT. SOL. PERF.
MERCK SHARP & DOHME ROMANIA S.R.L.

638

J01EE01

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01EE01
EPITRIM

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM SULFAMETHOXAZOLUM + TRIMETHOPRIMUM SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SUSP. ORALA
200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.

200mg/40mg /5ml 25mg/5mg/ml
EGIS PHARMACEUTICALS P.L.C.

J01EE01
SUMETROLIM

SIROP
25mg/5mg/ml

J01EE01
BISEPTRIM CO - TRIM ELL SUMETROLIM TAGREMIN

COMPR.
400mg/80mg 400mg/80mg 400mg/80mg 400mg/80mg EUROPHARM SA ARENA GROUP S.A. EGIS PHARMACEUTICALS P.L.C. ZENTIVA S.A.

400mg/80mg

J01EE01
SEPTRIN

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SOL. PERF.
400mg/80mg THE WELLCOME FOUNDATION LTD.

400mg/80mg

639
J01FA02 J01FA02

J01FA02
SPIRAMYCINUM

SPIRAMYCINUM
COMPR. FILM.
1.5 M ui LAB. AVENTIS

1.5 M ui 3M ui
LAB. AVENTIS

ROVAMYCINE® 1,5 Mil. UI

SPIRAMYCINUM
3M ui

COMPR. FILM.

ROVAMYCINE® 3 Mil. UI

640
J01FA06
ROKSOLIT ROXAMED® 150

J01FA06
ROXITHROMYCINUM

ROXITHROMYCINUM
COMPR. FILM.
150mg 150mg ECZACIBASI ILAC SANAYI VE TICARET AS DAR AL DAWA PHARMA S.R.L

150mg

641
J01FA09

J01FA09
CLARITHROMYCINUM

CLARITHROMYCINUM
GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml KRKA D.D. TERAPIA S.A. ABBOTT SPA SANDOZ S.R.L.

125mg/5ml

FROMILID® 125 mg/5 ml KLABAX 125 mg/5 ml KLACID® LEKOKLAR 125 mg/5 ml

J01FA09

CLARITHROMYCINUM
250mg 250mg 250mg 250mg 250mg 250mg 250mg

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT SPA MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

250mg

CLAR 250 CLARITROMICINA 250 mg FROMILID 250 KLABAX 250 mg KLACID® KLERIMED® 250 LEKOKLAR® 250 mg

J01FA09

CLARITHROMYCINUM

GRAN. PT. SUSP. ORALA
250mg/5ml 250mg/5ml TERAPIA S.A. SANDOZ SRL

250mg/5ml

KLABAX 250 mg/5 ml LEKOKLAR 250 mg/5 ml

J01FA09

CLARITHROMYCINUM
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

500mg

CLAR 500 CLARITROMICINA 500 mg FROMILID 500 KLABAX 500 mg KLERIMED® 500 LEKOKLAR® 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. MODIF.
TERAPIA S.A. LEK PHARMACEUTICALS D.D.

500mg

KLABAX MR 500 mg LEKOKLAR XL 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. PREL.
KRKA D.D. ABBOTT LABORATORIES LTD.

500mg

FROMILID® UNO KLACID SR

93 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
500mg

FORMA FARM.

FIRMA

PROTOCOL

J01FA09
KLACID I.V.

CLARITHROMYCINUM

LIOF. PT. SOL. PERF.
ABBOTT LABORATORIES LTD.

500mg

642
J01FA10 J01FA10 J01FA10 J01FA10 J01FA10 J01FA10 J01FA10

J01FA10
AZITHROMYCINUM AZITHROMYCINUM

AZITHROMYCINUM
PULB. PT. SUSP. ORALA
100mg/5ml SANDOZ SRL

100mg/5ml 125mg

AZITROMICINA SANDOZ 100 mg/5 ml SUMAMED 125 mg

COMPR. FILM.
125mg 200 mg/5 ml 200mg/5ml 200mg/5ml PLIVA LJUBLJANA D.O.O.

AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM
250mg

PULB. PT. SUSP. ORALA
SANDOZ SRL

200 mg/5 ml 200mg/5ml 200mg/5ml 250mg

AZITROMICINA SANDOZ 200 mg/5 ml AZITROX 200 mg/5 ml SUMAMED FORTE AZATRIL 250 mg

PULB. + SOLV. SUSP. ORALA
ECZACIBASI PHARMACEUTICALS S.R.L. PLIVA LJUBLIJANA D.O.O. BALKANPHARMA RAZGRAD AD

PULB. PT. SUSP. ORALA CAPS. COMPR. FILM.
250mg 250mg SANDOZ S.R.L. ZENTIVA AS

AZITHROMYCINUM

250mg

AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE AZITROX® 250

J01FA10

AZITHROMYCINUM
500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.
SANDOZ S.R.L. ZENTIVA AS ECZACIBASI PHARMACEUTICALS S.R.L. PLIVA LJUBLJANA D.O.O. OZONE LABORATORIES LTD.

500mg

AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE AZITROX® 500 AZRO® 500 mg SUMAMED 500 mg ZITROCIN 500 mg

J01FA10
SUMAMED®

AZITHROMYCINUM AZITHROMYCINUM
2g

LIOF. PT. SOL. PERF.
PLIVA LJUBLJANA D.O.O.

500mg 2g

J01FA10
ZMAX 2 g

GRAN. ELIB. PREL. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

643
J01GB03

J01GB03
GENTAMICINUM

GENTAMICINUM
SOL. INJ.
40mg/ml 40mg/ml KRKA D.D. NOVO MESTO SANDOZ GMBH

40mg/ml

GENTAMICIN KRKA GENTAMICINA SANDOZ® 40 mg/ml

J01GB03

GENTAMICINUM
40mg/ml 40mg/ml

SOL. INJ.
KRKA D.D. NOVO MESTO SANDOZ GMBH

40mg/ml

GENTAMICIN KRKA GENTAMICINA SANDOZ® 40 mg/ml

J01GB03
LYRAMYCIN

GENTAMICINUM
40mg/ml

SOL. PARENT.
MEDICAROM GROUP S.R.L.

40mg/ml 80mg/2ml
KRKA D.D. NOVO MESTO

J01GB03 J01GB03

GENTAMICINUM
80mg/2ml

SOL. INJ. SOL.INJ.
80mg/2ml LAB. PANPHARMA

GENTAMICIN KRKA

GENTAMICINUM

80mg/2ml

PAN - GENTAMICINE

644
J01GB06 J01GB06
AMIKIN

J01GB06
AMIKACINUM AMIKACINUM

AMIKACINUM
SOL. INJ.
100mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

100mg/2ml 250mg/ml
BRISTOL MYERS SQUIBB KFT

AMIKOZIT® 100 mg/2 ml

SOL. INJ.
250mg/ml

J01GB06

AMIKACINUM

SOL. INJ.
500mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

500mg/2ml

AMIKOZIT® 500 mg/2 ml

645
J01GB07 J01GB07 J01GB07
NETROMYCINE®

J01GB07
NETILMICINUM NETILMICINUM NETILMICINUM

NETILMICINUM
SOL. INJ.
150mg/1.5ml SCHERING PLOUGH EUROPE

150mg/1.5ml 200mg/2ml
SCHERING PLOUGH EUROPE

SOL. INJ.
200mg/2ml

NETROMYCINE® NETROMYCINE®

SOL. INJ.
50mg/2ml SCHERING PLOUGH EUROPE

50mg/2ml

646
OFLOXACIN 200 mg OFLOXIN 200 ZANOCIN

J01MA01

OFLOXACINUM
COMPR. FILM.
200mg 200mg 200mg 400mg ANTIBIOTICE SA ZENTIVA AS RANBAXY UK LIMITED

J01MA01 OFLOXACINUM

200mg

J01MA01 OFLOXACINUM
ZANOCIN® OD 400

COMPR. FILM. ELIB. PREL.
RANBAXY U.K. LIMITED

400mg

647

J01MA02

CIPROFLOXACINUM
CONC. PT. SOL. PERF.
100mg/10ml 100mg/10ml KRKA D.D. SICOMED SA

J01MA02 CIPROFLOXACINUM
CIPRINOL® CIPROFLOXACINA 100 mg/10 ml

100mg/10ml

J01MA02 CIPROFLOXACINUM
CIPRINOL

SOL. PERF.
100mg/50ml KRKA D.D. NOVO MESTO

100mg/50ml 200mg/100ml
KRKA D.D. NOVO MESTO BAYER HEALTHCARE AG

J01MA02 CIPROFLOXACINUM
CIPRINOL CIPROBAY® 200

SOL. PERF.
200mg/100ml 200mg/100ml

J01MA02 CIPROFLOXACINUM
EUCIPRIN 250mg

CAPS.
EUROPHARM SA

250mg 250mg
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. LAROPHARM SRL ALKALOID D.O.O. AC HELCOR SRL

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN® 250 mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg

COMPR. FILM.

94 / 153

DCI/DENUMIRE COMERCIALA
CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg

CONCENTRATIE
250mg 250mg 250mg

FORMA FARM.

FIRMA
DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA

PROTOCOL

J01MA02 CIPROFLOXACINUM
CIPROBAY® 400 UFEXIL 2mg/ml 2mg/ml

SOL. PERF.
BAYER HEALTHCARE AG DEMO SA

2mg/ml

J01MA02 CIPROFLOXACINUM
CIPRINOL®

SOL. PERF.
400mg/200ml KRKA D.D.

400mg/200ml 500mg
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO ANTIBIOTICE SA BAYER HEALTHCARE AG E.I.P.I.CO. MED S.R.L. DAR AL DAWA PHARMA S.R.L ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA ECZACIBASI ILAC SANAYI VE TICARET AS

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 500 CIPRINOL 500 mg CIPRO QUIN® CIPROBAY® 500 CIPROCIN 500 mg CIPRODAR CIPROFLOXACINA ALKALOID 500 mg CIPROLEN® 500 mg CIPROLET 500 mg CIPROZONE FORTE 500 mg CUMINOL 500 mg SIFLOKS® 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.

J01MA02 CIPROFLOXACINUM
CIPRINOL 750 mg 750mg

COMPR. FILM.
KRKA D.D. NOVO MESTO

750mg 250mg
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. LAROPHARM SRL ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN® 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg

COMPR. FILM.

648

J01MA03

PEFLOXACINUM
COMPR. FILM.
400mg 400mg 400mg/5ml LEK PHARMACEUTICALS D.D. LAROPHARM S.R.L.

J01MA03 PEFLOXACINUM
ABAKTAL PEFLOXACIN LAROPHARM

400mg

J01MA03 PEFLOXACINUM
ABAKTAL 400mg/5ml

CONC. PT. SOL. PERF.
LEK PHARMACEUTICALS D.D.

400mg/5ml

649

J01MA06

NORFLOXACINUM
COMPR. FILM.
400mg 400mg 400mg 400mg 400mg 400mg 400mg E.I.P.I.CO. MED S.R.L. AC HELCOR SRL KRKA D.D. NOVO MESTO LEK PHARMATECH SRL OZONE LABORATORIES LTD. OZONE LABORATORIES LTD. LABORMED PHARMA SA

J01MA06 NORFLOXACINUM
EPINOR H - NORFLOXACIN 400 mg NOLICIN 400 mg NORFLOX - 400 NORFLOXACIN 400 mg NORFLOXACIN OZONE 400 mg NORFLOXACINA LPH 400 mg

400mg

650

J01MA12

LEVOFLOXACINUM
COMPR. FILM.
250mg ACTAVIS GROUP PTC EHF.

J01MA12 LEVOFLOXACINUM
LEVOFLOXACINA ACTAVIS 250 mg

250mg 500mg
ACTAVIS GROUP PTC EHF. AVENTIS PHARMA DEUTSCHLAND GMBH

J01MA12 LEVOFLOXACINUM
LEVOFLOXACINA ACTAVIS 500 mg TAVANIC® 500mg 500mg

COMPR. FILM.

J01MA12 LEVOFLOXACINUM
TAVANIC® I.V. 500 mg 5mg/ml

SOL. PERF.
AVENTIS PHARMA DEUTSCHLAND GMBH

5mg/ml

651
AVELOX® 400 mg

J01MA14

MOXIFLOXACINUM
COMPR. FILM.
400mg BAYER HEALTHCARE AG

J01MA14 MOXIFLOXACINUM J01MA14 MOXIFLOXACINUM
AVELOX® 400 mg/250 ml

400mg 400mg/250ml
BAYER HEALTHCARE AG

SOL. PERF.
400mg/250ml

652

J01XA01

VANCOMYCINUM

Prescriere limitata: Tratamentul este initiat in spital pentru infectiile cu germeni sensibili la vancomicina. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01XA01 J01XA01
EDICIN

VANCOMYCINUM
1g 1g

LIOF. PT. SOL. PERF. PULB.LIOF.PT.SOL.PERF./INJ
LEK PHARMACEUTICALS D.D.

1g 1g 500mg 1g 1g 500mg 500mg

VANCOMYCIN TEVA

TEVA PHARM. WORKS PRIVATE LTD. COMPANY

VANCOMYCINUM VANCOMYCINUM
500mg 1g 1g

J01XA01 J01XA01 J01XA01
EDICIN

LIOF. PT. SOL. PERF. LIOF. PT. SOL. PERF. PULB.LIOF.PT.SOL.PERF./INJ
LEK PHARMACEUTICALS D.D.

VANCOMYCIN TEVA

TEVA PHARM. WORKS PRIVATE LTD. COMPANY TEVA PHARM. WORKS PRIVATE LTD. COMPANY

VANCOMYCINUM VANCOMYCINUM VANCOMYCINUM
500mg 500mg

VANCOMYCIN TEVA

J01XA01 J01XA01
EDICIN

LIOF. PT. SOL. PERF. LIOF. PT. SOL. PERF./INJ.
LEK PHARMACEUTICALS D.D.

VANCOMYCIN TEVA

TEVA PHARM. WORKS PRIVATE LTD. COMPANY

VANCOMYCINUM

653
J01XA02
TARGOCID® 400 mg

J01XA02
TEICOPLANINUM

TEICOPLANINUM
LIOF. + SOLV. PT. SOL. INJ.
400mg AVENTIS PHARMA LTD.

400mg

95 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

654
J01XB01

J01XB01
COLISTINUM

COLISTINUM
PULB. PT. SOL. PERF.
1000000ui ANTIBIOTICE SA

1000000ui

COLISTINA ANTIBIOTICE 1000000 UI

655

J01XD01
Prescriere limitata:

METRONIDAZOLUM

Tratamentul infectiilor cu anaerobi Tratamentul infectiilor cu protozoare sensibile la metronidazol: Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01XD01 J01XD01
FLAGYL

METRONIDAZOLUM
250mg

COMPR.
ARENA GROUP SA

250mg 250mg
LABORATOIRE AVENTIS

METRONIDAZOL 250 mg (J01XD01)

METRONIDAZOLUM
250mg

COMPR. FILM. SOL. PERF.
5g/l 5g/l INFOMED FLUIDS SRL INFOMED FLUIDS SRL

J01XD01

METRONIDAZOLUM

5g/l

METRONIDAZOL A 5 g/l METRONIDAZOL B 5 g/l

J01XD01 J01XD01 J01XD01
FLAGYL

METRONIDAZOLUM
5mg/ml

SOL. PERF.
B. BRAUN MELSUNGEN AG

5mg/ml 250mg
ARENA GROUP SA

METRONIDAZOL BRAUN 5mg/ml

METRONIDAZOLUM
250mg

COMPR. COMPR. FILM.
250mg LABORATOIRE AVENTIS

METRONIDAZOL 250 mg (J01XD01)

METRONIDAZOLUM METRONIDAZOLUM
4%

250mg 4%
LABORATOIRE AVENTIS

J01XD01

SUSP. ORALA

FLAGYL 4 % (J01XD01)

656
J01XX08
ZYVOXID®

J01XX08
LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID®

SOL. PERF.
2mg/ml PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID®

LINEZOLIDUM
600mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

600mg

657

J02AB02
Prescriere limitata:

KETOCONAZOLUM

Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade. Tratamentul candidozelor muco-cutanate cronice si candidozelor orofaringiene care nu pot fi tratate cu antifungice locale, la pacientii care prezinta rezistenta sau intoleranta la fluconazol si intraconazol. Micoze sistemice la care alte forme de terapie antifungica nu au avut efect. A fost raportată hepatotoxicitate la ketoconazol. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AB02

KETOCONAZOLUM
200mg 200mg 200mg 200mg 200mg

COMPR.
ANTIBIOTICE SA MAGISTRA C & C AC HELCOR SRL JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOSTIN 200 mg NIZORAL NIZORAL 200 mg

J02AB02

KETOCONAZOLUM
200mg 200mg 200mg 200mg 200mg

COMPR.
ANTIBIOTICE SA SLAVIA PHARM SRL AC HELCOR SRL JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOSTIN 200 mg NIZORAL NIZORAL 200 mg

658

J02AC01
Prescriere limitata:

FLUCONAZOLUM

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie. Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina. Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Tratamentul candidozei orofaringiene la pacienti cu imunosupresie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC01

FLUCONAZOLUM
100mg 100mg 100mg 100mg 100mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

100mg

DIFLAZON 100 mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

J02AC01

FLUCONAZOLUM
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG OZONE LABORATORIES LTD. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL ZENTIVA AS GEDEON RICHTER PLC.

150mg

DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ® 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCORIC 150 mg FLUCOVIM 150 MYCOMAX 150 MYCOSYST® 150 mg

J02AC01

FLUCONAZOLUM
200mg 200mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL

200mg

DIFLAZON 200 mg FLUCONAZOLE TEVA 200 mg

J02AC01

FLUCONAZOLUM
2mg/ml 2mg/ml 2mg/ml

SOL. PERF.
KRKA D.D. PFIZER EUROPE MA EEIG ZENTIVA AS

2mg/ml

DIFLAZON® DIFLUCAN® MYCOMAX® INF

J02AC01

FLUCONAZOLUM

CAPS.

50mg

96 / 153

DCI/DENUMIRE COMERCIALA
DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ® 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg

CONCENTRATIE
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg/5ml

FORMA FARM.

FIRMA
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

PROTOCOL

J02AC01

FLUCONAZOLUM

PULB. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

50mg/5ml

DIFLUCAN® 50 mg/5 ml

659

J02AC02
Prescriere limitata:

ITRACONAZOLUM

Aspergiloza sistemica. Histoplasmoza sistemica. Tratament si terapia de intretinere la pacienti cu SIDA si histoplasmoza pulmonara diseminata. Tratament si terapia de intretinere la pacienti cu SIDA si histoplasmoza pulmonara cronica; Criptococoza sistemica inclusiv meningeala. Cromoblastomicoză şi micetom. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC02

ITRACONAZOLUM
100mg 100mg 100mg 100mg

CAPS.
SLAVIA PHARM SRL MEDICO UNO PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV GEDEON RICHTER ROMANIA S.A.

100mg

ITRACONAZOL 100 mg OMICRAL 100 mg ORUNGAL SPORILIN 100 mg

660
J02AC03
VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM **
COMPR. FILM.
200mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg
PFIZER LTD.

J02AC03
VFEND 200mg

VORICONAZOLUM
200mg

PULB. PT. SOL. PERF.
PFIZER LTD.

J02AC03 J02AC03
VFEND 50mg

VORICONAZOLUM
40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LTD.

VFEND 40 mg/ml

VORICONAZOLUM
50mg

COMPR. FILM.

661

J02AC04
Prescriere limitata:

POSACONAZOLUM **

Aspergiloză invazivă la pacienţi cu boală rezistentă la amfotericina B sau itraconazol sau la pacienţi care nu tolerează aceste medicamente; Fusarioză la pacienţii cu boală rezistentă la amfotericina B sau la pacienţi care nu tolerează amfotericina B; Cromoblastomicoză şi micetom la pacienţii cu boală rezistentă la itraconazol sau la pacienţi care nu tolerează itraconazolul; Coccidioidomicoză la pacienţi cu boală rezistentă la amfotericina B, itraconazol sau fluconazol sau la pacienţi care nu tolerează aceste medicamente. Candidoză oro-faringiană: ca terapie de primă intenţie la pacienţii cu forme severe sau la pacienţii cu imunitate scăzută, la care este de aşteptat ca răspunsul la tratamentul topic să fie scăzut. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC04

POSACONAZOLUM
40mg/ml

SUSP. ORALA
SP EUROPE

40mg/ml

NOXAFIL SP 40mg/ml

662
J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 70mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 70mg

CASPOFUNGINUM

PULB. PT. CONC. PT. SOL. PERF.
MERCK SHARP & DOHME LTD

CANCIDAS 70 mg

664

J04AB04
Prescriere limitata:

RIFABUTINUM

Tratamentul contra infectiilor complexe cu Mycobacterium avium la pacientii HIV-pozitivi. Profilaxia contra infectiilor complexe cu Mycobacterium avium la pacientii HIV-pozitivi cu celule CD4 mai putin de 75 pe milimetru cub.

J04AB04

RIFABUTINUM
150mg

CAPS.
PFIZER EUROPE MA EEIG

150mg

MYCOBUTIN 150 mg

665
J04AC01 J04AC01
ISONIAZIDA ISONIAZIDA 100 mg

J04AC01
ISONIAZIDUM

ISONIAZIDUM
COMPR.
100mg ANTIBIOTICE SA

100mg 300mg
ANTIBIOTICE SA

ISONIAZIDUM
300mg

COMPR. SOL. INJ.
500mg/10ml TERAPIA SA

J04AC01

ISONIAZIDUM

500mg/10ml

IZONIAZIDA 500 mg

666
J04AK01

J04AK01
PYRAZINAMIDUM

PYRAZINAMIDUM
COMPR.
500mg ANTIBIOTICE S.A.

500mg

PIRAZINAMIDA ANTIBIOTICE 500 mg

667
J04AK02
ETAMBUTOL 250 mg

J04AK02
ETHAMBUTOLUM

ETHAMBUTOLUM
COMPR. FILM.
250mg ANTIBIOTICE SA

250mg

668
SINERDOL ISO

J04AM02

COMBINATII (RIFAMPICINUM+IZONIAZIDUM)
CAPS.
300mg+150mg ANTIBIOTICE SA

J04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)

300mg+150mg

669
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg ARENA GROUP SA EUROPHARM SA

200mg

J05AB01

ACICLOVIRUM
200mg 200mg 200mg

COMPR.
TERAPIA SA ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg CLOVIRAL 200 mg ZOVIRAX

J05AB01

ACICLOVIRUM
200mg

COMPR. DISP.
OZONE LABORATORIES LTD.

200mg

ACICLOVIR 200 mg

97 / 153

DCI/DENUMIRE COMERCIALA
LOVIR 200 mg

CONCENTRATIE
200mg

FORMA FARM.

FIRMA
RANBAXY UK LIMITED

PROTOCOL

J05AB01
VIROLEX

ACICLOVIRUM
250mg

PULB. PT. SOL. INJ./PERF.
KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01 J05AB01 J05AB01
ACIKLOVIR

ACICLOVIRUM
400mg

CAPS.
ARENA GROUP S.A.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR.
EGIS PHARMACEUTICALS P.L.C.

400mg 400mg
A & G MED TRADING S.R.L.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR. FILM.

670
J05AB04 J05AB04
COPEGUS® REBETOL 200 mg

J05AB04
RIBAVIRINUM

RIBAVIRINUM
CAPS.
200mg SP EUROPE

200mg 200mg
ROCHE ROMANIA SRL

RIBAVIRINUM
200mg

COMPR. FILM.

671
J05AB06
CYMEVENE

J05AB06
Prescriere limitata:

GANCICLOVIRUM
LIOF. PT. SOL. INJ.
500mg ROCHE ROMANIA S.R.L.

Infectii severe cu citomegalovirus (CMV) la pacienti imunocompromisi inclusiv cu localizare oculara.

GANCICLOVIRUM

500mg

672
J05AB11
VALTREX 500 mg

J05AB11
VALACYCLOVIRUM

VALACYCLOVIRUM
COMPR. FILM.
500mg THE WELLCOME FOUNDATION LTD.

500mg

673
J05AB14

J05AB14
Prescriere limitata:

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

VALGANCICLOVIRUM

450mg

VALCYTE® 450 mg

674
BRIVAL®

J05ABN1

BRIVUDINUM
COMPR.
125mg BERLIN CHEMIE AG MENARINI GROUP

J05ABN1 BRIVUDINUM

125mg

676

J06BB16
Prescriere limitata:

PALIVIZUMABUM **

Prevenirea bolilor severe ale tractului respirator inferior care necesită spitalizare, provocate de virusul sinciţial respirator (VSR) la copii născuţi la 35 săptămâni de gestaţie sau mai puţin şi cu vârsta mai mică de 6 luni la începutul sezonului de îmbolnăviri cu VSR sau la copii cu vârsta mai mică de 2 ani care au necesitat tratament pentru displazie bronhopulmonară în ultimele 6 luni. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J06BB16 J06BB16

PALIVIZUMABUM
100mg 50mg

PULB. + SOLV. PT. SOL. INJ.
ABBOTT LABORATORIES LTD.

100mg 50mg

SYNAGIS 100 mg

PALIVIZUMABUM

PULB. + SOLV. PT. SOL. INJ.
ABBOTT LABORATORIES LTD.

SYNAGIS 50 mg

681

L03AA02
Prescriere limitata:

FILGRASTIMUM (G-CSF) **

Tratamentul neutropeniei persistente (ANC mai mic sau egal cu 1,0 x 109/L) la pacienţii cu infecţie HIV aflaţi în stadii avansate, în scopul scăderii riscului de infecţii bacteriene în situaţiile în care alte opţiuni în tratamentul neutropeniei sunt inadecvate. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AA02
NEUPOGEN®

FILGRASTIMUM (G-CSF) FILGRASTIMUM (G-CSF)

SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

L03AA02
NEUPOGEN®

SOL. INJ.
48MU/0.5ml

682
NETTACIN®

S01AA23

NETILMICINUM
PICATURI OFT.-SOL.
0.3% S.I.F.I. SPA

S01AA23 NETILMICINUM S01AA23 NETILMICINUM
NETTAVISC 3mg/g 3mg/g

0.3% 3mg/g

UNG. OFT.
S.I.F.I. SPA

S01AA23 NETILMICINUM
NETTACIN® 0.3%

PIC. OFT., SOL
S.I.F.I. SPA

0.3%

683
OKACIN

S01AX17

LOMEFLOXACINUM
PICATURI OFT.-SOL.
3mg/ml NOVARTIS PHARMA GMBH

S01AX17 LOMEFLOXACINUM

3mg/ml

684
NORFLOX

S03AAN2

NORFLOXACINUM
PICATURI OFT./AURIC.-SOL.
0.3% CIPLA (UK) LIMITED

S03AAN2 NORFLOXACINUM

0.3%

685
MAXIDEX®

S01BA01

DEXAMETHASONUM
PICATURI OFT.-SUSP.
0.1% ALCON COUVREUR NV

S01BA01 DEXAMETHASONUM S01BA01 DEXAMETHASONUM
DEXAMETAZONA RPH 1mg/ml 1mg/ml

0.1% 1mg/ml

PIC. OFT. SUSP.
ROMPHARM COMPANY SRL

1207
J02AA01

J02AA01 P01AX06 J02AX01
FLUCYTOSINUM

AMPHOTERICINUM B LIPOSOMAL (4) ATOVAQUONA (4) FLUCYTOSINUM (4) MEFLOQUINE (4) MUPIROCINUM (4)

AMPHOTERICINUM B LIPOSOMAL

1208 1209
J02AX01

P01AX06 ATOVAQUONA

1210 1211

P01BC02 R01AX06

P01BC02 MEFLOQUINE

R01AX06 MUPIROCINUM

98 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

1212 1213 1214 1215 1216 1217
J01EA01

A07AA06 P01CX01 P01BA03 P01BD01 P01BD51 J01EA01
TRIMETHOPRIM

PAROMOMYCINUM (4) PENTAMIDINUM (4) PRIMAQUINUM (4) PYRIMETHAMINUM (4) PYRIMETHAMINUM+SULFADIAZINUM (4) TRIMETHOPRIM (4)

A07AA06 PAROMOMYCINUM

P01CX01 PENTAMIDINUM

P01BA03 PRIMAQUINUM

P01BD01 PYRIMETHAMINUM

P01BD51 PYRIMETHAMINUM+SULFADIAZINUM

99 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P1: PROGRAMUL NATIONAL DE BOLI TRANSMISIBILE. B) SUBPROGRAMUL DE TRATAMENT AL BOLNAVILOR CU TUBERCULOZA 686 A11HA02 PYRIDOXINUM
A11HA02 PYRIDOXINUM
VITAMINA B6 250 mg 250 mg

COMPR.
ARENA GROUP SA

250 mg 250mg
ZENTIVA SA

A11HA02 PYRIDOXINUM
SICOVIT B6 250 mg 250mg

COMPR. SOL. INJ.
250mg/5ml ZENTIVA SA

A11HA02 PYRIDOXINUM
SICOVIT B6 250 mg/5 ml

250mg/5ml 50mg/2ml
ZENTIVA SA

A11HA02 PYRIDOXINUM
SICOVIT B6 50 mg/2ml 50mg/2ml

SOL. INJ.

687

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

688
J01FA09

J01FA09
CLARITHROMYCINUM

CLARITHROMYCINUM
GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml KRKA D.D. TERAPIA S.A. ABBOTT SPA SANDOZ S.R.L.

125mg/5ml

FROMILID® 125 mg/5 ml KLABAX 125 mg/5 ml KLACID® LEKOKLAR 125 mg/5 ml

J01FA09

CLARITHROMYCINUM
250mg 250mg 250mg 250mg 250mg 250mg 250mg

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT SPA MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

250mg

CLAR 250 CLARITROMICINA 250 mg FROMILID 250 KLABAX 250 mg KLACID® KLERIMED® 250 LEKOKLAR® 250 mg

J01FA09

CLARITHROMYCINUM

GRAN. PT. SUSP. ORALA
250mg/5ml 250mg/5ml TERAPIA S.A. SANDOZ SRL

250mg/5ml

KLABAX 250 mg/5 ml LEKOKLAR 250 mg/5 ml

J01FA09

CLARITHROMYCINUM
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

500mg

CLAR 500 CLARITROMICINA 500 mg FROMILID 500 KLABAX 500 mg KLERIMED® 500 LEKOKLAR® 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. MODIF.
TERAPIA S.A. LEK PHARMACEUTICALS D.D.

500mg

KLABAX MR 500 mg LEKOKLAR XL 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. PREL.
KRKA D.D. ABBOTT LABORATORIES LTD.

500mg

FROMILID® UNO KLACID SR

J01FA09
KLACID I.V.

CLARITHROMYCINUM

LIOF. PT. SOL. PERF.
ABBOTT LABORATORIES LTD.

500mg

691
J01GB06 J01GB06
AMIKIN

J01GB06
AMIKACINUM AMIKACINUM

AMIKACINUM
SOL. INJ.
100mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

100mg/2ml 250mg/ml
BRISTOL MYERS SQUIBB KFT

AMIKOZIT® 100 mg/2 ml

SOL. INJ.
250mg/ml

J01GB06

AMIKACINUM

SOL. INJ.
500mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

500mg/2ml

AMIKOZIT® 500 mg/2 ml

692
OFLOXACIN 200 mg OFLOXIN 200 ZANOCIN

J01MA01

OFLOXACINUM
COMPR. FILM.
200mg 200mg 200mg 400mg ANTIBIOTICE SA ZENTIVA AS RANBAXY UK LIMITED

J01MA01 OFLOXACINUM

200mg

J01MA01 OFLOXACINUM
ZANOCIN® OD 400

COMPR. FILM. ELIB. PREL.
RANBAXY U.K. LIMITED

400mg

693

J01MA02

CIPROFLOXACINUM
CONC. PT. SOL. PERF.
100mg/10ml 100mg/10ml KRKA D.D. SICOMED SA

J01MA02 CIPROFLOXACINUM
CIPRINOL® CIPROFLOXACINA 100 mg/10 ml

100mg/10ml

J01MA02 CIPROFLOXACINUM
CIPRINOL

SOL. PERF.
100mg/50ml KRKA D.D. NOVO MESTO

100mg/50ml 200mg/100ml
KRKA D.D. NOVO MESTO BAYER HEALTHCARE AG

J01MA02 CIPROFLOXACINUM
CIPRINOL CIPROBAY® 200

SOL. PERF.
200mg/100ml 200mg/100ml

J01MA02 CIPROFLOXACINUM
EUCIPRIN 250mg

CAPS.
EUROPHARM SA

250mg 250mg
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. LAROPHARM SRL

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACIN 250 mg 250mg 250mg 250mg 250mg 250mg

COMPR. FILM.

100 / 153

DCI/DENUMIRE COMERCIALA
CIPROFLOXACINA ALKALOID 250 mg CIPROLEN® 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg

CONCENTRATIE
250mg 250mg 250mg 250mg 250mg

FORMA FARM.

FIRMA
ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA

PROTOCOL

J01MA02 CIPROFLOXACINUM
CIPROBAY® 400 UFEXIL 2mg/ml 2mg/ml

SOL. PERF.
BAYER HEALTHCARE AG DEMO SA

2mg/ml

J01MA02 CIPROFLOXACINUM
CIPRINOL®

SOL. PERF.
400mg/200ml KRKA D.D.

400mg/200ml 500mg
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO ANTIBIOTICE SA BAYER HEALTHCARE AG E.I.P.I.CO. MED S.R.L. DAR AL DAWA PHARMA S.R.L ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA ECZACIBASI ILAC SANAYI VE TICARET AS

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 500 CIPRINOL 500 mg CIPRO QUIN® CIPROBAY® 500 CIPROCIN 500 mg CIPRODAR CIPROFLOXACINA ALKALOID 500 mg CIPROLEN® 500 mg CIPROLET 500 mg CIPROZONE FORTE 500 mg CUMINOL 500 mg SIFLOKS® 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.

J01MA02 CIPROFLOXACINUM
CIPRINOL 750 mg 750mg

COMPR. FILM.
KRKA D.D. NOVO MESTO

750mg

694
AVELOX® 400 mg

J01MA14

MOXIFLOXACINUM
COMPR. FILM.
400mg BAYER HEALTHCARE AG

J01MA14 MOXIFLOXACINUM J01MA14 MOXIFLOXACINUM
AVELOX® 400 mg/250 ml

400mg 400mg/250ml
BAYER HEALTHCARE AG

SOL. PERF.
400mg/250ml

696
J04AB01

J04AB01
CICLOSERINUM

CICLOSERINUM
CAPS.
250mg 250mg ANTIBIOTICE S.A. HELP PHARMACEUTICALS LTD.

250mg

CICLOSERINA ANTIBIOTICE 250 mg HELPOCERIN

697
J04AB02 J04AB02
SINERDOL 150 mg

J04AB02
RIFAMPICINUM

RIFAMPICINUM
CAPS.
150mg ANTIBIOTICE SA

150mg 300mg
ANTIBIOTICE SA

RIFAMPICINUM
300mg

CAPS.

SINERDOL 300 mg

698
J04AB04
MYCOBUTIN 150 mg

J04AB04
RIFABUTINUM

RIFABUTINUM
CAPS.
150mg PFIZER EUROPE MA EEIG

150mg

699
J04AB30

J04AB30
CAPREOMYCINUM

CAPREOMYCINUM (4) ISONIAZIDUM
COMPR.
100mg ANTIBIOTICE SA

700
J04AC01 J04AC01
ISONIAZIDA ISONIAZIDA 100 mg

J04AC01
ISONIAZIDUM ISONIAZIDUM

100mg 300mg
ANTIBIOTICE SA

COMPR.
300mg

J04AC01

ISONIAZIDUM

SOL. INJ.
500mg/10ml TERAPIA SA

500mg/10ml

IZONIAZIDA 500 mg

701
J04AD01

J04AD01
PROTIONAMIDUM

PROTIONAMIDUM
COMPR. FILM.
250mg ANTIBIOTICE SA

250mg

PROTIONAMIDA 250 mg

702
J04AK01

J04AK01
PYRAZINAMIDUM

PYRAZINAMIDUM
COMPR.
500mg ANTIBIOTICE S.A.

500mg

PIRAZINAMIDA ANTIBIOTICE 500 mg

703
J04AK02
ETAMBUTOL 250 mg

J04AK02
ETHAMBUTOLUM

ETHAMBUTOLUM
COMPR. FILM.
250mg ANTIBIOTICE SA

250mg

704
SINERDOL ISO

J04AM02

COMBINATII (RIFAMPICINUM+IZONIAZIDUM)
CAPS.
300mg+150mg ANTIBIOTICE SA

J04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)

300mg+150mg

101 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P3: PROGRAMUL NATIONAL DE ONCOLOGIE. 705 G03HA01 CYPROTERONUM
G03HA01 CYPROTERONUM
ANDROCUR 50mg

Protocol: L025C
50mg
SCHERING AG

COMPR.

706
L01AA01 L01AA01 L01AA01 L01AA01
ENDOXAN® 1 g

L01AA01
CYCLOPHOSPHAMIDUM

CYCLOPHOSPHAMIDUM
PULB. PT. SOL. INJ./PERF.
1g 200mg 500mg BAXTER ONCOLOGY GMBH

1g 200mg 500mg 50mg

CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM
50mg

PULB. PT. SOL. PERF./INJ. I.V.
ACTAVIS S.R.L.

ENDOXAN 200 mg ENDOXAN® 500 mg ENDOXAN® 50 mg

PULB. PT. SOL. INJ./PERF.
BAXTER ONCOLOGY GMBH

DRAJ.
BAXTER ONCOLOGY GMBH

707

L01AA02

CHLORAMBUCILUM

NOTA: Indicat in schemele de tratament al limfomului Hodgkin. Indicat in schemele de tratament ale anumitor forme de limfoame non-Hodgkin. Indicat in schemele de tratament al leucemiei limfocitare cronice. Indicat in schemele de tratament a macroglobulinemiei Waldenstrom.

L01AA02
LEUKERAN

CHLORAMBUCILUM
2mg

COMPR. FILM.
THE WELLCOME FOUNDATION LTD.

2mg

708

L01AA03

MELPHALANUM

NOTA: Indicat in schemele de tratament al mielomului multiplu. Indicat in schemele de tratament ale adenocarcinomuluii ovarian avansat. Indicat in schemele de tratament al cancerului de san avansat. Indicat in schemele de tratament a policitemia vera.

L01AA03

MELPHALANUM
2mg

COMPR. FILM.
THE WELLCOME FOUNDATION LTD.

2mg

ALKERAN 2 mg

709
L01AA06
HOLOXAN 1 g

L01AA06
IFOSFAMIDUM

IFOSFAMIDUM
PULB. PT. SOL. PERF.
1g BAXTER ONCOLOGY GMBH

1g 2g 500mg

L01AA06
HOLOXAN 2 g

IFOSFAMIDUM
2g

PULB. PT. SOL. PERF.
BAXTER ONCOLOGY GMBH

L01AA06

IFOSFAMIDUM
500mg

PULB. PT. SOL. PERF.
BAXTER ONCOLOGY GMBH

HOLOXAN 500 mg

710

L01AB01

BUSULFANUM

NOTA: Indicat in schemele de tratament paliativ al fazei cronice in Leucemia Granulocitara Cronica. Indicat in schemele de tratament a polcitemiei vera. Indicat in schemele de tratament a mielofibrozei si trombocitemiei esentiale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L01AB01
MYLERAN

BUSULFANUM
2mg

COMPR. FILM.
THE WELLCOME FOUNDATION LTD.

2mg

712

L01AX03

TEMOZOLOMIDUM **

Protocol: L046C

NOTA: Tratamentul glioblastomului multiform nou diagnosticat, în asociere cu radioterapia şi apoi ca monoterapie. Tratamentul glioamelor maligne, (glioblastomul multiform sau astrocitomul anaplazic), care au prezentat recurenţă sau progresie după terapia standard. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L01AX03 L01AX03 L01AX03 L01AX03 L01AX03 L01AX03 L01AX03

TEMOZOLOMIDUM
100mg

CAPS.
SP EUROPE

100mg 20mg
SP EUROPE

TEMODAL 100 mg

TEMOZOLOMIDUM
20mg

CAPS. CAPS.
250mg SP EUROPE

TEMODAL 20 mg

TEMOZOLOMIDUM TEMOZOLOMIDUM
5mg 100mg 20mg 5mg

250mg 5mg
SP EUROPE SP EUROPE SP EUROPE SP EUROPE

TEMODAL 250 mg TEMODAL 5 mg

CAPS.

TEMOZOLOMIDUM TEMOZOLOMIDUM TEMOZOLOMIDUM

TEMODAL 100 mg TEMODAL 20 mg TEMODAL 5 mg

713
L01AX04
DALTRIZEN® 200 mg

L01AX04
DACARBAZINUM

DACARBAZINUM
LIOF. PT. SOL. PERF.
200mg ACTAVIS S.R.L.

200mg

714
L01BA01

L01BA01
METHOTREXATUM

METHOTREXATUM
CONC. PT. SOL. INJ./PERF.
100mg/ml 100mg/ml 100mg/ml EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

100mg/ml

METHOTREXAT "EBEWE" 1000 mg METHOTREXAT "EBEWE" 500 mg METHOTREXAT "EBEWE" 5000 mg

L01BA01 L01BA01 L01BA01

METHOTREXATUM
10mg/ml 50mg

SOL. INJ./PERF.
EBEWE PHARMA GMBH NFG. KG

10mg/ml 50mg 5mg/ml
EBEWE PHARMA GMBH NFG. KG

METHOTREXAT "EBEWE" 50 mg

METHOTREXATUM METHOTREXATUM
5mg/ml

PULB. PT. SOL. INJ./PERF.
SINDAN SRL

ANTIFOLAN® 50 mg METHOTREXAT "EBEWE" 5 mg

SOL. INJ.

715

L01BA04

PEMETREXEDUM ****

Protocol: L047C

102 / 153

DCI/DENUMIRE COMERCIALA CONCENTRATIE FORMA FARM. FIRMA PROTOCOL NOTA: Tratamentul în asociere cu cisplatină al pacienţilor cu mezoteliom pleural malign nerezecabil fără chimioterapie anterioară. Tratamentul ca monoterapie al pacienţilor cu cancer pulmonar cu alt tip de celulă decât cu celulă mică, avansat local sau metastazat, după chimioterapie anterioară. Doze mai mari de 500 mg pe metru pătrat de suprafaţă corporală nu se vor aproba pentru compensare. Suprafata corporala a pacientului va trebui declarata in dosarul de aprobare. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L01BA04
ALIMTA 500mg

PEMETREXEDUM
500mg

PULB. PT. CONC. PT. SOL. PERF.
ELI LILLY NEDERLAND BV

500mg

716
L01BB02
PURI - NETHOL

L01BB02
MERCAPTOPURINUM

MERCAPTOPURINUM
COMPR.
50mg THE WELLCOME FOUNDATION LTD.

50mg

717
L01BB03
LANVIS

L01BB03
TIOGUANINUM

TIOGUANINUM
COMPR.
40mg THE WELLCOME FOUNDATION LTD.

40mg

718

L01BB04

CLADRIBINUM

Prescriere limitata: Leucemia cu celule paroase. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L01BB04
LITAK 2 mg/ml

CLADRIBINUM
2mg/ml

SOL. INJ.
LIPOMED GMBH

2mg/ml

719

L01BB05

FLUDARABINUM ****

Protocol: L048C

NOTA: Tratamentul pacienţilor cu leucemie limfocitară cronică cu celule B (LLC), cu rezervă medulară suficientă, care nu au răspuns la tratament sau a căror boală a avansat în timpul tratamentului cu o schemă conţinând cel puţin un agent alchilant standard sau ulterior acestuia.

L01BB05

FLUDARABINUM
10mg

COMPR. FILM.
SCHERING AG

10mg

FLUDARA® ORAL

720
L01BC01 L01BC01 L01BC01 L01BC01
CYTOSAR™ 100 mg

L01BC01
CYTARABINUM

CYTARABINUM
PULB. + SOLV. PT. SOL. INJ.
100mg PFIZER EUROPE MA EEIG

100mg 20mg/ml

CYTARABINUM
20mg/ml

SOL. INJ.
EBEWE PHARMA GMBH NFG. KG

ALEXAN 20mg/ml

CYTARABINUM
50mg

SUSP. INJ.
SKYEPHARMKA PLC

50mg 50mg/ml
EBEWE PHARMA GMBH NFG. KG

DEPOCYTE 50mg

CYTARABINUM
50mg/ml

SOL. INJ.

ALEXAN 50mg/ml

721
L01BC02 L01BC02
EFUDIX

L01BC02
FLUOROURACILUM FLUOROURACILUM

FLUOROURACILUM
SOL. PERF./INJ.
250mg/5ml ACTAVIS S.R.L.

250mg/5ml 50 mg/g
ICN HUNGARY CO. LTD.

FLUOROSINDAN 250mg/5ml

UNGUENT
50 mg/g

L01BC02

FLUOROURACILUM
50mg/ml

CONC. PT. SOL. INJ./PERF.
EBEWE PHARMA GMBH NFG. KG

50mg/ml

5 - FLUOROURACIL EBEWE 50mg/ml

722

L01BC05
Prescriere limitata:

GEMCITABINUM **

Terapia asociata a cancerului mamar avansat cu paclitaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina. Terapia asociata a cancerului ovarian epitelial avansat cu carboplatinum la pacientele cu recadere la mai mult de 6 luni dupa chimioterpia cu derivati de platinum. Tratamentul de prima intentie al cancerului pulmonar cu alt tip de celule decat cu celule mici, stadiile IIIA sau IIIB sau IV in asociere cu cisplatin. Tratamentul paliativ al cancerului pulmonar cu alt tip de celule decat cu celule mici avansat local sau metastatic. Adenocarcinom pancreatic avansat local sau metastatic. Tratamentul asociat al cancerului vezical avansat local sau metastatic in combinatie cu cisplatin. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L01BC05 L01BC05

GEMCITABINUM
1g 200mg

PULB. PT. SOL. PERF.
ACTAVIS S.R.L.

1g 200mg

GEMCITABINA SINDAN 1 g

GEMCITABINUM

PULB. PT. SOL. PERF.
ACTAVIS S.R.L.

GEMCITABINA SINDAN 200 mg

723

L01BC06
Prescriere limitata:

CAPECITABINUM

Cancer mamar avansat local sau metastazat dupa esecul terapiei anterioare cu un taxan si un derivat de antraciclina. Cancer mamar avansat local sau metastazat in care terapia cu un derivat de antraciclina nu mai este indicata. Terapia asociata a cancerului mamar avansat local sau metastazat cu docetaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina. Tratamentul de prima linie al cancerului colorectal metastatic avansat. Tratamentul adjuvant al cancerului de colon stadiul III (Dukes C), dupa rezectia completa a tumorii primare.

NOTA: Durata recomandata a tratamentului adjuvant este de 24 de saptamani; nu se compenseaza tratamentul cu Capecitabinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal.

L01BC06 L01BC06

CAPECITABINUM
150mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

150mg 500mg
ROCHE REGISTRATION LTD.

XELODA 150 mg

CAPECITABINUM
500mg

COMPR. FILM.

XELODA 500 mg

724
L01BC53
UFT

L01BC53

COMBINATII (TEGAFUR+URACIL)
CAPS.
100mg+224mg MERCK KGAA

COMBINATII (TEGAFUR+URACIL)

100mg+224mg

726
L01CA02
SINDOVIN 1 mg

L01CA02
VINCRISTINUM

VINCRISTINUM
LIOF. PT. SOL. INJ./PERF. I.V.
1mg ACTAVIS S.R.L.

1mg

727
L01CA04 L01CA04

L01CA04
VINORELBINUM

VINORELBINUM
CONC. PT. SOL. INJ./PERF.
10mg/ml 10mg/ml 10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG

10mg/ml 10mg/ml

VINORELBIN EBEWE 10 mg/ ml

VINORELBINUM

CONC. PT. SOL. PERF.
ACTAVIS S.R.L. TEVA PHARMACEUTICALS SRL

VINORELBIN ACTAVIS 10 mg/ml VINORELBIN TEVA 10 mg/ml

L01CA04
NAVELBINE®

VINORELBINUM
10mg/ml

SOL. INJ.
LAB. PIERRE FABRE

10mg/ml

Prescriere limitata:

Tratamentul cancerului mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina.

103 / 153

DCI/DENUMIRE COMERCIALA CONCENTRATIE FORMA FARM. FIRMA Prescriere limitata: Tratamentul de prima intentie singular sau asociat al cancerului pulmonar cu alte celule decat celule mici avansat local sau metastatic.

PROTOCOL

L01CA04

VINORELBINUM
20mg

CAPS. MOI
PIERRE FABRE MEDICAMENT

20mg

NAVELBINE 20 mg

Prescriere limitata: Prescriere limitata:

Tratamentul cancerului mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina. Tratamentul de prima intentie singular sau asociat al cancerului pulmonar cu alte celule decat celule mici avansat local sau metastatic.

L01CA04

VINORELBINUM
30mg

CAPS. MOI
PIERRE FABRE MEDICAMENT

30mg

NAVELBINE 30 mg

Prescriere limitata: Prescriere limitata:

Tratamentul cancerului mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina. Tratamentul de prima intentie singular sau asociat al cancerului pulmonar cu alte celule decat celule mici avansat local sau metastatic.

728
L01CB01
VEPESID

L01CB01
ETOPOSIDUM

ETOPOSIDUM
CAPS. MOI
100mg BRISTOL MYERS SQUIBB KFT

100mg 100mg/5ml

L01CB01

ETOPOSIDUM

CONC. PT. SOL. PERF.
100mg/5ml 100mg/5ml 20mg/ml EBEWE PHARMA GMBH NFG. KG ACTAVIS S.R.L.

ETOPOSID "EBEWE" 100 mg/5 ml SINTOPOZID 100 mg/5 ml

L01CB01 L01CB01
VEPESID

ETOPOSIDUM ETOPOSIDUM
50mg

CONC. PT. SOL. PERF.
TEVA PHARMACEUTICALS S.R.L.

20mg/ml 50mg

ETOPOSIDE - TEVA

CAPS. MOI
BRISTOL MYERS SQUIBB KFT

729

L01CD01
Prescriere limitata:

PACLITAXELUM **

Tratamentul adjuvant al cancerului mamar cu ganglioni pozitivi administrat secvential cu un derivat de antraciclina si ciclofosfamida. Cancer mamar avansat dupa esecul terapiei anterioare sau intoleranta la un derivat de antraciclina. Terapia de linia a doua cancerului ovarian avansat la pacientele cu esec anterior la chimioterapia cu derivati de platinum. Cancer pulmonar cu celule altele decat celule mici avansat local sau metastatic. Terapia asociata a cancerului de san in stadiu precoce (HER2 pozitiv) cu trastuzumab si care nu sunt eeligibili pentru tratament cu un derivat de antraciclina. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L01CD01 PACLITAXELUM
ONXOL 6mg/ml PACLITAXEL 6 mg/ml PACLITAXEL EBEWE 6mg/ml SINDAXEL 6mg/ml 6mg/ml 6mg/ml 6mg/ml

CONC. PT. SOL. PERF.
IVAX - PHARMACEUTICALS S.R.O. PHARMEXPRESS S.R.L. EBEWE PHARMA GES.M.B.H. NFG KG ACTAVIS S.R.L.

6mg/ml

730

L01CD02

DOCETAXELUM **

Protocol: L049C

NOTA: Tratamentul adjuvant în asociere cu doxorubicină şi ciclofosfamidă, adjuvant al pacientelor cu cancer mamar operabil, cu ganglioni pozitivi. Tratamentul în asociere cu doxorubicină, al pacientelor cancer mamar avansat loco-regional sau metastazat, care nu au primit anterior tratament citotoxic pentru această afecţiune. Tratamentul in monoterapie al pacientelor cu cancer mamar avansat loco-regional sau metastazat, după eşecul tratamentului citotoxic. Chimioterapia anterioară trebuie să fi inclus o antraciclină sau un agent alchilant. Tratamentul în asociere cu trastuzumab, al pacientelor cu cancer mamar metastazat ale căror tumori exprimă în exces HER2 şi care nu au primit anterior chimioterapie pentru boala metastatică. Tratamentul în asociere cu capecitabină, al pacientelor cu cancer mamar avansat loco-regional sau metastazat, după eşecul chimioterapiei citotoxice. Tratamentul anterior trebuie să fi inclus o antraciclină. Tratamentul pacienţilor cu cancer bronhopulmonar, altul decât cel cu celule mici, avansat loco-regional sau metastazat, după eşecul chimioterapiei sau înainte de aceasta. Tratamentul în asociere cu cisplatină, al pacienţilor cu cancer bronhopulmonar, altul decât cel cu celule mici, nerezecabil, avansat loco-regional sau metastazat, la pacienţii care nu au primit anterior chimioterapie pentru această afecţiune. Tratamentul în asociere cu prednison sau prednisolon, al pacienţilor cu cancer de prostată metastazat, hormono-rezistent. Tratamentul în asociere cu cisplatină şi 5-fluorouracil, al pacienţilor cu adenocarcinom gastric metastazat, inclusiv adenocarcinom al joncţiunii gastroesofagiene, care nu au primit anterior chimioterapie pentru boala metastatică. Tratamentul în asociere cu cisplatină şi 5-fluorouracil de inducţie la pacienţi cu carcinom cu celule scuamoase, al capului şi gâtului, avansat local. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L01CD02 DOCETAXELUM
TAXOTERE 20 mg 20mg 80mg

CONC. + SOLV. PT. SOL. PERF.
AVENTIS PHARMA SA

20mg 80mg

L01CD02 DOCETAXELUM
TAXOTERE 80 mg

CONC. + SOLV. PT. SOL. PERF.
AVENTIS PHARMA SA

732
L01DB01 L01DB01

L01DB01
DOXORUBICINUM

DOXORUBICINUM
LIOF. PT. SOL. INJ.
10mg 2mg/ml ACTAVIS S.R.L.

10mg 2mg/ml

ADRIBLASTINA RD 10 mg

DOXORUBICINUM

CONC. PT. SOL. PERF.
SP EUROPE

CAELYX 2 mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul ca monoterapie al cancerului mamar metastatic, la paciente cu risc cardiac crescut. Tratamentul cancerului ovarian în stadiu avansat, la paciente care nu au răspuns la regimul chimioterapic de primă linie, cu compuşi de platină. Tratamentul sarcomului Kaposi (SK) corelat cu SIDA (SK-SIDA), la pacienţii cu număr mic de limfocite CD4 (< 200 limfocite CD4/mm3) şi cu afectare mucocutanată sau viscerală extinsă. Poate fi utilizat în chimioterapia sistemică de primă linie sau în chimioterapia de linia a doua la pacienţii cu SK-SIDA la care boala a avansat sau la pacienţii cu intoleranţă la tratament, la care s-a administrat anterior chimioterapie sistemică combinată, cuprinzând cel puţin două dintre următoarele chimioterapice: alcaloid de vinca, bleomicină şi doxorubicină standard (sau altă antraciclină).

L01DB01 L01DB01 L01DB01 L01DB01

DOXORUBICINUM
2mg/ml 2mg/ml

CONC. PT. SOL. PERF.
EBEWE PHARMA GMBH NFG. KG

2mg/ml 2mg/ml 2mg/ml

DOXORUBICIN "EBEWE" 2mg/ml

DOXORUBICINUM DOXORUBICINUM
2mg/ml

PULB. PT. SOL. PERF.
ACTAVIS S.R.L

SINDROXOCIN 2mg/ml DOXORUBICIN TEVA 2 mg/ml

SOL. INJ.
TEVA PHARMACEUTICALS S.R.L

DOXORUBICINUM
50mg

LIOF. PT. SOL. INJ.
ACTAVIS S.R.L.

50mg

ADRIBLASTINA RD 50 mg

733
L01DB03

L01DB03
EPIRUBICINUM

EPIRUBICINUM
LIOF. PT. SOL. INJ.
10mg 10mg 2mg/ml ACTAVIS S.R.L. ACTAVIS S.R.L.

10mg

EPISINDAN 10 mg FARMORUBICIN RD 10 mg

L01DB03 L01DB03

EPIRUBICINUM EPIRUBICINUM
50mg

CONC. PT. SOL. INJ.
EBEWE PHARMA GMBH NFG. KG

2mg/ml 50mg

EPIRUBICIN "EBEWE" 2 mg/ml EPISINDAN 50 mg

LIOF. PT. SOL. INJ.
ACTAVIS S.R.L.

104 / 153

DCI/DENUMIRE COMERCIALA
FARMORUBICIN® RD 50 mg

CONCENTRATIE
50mg

FORMA FARM.

FIRMA
ACTAVIS S.R.L.

PROTOCOL

734
L01DB06
ZAVEDOS

L01DB06
IDARUBICINUM

IDARUBICINUM
CAPS.
10mg PFIZER EUROPE MA EEIG

10mg 5mg
PFIZER EUROPE MA EEIG

L01DB06

IDARUBICINUM
5mg

LIOF. PT. SOL. INJ.

ZAVEDOS 5 mg

735
L01DB07 L01DB07 L01DB07
ONKOTRONE

L01DB07
MITOXANTRONUM

MITOXANTRONUM **
CONC. PT. SOL. PERF.
2 mg/ml TEVA PHARMACEUTICALS SRL

2 mg/ml 20mg/10ml

MITOXANTRONE TEVA 2 mg/ml

MITOXANTRONUM MITOXANTRONUM
2mg/ml

SOL. PERF.
20mg/10ml WYETH LEDERLE PHARMA GMBH

NOVANTRONE

CONC. PT. SOL. INJ.
BAXTER ONCOLOGY GMBH

2mg/ml

736
BLEOCIN

L01DC01

BLEOMYCINUM SULFAS
LIOF. PT. SOL. INJ.
15mg EURO NIPPON KAYAKU GMBH

L01DC01 BLEOMYCINUM SULFAS

15mg

738
L01XA01 L01XA01
SINPLATIN 10 mg

L01XA01
CISPLATINUM

CISPLATINUM
LIOF. PT. SOL. PERF.
10mg 10mg/20ml 10mg/20ml 1mg/1ml 25mg/50ml 50mg 50mg/100ml ACTAVIS S.R.L.

10mg 10mg/20ml

CISPLATINUM

CONC. PT. SOL. PERF.
EBEWE PHARMA GMBH NFG. KG TEVA PHARMACEUTICALS S.R.L.

CISPLATIN "EBEWE" 10 mg/20 ml CISPLATIN TEVA 10 mg/20 ml

L01XA01 L01XA01 L01XA01 L01XA01

CISPLATINUM CISPLATINUM CISPLATINUM CISPLATINUM

CONC. PT. SOL. PERF.
ACTAVIS S.R.L.

1mg/1ml 25mg/50ml 50mg 50mg/100ml

SINPLATIN 1 mg/1 ml CISPLATIN "EBEWE" 25 mg/50 ml SINPLATIN 50 mg CISPLATIN "EBEWE" 50 mg/100 ml

CONC. PT. SOL. PERF.
EBEWE PHARMA GMBH NFG. KG ACTAVIS S.R.L.

LIOF. PT. SOL. PERF. CONC. PT. SOL. PERF.
EBEWE PHARMA GMBH NFG. KG

739
L01XA02

L01XA02
CARBOPLATINUM

CARBOPLATINUM
CONC. PT. SOL. PERF.
10mg/ml 10mg/ml 10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG ACTAVIS S.R.L. TEVA PHARMACEUTICALS S.R.L.

10mg/ml

CARBOPLATIN "EBEWE" 10 mg/ml CARBOPLATIN ACTAVIS 10mg/ml CARBOPLATIN TEVA 10mg/ml

740

L01XA03
Prescriere limitata:

OXALIPLATINUM

Cancer colorectal metastazat in combinatie cu 5-FU si acid folic. Tratament adjuvant al cancerului de colon stadiul III (Dukes C) in combinatie cu 5-FU si acid folic dupa rezectia completa a tumorii primare. NOTA: Nu se compenseaza tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L01XA03

OXALIPLATINUM
5mg/ml 5mg/ml

LIOF. PT. SOL. PERF.
SANOFI-AVENTIS FRANCE ACTAVIS S.R.L.

5mg/ml

ELOXATIN 5 mg/ml OXALIPLATIN ACTAVIS 5 mg/ml

NOTA: Nu se compenseaza tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal..

742
L01XC04 L01XC04

L01XC04
ALEMTUZUMABUM

ALEMTUZUMABUM ****
CONC. PT. SOL. PERF.
10mg/ml 30mg/ml GENZYME EUROPE BV

Protocol: L024C
10mg/ml 30mg/ml

MABCAMPATH 10 mg/ml

ALEMTUZUMABUM

CONC. PT. SOL. PERF.
GENZYME EUROPE BV

MABCAMPATH 30 mg/ml

743
L01XC02
MABTHERA 100 mg MABTHERA 500 mg

L01XC02
RITUXIMABUM

RITUXIMABUM ****
CONC. PT. SOL. PERF.
10mg/ml 10mg/ml 10mg/ml 10mg/ml ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

Protocol: L014C
10mg/ml

L01XC02

RITUXIMABUM

CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

10mg/ml

MABTHERA 100 mg MABTHERA 500 mg

744

L01XC03

TRASTUZUMABUM ****

Protocol: L026C

NOTA: Tratamentul pacienţilor cu neoplasm de sân metastatic cu HER2 amplificat: a) ca monoterapie în cazul pacienţilor trataţi cu cel puţin două regimuri chimioterapice pentru boala lor metastatică. Chimioterapia anterioară trebuie să fi inclus cel puţin o antraciclină şi un taxan, cu excepţia cazurilor în care aceste chimioterapice nu erau indicate. Pacienţii pozitivi la receptorii hormonali trebuie de asemenea să fi prezentat un eşec la tratamentul hormonal, cu excepţia cazurilor în care acest tip de tratament nu a fost indicat b) în asociere cu Paclitaxel pentru tratamentul pacienţilor care nu au primit chimioterapie pentru boala lor metastatică şi pentru care nu este indicat tratamentul cu antracicline. Herceptin trebuie folosit numai la pacienţii ale căror tumori prezintă HER2 amplificat la nivel 3+ , determinat prin imunohistochimie. Trastuzumab nu trebuie utilizat la pacienti cu o fractie de ejectie ventriculara a ventriculului stang mai mica de 45% si/sau cu insuficienta cardiaca simptomatica. Functia cardiaca trebuie testata.

L01XC03

TRASTUZUMABUM
150mg

PULB. PT. CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD.

150mg

HERCEPTIN 150mg

745
L01XC06 L01XC06 L01XC06
ERBITUX 2mg/ml

L01XC06
CETUXIMABUM

CETUXIMABUM ****
SOL. PERF.
2mg/ml MERCK KGAA

Protocol: L037C
2mg/ml 5mg/ml
MERCK KGAA

CETUXIMABUM
5mg/ml

SOL. PERF. SOL. PERF.
5mg/ml MERCK KGAA

ERBITUX 5mg/ml

CETUXIMABUM

5mg/ml

ERBITUX 5mg/ml

746
L01XC07
AVASTIN 25mg/ml

L01XC07
BEVACIZUMABUM

BEVACIZUMABUM ****
CONC. PT. SOL. PERF.
25mg/ml ROCHE REGISTRATION LTD.

Protocol: L004C
25mg/ml

747

L01XE01

IMATINIBUM ****

Protocol: L008C

105 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
100mg

FORMA FARM.

FIRMA

PROTOCOL

L01XE01 L01XE01 L01XE01

IMATINIBUM IMATINIBUM
100mg

CAPS.
NOVARTIS EUROPHARM LTD.

100mg 100mg
NOVARTIS EUROPHARM LTD.

GLIVEC 100 mg GLIVEC 100 mg

CAPS. CAPS.
100mg NOVARTIS EUROPHARM LTD.

IMATINIBUM

100mg

GLIVEC 100 mg

748
L01XE03 L01XE03 L01XE03
TARCEVA 100 mg

L01XE03
ERLOTINIBUM

ERLOTINIBUM ****
COMPR. FILM.
100mg ROCHE REGISTRATION LTD.

Protocol: L031C
100mg 150mg
ROCHE REGISTRATION LTD.

ERLOTINIBUM
150mg

COMPR. FILM. COMPR. FILM.
25mg ROCHE REGISTRATION LTD.

TARCEVA 150 mg

ERLOTINIBUM

25mg

TARCEVA 25 mg

749
L01XE04 L01XE04
SUTENT 25mg SUTENT 12,5 mg

L01XE04
SUNITINIBUM

SUNITINIBUM ****
CAPS.
12,5mg PFIZER LIMITED

Protocol: L042C
12,5mg 25mg
PFIZER LIMITED

SUNITINIBUM
25mg

CAPS. CAPS.
50mg PFIZER LIMITED

L01XE04

SUNITINIBUM

50mg

SUTENT 50 mg

750
L01XE05
NEXAVAR 200 mg

L01XE05
SORAFENIBUM

SORAFENIBUM ****
COMPR. FILM.
200mg BAYER HEALTHCARE AG

Protocol: L038C
200mg

751
L01XE06 L01XE06 L01XE06 L01XE06 L01XE06 L01XE06
SPRYCEL 20mg

L01XE06
DASATINIBUM

DASATINIBUM ****
COMPR. FILM.
20 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

Protocol: L035C
20 mg 50 mg
BRISTOL-MYERS SQUIBB PHARMA EEIG

DASATINIBUM
50 mg

COMPR. FILM. COMPR. FILM.
70 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

SPRYCEL 50mg

DASATINIBUM DASATINIBUM
20 mg

70 mg 20 mg
BRISTOL-MYERS SQUIBB PHARMA EEIG

SPRYCEL 70mg SPRYCEL 20mg

COMPR. FILM. COMPR. FILM.
50 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

DASATINIBUM DASATINIBUM
70 mg

50 mg 70 mg
BRISTOL-MYERS SQUIBB PHARMA EEIG

SPRYCEL 50mg SPRYCEL 70mg

COMPR. FILM.

753
L01XX02 L01XX02

L01XX02
ASPARAGINAZUM

ASPARAGINAZUM
LIOF. PT. SOL. INJ./PERF.
10000ui 5000ui

10000ui 5000ui

ASPARAGINASE 10000 MEDAC

MEDAC GESELLSCAFT FUR KLINISCHE SPEZIALPRÄPARATE

ASPARAGINAZUM

LIOF. PT. SOL. INJ./PERF.

ASPARAGINASE 5000 MEDAC

MEDAC GESELLSCAFT FUR KLINISCHE SPEZIALPRÄPARATE

754
L01XX05
HYDREA

L01XX05
HYDROXYCARBAMIDUM

HYDROXYCARBAMIDUM
CAPS.
500mg BRISTOL MYERS SQUIBB KFT

500mg

755
L01XX11
ESTRACYT

L01XX11
ESTRAMUSTINUM

ESTRAMUSTINUM
CAPS.
140mg PFIZER EUROPE MA EEIG

140mg

757
L01XX17
HYCAMTIN 4 mg

L01XX17
TOPOTECAMUM

TOPOTECAMUM
PULB.CONC.SOL.PERF.
4mg SMITHKLINE BEECHAM PLC

4mg

758
L01XX19
CAMPTO 100 mg/5 ml IRINOTESIN 20mg/ml

L01XX19
IRINOTECANUM

IRINOTECANUM
CONC. PT. SOL. PERF.
20mg/ml 20mg/ml 20mg/ml 20mg/ml PFIZER EUROPE MA EEIG ACTAVIS S.R.L.

20mg/ml

L01XX19

IRINOTECANUM

CONC. PT. SOL. PERF.
PFIZER EUROPE MA EEIG ACTAVIS S.R.L.

20mg/ml

CAMPTO 100 mg/5 ml IRINOTESIN 20mg/ml

759
L01XX32
VELCADE 3,5 mg

L01XX32
BORTEZOMIBUM

BORTEZOMIBUM ****
PULB. PT. SOL. INJ.
3.5mg JANSSEN-CILAG INTERNATIONAL NV

Protocol: L012C
3.5mg

760
L02AB01 L02AB01
MEGACE MEGESIN 160 mg

L02AB01
MEGESTROLUM

MEGESTROLUM
COMPR.
160mg ACTAVIS S.R.L.

160mg 40mg/ml
BRISTOL MYERS SQUIBB KFT

MEGESTROLUM
40mg/ml

SUSP. ORALA

761

L02AE02

LEUPRORELINUM **

Prescriere limitata: Cancer de prostata hormonodependent avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D). Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L02AE02 L02AE02 L02AE02 L02AE02 L02AE02

LEUPRORELINUM
11.25mg 22.5mg 22.5mg 7.5mg 3.75mg

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.
ABBOTT LABORATORIES S.A.

11.25mg 11.25mg 11.25mg 11.25mg

LUCRIN DEPOT 11,25mg

LEUPRORELINUM LEUPRORELINUM LEUPRORELINUM LEUPRORELINUM

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.
ASTELLAS PHARMA EUROPE B.V.

ELIGARD 22,5 mg ELIGARD 22,5 mg ELIGARD 7,5 mg LUCRIN DEPOT 3,75mg

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.
ASTELLAS PHARMA EUROPE B.V.

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.
ASTELLAS PHARMA EUROPE B.V.

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.
ABBOTT LABORATORIES

106 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

762
L02AE03
ZOLADEX®

L02AE03
GOSERELINUM

GOSERELINUM **
IMPLANT
3.6mg ASTRAZENECA UK LTD.

3.6mg

Prescriere limitata: Prescriere limitata:

Cancer de prostata hormonodependent avansat local (echivalent stadiului T3 – T4) sau metastatic (echivalent stadiului M1). Cancer de sân hormonodependent avansat local (echivalent cu stadiul III) sau metastatic (echivalent cu stadiul IV) la femei în premenopauză.

763

L02AE04

TRIPTORELINUM **

Prescriere limitata: Cancer de prostata hormonodependent avansat local (echivalent stadiului T3 – T4) sau metastatic (echivalent stadiului M1). Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L02AE04 L02AE04 L02AE04

TRIPTORELINUM
0.1mg 11.25mg 3.75mg

LIOF. + SOLV. PT. SOL. INJ.
BEAUFOUR IPSEN PHARMA

0.1mg 11.25mg 3.75mg

DIPHERELINE 0,1 mg

TRIPTORELINUM TRIPTORELINUM

LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.
BEAUFOUR IPSEN PHARMA

DIPHERELINE® 11,25 mg DIPHERELINE® 3,75 mg

LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.
BEAUFOUR IPSEN PHARMA

764
L02BA01
TAMONEPRIN® 10 mg TAMOXIFEN 10 TEVA

L02BA01
TAMOXIFENUM

TAMOXIFENUM
COMPR.
10mg 10mg ACTAVIS S.R.L. PHARMACHEMIE BV

10mg

L02BA01

TAMOXIFENUM
10mg

COMPR. FILM.
HEXAL AG

10mg

TAMOXIFEN® 10 HEXAL

765
L02BA03
FASLODEX 250mg/5ml

L02BA03
FULVESTRANTUM

FULVESTRANTUM **
SOL. INJ.
250mg/5ml ASTRAZENECA UK LTD.

Protocol: L003C
250mg/5ml

766
L02BB01
FLUTAN FLUTASIN® 250 mg

L02BB01
FLUTAMIDUM

FLUTAMIDUM
COMPR.
250mg 250mg MEDOCHEMIE LTD. ACTAVIS S.R.L.

250mg

767
L02BB03 L02BB03
CASODEX 150 mg

L02BB03
BICALUTAMIDUM

BICALUTAMIDUM
COMPR. FILM.
150mg ASTRAZENECA UK LTD.

150mg 50mg
GEDEON RICHTER PLC. ASTRAZENECA UK LTD.

BICALUTAMIDUM
50mg 50mg

COMPR. FILM.

CALUMID CASODEX 50 mg

768
ROGLUTEN® 250 mg

L02BG01

AMINOGLUTETHIMIDUM
COMPR.
250mg ACTAVIS S.R.L.

L02BG01 AMINOGLUTETHIMIDUM

250mg

769
ARIMIDEX ARIMIDEX 1 mg

L02BG03

ANASTROZOLUM
COMPR. FILM.
1mg 1mg ACTAVIS S.R.L. ASTRAZENECA UK LTD.

L02BG03 ANASTROZOLUM

1mg

770
FEMARA 2,5 mg

L02BG04

LETROZOLUM
COMPR. FILM.
2.5mg NOVARTIS PHARMA GMBH

L02BG04 LETROZOLUM

2.5mg

771
AROMASIN 25 mg

L02BG06

EXEMESTANUM
DRAJ.
25mg PFIZER EUROPE MA EEIG

L02BG06 EXEMESTANUM

25mg

772

L03AA02
Prescriere limitata:

FILGRASTIMUM (G-CSF) **

Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei mieloide cronice şi a sindroamelor mielodisplazice), precum şi pentru reducerea duratei neutropeniei la pacienţii care primesc terapie mieloablativă urmată de transplant de măduvă osoasă. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AA02
NEUPOGEN®

FILGRASTIMUM (G-CSF) FILGRASTIMUM (G-CSF)

SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

L03AA02
NEUPOGEN®

SOL. INJ.
48MU/0.5ml

773

L03AA13
Prescriere limitata:

PEGFILGRASTIMUM ***

Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei mieloide cronice şi a sindroamelor mielodisplazice).

NOTA: Pentru indicatia mai sus mentionata, o doză de 6 mg (o singură seringă preumplută) de Pegfilgrastimum este recomandată pentru fiecare ciclu de chimioterapie, administrată ca injecţie subcutanată la aproximativ 24 de ore după chimioterapia citotoxică. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AA13

PEGFILGRASTIMUM
6mg

SOL. INJ.
AMGEN EUROPE B.V.

6mg

NEULASTA 6mg

774

L03AB04

INTERFERONUM ALFA 2a ***

Protocol: L050C

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB04
ROFERON A

INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a INTERFERONUM ALFA 2a

SOL. INJ.
18Mui/0.6ml ROCHE ROMANIA S.R.L.

18Mui/0.6ml 3Mui/0.5ml
ROCHE ROMANIA S.R.L.

L03AB04
ROFERON A

SOL. INJ.
3Mui/0.5ml

L03AB04
ROFERON A

SOL. INJ.
4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5ml 9Mui/0.5ml
ROCHE ROMANIA S.R.L.

L03AB04
ROFERON A

SOL. INJ.
9Mui/0.5ml

775

L03AB05

INTERFERONUM ALFA 2b ***

Protocol: L016C

107 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie monitorizat statusul psihiatric în timpul tratamentului. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AB05 L03AB05

INTERFERONUM ALFA 2b INTERFERONUM ALFA 2b

SOL. INJ. PEN MULTIDOZA
18 milioane U.I. 30 milioane U.I. 60 milioane U.I. 30 milioane U.I. 60 milioane U.I. SP EUROPE

18 milioane U.I. 30 milioane U.I.

INTRON A 18 milioane U.I. INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

SOL. INJ. PEN MULTIDOZA
SP EUROPE SP EUROPE

L03AB05

INTERFERONUM ALFA 2b

SOL. INJ. PEN MULTIDOZA
SP EUROPE SP EUROPE

60 milioane U.I.

INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

777
BONEFOS® 400 mg SINDRONAT® 400 mg

M05BA02

ACIDUM CLODRONICUM **
CAPS.
400mg 400mg SCHERING OY (SCHERING AG) ACTAVIS S.R.L.

M05BA02 ACIDUM CLODRONICUM

400mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:
BONEFOS® 60 mg/ml

Metastaze osoase consecutive cancerului de san. Tratament de întreţinere in hipercalcemia din cancerele refractare la terapia antineoplazica Mielomul multiplu

M05BA02 ACIDUM CLODRONICUM
60mg/ml

CONC. PT. SOL. PERF.
SCHERING OY

60mg/ml

Prescriere limitata:
BONEFOS® 800 mg

Tratamentul hipercalcemiei asociata cancerului

M05BA02 ACIDUM CLODRONICUM
800mg

COMPR. FILM.
SCHERING OY

800mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Metastaze osoase consecutive cancerului de san. Tratament de întreţinere in hipercalcemia din cancerele refractare la terapia antineoplazica Mielomul multiplu

778

M05BA03
Prescriere limitata:

ACIDUM PAMIDRONICUM **

Metastaze osoase consecutive cancerului de san. Tratament de întreţinere in hipercalcemia din cancerele refractare la terapia antineoplazica. Mielomul multiplu. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M05BA03 ACIDUM PAMIDRONICUM
AREDIA® 15 mg 15mg 15mg/ml 30mg 60mg

LIOF.+ SOLV. PT. SOL. PERF.
NOVARTIS PHARMA GMBH

15mg 15mg/ml 30mg 60mg

M05BA03 ACIDUM PAMIDRONICUM
PAMIDRONAT TORREX

CONC. PT. SOL. PERF.
TORREX CHIESI PHARMA GMBH

M05BA03 ACIDUM PAMIDRONICUM
PAMIRED 30

LIOF. PT. SOL. PERF. I.V.
DR. REDDY'S LABORATORIES

M05BA03 ACIDUM PAMIDRONICUM
PAMIRED 60

LIOF. PT. SOL. PERF. I.V.
DR. REDDY'S LABORATORIES

779
BONDRONAT 50mg

M05BA06

ACIDUM IBANDRONICUM **
COMPR. FILM.
50mg ROCHE REGISTRATION LTD.

M05BA06 ACIDUM IBANDRONICUM
Prescriere limitata:

50mg

Preventia afectarii osoase (fracturi patologice, complicatii osoase care necesita radioterapie sau interventii chirurgicale) la pacientii cu cancer de san si metastaze osoase.

M05BA06 ACIDUM IBANDRONICUM
BONDRONAT 6mg/6ml 6mg/6ml

CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD.

6mg/6ml

Prescriere limitata: Prescriere limitata:
BONVIVA 3mg/3ml

Preventia afectarii osoase (fracturi patologice, complicatii osoase care necesita radioterapie sau interventii chirurgicale) la pacientii cu cancer de san si metastaze osoase. Tratamentul hipercalcemiei induse de tumora cu sau fara metastaze osoase.

M05BA06 ACIDUM IBANDRONICUM
3mg/3ml

SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD

3mg/3ml

780

M05BA08
Prescriere limitata:

ACIDUM ZOLEDRONICUM **

Prevenirea manifestărilor osoase (fracturi patologice, compresie spinală, iradiere sau chirurgie osoasă sau hipercalcemie indusă de tumori) la pacienţi cu tumori maligne avansate, cu implicare osoasă. Tratamentul hipercalcemiei induse de tumori. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M05BA08 ACIDUM ZOLEDRONICUM
ZOMETA 4 mg 4mg

PULB. + SOLV. SOL. PERF.
NOVARTIS EUROPHARM LTD.

4mg 5mg/100ml

M05BA08 ACIDUM ZOLEDRONICUM
ACLASTA 5mg/100ml

SOL. PERF.
5mg/100ml NOVARTIS EUROPHARM LTD.

781
V03AF01

V03AF01
MESNUM

MESNUM
SOL. INJ.
400mg/4ml BAXTER ONCOLOGY GMBH

400mg/4ml

UROMITEXAN® 400 mg

782
V03AF03

V03AF03
CALCII FOLINAS

CALCII FOLINAS
SOL. INJ.
10mg/ml 10mg/ml 10mg/ml 10mg/ml ACTAVIS S.R.L. ACTAVIS S.R.L. TEVA PHARM. IND. LTD. TEVA PHARMACEUTICALS S.R.L.

10mg/ml

FOLCASIN 10 mg/ml FOLCASIN® 100 mg/10 ml LEUCOVORIN-TEVA 100 mg/10 ml LEUCOVORIN-TEVA 50 mg/5 ml

V03AF03

CALCII FOLINAS
10mg/ml 10mg/ml 10mg/ml 10mg/ml

SOL. INJ.
ACTAVIS S.R.L. ACTAVIS S.R.L. TEVA PHARM. IND. LTD. TEVA PHARMACEUTICALS S.R.L.

10mg/ml

FOLCASIN 10 mg/ml FOLCASIN® 100 mg/10 ml LEUCOVORIN-TEVA 100 mg/10 ml LEUCOVORIN-TEVA 50 mg/5 ml

V03AF03 V03AF03 V03AF03

CALCII FOLINAS
10mg/ml

SOL. INJ./PERF.
EBEWE PHARMA GMBH NFG. KG

10mg/ml 15mg
EBEWE PHARMA GES.M.B.H. NFG KG

CALCIUMFOLINAT "EBEWE" 10 mg/ml

CALCII FOLINAS
15mg

CAPS. SOL. INJ.
3mg/ml ACTAVIS S.R.L.

CALCIUM FOLINAT "EBEWE" 15 mg

CALCII FOLINAS

3mg/ml

FOLCASIN® 30 mg/10 ml

108 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

783
V03AF05
ETHYOL

V03AF05
AMIFOSTINUM

AMIFOSTINUM **
LIOF. PT. SOL. PERF.
375mg SCHERING PLOUGH EUROPE

375mg 500mg

V03AF05
ETHYOL®

AMIFOSTINUM
500mg

LIOF. PT. SOL. PERF.
SCHERING PLOUGH EUROPE

SUBLISTA C2-P4: PROGRAMUL NATIONAL DE BOLI NEUROLOGICE. SUBPROGRAMUL DE TRATAMENT AL SCLEROZEI MULTIPLE 784 L03AB07 INTERFERONUM BETA 1a ****
L03AB07 L03AB07 L03AB07 INTERFERONUM BETA 1a INTERFERONUM BETA 1a INTERFERONUM BETA 1a
44µg

Protocol: L002G

SOL. INJ.
22µg/0,5ml 30µg (6 mil. UI) SERONO EUROPE LTD.

22µg/0,5ml 30µg (6 mil. UI) 44µg
SERONO EUROPE LTD.

REBIF 22 micrograme AVONEX 30 µg BIO-SET REBIF 44 micrograme

PULB. + SOLV. PT. SOL. INJ.
BIOGEN IDEC LIMITED

SOL. INJ.

785
L03AB08
BETAFERON 250µg/ml

L03AB08
INTERFERONUM BETA 1B

INTERFERONUM BETA 1B ****
PULB. + SOLV. PT. SOL. INJ.
250µg/ml BAYER SCHERING AG

250µg/ml

786
L03AX13
COPAXONE

L03AX13
GLATIRAMER ACETAT

GLATIRAMER ACETAT ****
SOL. INJ.
20mg/ml TEVA PHARMACEUTICALS S.R.L.

20mg/ml

787
L04AA23
TYSABRI 300mg

L04AA23
NATALIZUMABUM

NATALIZUMABUM ****
CONC. PT. SOL. PERF.
20mg/ml ELAN PHARMA INTERNATIONAL LTD

20mg/ml

A fost raportat la acest medicament leucoencefalopatie multifocala progresiva.

788
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

109 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P5: PROGRAMUL NATIONAL DE DIABET ZAHARAT. 789 A10AB01 INSULINE UMANE
A10AB01 INSULINE UMANE
HUMULIN R 100UI/ml

Protocol: AE01E
100UI/ml
LILLY FRANCE SAS

SOL. INJ. SOL. INJ.
100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml LILLY FRANCE SAS

A10AB01 INSULINE UMANE
HUMULIN R

100UI/ml 100UI/ml

A10AB01 INSULINE UMANE
ACTRAPID PENFILL 100 UI/ml INSUMAN RAPID 100UI/ml

SOL. INJ. IN CARTUS
NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AB01 INSULINE UMANE
ACTRAPID 100 UI/ml INSUMAN RAPID 100UI/ml

SOL. INJ. IN FLACON
NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

A10AB01 INSULINE UMANE
ACTRAPID 100 UI/ml INSUMAN RAPID 100UI/ml

SOL. INJ. IN FLACON
NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

A10AB01 INSULINE UMANE
ACTRAPID NOVOLET 100 UI/ml INSUMAN RAPID 100 UI/ml OPTISET

SOL. INJ. IN STILOU INJECTOR PREUMPLUT
NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

790
HUMALOG 100 U/ml

A10AB04

INSULINUM LISPRO **
SOL. INJ.
100U/ml ELI LILLY NEDERLAND BV

A10AB04 INSULINUM LISPRO

100U/ml

791

A10AB05

INSULINUM ASPART **
SOL. INJ. IN CARTUS
100Uml NOVO NORDISK A/S

Protocol: A016E
100Uml

A10AB05 INSULINUM ASPART
NOVORAPID PENFILL 100 U/ml

792
APIDRA 100U/ml

A10AB06

INSULINUM GLULIZINA **
SOL. INJ. IN CARTUS
100U/ml 100U/ml 100U/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AB06 INSULINUM GLULIZINA A10AB06 INSULINUM GLULIZINA
APIDRA 100U/ml

100U/ml 100U/ml 100U/ml

SOL. INJ. IN FLACON
SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AB06 INSULINUM GLULIZINA
APIDRA 100U/ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT
SANOFI - AVENTIS DEUTSCHLAND GMBH

793
HUMULIN N

A10AC01

INSULINE UMANE
SUSP. INJ.
100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml LILLY FRANCE SAS

A10AC01 INSULINE UMANE A10AC01 INSULINE UMANE
INSULATARD NOVOLET 100 UI/ml INSUMAN BASAL 100UI/ml OPTISET

100UI/ml 100UI/ml

SUSP. INJ. IN STILOU INJECTOR PREUMPLUT
NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AC01 INSULINE UMANE
INSULATARD PENFILL 100 UI/ml INSUMAN BASAL 100UI/ml

SUSP. INJ. IN CARTUS
NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

A10AC01 INSULINE UMANE
INSULATARD 100 UI/ml INSUMAN BASAL 100UI/ml

SUSP. INJ. IN FLACON
NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

A10AC01 INSULINE UMANE
INSULATARD 100 UI/ml INSUMAN BASAL 100UI/ml

SUSP. INJ. IN FLACON
NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

794

A10AC04

INSULINUM LISPRO **
SOL. INJ.
100U/ml ELI LILLY NEDERLAND BV

Protocol: A029E
100U/ml

A10AC04 INSULINUM LISPRO
HUMALOG NPL 100 U/ml

795
HUMULIN M3

A10AD01

INSULINE UMANE
SUSP. INJ.
100ui/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml LILLY FRANCE S.A.S

A10AD01 INSULINE UMANE A10AD01 INSULINE UMANE
INSUMAN COMB 25 100UI/ml OPTISET INSUMAN COMB 50 100UI/ml OPTISET MIXTARD 30 NOVOLET 100 UI/ml

SUSP. INJ. IN STILOU INJECTOR PREUMPLUT
SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

100UI/ml

A10AD01 INSULINE UMANE
INSUMAN COMB 25 100UI/ml INSUMAN COMB 50 100UI/ml MIXTARD 20 PENFILL 100 UI/ml MIXTARD 30 PENFILL 100 UI/ml MIXTARD 40 PENFILL 100 UI/ml

SUSP. INJ. IN CARTUS
SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S

100UI/ml

A10AD01 INSULINE UMANE
INSUMAN COMB 25 100UI/ml INSUMAN COMB 50 100UI/ml MIXTARD 30 100UI/ml

SUSP. INJ. IN FLACON
SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

100UI/ml

A10AD01 INSULINE UMANE
INSUMAN COMB 25 100UI/ml INSUMAN COMB 50 100UI/ml MIXTARD 30 100UI/ml

SUSP. INJ. IN FLACON
SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

100UI/ml

796
HUMALOG MIX25 HUMALOG MIX50

A10AD04

INSULINUM LISPRO **
SUSP. INJ.
100U/ml 100U/ml ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV

Protocol: A015E
100U/ml

A10AD04 INSULINUM LISPRO

797
NOVOMIX 30 FLEXPEN

A10AD05

INSULINUM ASPART **
SUSP. INJ. IN STILOU INJECTOR PREUMPLUT
100UIml NOVO NORDISK A/S

Protocol: A018E
100UIml

A10AD05 INSULINUM ASPART

798
LANTUS 100UI/ml

A10AE04

INSULINUM GLARGINE **
SOL. INJ. IN CARTUS
100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

Protocol: A024E
100UI/ml

A10AE04 INSULINUM GLARGINE

110 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
100UI/ml 100UI/ml 100UI/ml

FORMA FARM.

FIRMA

PROTOCOL

A10AE04 INSULINUM GLARGINE
LANTUS 100UI/ml

SOL. INJ. IN FLACON
SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml 100UI/ml

A10AE04 INSULINUM GLARGINE
LANTUS OptiSet LANTUS SoloStar

SOL. INJ. IN STILOU INJECTOR PREUMPLUT
SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

799

A10AE05

INSULINUM DETEMIR **
SOL. INJ. IN CARTUS
100U/ml 100U/ml NOVO NORDISK A/S

Protocol: A023E
100U/ml 100U/ml

A10AE05 INSULINUM DETEMIR
LEVEMIR PENFILL 100 U/ml

A10AE05 INSULINUM DETEMIR
LEVEMIR FLEXPEN 100 U/ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT
NOVO NORDISK A/S

800
METFORMIN 1000 mg

A10BA02

METFORMINUM
COMPR.
1000mg ARENA GROUP S.A.

A10BA02 METFORMINUM A10BA02 METFORMINUM
GLUCOPHAGE 1000 mg METFOGAMMA 1000mg SIOFOR 1000 1000mg 1000mg 1000mg 1000mg

1000mg 1000mg
MERCK SANTE WORWAG PHARMA GMBH & CO. KG BERLIN CHEMIE AG MENARINI GROUP

COMPR. FILM.

A10BA02 METFORMINUM
FORMIRAN 1000 mg

COMPR. PT. SOL. ORALA
TERAPIA S.A.

1000mg 500mg

A10BA02 METFORMINUM
DIGUAN® 500 mg METFORMIN 500 mg 500mg 500mg 500mg

COMPR.
ZENTIVA S.A. ARENA GROUP SA

A10BA02 METFORMINUM
GLUCOPHAGE XR

COMPR. ELIB. PREL.
MERCK SANTE S.A.S.

500mg 500mg

A10BA02 METFORMINUM
DIPIMET 500 mg GLUCOPHAGE 500 MEGUAN® 500 mg METFOGAMMA® 500 METFORMIN AL 500 METFORMIN LPH® 500 mg METFORMIN-TEVA 500 mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.
ANTIBIOTICE SA MERCK SANTE GEDEON RICHTER ROMANIA SA WORWAG PHARMA GMBH & CO. KG ALIUD PHARMA GMBH & CO.KG LABORMED PHARMA SA TEVA PHARMACEUTICAL S.R.L.

A10BA02 METFORMINUM
FORMIRAN 500 mg

COMPR. PT. SOL. ORALA
TERAPIA S.A.

500mg 850mg

A10BA02 METFORMINUM
DIAFORMIN® 850 mg METFORMIN 850 mg 850mg 850mg

COMPR.
TERAPIA SA ARENA GROUP SA

A10BA02 METFORMINUM
GLUCOPHAGE 850 mg MEDIFOR 850 MEGUAN® 850 mg METFOGAMMA 850 METFORMIN AL 850 METFORMIN LPH® 850 mg METFORMIN-TEVA 850 mg SIOFOR® 850 850mg 850mg 850mg 850mg 850mg 850mg 850mg 850mg 850mg

COMPR. FILM.
MERCK SANTE STD CHEMICALS LTD. GEDEON RICHTER ROMANIA SA WORWAG PHARMA GMBH & CO. KG ALIUD PHARMA GMBH & CO.KG LABORMED PHARMA SA TEVA PHARMACEUTICAL S.R.L. BERLIN CHEMIE AG MENARINI GROUP

850mg

A10BA02 METFORMINUM
FORMIRAN 850 mg

COMPR. PT. SOL. ORALA
TERAPIA S.A.

850mg

801
SILUBIN RETARD

A10BA03

BUFORMINUM
DRAJ. RET.
100mg DITA IMPORT EXPORT SRL

A10BA03 BUFORMINUM

100mg

802

A10BB01

GLIBENCLAMIDUM
COMPR.
1,75 mg ANTIBIOTICE S.A.

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID ANTIBIOTICE 1,75 mg

1,75 mg 1.75mg
LABORMED PHARMA SA ARENA GROUP SA BERLIN CHEMIE AG MENARINI GROUP

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID LPH 1,75 mg GLIBENCLAMID ARENA 1,75 mg MANINIL 1,75 mg 1.75mg 1.75mg 1.75mg

COMPR.

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID ANTIBIOTICE 3,5 mg 3,5mg

COMPR.
ANTIBIOTICE S.A.

3,5mg 3.5mg
ARENA GROUP SA LABORMED PHARMA SA BERLIN CHEMIE AG MENARINI GROUP

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID ARENA 3,5 mg GLIBENCLAMID LPH 3,5 mg MANINIL 3,5 mg 3.5mg 3.5mg 3.5mg

COMPR.

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID 5 mg 5mg

COMPR.
ARENA GROUP SA

5mg

803
TOLBUTAMID

A10BB03

TOLBUTAMIDUM
COMPR.
500mg SINTOFARM SA

A10BB03 TOLBUTAMIDUM

500mg

804

A10BB07

GLIPIZIDUM

Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A10BB07 GLIPIZIDUM
GLUCOTROL XL 10 mg 10mg

COMPR. FILM. ELIB. MODIF.
PFIZER EUROPE MA EEIG

10mg 5mg

A10BB07 GLIPIZIDUM
GLIPIZID LPH 5 mg 5mg 5mg

COMPR.
LABORMED PHARMA SA

A10BB07 GLIPIZIDUM
GLUCOTROL XL 5mg

COMPR. FILM. ELIB. MODIF.
PFIZER EUROPE MA EEIG

5mg

805

A10BB08

GLIQUIDONUM

Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

111 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
30mg

FORMA FARM.

FIRMA

PROTOCOL

A10BB08 GLIQUIDONUM
GLURENORM

COMPR.
BOEHRINGER INGELHEIM INT. GMBH

30mg

806

A10BB09

GLICLAZIDUM

Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A10BB09 GLICLAZIDUM
DIAPREL MR 30mg 30mg

COMPR. ELIB. MODIF.
LES LABORATOIRES SERVIER

30mg 30mg 80mg

A10BB09 GLICLAZIDUM
GLICLAZID MR LPH 30 mg

COMPR. ELIB. PREL.
LABORMED PHARMA SA

A10BB09 GLICLAZIDUM
DIABREZIDE ESQUEL® 80 mg GLICLAZID LPH GLIDIET 80mg 80mg 80mg 80mg

COMPR.
L. MOLTENI GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA MEDICAROM GROUP S.R.L.

A10BB09 GLICLAZIDUM
DIAPREL 80mg

COMPR. DIVIZ.
LES LABORATOIRES SERVIER

80mg

807

A10BB12

GLIMEPIRIDUM

Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A10BB12 GLIMEPIRIDUM
AMYX 1 1 mg

COMPR.
ZENTIVA A.S.

1 mg 1mg
AVENTIS PHARMA DEUTSCHLAND EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH LABORMED PHARMA SA RANBAXY UK LIMITED MEDICO UNO PHARMACEUTICAL SRL KRKA D.D. BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER ROMANIA S.A.

A10BB12 GLIMEPIRIDUM
AMARYL 1mg GLEMPID 1 mg GLIME TAD 1 mg GLIMEPIRID LPH 1 mg GLIMERAN 1 mg GLIPREX 1 mg MEGLIMID 1 mg OLTAR 1 mg TINERIL 1 mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg

COMPR.

A10BB12 GLIMEPIRIDUM
AMARYL 2 mg AMYX 2 DIBIGLIM 2 mg GLEMPID 2 mg GLIME TAD 2 mg GLIMEPIRID LPH 2 mg GLIMEPIRIDE 2 mg GLIMERAN 2 mg GLIPREX 2 mg MEGLIMID 2 mg TINERIL 2 mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg

COMPR.
AVENTIS PHARMA DEUTSCHLAND ZENTIVA A.S. SANDOZ SRL EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH LABORMED PHARMA SA ACTAVIS GROUP HF. RANBAXY UK LIMITED MEDICO UNO PHARMACEUTICAL SRL KRKA D.D. GEDEON RICHTER ROMANIA S.A.

2mg

A10BB12 GLIMEPIRIDUM
AMARYL 3 mg AMYX 3 DIBIGLIM 3 mg GLEMPID 3 mg GLIME TAD 3 mg GLIMEPIRID LPH 3 mg GLIMEPIRIDE 3 mg GLIMERAN 3 mg GLIPREX 3 mg MEGLIMID 3 mg OLTAR 3 mg TINERIL 3 mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg

COMPR.
AVENTIS PHARMA DEUTSCHLAND ZENTIVA A.S. SANDOZ SRL EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH LABORMED PHARMA SA ACTAVIS GROUP HF. RANBAXY UK LIMITED MEDICO UNO PHARMACEUTICAL SRL KRKA D.D. BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER ROMANIA S.A.

3mg

A10BB12 GLIMEPIRIDUM
AMYX 4 GLEMPID 4 mg GLIMERAN 4 mg GLIPREX 4 mg MEGLIMID 4 mg 4mg 4mg 4mg 4mg 4mg

COMPR.
ZENTIVA A.S. EGIS PHARMACEUTICALS P.L.C. RANBAXY UK LIMITED MEDICO UNO PHARMACEUTICAL SRL KRKA D.D.

4mg

A10BB12 GLIMEPIRIDUM
MEGLIMID 6 mg 6mg

COMPR.
KRKA D.D.

6mg 4mg
GEDEON RICHTER ROMANIA S.A.

A10BB12 GLIMEPIRIDUM
TINERIL 4 mg 4mg

COMPR

808

A10BD02

COMBINATII(GLIBENCLAMIDUM+METFORMINUM)

Protocol: A027E

Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN UM)
GLIBOMET®

COMPR. FILM.
LAB. GUIDOTTI SPA

2,5mg/400mg

2,5mg/400mg

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN UM)
GLIFORMIN

COMPR. FILM.
LABORMED PHARMA SA

400mg + 2.5mg

400mg + 2.5mg

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN UM)
BIDIAB

CAPS.
ARENA GROUP SA

400mg+2.5mg

400mg+2.5mg

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN UM)
GLUCOVANCE® 500 mg/2,5 mg

COMPR. FILM.
MERCK SANTE

500mg/2.5mg

500mg/2.5mg

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN UM)

COMPR. FILM.

500mg/5mg

112 / 153

DCI/DENUMIRE COMERCIALA
GLUCOVANCE® 500 mg/5 mg

CONCENTRATIE
500mg/5mg

FORMA FARM.

FIRMA
MERCK SANTE

PROTOCOL

809

A10BD03

COMBINATII(ROSIGLITAZONUM+METFORMINUM) ***
COMPR. FILM.
SMITHKLINE BEECHAM PLC

Protocol: A026E
1mg/500mg

A10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN UM)
AVANDAMET 1mg/500mg

1mg/500mg

A10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN UM)
AVANDAMET 2mg/1000mg

COMPR. FILM.
SMITHKLINE BEECHAM PLC

2mg/1000mg

2mg/1000mg

A10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN UM)
AVANDAMET 2mg/500mg

COMPR. FILM.
SMITHKLINE BEECHAM PLC

2mg/500mg

2mg/500mg

A10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN UM)
AVANDAMET 4mg/1000mg

COMPR. FILM.
SMITHKLINE BEECHAM PLC

4mg/1000mg

4mg/1000mg

810

A10BD04

COMBINATII (ROSIGLITAZONUM + GLIMEPIRIDUM) ***
COMPR. FILM.
4mg/4mg SMITHKLINE BEECHAM PLC

Protocol: A027E
4mg/4mg

A10BD04 COMBINATII (ROSIGLITAZONUM + GLIMEPIRIDUM)
AVAGLIM 4mg/4mg

A10BD04 COMBINATII (ROSIGLITAZONUM + GLIMEPIRIDUM)
AVAGLIM 8mg/4mg 8mg/4mg

COMPR. FILM.
SMITHKLINE BEECHAM PLC

8mg/4mg

811

A10BD05

COMBINATII (PIOGLITAZONUM + METFORMINUM) ***
COMPR. FILM.
15mg/850mg

Protocol: A025E
15mg/850mg

A10BD05 COMBINATII (PIOGLITAZONUM + METFORMINUM)
COMPETACT

TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

812
A10BF01 A10BF01
GLUCOBAY® 100

A10BF01
ACARBOSUM

ACARBOSUM
COMPR.
100mg BAYER HEALTHCARE AG

100mg 50mg
BAYER HEALTHCARE AG

ACARBOSUM
50mg

COMPR.

GLUCOBAY® 50

813
AVANDIA 4mg

A10BG02

ROSIGLITAZONUM ***
COMPR. FILM.
4mg SMITHKLINE BEECHAM PLC

Protocol: A020E
4mg

A10BG02 ROSIGLITAZONUM

814
ACTOS 15mg

A10BG03

PIOGLITAZONUM ***
COMPR.
15mg

Protocol: A020E
15mg
TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

A10BG03 PIOGLITAZONUM A10BG03 PIOGLITAZONUM
ACTOS 30mg 30mg

COMPR. COMPR.
45mg

30mg
TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

A10BG03 PIOGLITAZONUM
ACTOS 45mg

45mg
TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

815
JANUVIA 100mg

A10BH01

SITAGLIPTINUM ***
COMPR. FILM.
100mg MERCK SHARP & DOHME LTD.

Protocol: A022E
100mg

A10BH01 SITAGLIPTINUM

816
NOVONORM 0,5 mg

A10BX02

REPAGLINIDUM
COMPR.
0.5mg NOVO NORDISK A/S

A10BX02 REPAGLINIDUM A10BX02 REPAGLINIDUM
NOVONORM 1 mg 1mg

0.5mg 1mg
NOVO NORDISK A/S

COMPR. COMPR.
2mg NOVO NORDISK A/S

A10BX02 REPAGLINIDUM
NOVONORM 2 mg

2mg

817
BYETTA 10µg/doza

A10BX04

EXENATIDUM ***
SOL. INJ. IN STILOU INJECTOR PREUMPLUT
10µg/doza 5µg/doza ELI LILLY NEDERLAND BV

Protocol: A028E
10µg/doza 5µg/doza

A10BX04 EXENATIDUM A10BX04 EXENATIDUM
BYETTA 5µg/doza

SOL. INJ. IN STILOU INJECTOR PREUMPLUT
ELI LILLY NEDERLAND BV

818
BENFOGAMMA

A11DA03

BENFOTIAMINUM
DRAJ.
50mg WORWAG PHARMA GMBH & CO. KG

A11DA03 BENFOTIAMINUM

50mg

819
MILGAMMA® N

A11DBN1

COMBINATII **
CAPS. MOI
WORWAG PHARMA GMBH & CO. KG

A11DBN1 COMBINATII A11DBN1 COMBINATII
MILGAMMA® N

SOL. INJ.
WORWAG PHARMA GMBH & CO. KG

820

H04AA01

GLUCAGONUM
PULB. + SOLV. PT. SOL. INJ.
1mg NOVO NORDISK A/S

H04AA01 GLUCAGONUM
GLUCAGEN HYPOKIT 1 mg

1mg

113 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.1: HEMOFILIE SI TALASEMIE 827 V03AC01 DEFEROXAMINUM **(3) Protocol: V001D
V03AC01 DEFEROXAMINUM
DESFERAL 500mg

LIOF. PT. SOL. INJ./PERF.
NOVARTIS PHARMA GMBH

500mg

828
EXJADE 125mg

V03AC03

DEFERASIROXUM ****
COMPR. DISP.
125mg NOVARTIS EUROPHARM LTD.

Protocol: V002D
125mg 250mg
NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM V03AC03 DEFERASIROXUM
EXJADE 250mg 250mg

COMPR. DISP. COMPR. DISP.
500mg NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM
EXJADE 500mg

500mg

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.2: EPIDERMOLIZA BULOASA 830 D06AA04 TETRACYCLINUM
D06AA04 TETRACYCLINUM
TETRACICLINA CLORHIDRAT 3%

UNGUENT
ANTIBIOTICE SA

3,00%

831
FUCIDIN®

D06AX01

ACIDUM FUSIDICUM
CREMA
2% LEO PHARMACEUTICAL PRODUCTS

D06AX01 ACIDUM FUSIDICUM D06AX01 ACIDUM FUSIDICUM
FUCIDIN® 2%

2,00% 2,00%
LEO PHARMACEUTICAL PRODUCTS

UNGUENT

832
DERMAZIN® 1%

D06BA01

SULFADIAZINUM
CREMA
1% LEK PHARMACEUTICALS D.D.

D06BA01 SULFADIAZINUM

1,00%

833

D07CA01

COMBINATII (ACIDUM FUSIDICUM + HYDROCORTISONUM)
CREMA
LEO PHARMACEUTICAL PRODUCTS

Protocol: D001L

D07CA01 COMBINATII (ACIDUM FUSIDICUM + HYDROCORTISONUM)
FUCIDIN® H

834
BELOGENT DIPROGENTA® TRIDERM®

D07CC01

COMBINATII
CREMA
A & G MED TRADING S.R.L. SCHERING PLOUGH EUROPE SCHERING PLOUGH EUROPE

Protocol: D001L

D07CC01 COMBINATII

D07CC01 COMBINATII
BELOGENT DIPROGENTA® TRIDERM

UNGUENT
A & G MED TRADING S.R.L. SCHERING PLOUGH EUROPE SCHERING PLOUGH EUROPE

836
J01AA07

J01AA07
TETRACYCLINUM

TETRACYCLINUM
CAPS.
250mg 250mg EUROPHARM SA SANDOZ SRL

250mg

TETRACICLINA 250 mg TETRACICLINA SANDOZ 250 mg

838
FENITOIN 100 mg

N03AB02

PHENYTOINUM
COMPR.
100mg GEDEON RICHTER ROMANIA SA

N03AB02 PHENYTOINUM N03AB02 PHENYTOINUM
PHENHYDAN®SOLUTIE INJECTABILA 50mg/ml

100mg 50mg/ml
DESITIN

SOL. INJ.

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.3: HIPERTENSIUNEA PULMONARA 839 C02KX01 BOSENTANUM **
C02KX01 BOSENTANUM
TRACLEER 125 mg 125mg

Protocol: CI01I

COMPR. FILM.
ACTELION REGISTRATION LTD.

125mg

Bosentanum este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitată timp de trei luni după întreruperea tratamentului.

840
REVATIO 20 mg

G04BE03

SILDENAFILUM **
COMPR. FILM.
20mg PFIZER LTD.

Protocol: CI01I
20mg

G04BE03 SILDENAFILUM

114 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.4: MUCOVISCIDOZA 841 J01FA09 CLARITHROMYCINUM
J01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml KRKA D.D. TERAPIA S.A. ABBOTT SPA SANDOZ S.R.L.

125mg/5ml

FROMILID® 125 mg/5 ml KLABAX 125 mg/5 ml KLACID® LEKOKLAR 125 mg/5 ml

J01FA09

CLARITHROMYCINUM
250mg 250mg 250mg 250mg 250mg 250mg 250mg

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT SPA MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

250mg

CLAR 250 CLARITROMICINA 250 mg FROMILID 250 KLABAX 250 mg KLACID® KLERIMED® 250 LEKOKLAR® 250 mg

J01FA09

CLARITHROMYCINUM

GRAN. PT. SUSP. ORALA
250mg/5ml 250mg/5ml TERAPIA S.A. SANDOZ SRL

250mg/5ml

KLABAX 250 mg/5 ml LEKOKLAR 250 mg/5 ml

J01FA09

CLARITHROMYCINUM
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

500mg

CLAR 500 CLARITROMICINA 500 mg FROMILID 500 KLABAX 500 mg KLERIMED® 500 LEKOKLAR® 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. MODIF.
TERAPIA S.A. LEK PHARMACEUTICALS D.D.

500mg

KLABAX MR 500 mg LEKOKLAR XL 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. PREL.
KRKA D.D. ABBOTT LABORATORIES LTD.

500mg

FROMILID® UNO KLACID SR

J01FA09
KLACID I.V.

CLARITHROMYCINUM

LIOF. PT. SOL. PERF.
ABBOTT LABORATORIES LTD.

500mg

842
J01GB01
TOBI®

J01GB01
TOBRAMYCINUM

TOBRAMYCINUM **
SOL. INHAL.
300mg/5ml NOVARTIS PHARMA GMBH

300mg/5ml

Prescriere limitata:

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic.

843
PULMOZYME

R05CB13

DORNAZA ALFA **
SOL. INHAL.
1mg/ml ROCHE ROMANIA S.R.L.

R05CB13 DORNAZA ALFA

1mg/ml

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.5: BOLI NEUROLOGICE DEGENERATIVE / INFLAMATORII (POLIRADICULONEVRITA PRIMITIVA, POLINEUROPATIE INFLAMATORIE CRONICA DEMIELINIZANTA, SCLEROZA LATERALA AMIOTROFICA) SI MIASTENIA GRAVIS 844 N07XX02 RILUZOLUM **
N07XX02 RILUZOLUM
RILUTEK 50 mg 50mg

Protocol: N024G

COMPR. FILM.
AVENTIS PHARMA SA

50mg

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.6: OSTEOGENEZA IMPERFECTA 846 M05BA03 ACIDUM PAMIDRONICUM
M05BA03 ACIDUM PAMIDRONICUM
AREDIA® 15 mg 15mg 15mg/ml 30mg 60mg

Protocol: M002Q

LIOF.+ SOLV. PT. SOL. PERF.
NOVARTIS PHARMA GMBH

15mg 15mg/ml 30mg 60mg

M05BA03 ACIDUM PAMIDRONICUM
PAMIDRONAT TORREX

CONC. PT. SOL. PERF.
TORREX CHIESI PHARMA GMBH

M05BA03 ACIDUM PAMIDRONICUM
PAMIRED 30

LIOF. PT. SOL. PERF. I.V.
DR. REDDY'S LABORATORIES

M05BA03 ACIDUM PAMIDRONICUM
PAMIRED 60

LIOF. PT. SOL. PERF. I.V.
DR. REDDY'S LABORATORIES

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.7: SINDROM PRADER WILLI 847 H01AC01 SOMATROPINUM ** Protocol: H011Q
H01AC01 SOMATROPINUM
NORDITROPIN SIMPLEX x 10mg/1,5ml

SOL. INJ.
10mg/1.5ml NOVO NORDISK A/S

10mg/1.5ml 10mg/2ml
IPSEN LIMITED

H01AC01 SOMATROPINUM
NUTROPINAq 10 mg/2 ml 10mg/2ml

SOL. INJ. SOL. INJ.
3,3mg/ml 4mg (12ui) 5.3mg/ml (16ui) SANDOZ GMBH

H01AC01 SOMATROPINUM
OMNITROPE 3,3mg/ml

3,3mg/ml 4mg (12ui) 5.3mg/ml (16ui) 5mg/1.5ml
NOVO NORDISK A/S

H01AC01 SOMATROPINUM
ZOMACTON

LIOF. + SOLV. PT. SOL. INJ.
FERING GMBH PFIZER EUROPE MA EEIG

H01AC01 SOMATROPINUM
GENOTROPIN® 16 ui (5,3 mg)

PULB. + SOLV. PT. SOL. INJ. SOL. INJ.
5mg/1.5ml

H01AC01 SOMATROPINUM
NORDITROPIN SIMPLEXx 5 mg/1,5 ml

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.8: BOALA FABRY 848 A16AB04 AGALSIDASUM BETA **
A16AB04 AGALSIDASUM BETA
FABRAZYME 35 mg 35mg

Protocol: A014E

PULB. PT. CONC. PT. SOL. PERF.
GENZYME EUROPE BV

35mg

115 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.9: BOALA POMPE 849 A16AB07 ALGLUCOSIDASUM ALPHA **
A16AB07 ALGLUCOSIDASUM ALPHA
MYOZYME 50mg 50mg

Protocol: A030Q

PULB. PT. CONC. PT. SOL. PERF.
GENZYME EUROPE B.V.

50mg

116 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P7: PROGRAMUL NATIONAL DE BOLI ENDOCRINE. TRATAMENTUL MEDICAMENTOS AL BOLNAVILOR CU OSTEOPOROZA, GUSA DATORATA CARENTEI DE IOD SI PROLIFERARII MALIGNE 850 A11CC02 DIHYDROTACHYSTEROLUM
A11CC02 DIHYDROTACHYSTEROLUM
TACHYSTIN 0.1mg/ml 1mg/ml

PICATURI ORALE-SOL.
CHAUVIN ANKERPHARM GMBH

0.1mg/ml 1mg/ml

A11CC02 DIHYDROTACHYSTEROLUM
A.T. 10®

PICATURI ORALE-SOL.
MERCK KGAA

851
ALPHA D3 0,25 µg

A11CC03

ALFACALCIDOLUM
CAPS. MOI
0.25µg TEVA PHARMACEUTICALS SRL

A11CC03 ALFACALCIDOLUM A11CC03 ALFACALCIDOLUM
ALPHA D3 0.50 µg 0.50µg

0.25µg 0.50µg
TEVA PHARMACEUTICALS S.R.L.

CAPS. MOI

852
ROCALTROL

A11CC04

CALCITRIOLUM
CAPS. MOI
0.25µg ROCHE ROMANIA S.R.L.

A11CC04 CALCITRIOLUM

0.25µg

853

G03CA03
Prescriere limitata:

ESTRADIOLUM

Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. Aceasta limitare este valabila doar pentru formele farmaceutice Sistem terapeutic transdermic si plasture transdermic. NOTA: Estradiol trebuie folosit împreuna cu un progestativ oral la femeile nehisterectomizate. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

G03CA03 ESTRADIOLUM
OESTROGEL® 0.06%

GEL
LAB. BESINS INTERNATIONAL

0.06% 0.1%
LAB. THERAMEX

G03CA03 ESTRADIOLUM
ESTREVA® 0.1%

GEL COMPR. FILM.
1mg NOVO NORDISK A/S

G03CA03 ESTRADIOLUM
ESTROFEM 1 mg

1mg 25µg
NOVO NORDISK A/S

G03CA03 ESTRADIOLUM
VAGIFEM 25µg

COMPR. VAG. IMPLANT
25mg 50µg/24ore ORGANON NV

G03CA03 ESTRADIOLUM
RISELLE 25 mg

25mg 50µg/24ore

G03CA03 ESTRADIOLUM
CLIMARA

PLASTURE TRANSDERM.
SCHERING AG

854
LADYBON

G03DC05

TIBOLONUM
COMPR.
2,5mg ZENTIVA A.S.

Protocol: G007N
2,5mg 2.5mg
ORGANON NV

G03DC05 TIBOLONUM G03DC05 TIBOLONUM
LIVIAL® 2,5 mg 2.5mg

COMPR.

855
KLIMODIEN

G03FA15

ESTRADIOLUMVALERAT+DIENOGEST
DRAJ.
SCHERING AG

Protocol: G002N

G03FA15 ESTRADIOLUMVALERAT+DIENOGEST

856

G03XC01

RALOXIFENUM

Cod restrictie 2647: Monoterapie cu medicamente antiresorbtive pentru tratamentul osteoporozei sexoidoprive la femeile pana la varsta de 60 ani, cu scor T</= -2,5, masurat DEXA (coloana vertebrala sau sold).

G03XC01 RALOXIFENUM
EVISTA 60mg 60mg

COMPR. FILM.
ELI LILLY NEDERLAND BV

60mg

857

H01AB01
Prescriere limitata:

TIREOTROPINUM ALFA
PULB. PT. SOL. INJ.
0.9mg GENZYME EUROPE BV

Anterior administrarii iodului radioactiv pentru tratamentul carcinomului tiroidian diferentiat posttiroidectomie totala.

H01AB01 TIREOTROPINUM ALFA
THYROGEN 0,9 mg

0.9mg

858
LEMOD SOLU 125 mg

H02AB04

METHYLPREDNISOLONUM
LIOF. PT. SOL. INJ.
125mg 125mg/2ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

125mg 125mg/2ml 16mg
PFIZER EUROPE MA EEIG

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg

COMPR. LIOF. PT. SOL. INJ.
20mg 250mg/4ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg

20mg 250mg/4ml 32mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg

COMPR. LIOF. PT. SOL. INJ.
40mg 40mg/1ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg

40mg 40mg/1ml 4mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg 4mg

COMPR. LIOF. PT. SOL. INJ.
500mg 500mg/7.8ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg

500mg 500mg/7.8ml

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.
PFIZER EUROPE MA EEIG

859

H03AA01

LEVOTHYROXINUM
COMPR.
100µg 100µg MERCK KGAA BERLIN CHEMIE AG MENARINI GROUP

H03AA01 LEVOTHYROXINUM
EUTHYROX® 100 L-THYROXIN 100 BERLIN - CHEMIE

100µg

H03AA01 LEVOTHYROXINUM

COMPR.

200µg

117 / 153

DCI/DENUMIRE COMERCIALA
EUTHYROX® 200

CONCENTRATIE
200µg

FORMA FARM.

FIRMA
MERCK KGAA

PROTOCOL

H03AA01 LEVOTHYROXINUM
EUTHYROX® 25 25µg

COMPR.
MERCK KGAA

25µg 50µg
MERCK KGAA BERLIN CHEMIE AG MENARINI GROUP

H03AA01 LEVOTHYROXINUM
EUTHYROX® 50 L-THYROXIN 50 50µg 50µg

COMPR.

860

H03AAN1

LEVOTHYROXINUM+KALII IODIDUM
COMPR.
MERCK KGAA

H03AAN1 LEVOTHYROXINUM+KALII IODIDUM
JODTHYROX® 100/130,8

861
THYROZOL® 10 mg

H03BB02

THIAMAZOLUM
COMPR. FILM.
10mg MERCK KGAA

H03BB02 THIAMAZOLUM H03BB02 THIAMAZOLUM
THYROZOL® 20 mg 20mg

10mg 20mg
MERCK KGAA

COMPR. FILM. COMPR. FILM.
5mg MERCK KGAA

H03BB02 THIAMAZOLUM
THYROZOL® 5 mg

5mg

862
JODID 100

H03CA01

KALII IODIDUM
COMPR.
100µg MERCK KGAA

H03CA01 KALII IODIDUM H03CA01 KALII IODIDUM
JODID 200 200µg

100µg 200µg
MERCK KGAA

COMPR.

863
FORSTEO 20µg/80µg

H05AA02

TERIPARATIDUM **
SOL. INJ.
20µg/80µg ELI LILLY NEDERLAND BV

Protocol: M003M
20µg/80µg

H05AA02 TERIPARATIDUM

864
TONOCALCIN 100 UI

H05BA01

CALCITONINUM (SOMON)
SOL. INJ.
100UI ALFA WASSERMANN SPA

H05BA01 CALCITONINUM (SOMON) H05BA01 CALCITONINUM (SOMON)
NYLEX 100 UI/doza

100UI 100ui/doza
PHARMACEUTICAL IND. PROEL EPAM. G.CORONIS SA

SPRAY NAZ.,SOL.
100UI/doza

H05BA01 CALCITONINUM (SOMON)
NYLEX® 100UI/ml

SOL. INJ.
PROEL E.P. CORONIS SA

100UI/ml 200UI/doza

H05BA01 CALCITONINUM (SOMON)
MIACALCIC® NASAL 200 NYLEX®

SPRAY NAZAL - SOL.
200ui/doza 200UI/doza NOVARTIS PHARMA GMBH PROEL E.P. CORONIS SA

H05BA01 CALCITONINUM (SOMON)
MIACALCIC® 50ui/ml

SOL. INJ.
NOVARTIS PHARMA GMBH

50ui/ml

865
FOSAMAX 10 mg

M05BA04

ACIDUM ALENDRONICUM **
COMPR.
10mg MERCK SHARP & DOHME S.R.L.

Protocol: M003M
10mg 70 mg
TEVA PHARMACEUTICALS SRL

M05BA04 ACIDUM ALENDRONICUM M05BA04 ACIDUM ALENDRONICUM
TEVA NAT 70 mg

COMPR. COMPR.
70mg MERCK SHARP & DOHME S.R.L.

M05BA04 ACIDUM ALENDRONICUM
FOSAMAX 70 mg

70mg

866
BONVIVA 3mg/3ml

M05BA06

ACIDUM IBANDRONICUM **
SOL. INJ. IN SERINGA PREUMPLUTA
3mg/3ml 6mg/6ml ROCHE REGISTRATION LTD

Protocol: M003M
3mg/3ml

M05BA06 ACIDUM IBANDRONICUM M05BA06 ACIDUM IBANDRONICUM
BONDRONAT 6 mg/6 ml

CONC. PT. SOL. PERF.
ROCHE REGISTRATION L

M05BA06 ACIDUM IBANDRONICUM
BONDRONAT 50 mg 50mg

COMPR. FILM.
ROCHE REGISTRATION L

M05BA06 ACIDUM IBANDRONICUM
BONDRONAT 50 mg 50mg

COMPR. FILM.
ROCHE REGISTRATION L

867

M05BA07

ACIDUM RISEDRONICUM **
COMPR. FILM.
35mg 35mg AVENTIS PHARMA AB ZENTIVA A.S.

Protocol: M003M
35mg

M05BA07 ACIDUM RISEDRONICUM
ACTONEL® SAPTAMANAL RISENDROS 35 mg

868

M05BB03

COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM) **
COMPR.
70mg/2800UI MERCK SHARP & DOHME LTD.

Protocol: M003M
70mg/2800UI

M05BB03 COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM)
FOSAVANCE 70mg/2800UI

869
OSSEOR 2 g

M05BX03

STRONTIUM RANELATUM
GRAN. PT. SUSP. ORALA
2g LES LAB. SERVIER

M05BX03 STRONTIUM RANELATUM

2g

872
ACLASTA 5mg/100ml

M05BA08

ACIDUM ZOLEDRONICUM **
SOL. PERF.
5mg/100ml 4mg NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM L

Protocol: M001M
5mg/100ml

M05BA08 ACIDUM ZOLEDRONICUM M05BA08 ACIDUM ZOLEDRONICUM
ZOMETA 4 mg

PULB. + SOLV. SOL. PERF.

1218
CARBIMAZOLE 5

H03BB01

CARBIMAZOLUM
COMPR. FILM.
5mg REMEDICA LTD.

H03BB01 CARBIMAZOLUM

5mg

118 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.1: TRANSPLANT MEDULAR 873 A04AA01 ONDANSETRONUM **
A04AA01 ONDANSETRONUM
OSETRON 4 mg OSETRON 8 mg 2mg/ml 2mg/ml

SOL. INJ.
DR. REDDY'S LABORATO DR. REDDY'S LABORATORIES

A04AA01 ONDANSETRONUM
EMESET 4 mg/2 ml EMESET 8 mg/4 ml 2mg/ml 2mg/ml

SOL. INJ./PERF.
CIPLA (UK) LIMITED CIPLA (UK) LIMITED

2mg/ml

A04AA01 ONDANSETRONUM
ONDANSETRON TEVA 4mg ONDANTOR 4 mg OSETRON 4 mg SETRONON 4 mg ZOFRAN 4 mg 4mg 4mg 4mg 4mg 4mg 4mg

COMPR. FILM.
TEVA PHARMACEUTICALS SRL SANDOZ SRL DR. REDDY'S LABORATORIES PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

4mg

A04AA01 ONDANSETRONUM
ONDARAN MD 4mg

COMPR. ORODISPERSABILE
RANBAXY UK LTD.

4mg 4mg/2ml

A04AA01 ONDANSETRONUM
ZOFRAN 4mg/2ml 4mg/2ml

SOL. INJ.
GLAXO WELLCOME UK LIMITED

A04AA01 ONDANSETRONUM
SETRONON 4 mg/2 ml 4mg/2ml

SOL. INJ./PERF.
PLIVA LJUBLJANA D.O.O.

4mg/2ml 8mg
TEVA PHARMACEUTICALS SRL SANDOZ SRL DR. REDDY'S LABORATORIES (UK) LTD PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

A04AA01 ONDANSETRONUM
ONDANSETRON TEVA 8 mg ONDANTOR 8 mg OSETRON 8 mg SETRONON 8 mg ZOFRAN 8 mg 8mg 8mg 8mg 8mg 8mg 8mg

COMPR. FILM.

A04AA01 ONDANSETRONUM
ONDARAN MD 8 mg

COMPR. ORODISPERSABILE
RANBAXY UK LIMITED

8mg 8mg/4ml

A04AA01 ONDANSETRONUM
ZOFRAN 8mg/4ml 8mg/4ml

SOL. INJ.
GLAXO WELLCOME UK LIMITED

A04AA01 ONDANSETRONUM
SETRONON 8 mg/4 ml 8mg/4 ml

SOL. INJ./PERF.
PLIVA LJUBLJANA D.O.O.

8mg/4 ml

874

A05AA02

ACIDUM URSODEOXYCHOLICUM

NOTA: Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOFALK® URSOSAN 250mg 250mg

CAPS.
DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

875

B01AB08

REVIPARINUM
SOL. INJ.
1432ui/0.25ml ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 1432UI/0,25 ml

1432ui/0.25ml 3436ui/0.6ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml

878
EPREX® 10000 UI

B03XA01

EPOETINUM ALFA
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA
EPOKINE 1000 UI/0,5 ml EPREX® 1000 UI

10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOPHAR 2000 U.I. 2000UI

SOL. INJ.
GULF PHARMACEUTICAL IND. S.R.L.

2000UI 2000ui/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/0,5 ml EPREX® 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPREX® 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA
EPREX® 40 000 UI 40 000UI

SOL. INJ.
JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA
EPOPHAR 4000 U.I. 4000UI

SOL. INJ. SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/0,4 ml EPREX® 4000 UI

4000ui/0.4ml

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 1000UI/0,5ml 2000UI/1,0ml 3000UI/0,3ml 4000UI/0,4ml RENAMED FARMA S.R.L. SANDOZ GMBH SANDOZ GMBH SANDOZ GMBH SANDOZ GMBH

4000UI/1ml

B03XA01 EPOETINUM ALFA
BINOCRIT

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA
BINOCRIT

B03XA01 EPOETINUM ALFA
BINOCRIT

B03XA01 EPOETINUM ALFA
BINOCRIT

879

B03XA01

EPOETINUM BETA
SOL. INJ. IN SERINGA PREUMPLUTA
10000UI/0,6ml ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA
NEORECORMON 10000 UI

B03XA01 EPOETINUM BETA

SOL. INJ. IN SERINGA PREUMPLUTA

119 / 153

DCI/DENUMIRE COMERCIALA
NEORECORMON 1000 UI

CONCENTRATIE
1000UI/0,3ml 2000UI/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml

FORMA FARM.

FIRMA
ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L

PROTOCOL

B03XA01 EPOETINUM BETA
NEORECORMON 2000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 4000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 5000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 500 UI

880
J01CR03
TIMENTIN 3,2 g

J01CR03

TICARCILLINUM + ACIDUM CLAVULANICUM
PULB. PT. SOL. INJ./PERF.
3.2g BEECHAM GROUP PLC

TICARCILLINUM + ACIDUM CLAVULANICUM

3.2g

881
J01CR05
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

PIPERACILLINUM + TAZOBACTAMUM

882
J01DH02 J01DH02
MERONEM IV 1 g

J01DH02
MEROPENEMUM

MEROPENEMUM
PULB. PT. SOL. INJ. I.V./PERF.
1g 500mg ASTRAZENECA UK LTD.

1g 500mg

MEROPENEMUM

PULB. PT. SOL. INJ. I.V./PERF.
ASTRAZENECA UK LTD.

MERONEM IV 500 mg

883
J01DH51
TIENAM I.V.

J01DH51
IMIPENEMUM + CILASTATINUM

IMIPENEMUM + CILASTATINUM
PULB. PT. SOL. PERF.
MERCK SHARP & DOHME ROMANIA S.R.L.

884
J01XA01 J01XA01
EDICIN VANCOMYCIN TEVA

J01XA01
VANCOMYCINUM

VANCOMYCINUM
LIOF. PT. SOL. PERF.
1g 1g

1g 1g 500mg 500mg

TEVA PHARM. WORKS PRIVATE LTD. COMPANY

VANCOMYCINUM VANCOMYCINUM
500mg 500mg

PULB.LIOF.PT.SOL.PERF./INJ
LEK PHARMACEUTICALS D.D.

J01XA01 J01XA01
EDICIN

LIOF. PT. SOL. PERF. LIOF. PT. SOL. PERF./INJ.
LEK PHARMACEUTICALS D.D.

VANCOMYCIN TEVA

TEVA PHARM. WORKS PRIVATE LTD. COMPANY

VANCOMYCINUM

885
J01XA02
TARGOCID® 400 mg

J01XA02
TEICOPLANINUM

TEICOPLANINUM
LIOF. + SOLV. PT. SOL. INJ.
400mg AVENTIS PHARMA LTD.

400mg

887
J01XX08
ZYVOXID®

J01XX08
LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID®

SOL. PERF.
2mg/ml PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID®

LINEZOLIDUM
600mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

600mg

888

J02AC01
Prescriere limitata:

FLUCONAZOLUM

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie. Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina. Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Tratamentul candidozei orofaringiene la pacienti cu imunosupresie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC01

FLUCONAZOLUM
100mg 100mg 100mg 100mg 100mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

100mg

DIFLAZON 100 mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

J02AC01

FLUCONAZOLUM
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG OZONE LABORATORIES LTD. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL ZENTIVA AS GEDEON RICHTER PLC.

150mg

DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ® 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCORIC 150 mg FLUCOVIM 150 MYCOMAX 150 MYCOSYST® 150 mg

J02AC01

FLUCONAZOLUM
200mg 200mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL

200mg

DIFLAZON 200 mg FLUCONAZOLE TEVA 200 mg

J02AC01

FLUCONAZOLUM
2mg/ml 2mg/ml 2mg/ml

SOL. PERF.
KRKA D.D. PFIZER EUROPE MA EEIG ZENTIVA AS

2mg/ml

DIFLAZON® DIFLUCAN® MYCOMAX® INF

J02AC01

FLUCONAZOLUM
50mg 50mg 50mg 50mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA MEDOCHEMIE ROMANIA SRL

50mg

DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL MEDOCHEMIE 50 mg

120 / 153

DCI/DENUMIRE COMERCIALA
FLUCONAZOL SANDOZ® 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg

CONCENTRATIE
50mg 50mg 50mg 50mg 50mg 50mg 50mg/5ml

FORMA FARM.

FIRMA
SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

PROTOCOL

J02AC01

FLUCONAZOLUM

PULB. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

50mg/5ml

DIFLUCAN® 50 mg/5 ml

889
J02AC03
VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM **
COMPR. FILM.
200mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg
PFIZER LTD.

J02AC03
VFEND 200mg

VORICONAZOLUM
200mg

PULB. PT. SOL. PERF.
PFIZER LTD.

J02AC03 J02AC03
VFEND 50mg

VORICONAZOLUM
40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LTD.

VFEND 40 mg/ml

VORICONAZOLUM
50mg

COMPR. FILM.

890

J02AC04
Prescriere limitata:

POSACONAZOLUM **

Profilaxia si tratamentul infectiilor fungice invazive la pacientii aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care prezinta risc inalt de a dezvolta infectii fungice masive. Profilaxia si tratamentul infectiilor fungice invazive la pacientii in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de a dezvolta infectii fungice masive.

J02AC04

POSACONAZOLUM
40mg/ml

SUSP. ORALA
SP EUROPE

40mg/ml

NOXAFIL SP 40mg/ml

891
J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 70mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 70mg

CASPOFUNGINUM

PULB. PT. CONC. PT. SOL. PERF.
MERCK SHARP & DOHME LTD

CANCIDAS 70 mg

893
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg ARENA GROUP SA EUROPHARM SA

200mg

J05AB01

ACICLOVIRUM
200mg 200mg 200mg

COMPR.
TERAPIA SA ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg CLOVIRAL 200 mg ZOVIRAX

J05AB01

ACICLOVIRUM
200mg 200mg 250mg

COMPR. DISP.
OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM
400mg

PULB. PT. SOL. INJ./PERF.
KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01 J05AB01 J05AB01
ACIKLOVIR

CAPS.
ARENA GROUP S.A.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR.
EGIS PHARMACEUTICALS P.L.C.

400mg 400mg
A & G MED TRADING S.R.L.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR. FILM.

894
J05AB11
VALTREX 500 mg

J05AB11
VALACYCLOVIRUM

VALACYCLOVIRUM
COMPR. FILM.
500mg THE WELLCOME FOUNDATION LTD.

500mg

895
J05AB14

J05AB14
Prescriere limitata:

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

VALGANCICLOVIRUM

450mg

VALCYTE® 450 mg

897
L01AA01 L01AA01 L01AA01 L01AA01
ENDOXAN® 1 g

L01AA01
CYCLOPHOSPHAMIDUM

CYCLOPHOSPHAMIDUM
PULB. PT. SOL. INJ./PERF.
1g 200mg 500mg BAXTER ONCOLOGY GMBH

1g 200mg 500mg 50mg

CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM
50mg

PULB. PT. SOL. PERF./INJ. I.V.
ACTAVIS S.R.L.

ENDOXAN 200 mg ENDOXAN® 500 mg ENDOXAN® 50 mg

PULB. PT. SOL. INJ./PERF.
BAXTER ONCOLOGY GMBH

DRAJ.
BAXTER ONCOLOGY GMBH

898
L01AA03
ALKERAN 2 mg

L01AA03
MELPHALANUM

MELPHALANUM
COMPR. FILM.
2mg THE WELLCOME FOUNDATION LTD.

2mg

899
L01AA06
HOLOXAN 1 g

L01AA06
IFOSFAMIDUM

IFOSFAMIDUM
PULB. PT. SOL. PERF.
1g BAXTER ONCOLOGY GMBH

1g 2g 500mg

L01AA06
HOLOXAN 2 g

IFOSFAMIDUM
2g

PULB. PT. SOL. PERF.
BAXTER ONCOLOGY GMBH

L01AA06

IFOSFAMIDUM
500mg

PULB. PT. SOL. PERF.
BAXTER ONCOLOGY GMBH

HOLOXAN 500 mg

900
L01AB01
MYLERAN

L01AB01
BUSULFANUM

BUSULFANUM
COMPR. FILM.
2mg THE WELLCOME FOUNDATION LTD.

2mg

901
L01BA01

L01BA01
METHOTREXATUM

METHOTREXATUM
CONC. PT. SOL. INJ./PERF. 100mg/ml

121 / 153

DCI/DENUMIRE COMERCIALA
METHOTREXAT "EBEWE" 1000 mg METHOTREXAT "EBEWE" 500 mg METHOTREXAT "EBEWE" 5000 mg

CONCENTRATIE
100mg/ml 100mg/ml 100mg/ml

FORMA FARM.

FIRMA
EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

PROTOCOL

L01BA01 L01BA01 L01BA01

METHOTREXATUM
10mg/ml 50mg

SOL. INJ./PERF.
EBEWE PHARMA GMBH NFG. KG

10mg/ml 50mg 5mg/ml
EBEWE PHARMA GMBH NFG. KG

METHOTREXAT "EBEWE" 50 mg

METHOTREXATUM METHOTREXATUM
5mg/ml

PULB. PT. SOL. INJ./PERF.
SINDAN SRL

ANTIFOLAN® 50 mg METHOTREXAT "EBEWE" 5 mg

SOL. INJ.

902
L01BB05 L01BB05
FLUDARA FLUDARA® ORAL

L01BB05
FLUDARABINUM

FLUDARABINUM
COMPR. FILM.
10mg 50mg SCHERING AG

10mg 50mg

FLUDARABINUM

LIOF. PT. SOL. INJ./PERF.
SCHERING AG

903
L01CB01
VEPESID

L01CB01
ETOPOSIDUM

ETOPOSIDUM
CAPS. MOI
100mg BRISTOL MYERS SQUIBB KFT

100mg 100mg/5ml

L01CB01

ETOPOSIDUM

CONC. PT. SOL. PERF.
100mg/5ml 100mg/5ml 20mg/ml EBEWE PHARMA GMBH NFG. KG ACTAVIS S.R.L.

ETOPOSID "EBEWE" 100 mg/5 ml SINTOPOZID 100 mg/5 ml

L01CB01 L01CB01
VEPESID

ETOPOSIDUM ETOPOSIDUM
50mg

CONC. PT. SOL. PERF.
TEVA PHARMACEUTICALS S.R.L.

20mg/ml 50mg

ETOPOSIDE - TEVA

CAPS. MOI
BRISTOL MYERS SQUIBB KFT

904
L01DB06
ZAVEDOS

L01DB06
IDARUBICINUM

IDARUBICINUM
CAPS.
10mg PFIZER EUROPE MA EEIG

10mg 5mg
PFIZER EUROPE MA EEIG

L01DB06

IDARUBICINUM
5mg

LIOF. PT. SOL. INJ.

ZAVEDOS 5 mg

905
L01DB07 L01DB07 L01DB07
ONKOTRONE

L01DB07
MITOXANTRONUM

MITOXANTRONUM **
CONC. PT. SOL. PERF.
2 mg/ml TEVA PHARMACEUTICALS SRL

2 mg/ml 20mg/10ml

MITOXANTRONE TEVA 2 mg/ml

MITOXANTRONUM MITOXANTRONUM
2mg/ml

SOL. PERF.
20mg/10ml WYETH LEDERLE PHARMA GMBH

NOVANTRONE

CONC. PT. SOL. INJ.
BAXTER ONCOLOGY GMBH

2mg/ml

906
L01XA01 L01XA01
SINPLATIN 10 mg

L01XA01
CISPLATINUM

CISPLATINUM
LIOF. PT. SOL. PERF.
10mg 10mg/20ml 10mg/20ml 1mg/1ml 25mg/50ml 50mg 50mg/100ml ACTAVIS S.R.L.

10mg 10mg/20ml

CISPLATINUM

CONC. PT. SOL. PERF.
EBEWE PHARMA GMBH NFG. KG TEVA PHARMACEUTICALS S.R.L.

CISPLATIN "EBEWE" 10 mg/20 ml CISPLATIN TEVA 10 mg/20 ml

L01XA01 L01XA01 L01XA01 L01XA01

CISPLATINUM CISPLATINUM CISPLATINUM CISPLATINUM

CONC. PT. SOL. PERF.
ACTAVIS S.R.L.

1mg/1ml 25mg/50ml 50mg 50mg/100ml

SINPLATIN 1 mg/1 ml CISPLATIN "EBEWE" 25 mg/50 ml SINPLATIN 50 mg CISPLATIN "EBEWE" 50 mg/100 ml

CONC. PT. SOL. PERF.
EBEWE PHARMA GMBH NFG. KG ACTAVIS S.R.L.

LIOF. PT. SOL. PERF. CONC. PT. SOL. PERF.
EBEWE PHARMA GMBH NFG. KG

907
L01XA02

L01XA02
CARBOPLATINUM

CARBOPLATINUM
CONC. PT. SOL. PERF.
10mg/ml 10mg/ml 10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG ACTAVIS S.R.L. TEVA PHARMACEUTICALS S.R.L.

10mg/ml

CARBOPLATIN "EBEWE" 10 mg/ml CARBOPLATIN ACTAVIS 10mg/ml CARBOPLATIN TEVA 10mg/ml

908
L01XC04 L01XC04

L01XC04
ALEMTUZUMABUM

ALEMTUZUMABUM **
CONC. PT. SOL. PERF.
10mg/ml 30mg/ml GENZYME EUROPE BV

10mg/ml 30mg/ml

MABCAMPATH 10 mg/ml

ALEMTUZUMABUM

CONC. PT. SOL. PERF.
GENZYME EUROPE BV

MABCAMPATH 30 mg/ml

909
L01XC02
MABTHERA 100 mg MABTHERA 500 mg

L01XC02
RITUXIMABUM

RITUXIMABUM **
CONC. PT. SOL. PERF.
10mg/ml 10mg/ml ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

10mg/ml

910

L03AA02
Prescriere limitata:

FILGRASTIMUM (G-CSF) **

Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei mieloide cronice şi a sindroamelor mielodisplazice), precum şi pentru reducerea duratei neutropeniei la pacienţii care primesc terapie mieloablativă urmată de transplant de măduvă osoasă. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L03AA02
NEUPOGEN®

FILGRASTIMUM (G-CSF) FILGRASTIMUM (G-CSF)

SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

L03AA02
NEUPOGEN®

SOL. INJ.
48MU/0.5ml

911

L04AA01

CICLOSPORINUM

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA01

CICLOSPORINUM
100mg

CAPS. MOI
IVAX - PHARMACEUTICALS S.R.O.

100mg

EQUORAL® 100 mg

122 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
100mg/ml 100mg/ml

FORMA FARM.

FIRMA

PROTOCOL

L04AA01

CICLOSPORINUM

SOL. ORALA
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

EQUORAL® SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

913

L04AA05

TACROLIMUSUM **

Prescriere limitata: Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA05 L04AA05 L04AA05 L04AA05 L04AA05 L04AA05 L04AA05

TACROLIMUSUM
0,5mg

CAPS. ELIB. PREL.
ASTELLAS PHARMA GMBH

0,5mg 0.5mg
ASTELLAS PHARMA GMBH

ADVAGRAF 0,5mg

TACROLIMUSUM
0.5mg

CAPS. CAPS.
1mg ASTELLAS IRELAND CO. LTD.

PROGRAF® 0,5 mg

TACROLIMUSUM TACROLIMUSUM
1mg

1mg 1mg
ASTELLAS PHARMA GMBH

PROGRAF® 1 mg ADVAGRAF 1mg

CAPS. ELIB. PREL. CAPS.
5mg ASTELLAS PHARMA GMBH

TACROLIMUSUM TACROLIMUSUM
5mg 5mg/ml

5mg 5mg
ASTELLAS PHARMA GMBH

PROGRAF® 5 mg ADVAGRAF 5mg

CAPS. ELIB. PREL. CONC. PT. SOL. PERF.
ASTELLAS PHARMA GMBH

TACROLIMUSUM

5mg/ml

PROGRAF® 5 mg/ml

914
L04AA06 L04AA06 L04AA06
MYFORTIC 180 mg

L04AA06
MYCOPHENOLATUM

MYCOPHENOLATUM **
COMPR. FILM. GASTROREZ.
180mg 1g/5ml NOVARTIS PHARMA GMBH

180mg 1g/5ml 250mg

MYCOPHENOLATUM MYCOPHENOLATUM
250mg 250mg 360mg

PULB. PT. SUSP. ORALA
ROCHE REGISTRATION LTD.

CELLCEPT 1mg/5ml CELLCEPT 250mg MYFENAX 250mg

CAPS.
ROCHE REGISTRATION LTD. TEVA PHARMA BV

L04AA06 L04AA06 L04AA06 L04AA06

MYCOPHENOLATUM MYCOPHENOLATUM
500mg

COMPR. FILM. GASTROREZ.
NOVARTIS PHARMA GMBH

360mg 500mg

MYFORTIC 360 mg MYFENAX 500mg

CAPS.
TEVA PHARMA BV

MYCOPHENOLATUM
500mg 500mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

500mg 500mg

CELLCEPT 500mg

MYCOPHENOLATUM

PULB. PT. CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD.

CELLCEPT 500mg

915
L04AA08
ZENAPAX 5 mg/ml

L04AA08
DACLIZUMABUM

DACLIZUMABUM **
CONC. PT. SOL. PERF.
5mg/ml ROCHE REGISTRATION LTD.

5mg/ml

916

L04AA10

SIROLIMUS **

Monitorizarea atentă a pacienţilor este obligatorie Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA10

SIROLIMUS
1mg

COMPR. FILM.
WYETH EUROPA LTD.

1mg

RAPAMUNE 1mg

917
L04AA11
ENBREL 25mg

L04AA11
ETANERCEPTUM

ETANERCEPTUM **
PULB. + SOLV. PT. SOL. INJ.
25mg WYETH EUROPA LIMITED

25mg 50mg 25mg 50mg

L04AA11 L04AA11
ENBREL 25mg

ETANERCEPTUM
50mg 25mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

ENBREL 50 mg

ETANERCEPTUM ETANERCEPTUM
50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

L04AA11
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA
WYETH EUROPA LIMITED

918

N02AX02
Prescriere limitata:

TRAMADOLUM

Durere severa, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N02AX02 TRAMADOLUM
TRAMADOLOR® 100 ID 100mg 100mg 100mg 100mg 100mg

COMPR. ELIB. MODIF.
HEXAL AG

100mg 100mg

N02AX02 TRAMADOLUM
NOAX UNO 100 mg TRALGIT SR 100 TRAMADOL® RETARD

COMPR. ELIB. PREL.
LABOPHARM EUROPE LIMITED ZENTIVA AS KRKA D.D.

N02AX02 TRAMADOLUM
TRAMAL RETARD 100 mg

COMPR. FILM. ELIB. PREL.
GRUNENTHAL GMBH

100mg 100mg

N02AX02 TRAMADOLUM
MABRON TRADOLAN 100mg 100mg

SOL. INJ.
MEDOCHEMIE LTD. LANNACHER HEILMITTEL GMBH

Prescriere limitata:
TRADOLAN TRAMADOL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM
100mg 100mg

SUPOZ.
LANNACHER HEILMITTEL GMBH KRKA D.D.

100mg

123 / 153

DCI/DENUMIRE COMERCIALA
TRAMAG 100 TRAMAL®

CONCENTRATIE
100mg 100mg

FORMA FARM.

FIRMA
MAGISTRA C & C GRUNENTHAL GMBH

PROTOCOL

N02AX02 TRAMADOLUM
TRALGIT 100

SOL. INJ.
100mg/2ml ZENTIVA A.S.

100mg/2ml

Prescriere limitata:
TRALGIT

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM
100mg/ml

PIC. ORALE, SOL.
ZENTIVA A.S.

100mg/ml 100mg/ml
LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM
TRADOLAN 100mg/ml 150mg 150mg 150mg 200mg 200mg 200mg 200mg 300mg

SOL. ORALA COMPR. ELIB. PREL.
ZENTIVA AS

N02AX02 TRAMADOLUM
TRALGIT SR 150

150mg 150mg

N02AX02 TRAMADOLUM
TRAMADOL RETARD 150 mg TRAMAL RETARD 150 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

N02AX02 TRAMADOLUM
NOAX UNO 200 mg TRALGIT SR 200

COMPR. ELIB. PREL.
LABOPHARM EUROPE LIMITED ZENTIVA AS

200mg

N02AX02 TRAMADOLUM
TRAMADOL RETARD 200 mg TRAMAL RETARD 200 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

200mg

N02AX02 TRAMADOLUM
NOAX UNO 300 mg

COMPR. ELIB. PREL.
LABOPHARM EUROPE LIMITED

300mg 50mg

N02AX02 TRAMADOLUM
K-ALMA® MABRON 50 mg TRALGIT 50 TRAMACALM TRAMADOL TRAMADOL LPH 50 mg TRAMADOL AL 50 TRAMADOL ARENA TRAMAL® URGENDOL 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
ANTIBIOTICE SA MEDOCHEMIE LTD. ZENTIVA A.S. AC HELCOR SRL KRKA D.D. LABORMED PHARMA SA ALIUD® PHARMA GMBH & CO.KG ARENA GROUP S.A. GRUNENTHAL GMBH MEDICAROM GROUP SRL

N02AX02 TRAMADOLUM
TRAMADOL 50 mg TRAMADOL EEL TRAMAG 50 50mg 50mg 50mg

COMPR.
OZONE LABORATORIES LTD. BIO EEL SRL MAGISTRA C & C

50mg

N02AX02 TRAMADOLUM
TRADOLAN 50 mg 50mg

COMPR. FILM.
LANNACHER HEILMITTEL GMBH

50mg 50mg
LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM
TRADOLAN 50 mg 50mg

SOL. INJ.

Prescriere limitata:
TRALGIT 50 TRAMADOL TRAMADOL® AL 100 Fiole TRAMAL® 100 TRAMAL® 50 URGENDOL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM
50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml

SOL. INJ.
ZENTIVA A.S. KRKA D.D. ALIUD® PHARMA GMBH & CO.KG GRUNENTHAL GMBH GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg/ml

Prescriere limitata:
TRAMADOL AL PICATURI

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM N02AX02 TRAMADOLUM
TRAMAL® 100mg/ml

PIC. ORALE, SOL.
ALIUD PHARMA GMBH & CO.KG

PICATURI ORALE-SOL.
GRUNENTHAL GMBH

100mg/ml

919
PULMOZYME

R05CB13

DORNAZA ALFA **
SOL. INHAL.
1mg/ml ROCHE ROMANIA S.R.L.

R05CB13 DORNAZA ALFA

1mg/ml

920
EXJADE 125mg

V03AC03

DEFERASIROXUM **
COMPR. DISP.
125mg NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM V03AC03 DEFERASIROXUM
EXJADE 250mg 250mg

125mg 250mg
NOVARTIS EUROPHARM LTD.

COMPR. DISP. COMPR. DISP.
500mg NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM
EXJADE 500mg

500mg

921
V03AF01

V03AF01
MESNUM

MESNUM
SOL. INJ.
400mg/4ml BAXTER ONCOLOGY GMBH

400mg/4ml

UROMITEXAN® 400 mg

124 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.2: TRANSPLANT DE CORD 922 B01AB08 REVIPARINUM
B01AB08 REVIPARINUM
CLIVARIN® 1432UI/0,25 ml

SOL. INJ.
1432ui/0.25ml ABBOTT GMBH&CO.KG

1432ui/0.25ml 3436ui/0.6ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml

923
HAEMACCEL

B05AA06

POLYGELINUM
SOL. PERF.
3.5% THERASELECT GMBH

B05AA06 POLYGELINUM

3.5%

924
ADRENALINA 1 mg

C01CA24

EPINEPHRINUM
SOL. INJ.
1mg/ml TERAPIA SA

C01CA24 EPINEPHRINUM

1mg/ml

925
J01CR05
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

PIPERACILLINUM + TAZOBACTAMUM

926
J01DD12
LYZONE 1 g MEDOCEF 1 g

J01DD12
CEFOPERAZONUM

CEFOPERAZONUM
PULB. PT. SOL. INJ.
1g 1g MEDICAROM GROUP S.R.L. MEDOCHEMIE LTD.

1g

J01DD12
LYZONE 2 g MEDOCEF 2 g

CEFOPERAZONUM
2g 2g

PULB. PT. SOL. INJ.
MEDICAROM GROUP S.R.L. MEDOCHEMIE LTD.

2g

J01DD12 J01DD12
CEFOZON 1 g

CEFOPERAZONUM
500mg 1g

PULB. PT. SOL. INJ.
E.I.P.I.CO. MED S.R.L.

500mg 1g

CEFOZON 500 mg

CEFOPERAZONUM

PULB. PT. SOL. INJ./PERF.I.M./I.V.
E.I.P.I.CO. MED S.R.L.

927
J01DH51
TIENAM I.V.

J01DH51
IMIPENEMUM + CILASTATINUM

IMIPENEMUM + CILASTATINUM
PULB. PT. SOL. PERF.
MERCK SHARP & DOHME ROMANIA S.R.L.

928
J01XX08
ZYVOXID®

J01XX08
LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID®

SOL. PERF.
2mg/ml PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID®

LINEZOLIDUM
600mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

600mg

929

J02AC01
Prescriere limitata:

FLUCONAZOLUM

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie. Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina. Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Tratamentul candidozei orofaringiene la pacienti cu imunosupresie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC01

FLUCONAZOLUM
100mg 100mg 100mg 100mg 100mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

100mg

DIFLAZON 100 mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

J02AC01

FLUCONAZOLUM
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG OZONE LABORATORIES LTD. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL ZENTIVA AS GEDEON RICHTER PLC.

150mg

DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ® 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCORIC 150 mg FLUCOVIM 150 MYCOMAX 150 MYCOSYST® 150 mg

J02AC01

FLUCONAZOLUM
200mg 200mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL

200mg

DIFLAZON 200 mg FLUCONAZOLE TEVA 200 mg

J02AC01

FLUCONAZOLUM
2mg/ml 2mg/ml 2mg/ml

SOL. PERF.
KRKA D.D. PFIZER EUROPE MA EEIG ZENTIVA AS

2mg/ml

DIFLAZON® DIFLUCAN® MYCOMAX® INF

J02AC01

FLUCONAZOLUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL

50mg

DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ® 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCORIC 50 mg FLUCOVIM 50

125 / 153

DCI/DENUMIRE COMERCIALA
FUNGOLON 50 mg

CONCENTRATIE
50mg 50mg/5ml

FORMA FARM.

FIRMA
BALKANPHARMA RAZGRAD AD

PROTOCOL

J02AC01

FLUCONAZOLUM

PULB. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

50mg/5ml

DIFLUCAN® 50 mg/5 ml

930
J02AC03
VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM **
COMPR. FILM.
200mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg
PFIZER LTD.

J02AC03
VFEND 200mg

VORICONAZOLUM
200mg

PULB. PT. SOL. PERF.
PFIZER LTD.

J02AC03 J02AC03
VFEND 50mg

VORICONAZOLUM
40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LTD.

VFEND 40 mg/ml

VORICONAZOLUM
50mg

COMPR. FILM.

932
J05AB14

J05AB14
Prescriere limitata:

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

VALGANCICLOVIRUM

450mg

VALCYTE® 450 mg

933

L04AA01

CICLOSPORINUM

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA01 L04AA01

CICLOSPORINUM
100mg

CAPS. MOI
IVAX - PHARMACEUTICALS S.R.O.

100mg 100mg/ml
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

EQUORAL® 100 mg

CICLOSPORINUM
100mg/ml 100mg/ml

SOL. ORALA

EQUORAL® SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

935

L04AA05

TACROLIMUSUM **

Prescriere limitata: Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA05 L04AA05

TACROLIMUSUM
0,5mg

CAPS. ELIB. PREL.
ASTELLAS PHARMA GMBH

0,5mg 0.5mg
ASTELLAS PHARMA GMBH

ADVAGRAF 0,5mg

TACROLIMUSUM
0.5mg

CAPS.

PROGRAF® 0,5 mg

Prescriere limitata:

Profilaxia rejetului de alogrefă la adulţii cu transplant cardiac

L04AA05

TACROLIMUSUM
1mg

CAPS.
ASTELLAS IRELAND CO. LTD.

1mg

PROGRAF® 1 mg

Prescriere limitata:

Profilaxia rejetului de alogrefă la adulţii cu transplant cardiac

L04AA05 L04AA05

TACROLIMUSUM
1mg

CAPS. ELIB. PREL.
ASTELLAS PHARMA GMBH

1mg 5mg
ASTELLAS PHARMA GMBH

ADVAGRAF 1mg

TACROLIMUSUM
5mg

CAPS.

PROGRAF® 5 mg

Prescriere limitata:

Profilaxia rejetului de alogrefă la adulţii cu transplant cardiac

L04AA05 L04AA05

TACROLIMUSUM
5mg 5mg/ml

CAPS. ELIB. PREL.
ASTELLAS PHARMA GMBH

5mg 5mg/ml

ADVAGRAF 5mg

TACROLIMUSUM

CONC. PT. SOL. PERF.
ASTELLAS PHARMA GMBH

PROGRAF® 5 mg/ml

Prescriere limitata:

Profilaxia rejetului de alogrefă la adulţii cu transplant cardiac

936
L04AA06 L04AA06
MYFORTIC 180 mg

L04AA06
MYCOPHENOLATUM

MYCOPHENOLATUM **
COMPR. FILM. GASTROREZ.
180mg 1g/5ml NOVARTIS PHARMA GMBH

180mg 1g/5ml

MYCOPHENOLATUM

PULB. PT. SUSP. ORALA
ROCHE REGISTRATION LTD.

CELLCEPT 1mg/5ml

Prescriere limitata:

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.

L04AA06

MYCOPHENOLATUM
250mg 250mg

CAPS.
ROCHE REGISTRATION LTD. TEVA PHARMA BV

250mg

CELLCEPT 250mg MYFENAX 250mg

Prescriere limitata:

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.

L04AA06 L04AA06 L04AA06

MYCOPHENOLATUM
360mg

COMPR. FILM. GASTROREZ.
NOVARTIS PHARMA GMBH

360mg 500mg

MYFORTIC 360 mg

MYCOPHENOLATUM
500mg

CAPS.
TEVA PHARMA BV

MYFENAX 500mg

MYCOPHENOLATUM
500mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

500mg

CELLCEPT 500mg

Prescriere limitata:

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.

L04AA06

MYCOPHENOLATUM
500mg

PULB. PT. CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD.

500mg

CELLCEPT 500mg

Prescriere limitata:

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.

126 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.3 TRANSPLANT HEPATIC 937 A05AA02 ACIDUM URSODEOXYCHOLICUM
NOTA: Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOFALK® URSOSAN 250mg 250mg

CAPS.
DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

938

B01AB05

ENOXAPARINUM
SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

939

B01AB08

REVIPARINUM
SOL. INJ.
1432ui/0.25ml ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 1432UI/0,25 ml

1432ui/0.25ml 3436ui/0.6ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml

940
ILOMEDIN® 20

B01AC11

ILOPROSTUM **
CONC. PT. SOL. PERF.
20µg/ml SCHERING AG

B01AC11 ILOPROSTUM

20µg/ml

941
ACTILYSE

B01AD02

ALTEPLASUM **
LIOF. + SOLV. PT. SOL. INJ.
50mg BOEHRINGER INGELHEIM INT. GMBH

B01AD02 ALTEPLASUM

50mg

944

C03EB01

COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM)
CAPS.
TERAPIA SA

Electroliţii serici trebuie să fie verificaţi periodic.

C03EB01 COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM)
DIUREX 50

945
MINIRIN 0,2 mg

H01BA02

DESMOPRESSINUM
0.2mg FERRING AB

H01BA02 DESMOPRESSINUM H01BA02 DESMOPRESSINUM
MINIRIN 0,2 mg 0.2mg

COMPR.
FERRING AB

0.2mg

946
J01CR05
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

PIPERACILLINUM + TAZOBACTAMUM

947
J01XX08
ZYVOXID®

J01XX08
LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID®

SOL. PERF.
2mg/ml PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID®

LINEZOLIDUM
600mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

600mg

948
J02AC03
VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM **
COMPR. FILM.
200mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03
VFEND 200mg

VORICONAZOLUM
200mg

PULB. PT. SOL. PERF.
PFIZER LTD.

J02AC03 J02AC03

VORICONAZOLUM
40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LTD.

VFEND 40 mg/ml

VORICONAZOLUM

COMPR. FILM.

127 / 153

DCI/DENUMIRE COMERCIALA
VFEND 50mg

CONCENTRATIE
50mg

FORMA FARM.

FIRMA
PFIZER LTD.

PROTOCOL

949
J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 70mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 70mg

CASPOFUNGINUM

PULB. PT. CONC. PT. SOL. PERF.
MERCK SHARP & DOHME LTD

CANCIDAS 70 mg

951
J05AB14

J05AB14
Prescriere limitata:

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

VALGANCICLOVIRUM

450mg

VALCYTE® 450 mg

953
L03AA02
NEUPOGEN®

L03AA02
FILGRASTIMUM (G-CSF) FILGRASTIMUM (G-CSF)

FILGRASTIMUM (G-CSF)
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

L03AA02
NEUPOGEN®

SOL. INJ.
48MU/0.5ml

954

L04AA01

CICLOSPORINUM

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA01 L04AA01

CICLOSPORINUM
100mg

CAPS. MOI
IVAX - PHARMACEUTICALS S.R.O.

100mg 100mg/ml
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

EQUORAL® 100 mg

CICLOSPORINUM
100mg/ml 100mg/ml

SOL. ORALA

EQUORAL® SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

955

L04AA05
Prescriere limitata:

TACROLIMUSUM **

Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi. Profilaxia rejetului de grefa la pacientii care primesc transplant hepatic alogen. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA05 L04AA05 L04AA05 L04AA05 L04AA05 L04AA05 L04AA05

TACROLIMUSUM
0,5mg

CAPS. ELIB. PREL.
ASTELLAS PHARMA GMBH

0,5mg 0.5mg
ASTELLAS PHARMA GMBH

ADVAGRAF 0,5mg

TACROLIMUSUM
0.5mg

CAPS. CAPS.
1mg ASTELLAS IRELAND CO. LTD.

PROGRAF® 0,5 mg

TACROLIMUSUM TACROLIMUSUM
1mg

1mg 1mg
ASTELLAS PHARMA GMBH

PROGRAF® 1 mg ADVAGRAF 1mg

CAPS. ELIB. PREL. CAPS.
5mg ASTELLAS PHARMA GMBH

TACROLIMUSUM TACROLIMUSUM
5mg 5mg/ml

5mg 5mg
ASTELLAS PHARMA GMBH

PROGRAF® 5 mg ADVAGRAF 5mg

CAPS. ELIB. PREL. CONC. PT. SOL. PERF.
ASTELLAS PHARMA GMBH

TACROLIMUSUM

5mg/ml

PROGRAF® 5 mg/ml

956
L04AA06 L04AA06

L04AA06
Prescriere limitata:

MYCOPHENOLATUM **
COMPR. FILM. GASTROREZ.
180mg 1g/5ml NOVARTIS PHARMA GMBH

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepatic.

MYCOPHENOLATUM MYCOPHENOLATUM

180mg 1g/5ml

MYFORTIC 180 mg CELLCEPT 1mg/5ml

PULB. PT. SUSP. ORALA
ROCHE REGISTRATION LTD.

Prescriere limitata:

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepatic

L04AA06

MYCOPHENOLATUM
250mg 250mg

CAPS.
ROCHE REGISTRATION LTD. TEVA PHARMA BV

250mg

CELLCEPT 250mg MYFENAX 250mg

Prescriere limitata:

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepatic

L04AA06 L04AA06

MYCOPHENOLATUM
360mg

COMPR. FILM. GASTROREZ.
NOVARTIS PHARMA GMBH

360mg 500mg

MYFORTIC 360 mg

MYCOPHENOLATUM
500mg

CAPS.
TEVA PHARMA BV

MYFENAX 500mg

Prescriere limitata:

Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepatic

L04AA06 L04AA06

MYCOPHENOLATUM
500mg 500mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

500mg 500mg

CELLCEPT 500mg

MYCOPHENOLATUM

PULB. PT. CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD.

CELLCEPT 500mg

957
L04AA10
RAPAMUNE 1mg

L04AA10
SIROLIMUS

SIROLIMUS **
COMPR. FILM.
1mg WYETH EUROPA LTD.

1mg

Monitorizarea atentă a pacienţilor este obligatorie

128 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.4 TRANSPLANT RENAL, TRANSPLANT COMBINAT RINICHI SI PANCREAS 958 A05AA02 ACIDUM URSODEOXYCHOLICUM
NOTA: Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOFALK® URSOSAN 250mg 250mg

CAPS.
DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

959
ALPHA D3 0,25 µg

A11CC03

ALFACALCIDOLUM
CAPS. MOI
0.25µg TEVA PHARMACEUTICALS SRL

A11CC03 ALFACALCIDOLUM A11CC03 ALFACALCIDOLUM
ALPHA D3 0.50 µg 0.50µg

0.25µg 0.50µg
TEVA PHARMACEUTICALS S.R.L.

CAPS. MOI

960

B01AB05

ENOXAPARINUM
SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

961
FRAGMIN 10000 UI/ml

B01AB04

DALTEPARINUM
SOL. INJ.
10000ui/ml PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM B01AB04 DALTEPARINUM
FRAGMIN15000 UI/0,6 ml

10000ui/ml 15000ui/0.6ml
PFIZER EUROPE MA EEIG

SOL. INJ.
15000ui/0.6ml

B01AB04 DALTEPARINUM
FRAGMIN 2500 UI/0,2 ml

SOL. INJ.
2500ui/0.2ml PFIZER EUROPE MA EEIG

2500ui/0.2ml 5000ui/0.2ml
PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN 5000 UI/0,2 ml

SOL. INJ.
5000ui/0.2ml

B01AB04 DALTEPARINUM
FRAGMIN 7500 UI/0,3 ml

SOL. INJ.
7500ui/0.3ml PFIZER EUROPE MA EEIG

7500ui/0.3ml

962

B01AB08

REVIPARINUM
SOL. INJ.
1432ui/0.25ml ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 1432UI/0,25 ml

1432ui/0.25ml 3436ui/0.6ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml

963
EPREX® 10000 UI

B03XA01

EPOETINUM ALFA
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA
EPOKINE 1000 UI/0,5 ml EPREX® 1000 UI

10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOPHAR 2000 U.I. 2000UI

SOL. INJ.
GULF PHARMACEUTICAL IND. S.R.L.

2000UI 2000ui/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/0,5 ml EPREX® 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPREX® 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA
EPREX® 40 000 UI 40 000UI

SOL. INJ.
JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA
EPOPHAR 4000 U.I. 4000UI

SOL. INJ. SOL. INJ.
4000UI/0.4ml RENAMED FARMA S.R.L.

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/0,4 ml

4000ui/0.4ml

129 / 153

DCI/DENUMIRE COMERCIALA
EPREX® 4000 UI

CONCENTRATIE
4000ui/0.4ml

FORMA FARM.

FIRMA
JOHNSON & JOHNSON D.O.O.

PROTOCOL

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 1000UI/0,5ml 2000UI/1,0ml 3000UI/0,3ml 4000UI/0,4ml RENAMED FARMA S.R.L. SANDOZ GMBH SANDOZ GMBH SANDOZ GMBH SANDOZ GMBH

4000UI/1ml

B03XA01 EPOETINUM ALFA
BINOCRIT

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA
BINOCRIT

B03XA01 EPOETINUM ALFA
BINOCRIT

B03XA01 EPOETINUM ALFA
BINOCRIT

964

B03XA01

EPOETINUM BETA
SOL. INJ. IN SERINGA PREUMPLUTA
10000UI/0,6ml 1000UI/0,3ml 2000UI/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L ROCHE REGISTRATION L

B03XA01 EPOETINUM BETA
NEORECORMON 10000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 1000 UI

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 2000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 4000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 5000 UI

B03XA01 EPOETINUM BETA
NEORECORMON 500 UI

965
HAEMACCEL

B05AA06

POLYGELINUM
SOL. PERF.
3.5% THERASELECT GMBH

B05AA06 POLYGELINUM

3.5%

966
SANDOSTATIN®

H01CB02

OCTREOTIDUM **
SOL. INJ.
0.1mg/ml NOVARTIS PHARMA GMBH

Protocol: H010C
0.1mg/ml 10mg

H01CB02 OCTREOTIDUM H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 10 mg 10mg

PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB. PRELUNG.
NOVARTIS PHARMA GMBH

H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 20 mg 20mg

PULB. + SOLV. PT. SUSP. INJ. (I.M.) CU ELIB. PRELU
NOVARTIS PHARMA GMBH

20mg

H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 30 mg 30mg

PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB. PRELUNG.
NOVARTIS PHARMA GMBH

30mg

967
J01CR05
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

PIPERACILLINUM + TAZOBACTAMUM

968
J01XA02
TARGOCID® 400 mg

J01XA02
TEICOPLANINUM

TEICOPLANINUM
LIOF. + SOLV. PT. SOL. INJ.
400mg AVENTIS PHARMA LTD.

400mg

969
J01XX08
ZYVOXID®

J01XX08
LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID®

SOL. PERF.
2mg/ml PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID®

LINEZOLIDUM
600mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

600mg

970

J02AB02
Prescriere limitata:

KETOCONAZOLUM

Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade. Candidoza orala la persoanele imunocompromise sever la care tratamentul local nu a avut rezultate Micoze sistemice la care alte forme de terapie antifungica nu au avut efect. A fost raportată hepatotoxicitate la ketoconazol. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AB02

KETOCONAZOLUM
200mg 200mg 200mg 200mg 200mg

COMPR.
ANTIBIOTICE SA MAGISTRA C & C AC HELCOR SRL JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOSTIN 200 mg NIZORAL NIZORAL 200 mg

J02AB02

KETOCONAZOLUM
200mg 200mg 200mg 200mg 200mg

COMPR.
ANTIBIOTICE SA MAGISTRA C & C AC HELCOR SRL JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOSTIN 200 mg NIZORAL NIZORAL 200 mg

971

J02AC01
Prescriere limitata:

FLUCONAZOLUM

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie. Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina. Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Tratamentul candidozei orofaringiene la pacienti cu imunosupresie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC01

FLUCONAZOLUM

CAPS.

100mg

130 / 153

DCI/DENUMIRE COMERCIALA
DIFLAZON 100 mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

CONCENTRATIE
100mg 100mg 100mg 100mg 100mg

FORMA FARM.

FIRMA
KRKA D.D. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

PROTOCOL

J02AC01

FLUCONAZOLUM
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG OZONE LABORATORIES LTD. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL ZENTIVA AS GEDEON RICHTER PLC.

150mg

DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ® 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCORIC 150 mg FLUCOVIM 150 MYCOMAX 150 MYCOSYST® 150 mg

J02AC01

FLUCONAZOLUM
200mg 200mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL

200mg

DIFLAZON 200 mg FLUCONAZOLE TEVA 200 mg

J02AC01

FLUCONAZOLUM
2mg/ml 2mg/ml 2mg/ml

SOL. PERF.
KRKA D.D. PFIZER EUROPE MA EEIG ZENTIVA AS

2mg/ml

DIFLAZON® DIFLUCAN® MYCOMAX® INF

J02AC01

FLUCONAZOLUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg/5ml

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

50mg

DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ® 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg

J02AC01

FLUCONAZOLUM

PULB. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

50mg/5ml

DIFLUCAN® 50 mg/5 ml

972
J02AC02
ITRACONAZOL 100 mg OMICRAL 100 mg ORUNGAL SPORILIN 100 mg

J02AC02
ITRACONAZOLUM

ITRACONAZOLUM
CAPS.
100mg 100mg 100mg 100mg TERAPIA S.A. MEDICO UNO PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV GEDEON RICHTER ROMANIA S.A.

100mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Sporotricoza sistemica Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

973
J02AC03
VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM **
COMPR. FILM.
200mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg
PFIZER LTD.

J02AC03
VFEND 200mg

VORICONAZOLUM
200mg

PULB. PT. SOL. PERF.
PFIZER LTD.

J02AC03 J02AC03
VFEND 50mg

VORICONAZOLUM
40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LTD.

VFEND 40 mg/ml

VORICONAZOLUM
50mg

COMPR. FILM.

974
J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 70mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 70mg

CASPOFUNGINUM

PULB. PT. CONC. PT. SOL. PERF.
MERCK SHARP & DOHME LTD

CANCIDAS 70 mg

976
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg SLAVIA PHARM SRL EUROPHARM SA

200mg

J05AB01

ACICLOVIRUM
200mg 200mg 200mg

COMPR.
TERAPIA SA ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg CLOVIRAL 200 mg ZOVIRAX

J05AB01

ACICLOVIRUM
200mg 200mg 250mg

COMPR. DISP.
OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM
400mg

PULB. PT. SOL. INJ./PERF.
KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01 J05AB01 J05AB01
ACIKLOVIR

CAPS.
ARENA GROUP S.A.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR.
EGIS PHARMACEUTICALS P.L.C.

400mg 400mg
A & G MED TRADING S.R.L.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR. FILM.

977
J05AB14

J05AB14
Prescriere limitata:

VALGANCICLOVIRUM **
COMPR. FILM. 450mg

Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

VALGANCICLOVIRUM

131 / 153

DCI/DENUMIRE COMERCIALA
VALCYTE® 450 mg

CONCENTRATIE
450mg

FORMA FARM.

FIRMA
ROCHE ROMANIA SRL

PROTOCOL

978
J05AB11
VALTREX 500 mg

J05AB11
VALACYCLOVIRUM

VALACYCLOVIRUM
COMPR. FILM.
500mg THE WELLCOME FOUNDATION LTD.

500mg

Prescriere limitata:

Profilaxia infectiei si bolii cu citomegalovirus in urma transplantului renal la pacientii cu risc de boala cu citomegalovirus

980
L01AA01 L01AA01 L01AA01 L01AA01
ENDOXAN® 1 g

L01AA01
CYCLOPHOSPHAMIDUM

CYCLOPHOSPHAMIDUM
PULB. PT. SOL. INJ./PERF.
1g 200mg 500mg BAXTER ONCOLOGY GMBH

1g 200mg 500mg 50mg

CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM CYCLOPHOSPHAMIDUM
50mg

PULB. PT. SOL. PERF./INJ. I.V.
ACTAVIS S.R.L.

ENDOXAN 200 mg ENDOXAN® 500 mg ENDOXAN® 50 mg

PULB. PT. SOL. INJ./PERF.
BAXTER ONCOLOGY GMBH

DRAJ.
BAXTER ONCOLOGY GMBH

981
L03AA02
NEUPOGEN®

L03AA02
FILGRASTIMUM (G-CSF) FILGRASTIMUM (G-CSF)

FILGRASTIMUM (G-CSF)
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

L03AA02
NEUPOGEN®

SOL. INJ.
48MU/0.5ml

982

L04AA01

CICLOSPORINUM

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA01 L04AA01

CICLOSPORINUM
100mg

CAPS. MOI
IVAX - PHARMACEUTICALS S.R.O.

100mg 100mg/ml
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

EQUORAL® 100 mg

CICLOSPORINUM
100mg/ml 100mg/ml

SOL. ORALA

EQUORAL® SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

984

L04AA05
Prescriere limitata:

TACROLIMUSUM **

Profilaxia rejetului de alogrefă la adulţii cu transplant renal. Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA05 L04AA05 L04AA05 L04AA05 L04AA05 L04AA05 L04AA05

TACROLIMUSUM
0,5mg

CAPS. ELIB. PREL.
ASTELLAS PHARMA GMBH

0,5mg 0.5mg
ASTELLAS PHARMA GMBH

ADVAGRAF 0,5mg

TACROLIMUSUM
0.5mg

CAPS. CAPS.
1mg ASTELLAS IRELAND CO. LTD.

PROGRAF® 0,5 mg

TACROLIMUSUM TACROLIMUSUM
1mg

1mg 1mg
ASTELLAS PHARMA GMBH

PROGRAF® 1 mg ADVAGRAF 1mg

CAPS. ELIB. PREL. CAPS.
5mg ASTELLAS PHARMA GMBH

TACROLIMUSUM TACROLIMUSUM
5mg 5mg/ml

5mg 5mg
ASTELLAS PHARMA GMBH

PROGRAF® 5 mg ADVAGRAF 5mg

CAPS. ELIB. PREL. CONC. PT. SOL. PERF.
ASTELLAS PHARMA GMBH

TACROLIMUSUM

5mg/ml

PROGRAF® 5 mg/ml

985

L04AA06

MYCOPHENOLATUM **

Prescriere limitata: Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen renal. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA06 L04AA06 L04AA06

MYCOPHENOLATUM
180mg 1g/5ml

COMPR. FILM. GASTROREZ.
NOVARTIS PHARMA GMBH

180mg 1g/5ml 250mg

MYFORTIC 180 mg

MYCOPHENOLATUM MYCOPHENOLATUM
250mg 250mg 360mg

PULB. PT. SUSP. ORALA
ROCHE REGISTRATION LTD.

CELLCEPT 1mg/5ml CELLCEPT 250mg MYFENAX 250mg

CAPS.
ROCHE REGISTRATION LTD. TEVA PHARMA BV

L04AA06 L04AA06 L04AA06 L04AA06

MYCOPHENOLATUM MYCOPHENOLATUM
500mg

COMPR. FILM. GASTROREZ.
NOVARTIS PHARMA GMBH

360mg 500mg

MYFORTIC 360 mg MYFENAX 500mg

CAPS.
TEVA PHARMA BV

MYCOPHENOLATUM
500mg 500mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

500mg 500mg

CELLCEPT 500mg

MYCOPHENOLATUM

PULB. PT. CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD.

CELLCEPT 500mg

986

L04AA08
Prescriere limitata:

DACLIZUMABUM **

Profilaxia rejectiei acute de organ în transplantul renal alogen de novo şi se utilizează concomitent cu o schemă de tratament cu imunosupresoare, incluzând ciclosporină şi glucocorticoizi, la pacienţii care nu sunt hiperimunizaţi.

L04AA08

DACLIZUMABUM
5mg/ml

CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD.

5mg/ml

ZENAPAX 5 mg/ml

987

L04AA09

BASILIXIMABUM **

132 / 153

DCI/DENUMIRE COMERCIALA CONCENTRATIE FORMA FARM. FIRMA PROTOCOL Prescriere limitata: Profilaxia rejetului acut de organ în transplantul renal alogen de novo la pacienţii adulţi şi copii. Se utilizează concomitent cu tratamentul imunosupresor cu ciclosporină microemulsionată şi corticosteroizi, la pacienţii cu mai puţin de 80% anticorpi reactivi, sau în tratament imunosupresor de întreţinere triplu cu ciclosporină microemulsionată, corticosteroizi şi azatioprină sau mofetil micofenolat.

L04AA09

BASILIXIMABUM
20mg

LIOF. + SOLV. PT. SOL. INJ./PERF.
NOVARTIS EUROPHARM LTD.

20mg

SIMULECT 20 mg

988

L04AA10

SIROLIMUS **

Prescriere limitata: Profilaxia rejetului de organ la pacienţii adulţi cu transplant renal şi risc imunologic mic sau moderat. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA10

SIROLIMUS
1mg

COMPR. FILM.
WYETH EUROPA LTD.

1mg

RAPAMUNE 1mg

989
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

990
FOSAMAX 10 mg

M05BA04

ACIDUM ALENDRONICUM
COMPR.
10mg MERCK SHARP & DOHME S.R.L.

M05BA04 ACIDUM ALENDRONICUM M05BA04 ACIDUM ALENDRONICUM
TEVA NAT 70 mg

10mg 70 mg
TEVA PHARMACEUTICALS SRL

COMPR. COMPR.
70mg MERCK SHARP & DOHME S.R.L.

M05BA04 ACIDUM ALENDRONICUM
FOSAMAX 70 mg

70mg

991
MIALGIN® 100 mg/2 ml

N02AB02

PETHIDINUM
SOL. INJ.
50mg/ml ZENTIVA SA

N02AB02 PETHIDINUM

50mg/ml

993

B01AB08

REVIPARINUM
SOL. INJ.
1432ui/0.25ml 1432ui/0.25ml ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN (R) 1432UI/0,25 ml CLIVARIN® 1432UI/0,25 ml

B01AB08 REVIPARINUM
CLIVARIN (R) 3436 UI/0,6 ml CLIVARIN® 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml 3436ui/0.6ml

994
HAEMACCEL

B05AA06

POLYGELINUM
SOL. PERF.
3.5% THERASELECT GMBH

B05AA06 POLYGELINUM

3.5%

995
J01XX08
ZYVOXID (R) ZYVOXID®

J01XX08
LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml 100mg/5ml PFIZER EUROPE MA EEI PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEI PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID (R) ZYVOXID®

LINEZOLIDUM
2mg/ml 2mg/ml

SOL. PERF.

J01XX08
ZYVOXID (R) ZYVOXID®

LINEZOLIDUM
600mg 600mg

COMPR. FILM.
PFIZER EUROPE MA EEI PFIZER EUROPE MA EEIG

996
J02AC03
VFEND (R) VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg PFIZER LIMITED PFIZER LTD.

Protocol: J012B

J02AC03
VFEND (R) VFEND 200mg

VORICONAZOLUM
200mg 200mg

PULB. PT. SOL. PERF.
PFIZER LIMITED PFIZER LTD.

J02AC03

VORICONAZOLUM
40mg/ml 40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LIMITED PFIZER LTD.

VFEND (R) 40 mg/ml VFEND 40 mg/ml

J02AC03
VFEND (R) VFEND 50mg

VORICONAZOLUM
50mg 50mg

COMPR. FILM.
PFIZER LIMITED PFIZER LTD.

998
J05AB14 J05AB14

J05AB14
Prescriere limitata:

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

VALGANCICLOVIRUM VALGANCICLOVIRUM
450mg

450mg

VALCYTE® 450 mg VALCYTE (R) 450 mg

COMPR. FILM.
ROCHE ROMANIA SRL

133 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.6 TRANSPLANT PULMONAR 999 B01AB05 ENOXAPARINUM
B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

1000

B01AB08

REVIPARINUM
SOL. INJ.
1432ui/0.25ml ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 1432UI/0,25 ml

1432ui/0.25ml 3436ui/0.6ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml

1002
ADRENALINA 1 mg

C01CA24

EPINEPHRINUM
SOL. INJ.
1mg/ml TERAPIA SA

C01CA24 EPINEPHRINUM

1mg/ml

1003
J01CR05
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

PIPERACILLINUM + TAZOBACTAMUM

1004
J01XX08
ZYVOXID®

J01XX08
LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID®

SOL. PERF.
2mg/ml PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID®

LINEZOLIDUM
600mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

600mg

1005

J02AC01
Prescriere limitata:

FLUCONAZOLUM

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie. Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina. Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Tratamentul candidozei orofaringiene la pacienti cu imunosupresie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC01

FLUCONAZOLUM
100mg 100mg 100mg 100mg 100mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

100mg

DIFLAZON 100 mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

J02AC01

FLUCONAZOLUM
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG OZONE LABORATORIES LTD. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL ZENTIVA AS GEDEON RICHTER PLC.

150mg

DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ® 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCORIC 150 mg FLUCOVIM 150 MYCOMAX 150 MYCOSYST® 150 mg

J02AC01

FLUCONAZOLUM
200mg 200mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL

200mg

DIFLAZON 200 mg FLUCONAZOLE TEVA 200 mg

J02AC01

FLUCONAZOLUM

SOL. PERF.

2mg/ml

134 / 153

DCI/DENUMIRE COMERCIALA
DIFLAZON® DIFLUCAN® MYCOMAX® INF

CONCENTRATIE
2mg/ml 2mg/ml 2mg/ml

FORMA FARM.

FIRMA
KRKA D.D. PFIZER EUROPE MA EEIG ZENTIVA AS

PROTOCOL

J02AC01

FLUCONAZOLUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg/5ml

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

50mg

DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ® 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg

J02AC01

FLUCONAZOLUM

PULB. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

50mg/5ml

DIFLUCAN® 50 mg/5 ml

1006
J02AC03
VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM **
COMPR. FILM.
200mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg
PFIZER LTD.

J02AC03
VFEND 200mg

VORICONAZOLUM
200mg

PULB. PT. SOL. PERF.
PFIZER LTD.

J02AC03 J02AC03
VFEND 50mg

VORICONAZOLUM
40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LTD.

VFEND 40 mg/ml

VORICONAZOLUM
50mg

COMPR. FILM.

1008
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg ARENA GROUP SA EUROPHARM SA

200mg

J05AB01

ACICLOVIRUM
200mg 200mg 200mg

COMPR.
TERAPIA SA ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg CLOVIRAL 200 mg ZOVIRAX

J05AB01

ACICLOVIRUM
200mg 200mg 250mg

COMPR. DISP.
OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM
400mg

PULB. PT. SOL. INJ./PERF.
KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01 J05AB01 J05AB01
ACIKLOVIR

CAPS.
ARENA GROUP S.A.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR.
EGIS PHARMACEUTICALS P.L.C.

400mg 400mg
A & G MED TRADING S.R.L.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR. FILM.

1009
J05AB14

J05AB14
Prescriere limitata:

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

VALGANCICLOVIRUM

450mg

VALCYTE® 450 mg

1010

L04AA01

CICLOSPORINUM

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA01 L04AA01

CICLOSPORINUM
100mg

CAPS. MOI
IVAX - PHARMACEUTICALS S.R.O.

100mg 100mg/ml
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

EQUORAL® 100 mg

CICLOSPORINUM
100mg/ml 100mg/ml

SOL. ORALA

EQUORAL® SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

1012
L04AA06 L04AA06 L04AA06
MYFORTIC 180 mg

L04AA06
MYCOPHENOLATUM

MYCOPHENOLATUM **
COMPR. FILM. GASTROREZ.
180mg 1g/5ml NOVARTIS PHARMA GMBH

180mg 1g/5ml 250mg

MYCOPHENOLATUM MYCOPHENOLATUM
250mg 250mg 360mg

PULB. PT. SUSP. ORALA
ROCHE REGISTRATION LTD.

CELLCEPT 1mg/5ml CELLCEPT 250mg MYFENAX 250mg

CAPS.
ROCHE REGISTRATION LTD. TEVA PHARMA BV

L04AA06 L04AA06 L04AA06 L04AA06

MYCOPHENOLATUM MYCOPHENOLATUM
500mg

COMPR. FILM. GASTROREZ.
NOVARTIS PHARMA GMBH

360mg 500mg

MYFORTIC 360 mg MYFENAX 500mg

CAPS.
TEVA PHARMA BV

MYCOPHENOLATUM
500mg 500mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

500mg 500mg

CELLCEPT 500mg

MYCOPHENOLATUM

PULB. PT. CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD.

CELLCEPT 500mg

135 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

1013
L04AA09
SIMULECT 20 mg

L04AA09
BASILIXIMABUM

BASILIXIMABUM **
LIOF. + SOLV. PT. SOL. INJ./PERF.
20mg NOVARTIS EUROPHARM LTD.

20mg

1014
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

1015

N02AX02
Prescriere limitata:

TRAMADOLUM

Durere severa, care nu raspunde la analgezice non-opioide. Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N02AX02 TRAMADOLUM
TRAMADOLOR® 100 ID 100mg 100mg 100mg 100mg 100mg

COMPR. ELIB. MODIF.
HEXAL AG

100mg 100mg

N02AX02 TRAMADOLUM
NOAX UNO 100 mg TRALGIT SR 100 TRAMADOL® RETARD

COMPR. ELIB. PREL.
LABOPHARM EUROPE LIMITED ZENTIVA AS KRKA D.D.

N02AX02 TRAMADOLUM
TRAMAL RETARD 100 mg

COMPR. FILM. ELIB. PREL.
GRUNENTHAL GMBH

100mg 100mg

N02AX02 TRAMADOLUM
MABRON TRADOLAN 100mg 100mg

SOL. INJ.
MEDOCHEMIE LTD. LANNACHER HEILMITTEL GMBH

Prescriere limitata:
TRADOLAN TRAMADOL TRAMAG 100 TRAMAL®

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM
100mg 100mg 100mg 100mg

SUPOZ.
LANNACHER HEILMITTEL GMBH KRKA D.D. MAGISTRA C & C GRUNENTHAL GMBH

100mg

N02AX02 TRAMADOLUM
TRALGIT 100

SOL. INJ.
100mg/2ml ZENTIVA A.S.

100mg/2ml

Prescriere limitata:
TRALGIT

Tratamentul de scurta durata al durerii acute.

N02AX02 TRAMADOLUM
100mg/ml

PIC. ORALE, SOL.
ZENTIVA A.S.

100mg/ml 100mg/ml
LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM
TRADOLAN 100mg/ml 150mg 150mg 150mg 200mg 200mg 200mg 200mg 300mg

SOL. ORALA COMPR. ELIB. PREL.
ZENTIVA AS

N02AX02 TRAMADOLUM
TRALGIT SR 150

150mg 150mg

N02AX02 TRAMADOLUM
TRAMADOL RETARD 150 mg TRAMAL RETARD 150 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

N02AX02 TRAMADOLUM
NOAX UNO 200 mg TRALGIT SR 200

COMPR. ELIB. PREL.
LABOPHARM EUROPE LIMITED ZENTIVA AS

200mg

N02AX02 TRAMADOLUM
TRAMADOL RETARD 200 mg TRAMAL RETARD 200 mg

COMPR. FILM. ELIB. PREL.
KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

200mg

N02AX02 TRAMADOLUM
NOAX UNO 300 mg

COMPR. ELIB. PREL.
LABOPHARM EUROPE LIMITED

300mg 50mg

N02AX02 TRAMADOLUM
K-ALMA® MABRON 50 mg TRALGIT 50 TRAMACALM TRAMADOL TRAMADOL LPH 50 mg TRAMADOL AL 50 TRAMADOL ARENA TRAMAL® URGENDOL 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
ANTIBIOTICE SA MEDOCHEMIE LTD. ZENTIVA A.S. AC HELCOR SRL KRKA D.D. LABORMED PHARMA SA ALIUD® PHARMA GMBH & CO.KG ARENA GROUP S.A. GRUNENTHAL GMBH MEDICAROM GROUP SRL

N02AX02 TRAMADOLUM
TRAMADOL 50 mg TRAMADOL EEL TRAMAG 50 50mg 50mg 50mg

COMPR.
OZONE LABORATORIES LTD. BIO EEL SRL MAGISTRA C & C

50mg

N02AX02 TRAMADOLUM
TRADOLAN 50 mg 50mg

COMPR. FILM.
LANNACHER HEILMITTEL GMBH

50mg 50mg
LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM
TRADOLAN 50 mg 50mg

SOL. INJ.

Prescriere limitata:
TRALGIT 50 TRAMADOL TRAMADOL® AL 100 Fiole TRAMAL® 100 TRAMAL® 50 URGENDOL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM
50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml

SOL. INJ.
ZENTIVA A.S. KRKA D.D. ALIUD® PHARMA GMBH & CO.KG GRUNENTHAL GMBH GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg/ml

Prescriere limitata:
TRAMADOL AL PICATURI

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM N02AX02 TRAMADOLUM
TRAMAL® 100mg/ml

PIC. ORALE, SOL.
ALIUD PHARMA GMBH & CO.KG

PICATURI ORALE-SOL.
GRUNENTHAL GMBH

100mg/ml

136 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.7 TRATAMENTUL STARII POSTTRANSPLANT IN AMBULATORIU A PACIENTILOR TRANSPLANTATI 1016 A05AA02 ACIDUM URSODEOXYCHOLICUM
NOTA: Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOFALK® URSOSAN 250mg 250mg

CAPS.
DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

1017
EPREX® 10000 UI

B03XA01

EPOETINUM ALFA **
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA
EPOKINE 1000 UI/0,5 ml EPREX® 1000 UI

10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOPHAR 2000 U.I. 2000UI

SOL. INJ.
GULF PHARMACEUTICAL IND. S.R.L.

2000UI 2000ui/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/0,5 ml EPREX® 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPREX® 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA
EPREX® 40 000 UI 40 000UI

SOL. INJ.
JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA
EPOPHAR 4000 U.I. 4000UI

SOL. INJ. SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/0,4 ml EPREX® 4000 UI

4000ui/0.4ml

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 1000UI/0,5ml 2000UI/1,0ml 3000UI/0,3ml 4000UI/0,4ml RENAMED FARMA S.R.L. SANDOZ GMBH SANDOZ GMBH SANDOZ GMBH SANDOZ GMBH

4000UI/1ml

B03XA01 EPOETINUM ALFA
BINOCRIT

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA
BINOCRIT

B03XA01 EPOETINUM ALFA
BINOCRIT

B03XA01 EPOETINUM ALFA
BINOCRIT

1018
EPREX® 10000 UI

B03XA01

EPOETINUM BETA **
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM BETA B03XA01 EPOETINUM BETA
EPOKINE 1000 UI/0,5 ml EPREX® 1000 UI

10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml 1000UI/ml 20000UI/ml

B03XA01 EPOETINUM BETA
NEORECORMON 500UI

LIOF. + SOLV. PT. SOL. INJ.
ROCHE REGISTRATION LTD.

1000UI/ml 20000UI/ml 2000UI

B03XA01 EPOETINUM BETA
NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.
ROCHE REGISTRATION LTD. GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM BETA
EPOPHAR 2000 U.I. 2000UI

SOL. INJ. SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM BETA
EPOKINE 2000 UI/0,5 ml EPREX® 2000 UI

2000ui/0.5ml

B03XA01 EPOETINUM BETA
EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM BETA
EPREX® 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM BETA
EPREX® 40 000 UI 40 000UI

SOL. INJ.
JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM BETA
EPOPHAR 4000 U.I. 4000UI

SOL. INJ. SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM BETA
EPOKINE 4000 UI/0,4 ml EPREX® 4000 UI

4000ui/0.4ml

B03XA01 EPOETINUM BETA
EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 50000UI/ml 10000UI/0,6ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 1000UI/0,3ml 20000UI/0,6ml RENAMED FARMA S.R.L.

4000UI/1ml 50000UI/ml

B03XA01 EPOETINUM BETA
NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.
ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA
NEORECORMON 10000 UI NEORECORMON 10000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 10000UI/ml

LIOF. + SOLV. PT. SOL. INJ. IN CARTUS
ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION LTD.

10000UI/ml

B03XA01 EPOETINUM BETA
NEORECORMON 1000 UI NEORECORMON 1000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 20000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD.

20000UI/0,6ml

137 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
20000UI/ml 2000UI/0,3ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 4000UI/0,3ml 5000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

FORMA FARM.

FIRMA

PROTOCOL

B03XA01 EPOETINUM BETA
NEORECORMON 20000UI/ml

LIOF. + SOLV. PT. SOL. INJ. IN CARTUS
ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION LTD.

20000UI/ml

B03XA01 EPOETINUM BETA
NEORECORMON 2000 UI NEORECORMON 2000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 30000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD.

30000 UI/0,6ml 3000I/0,3ml

B03XA01 EPOETINUM BETA
NEORECORMON 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION LTD. ROCHE REGISTRATION L ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA
NEORECORMON 4000 UI NEORECORMON 4000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 5000 UI NEORECORMON 5000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 500 UI NEORECORMON 500UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 60000UI/ml

LIOF. + SOLV. PT. SOL. INJ. IN CARTUS
ROCHE REGISTRATION LTD.

60000UI/ml 6000UI/0,3ml

B03XA01 EPOETINUM BETA
NEORECORMON 6000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD.

1019
ARANESP 10µg/0.4ml

B03XA02

DARBEPOETINUM ALFA **
SOL. INJ. IN SERINGA PREUMPLUTA
10µg/0.4ml 100µg/0.5ml 15µg/0.375ml 150µg/0.3ml 20µg/0.5ml 30µg/0.3ml 300µg/0.6ml 40µg/0.4ml 50µg/0.5ml 500µg/ml 60µg/0.3ml 80µg/0.4ml AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA B03XA02 DARBEPOETINUM ALFA
ARANESP 100µg/0.5ml

10µg/0.4ml 100µg/0.5ml 15µg/0.375ml 150µg/0.3ml 20µg/0.5ml 30µg/0.3ml 300µg/0.6ml 40µg/0.4ml 50µg/0.5ml 500µg/ml 60µg/0.3ml 80µg/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA
ARANESP 15µg/0.375ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA
ARANESP 150µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 20µg/0.5ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 30µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 300µg/0.6ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 40µg/0.4ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 50µg/0.5ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 500µg/ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 60µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 80µg/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA

1021
LEMOD SOLU 125 mg

H02AB04

METHYLPREDNISOLONUM
LIOF. PT. SOL. INJ.
125mg 125mg/2ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

125mg 125mg/2ml 16mg
PFIZER EUROPE MA EEIG

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg

COMPR. LIOF. PT. SOL. INJ.
20mg 250mg/4ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg

20mg 250mg/4ml 32mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg

COMPR. LIOF. PT. SOL. INJ.
40mg 40mg/1ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg

40mg 40mg/1ml 4mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg 4mg

COMPR. LIOF. PT. SOL. INJ.
500mg 500mg/7.8ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg

500mg 500mg/7.8ml

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.
PFIZER EUROPE MA EEIG

1022

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

1023

J01EE01

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

138 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

J01EE01
EPITRIM

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM SULFAMETHOXAZOLUM + TRIMETHOPRIMUM SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SUSP. ORALA
200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.

200mg/40mg /5ml 25mg/5mg/ml
EGIS PHARMACEUTICALS P.L.C.

J01EE01
SUMETROLIM

SIROP
25mg/5mg/ml

J01EE01
BISEPTRIM CO - TRIM ELL SUMETROLIM TAGREMIN

COMPR.
400mg/80mg 400mg/80mg 400mg/80mg 400mg/80mg EUROPHARM SA BIO EEL SRL EGIS PHARMACEUTICALS P.L.C. ZENTIVA S.A.

400mg/80mg

J01EE01
SEPTRIN

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SOL. PERF.
400mg/80mg THE WELLCOME FOUNDATION LTD.

400mg/80mg

1024

J02AC01
Prescriere limitata:

FLUCONAZOLUM

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie. Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina. Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Tratamentul candidozei orofaringiene la pacienti cu imunosupresie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC01

FLUCONAZOLUM
100mg 100mg 100mg 100mg 100mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

100mg

DIFLAZON 100 mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

J02AC01

FLUCONAZOLUM
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG OZONE LABORATORIES LTD. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL ZENTIVA AS GEDEON RICHTER PLC.

150mg

DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ® 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCORIC 150 mg FLUCOVIM 150 MYCOMAX 150 MYCOSYST® 150 mg

J02AC01

FLUCONAZOLUM
200mg 200mg

CAPS.
KRKA D.D. TEVA PHARMACEUTICALS SRL

200mg

DIFLAZON 200 mg FLUCONAZOLE TEVA 200 mg

J02AC01

FLUCONAZOLUM
2mg/ml 2mg/ml 2mg/ml

SOL. PERF.
KRKA D.D. PFIZER EUROPE MA EEIG ZENTIVA AS

2mg/ml

DIFLAZON® DIFLUCAN® MYCOMAX® INF

J02AC01

FLUCONAZOLUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg/5ml

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

50mg

DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ® 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg

J02AC01

FLUCONAZOLUM

PULB. PT. SUSP. ORALA
PFIZER EUROPE MA EEIG

50mg/5ml

DIFLUCAN® 50 mg/5 ml

1025
J02AC03
VFEND (R) VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM
PULB. PT. SOL. PERF.
200mg 200mg PFIZER LIMITED PFIZER LTD.

J02AC03
VFEND 50mg

VORICONAZOLUM
50mg

COMPR. FILM.
PFIZER LTD.

50mg

J02AC03

VORICONAZOLUM
40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LIMITED

VFEND (R) 40 mg/ml

1026

J02AC04
Prescriere limitata:

POSACONAZOLUM **

Profilaxia si tratamentul infectiilor fungice invazive la pacientii aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care prezinta risc inalt de a dezvolta infectii fungice masive. Profilaxia si tratamentul infectiilor fungice invazive la pacientii in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de a dezvolta infectii fungice masive. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J02AC04

POSACONAZOLUM
40mg/ml

SUSP. ORALA
SP EUROPE

40mg/ml

NOXAFIL SP 40mg/ml

1027
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg SLAVIA PHARM SRL EUROPHARM SA

200mg

J05AB01

ACICLOVIRUM
200mg

COMPR.
EGIS PHARMACEUTICALS P.L.C.

200mg

ACICLOVIR 200 mg

139 / 153

DCI/DENUMIRE COMERCIALA
CLOVIRAL 200 mg ZOVIRAX

CONCENTRATIE
200mg 200mg

FORMA FARM.

FIRMA
ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

PROTOCOL

J05AB01

ACICLOVIRUM
200mg 200mg 250mg

COMPR. DISP.
OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM
400mg

PULB. PT. SOL. INJ./PERF.
KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01 J05AB01 J05AB01
ACIKLOVIR

CAPS.
ARENA GROUP S.A.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR.
EGIS PHARMACEUTICALS P.L.C.

400mg 400mg
A & G MED TRADING S.R.L.

ACICLOVIR 400 mg

ACICLOVIRUM
400mg

COMPR. FILM.

1028
J05AB14

J05AB14
Prescriere limitata:

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.

VALGANCICLOVIRUM

450mg

VALCYTE® 450 mg

1029
J05AF05 J05AF05 J05AF05
EPIVIR 150mg ZEFFIX 100 mg

J05AF05
LAMIVUDINUM

LAMIVUDINUM
COMPR. FILM.
100mg GLAXO GROUP LTD.

100mg 10mg/ml
GLAXO GROUP LTD.

LAMIVUDINUM
10mg/ml

SOL. ORALA COMPR. FILM.
150mg GLAXO GROUP LTD.

EPIVIR 10mg/ml

LAMIVUDINUM LAMIVUDINUM
5mg/ml

150mg 5mg/ml
GLAXO GROUP LTD.

J05AF05

SOL. ORALA

ZEFFIX 5 mg/ml

1030

L04AA01

CICLOSPORINUM

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA01 L04AA01

CICLOSPORINUM
100mg

CAPS. MOI
IVAX - PHARMACEUTICALS S.R.O.

100mg 100mg/ml
IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

EQUORAL® 100 mg

CICLOSPORINUM
100mg/ml 100mg/ml

SOL. ORALA

EQUORAL® SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

25mg

CICLORAL® HEXAL® 25 mg EQUORAL® 25 mg SANDIMMUN NEORAL®

L04AA01

CICLOSPORINUM
50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

50mg

CICLORAL® HEXAL 50 mg EQUORAL® 50 mg SANDIMMUN NEORAL®

1031

L04AA05
Prescriere limitata:

TACROLIMUSUM **

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen renal. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen cardiac. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen hepatic. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA05 L04AA05 L04AA05 L04AA05 L04AA05 L04AA05 L04AA05

TACROLIMUSUM
0,5mg

CAPS. ELIB. PREL.
ASTELLAS PHARMA GMBH

0,5mg 0.5mg
ASTELLAS PHARMA GMBH

ADVAGRAF 0,5mg

TACROLIMUSUM
0.5mg

CAPS. CAPS.
1mg ASTELLAS IRELAND CO. LTD.

PROGRAF® 0,5 mg

TACROLIMUSUM TACROLIMUSUM
1mg

1mg 1mg
ASTELLAS PHARMA GMBH

PROGRAF® 1 mg ADVAGRAF 1mg

CAPS. ELIB. PREL. CAPS.
5mg ASTELLAS PHARMA GMBH

TACROLIMUSUM TACROLIMUSUM
5mg 5mg/ml

5mg 5mg
ASTELLAS PHARMA GMBH

PROGRAF® 5 mg ADVAGRAF 5mg

CAPS. ELIB. PREL. CONC. PT. SOL. PERF.
ASTELLAS PHARMA GMBH

TACROLIMUSUM

5mg/ml

PROGRAF® 5 mg/ml

1032

L04AA06
Prescriere limitata:

MYCOPHENOLATUM **

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen renal. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen cardiac. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen hepatic. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA06 L04AA06 L04AA06

MYCOPHENOLATUM
180mg 1g/5ml

COMPR. FILM. GASTROREZ.
NOVARTIS PHARMA GMBH

180mg 1g/5ml 250mg

MYFORTIC 180 mg

MYCOPHENOLATUM MYCOPHENOLATUM
250mg 250mg 360mg

PULB. PT. SUSP. ORALA
ROCHE REGISTRATION LTD.

CELLCEPT 1mg/5ml CELLCEPT 250mg MYFENAX 250mg

CAPS.
ROCHE REGISTRATION LTD. TEVA PHARMA BV

L04AA06 L04AA06

MYCOPHENOLATUM MYCOPHENOLATUM
500mg

COMPR. FILM. GASTROREZ.
NOVARTIS PHARMA GMBH

360mg 500mg

MYFORTIC 360 mg MYFENAX 500mg

CAPS.
TEVA PHARMA BV

140 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
500mg 500mg

FORMA FARM.

FIRMA

PROTOCOL

L04AA06 L04AA06

MYCOPHENOLATUM MYCOPHENOLATUM

COMPR. FILM.
ROCHE REGISTRATION LTD.

500mg 500mg

CELLCEPT 500mg CELLCEPT 500mg

PULB. PT. CONC. PT. SOL. PERF.
ROCHE REGISTRATION LTD.

1033

L04AA10

SIROLIMUS **

Prescriere limitata: Terapie de menţinere, urmare a iniţierii şi stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in unităţi de transplant. Monitorizarea atentă a pacienţilor este obligatorie. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

L04AA10

SIROLIMUS
1mg

COMPR. FILM.
WYETH EUROPA LTD.

1mg

RAPAMUNE 1mg

1034
L04AX01
IMURAN®

L04AX01
AZATHIOPRINUM

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

50mg

141 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-P10: PROGRAM NATIONAL DE SUPLEERE A FUNCTIEI RENALE LA BOLNAVII CU INSUFICIENTA RENALA CRONICA. 1035 A11CC03 ALFACALCIDOLUM
A11CC03 ALFACALCIDOLUM
ALPHA D3 0,25 µg 0.25µg

Protocol: A007E

CAPS. MOI
TEVA PHARMACEUTICALS SRL

0.25µg 0.50µg
TEVA PHARMACEUTICALS S.R.L.

A11CC03 ALFACALCIDOLUM
ALPHA D3 0.50 µg 0.50µg

CAPS. MOI

1036
ROCALTROL

A11CC04

CALCITRIOLUM **
CAPS. MOI
0.25µg ROCHE ROMANIA S.R.L.

Protocol: A006E
0.25µg

A11CC04 CALCITRIOLUM

1037
ZEMPLAR

A11CC07

PARICALCITOLUM **
SOL. INJ.
5 µg/ml ABBOTT LABORATORIES S.A.

Protocol: A005E
5 µg/ml

A11CC07 PARICALCITOLUM

1038

B01AB01

HEPARINUM **
SOL. INJ.
5000ui/ml 5000ui/ml 5000ui/ml POLIPHARMA INDUSTRIES S.R.L. SANDOZ GMBH LAB. PANPHARMA

B01AB01 HEPARINUM
HEPARIN HEPARIN SANDOZ® 25000 UI/5 ml HEPARINE SODIQUE PANPHARMA

5000ui/ml

1039

B01AB05

ENOXAPARINUM **
SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

1040

B01AB06

NADROPARINUM **
SOL. INJ.
11400 uiAXa/0.6ml GLAXO GROUP LTD.

B01AB06 NADROPARINUM
FRAXODI 11400 UI anti-factor Xa/0,6ml

11400 uiAXa/0.6ml 15200 uiAXa/0.8ml
GLAXO GROUP LTD.

B01AB06 NADROPARINUM
FRAXODI 15200 UI anti-factor Xa/0,8ml

SOL. INJ.
15200 uiAXa/0.8ml

B01AB06 NADROPARINUM
FRAXIPARINE® 2850 UI anti-factor Xa/0,3 ml

SOL. INJ.
2850 ui AFXa/0.3ml GLAXO GROUP LTD.

2850 ui AFXa/0.3ml

B01AB06 NADROPARINUM
FRAXIPARINE® 3800 UI anti-factor Xa/0,4 ml

SOL. INJ.
3800 ui AFXa/0.4ml GLAXO GROUP LTD.

3800 ui AFXa/0.4ml

B01AB06 NADROPARINUM
FRAXIPARINE® 5700 UI anti-factor Xa/0,6 ml

SOL. INJ.
5700 ui AFXa/0.6ml GLAXO GROUP LTD.

5700 ui AFXa/0.6ml

B01AB06 NADROPARINUM
FRAXIPARINE® 7600 UI anti-factor Xa/0,8 ml

SOL. INJ.
7600 ui AXa/0.8ml GLAXO GROUP LTD.

7600 ui AXa/0.8ml

1041

B01AB08

REVIPARINUM **
SOL. INJ.
1432ui/0.25ml ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 1432UI/0,25 ml

1432ui/0.25ml 3436ui/0.6ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN® 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml

1042

B01AB10

TINZAPARINUM **
SOL. INJ. 10000u ANTIF. Xa/ml

B01AB10 TINZAPARINUM

142 / 153

DCI/DENUMIRE COMERCIALA
INNOHEP

CONCENTRATIE
10000u ANTIF. Xa/ml

FORMA FARM.

FIRMA
LEO PHARMACEUTICAL PRODUCTS

PROTOCOL

B01AB10 TINZAPARINUM
INNOHEP

SOL. INJ.
20000u ANTIF. Xa/ml LEO PHARMACEUTICAL PRODUCTS

20000u ANTIF. Xa/ml

1043

B03AC02

COMPLEX DE HIDROXID DE FER (III) SUCROZA
SOL. INJ./PERF.
20mg/ml VIFOR FRANCE S.A.

Protocol: A010N
20mg/ml

B03AC02 COMPLEX DE HIDROXID DE FER (III) SUCROZA
VENOFER®

1044
EPREX® 10000 UI

B03XA01

EPOETINUM ALFA **
SOL. INJ.
10000ui/ml 1000ui/0.5ml 1000UI/0,5ml 1000UI/0.5ml 2000UI/0.5ml JOHNSON & JOHNSON D.O.O.

Protocol: B010N
10000ui/ml 1000UI/0,3ml 1000UI/0,5ml

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA
EPREX® 1000 UI

SOL. INJ. IN SERINGA PREUMPLUTA
JOHNSON & JOHNSON D.O.O. SANDOZ GMBH RENAMED FARMA S.R.L.

B03XA01 EPOETINUM ALFA
BINOCRIT 1000UI/0,5ml EPOKINE 1000 UI/0,5 ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA
EPOKINE 2000 UI/0,5 ml

SOL. INJ. IN SERINGA PREUMPLUTA
RENAMED FARMA S.R.L.

20000UI/0,5ml 2000UI

B03XA01 EPOETINUM ALFA
EPOPHAR 2000 U.I. EPREX® 2000 UI

SOL. INJ.
2000UI 2000ui/0.5ml 2000UI/1,0ml 2000UI/1ml 3000UI/0,3ml GULF PHARMACEUTICAL IND. S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
BINOCRIT 2000UI/1,0ml EPOKINE 2000 UI/1 ml

SOL. INJ. IN SERINGA PREUMPLUTA
SANDOZ GMBH RENAMED FARMA S.R.L.

2000UI/1,0ml

B03XA01 EPOETINUM ALFA
BINOCRIT 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA
SANDOZ GMBH

3000UI/0,3ml 3000ui/0.3ml

B03XA01 EPOETINUM ALFA
EPREX® 3000 UI

SOL. INJ.
3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
EPREX® 40 000 UI 40 000UI

SOL. INJ.
JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA
EPOPHAR 4000 U.I. 4000UI

SOL. INJ. SOL. INJ. IN SERINGA PREUMPLUTA
4000UI/0,4ml 4000UI/0.4ml 4000ui/0.4ml SANDOZ GMBH RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA
BINOCRIT 4000UI/0,4ml EPOKINE 4000 UI/0,4 ml EPREX® 4000 UI

4000UI/0,4ml

B03XA01 EPOETINUM ALFA
EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml RENAMED FARMA S.R.L.

4000UI/1ml

1045

B03XA01

EPOETINUM BETA **
SOL. INJ. IN SERINGA PREUMPLUTA
10000UI/0,6ml 1000UI/0,3ml 2000UI/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml ROCHE REGISTRATION LTD.

Protocol: B009N
10000UI/0,6ml 1000UI/0,3ml 2000UI/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml

B03XA01 EPOETINUM BETA
NEORECORMON 10000UI/0,6ml

B03XA01 EPOETINUM BETA
NEORECORMON 1000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA
ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA
NEORECORMON 2000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA
NEORECORMON 4000UI/0,3ml

B03XA01 EPOETINUM BETA
NEORECORMON 5000UI/0,3ml

B03XA01 EPOETINUM BETA
NEORECORMON 500UI/0,3ml

1046
ARANESP 10µg/0.4ml

B03XA02

DARBEPOETINUM ALFA **
SOL. INJ. IN SERINGA PREUMPLUTA
10µg/0.4ml 100µg/0.5ml 15µg/0.375ml 150µg/0.3ml 20µg/0.5ml 30µg/0.3ml 300µg/0.6ml 40µg/0.4ml 50µg/0.5ml 500µg/ml 60µg/0.3ml 80µg/0.4ml AMGEN EUROPE BV

Protocol: B011N
10µg/0.4ml 100µg/0.5ml 15µg/0.375ml 150µg/0.3ml 20µg/0.5ml 30µg/0.3ml 300µg/0.6ml 40µg/0.4ml 50µg/0.5ml 500µg/ml 60µg/0.3ml 80µg/0.4ml

B03XA02 DARBEPOETINUM ALFA B03XA02 DARBEPOETINUM ALFA
ARANESP 100µg/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA
ARANESP 15µg/0.375ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA
ARANESP 150µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 20µg/0.5ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 30µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 300µg/0.6ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 40µg/0.4ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 50µg/0.5ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 500µg/ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 60µg/0.3ml

B03XA02 DARBEPOETINUM ALFA
ARANESP 80µg/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA

1049

V03AE02

SEVELAMER **
COMPR. FILM. 800mg

Protocol: V003D

V03AE02 SEVELAMER

143 / 153

DCI/DENUMIRE COMERCIALA
RENAGEL 800mg

CONCENTRATIE
800mg

FORMA FARM.

FIRMA
GENZYME EUROPE BV

PROTOCOL

1050
MIMPARA 30 mg

H05BX01

CINACALCETUM ****
COMPR. FILM.
30mg AMGEN EUROPE B.V.

Protocol: H003N
30mg 60mg
AMGEN EUROPE B.V.

H05BX01 CINACALCETUM H05BX01 CINACALCETUM
MIMPARA 60 mg 60mg

COMPR. FILM. COMPR. FILM.
90mg AMGEN EUROPE B.V.

H05BX01 CINACALCETUM
MIMPARA 90 mg

90mg

SUBLISTA C2-P11: PROGRAM NATIONAL DE SANATATE MINTALA. SUBPROGRAMUL TRATAMENTUL TOXICODEPENDENTELOR 1051 N07BB04 NALTREXONUM
N07BB04 NALTREXONUM
REVIA 50mg

COMPR. FILM.
TORREX CHIESI PHARMA GMBH

50mg

Naltrexone hydrochloride este contraindicata la pacientii tratati cu medicamente opioide

1052

N07BC02

METHADONUM

Risc inalt de aparitie a dependentei. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N07BC02 METHADONUM
SINTALGON 2,5 mg 2.5mg

COMPR.
ZENTIVA S.A.

2.5mg

1053

N07BC51

COMBINATII ( BUPRENORPHINUM + NALAXONE)

Prescriere limitata: Tratamentul dependentei de opioide in cadrul terapiei medicale, sociale si psihologice. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

N07BC51 COMBINATII ( BUPRENORPHINUM + NALAXONE)
SUBOXONE 2mg/0,5mg

COMPR. SUBLING.
2mg/0,5mg SP EUROPE

2mg/0,5mg

N07BC51 COMBINATII ( BUPRENORPHINUM + NALAXONE)
SUBOXONE 8mg/2mg 8mg/2mg

COMPR. SUBLING.
SP EUROPE

8mg/2mg

144 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C3 - DCI-URI CORESPUNZĂTOARE MEDICAMENTELOR DE CARE BENEFICIAZĂ COPIII PANĂ LA 18 ANI, TINERII DE LA 18 LA 26 ANI DACA SUNT ELEVI, UCENICI SAU STUDENTI DACĂ NU REALIZEAZĂ VENITURI PRECUM SI GRAVIDE SI LEHUZE, IN TRATAMENTUL AMBULATORIU IN REGIM DE COMPENSARE 100% DIN PRETUL DE REFERINTĂ 1056 A03AD02 DROTAVERINUM
A03AD02 DROTAVERINUM
NO - SPA 40 mg/2 ml 40mg/2ml

SOL. INJ.
CHINOIN PRIVATE CO. LTD.

40mg/2ml

1057
SULFAT DE ATROPINA

A03BA01

ATROPINUM
SOL. INJ.
1mg/ml ZENTIVA S.A.

A03BA01 ATROPINUM

1mg/ml

1058
SCOBUTIL 10 mg/ml

A03BB01

BUTYLSCOPOLAMMONII BROMIDUM
SOL. INJ.
10mg/ml ZENTIVA SA

A03BB01 BUTYLSCOPOLAMMONII BROMIDUM A03BB01 BUTYLSCOPOLAMMONII BROMIDUM
BUSCOPAN 20 mg/ml FARCORELAXIN 20mg/ml 20mg/ml

10mg/ml 20mg/ml
BOEHRINGER INGELHEIM INT. GMBH PHARCO IMPEX 93 S.R.L.

SOL. INJ.

1059

A03DA02

COMBINATII
COMPR.
ZENTIVA SA ANTIBIOTICE SA

A03DA02 COMBINATII
ALGIFEN COMPRIMATE PIAFEN

A03DA02 COMBINATII
ALGIFEN SOLUTIE INJECTABILA

SOL. INJ.
ZENTIVA SA

A03DA02 COMBINATII
PIAFEN

SUPOZ.
ANTIBIOTICE SA

1060
ASPATOFORT®

A05BAN3

COMBINATII
SOL. INJ.
TERAPIA SA

A05BAN3 COMBINATII

1061
ENDOFALK

A06AD65

COMBINATII
PULB. PT. SOL. ORALA
DR. FALK PHARMA GMBH

A06AD65 COMBINATII

1062
ERCEFURYL® 200 mg

A07AX03

NIFUROXAZIDUM
CAPS.
200mg SANOFI-SYNTHELABO OTC

A07AX03 NIFUROXAZIDUM

200mg

1063
VITAMINA A

A11CA01

RETINOLUM
PIC. ORALE, SOL.
1500000ui/g BIOFARM SA

A11CA01 RETINOLUM A11CA01 RETINOLUM
VITAMINA A FORTE 50000ui

1500000ui/g 50000ui
BIOFARM SA

CAPS. MOI

1064
TACHYSTIN

A11CC02

DIHYDROTACHYSTEROLUM
PICATURI ORALE-SOL.
0.1mg/ml 1mg/ml CHAUVIN ANKERPHARM GMBH

A11CC02 DIHYDROTACHYSTEROLUM A11CC02 DIHYDROTACHYSTEROLUM
A.T. 10®

0.1mg/ml 1mg/ml

PICATURI ORALE-SOL.
MERCK KGAA

1065
ROCALTROL

A11CC04

CALCITRIOLUM
CAPS. MOI
0.25µg ROCHE ROMANIA S.R.L.

A11CC04 CALCITRIOLUM

0.25µg

1066
VITAMINA D3

A11CC05

COLECALCIFEROLUM
PIC. ORALE, SOL.
0,45mg/ml BIOFARM S.A.

A11CC05 COLECALCIFEROLUM A11CC05 COLECALCIFEROLUM
VIGANTOL OIL 0.5mg/ml

0,45mg/ml 0.5mg/ml
MERCK KGAA

PIC. ORALE, SOL. COMPR.
1000UI MERCK KGAA

A11CC05 COLECALCIFEROLUM
VIGANTOLETTEN 1000

1000UI 500UI
MERCK KGAA

A11CC05 COLECALCIFEROLUM
VIGANTOLETTEN 500 500UI

COMPR.

1067

A11CC20

COMBINATII
COMPR.
MERCK KGAA MERCK KGAA

A11CC20 COMBINATII
FLUOR VIGANTOLETTEN 1000 FLUOR VIGANTOLETTEN 500

1068

A11DA01

THIAMINUM
SOL. INJ.
100mg/2ml ZENTIVA SA

A11DA01 THIAMINUM
SICOVIT® B1 100 mg/2 ml

100mg/2ml 10mg
ZENTIVA SA

A11DA01 THIAMINUM
SICOVIT® B1 10 mg 10mg

COMPR.

1069
BENFOGAMMA

A11DA03

BENFOTIAMINUM
DRAJ.
50mg WORWAG PHARMA GMBH & CO. KG

A11DA03 BENFOTIAMINUM

50mg

1070
MILGAMMA® N

A11DBN1

COMBINATII
CAPS. MOI
WORWAG PHARMA GMBH & CO. KG

A11DBN1 COMBINATII A11DBN1 COMBINATII
MILGAMMA® N

SOL. INJ.
WORWAG PHARMA GMBH & CO. KG

1071
NEUROMULTIVIT®

A11DBN2

COMBINATII
COMPR. FILM.
LANNACHER HEILMITTEL GMBH

A11DBN2 COMBINATII

1072

A11GA01

ACIDUM ASCORBICUM
SOL. INJ. 750mg

A11GA01 ACIDUM ASCORBICUM

145 / 153

DCI/DENUMIRE COMERCIALA
VITAMINA C ARENA 750 mg

CONCENTRATIE
750mg

FORMA FARM.

FIRMA
ARENA GROUP S.A.

PROTOCOL

1073
VITAMINA B6 250 mg

A11HA02

PYRIDOXINUM
COMPR.
250 mg ARENA GROUP SA

A11HA02 PYRIDOXINUM A11HA02 PYRIDOXINUM
SICOVIT B6 250 mg 250mg

250 mg 250mg
ZENTIVA SA

COMPR. SOL. INJ.
250mg/5ml ZENTIVA SA

A11HA02 PYRIDOXINUM
SICOVIT B6 250 mg/5 ml

250mg/5ml 50mg/2ml
ZENTIVA SA

A11HA02 PYRIDOXINUM
SICOVIT B6 50 mg/2ml 50mg/2ml

SOL. INJ.

1074
VITAMIN E 200

A11HA03

TOCOFEROLUM
CAPS. MOI
200mg ZENTIVA AS

A11HA03 TOCOFEROLUM A11HA03 TOCOFEROLUM
VITAMIN E 400 400mg

200mg 400mg
ZENTIVA AS

CAPS. MOI

1076

A12AA03

CALCII GLUCONAS
SOL. INJ.
10% ZENTIVA SA B. BRAUN MELSUNGEN AG

A12AA03 CALCII GLUCONAS
GLUCONAT DE CALCIU GLUCONAT DE CALCIU 10%

A12AA03 CALCII GLUCONAS
GLUCONAT DE CALCIU GLUCONAT DE CALCIU 10% 10%

SOL. INJ.
ZENTIVA SA B. BRAUN MELSUNGEN AG

10,00%

1077
NAPOSIM 5 mg

A14AA03

METANDIENONUM
COMPR.
5mg TERAPIA SA

A14AA03 METANDIENONUM

5mg

1078
CARNIL®

A16AA01

LEVOCARNITINUM
SOL. ORALA
100mg/ml ANFARM HELLAS S.A. PHARMACEUTICALS

A16AA01 LEVOCARNITINUM A16AA01 LEVOCARNITINUM
MIOCOR 10%

100mg/ml 10%
ECOBI PHARMACEUTICI

SOL. ORALA

1079
ACTOVEGIN®

A16AXN1

DIVERSE
DRAJ.
200mg NYCOMED AUSTRIA GMBH

A16AXN1 DIVERSE A16AXN1 DIVERSE
ACTOVEGIN®

200mg 200mg/5ml
NYCOMED AUSTRIA GMBH

SOL. INJ.
200mg/5ml

A16AXN1 DIVERSE
ACTOVEGIN® 80mg/2ml

SOL. INJ.
NYCOMED AUSTRIA GMBH

80mg/2ml

1080
ETAMSILAT 250mg/2ml

B02BX01

ETAMSYLATUM
SOL. INJ.
250mg/2ml ZENTIVA S.A

B02BX01 ETAMSYLATUM

250mg/2ml

1081
ADRENOSTAZIN

B02BX02

CARBAZOCHROMI SALICYLAS
SOL. INJ.
0.3mg/ml TERAPIA SA

B02BX02 CARBAZOCHROMI SALICYLAS

0.3mg/ml

1082
FERRONAT®

B03AA02

FERROSI FUMARAS
SUSP. ORALA
3% IVAX - PHARMACEUTICALS S.R.O.

B03AA02 FERROSI FUMARAS

3,00%

1083
ASCOFER

B03AA03

FERROSI GLUCONAS
COMPR.
ARENA GROUP SA

B03AA03 FERROSI GLUCONAS

1084
FER-SOL

B03ABN1

FERROCHOLINATUM
SOL. ORALA IN PICATURI
24mg Fe/ml E.I.P.I.CO. MED S.R.L.

B03ABN1 FERROCHOLINATUM

24mg Fe/ml

1085
FERRETAB®

B03AD02

COMBINATII
CAPS. ELIB. PREL.
LANNACHER HEILMITTEL GMBH

B03AD02 COMBINATII

1086
FERRO SANOL GYN

B03AD03

COMBINATII
CAPS.
SCHWARZ PHARMA AG

B03AD03 COMBINATII B03AD03 COMBINATII
TARDYFERON FOL®

DRAJ. ELIB. PREL.
LAB. PIERRE FABRE

1087
MALTOFER FOL

B03AD04

COMBINATII
COMPR. MAST.
VIFOR FRANCE S.A.

B03AD04 COMBINATII

1088
FERRO - FOLGAMMA®

B03AE01

COMBINATII
CAPS. MOI
WORWAG PHARMA GMBH & CO. KG

B03AE01 COMBINATII

1089
TOT'HEMA

B03AE10

COMBINATII
SOL. ORALA
LAB. INNOTHERA

B03AE10 COMBINATII

1090

B03BA01

CYANOCOBALAMINUM
SOL. INJ.
1000µg/ml ZENTIVA S.A.

B03BA01 CYANOCOBALAMINUM
SICOVIT® B12 1000µg/ml

1000µg/ml 50µg/ml
ZENTIVA SA

B03BA01 CYANOCOBALAMINUM
SICOVIT B12 50µg/ml 50µg/ml

SOL. INJ.

1091
MILGAMMA®

B03BA51

COMBINATII
DRAJ.
WORWAG PHARMA GMBH & CO. KG

B03BA51 COMBINATII

146 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

1092

C01EA01

ALPROSTADILUM **
CONC. PT. SOL. PERF.
500µg PINT-PHARMA GMBH

C01EA01 ALPROSTADILUM
ALPROSTADIL "PINT" 500 µg

500µg

1093
C02LA51
NEOCRYSTEPIN

C02LA51
COMBINATII

COMBINATII
DRAJ.
ZENTIVA AS

1094
CO-DERGOCRIN

C04AE01

CODERGOCRINUM
SOL. ORALA IN PICATURI
0.1% 1mg/ml 0.1% TERAPIA SA

C04AE01 CODERGOCRINUM C04AE01 CODERGOCRINUM
SECATOXIN

0.1% 1mg/ml 0.1%

SOL. ORALA IN PICATURI
IVAX - PHARMACEUTICALS S.R.O.

C04AE01 CODERGOCRINUM
REDERGIN 1 mg/ml

PICATURI ORALE-SOL.
LEK PHARMACEUTICALS D.D.

1095
HEMORZON

C05AA01

COMBINATII
UNGUENT
ANTIBIOTICE SA

C05AA01 COMBINATII

1096
ULTRAPROCT®

C05AA08

COMBINATII
SUPOZ.
INTENDIS GmbH

C05AA08 COMBINATII C05AA08 COMBINATII
ULTRAPROCT®

UNGUENT RECTAL
INTENDIS GmbH

1097
DOXIPROCT DOXIPROCT PLUS

C05AD01

COMBINATII
UNGUENT RECTAL
OM PORTUGUESA S.A. OM PORTUGUESA S.A.

C05AD01 COMBINATII

1098
DOXILEK DOXIUM 500

C05BX01

CALCII DOBESILAS
CAPS.
500mg 500mg LEK PHARMACEUTICALS D.D. OM PORTUGUESA S.A.

C05BX01 CALCII DOBESILAS

500mg

1099
GINKOR FORT

C05CA54

TROXERUTINUM (COMBINATII)
CAPS.
BEAUFOUR IPSEN PHARMA

C05CA54 TROXERUTINUM (COMBINATII)

1100
CELIPRES®

C07AB08

CELIPROLOLUM
COMPR. FILM.
100mg RANBAXY U.K. LIMITED

C07AB08 CELIPROLOLUM C07AB08 CELIPROLOLUM
CELIPRES® 200mg

100mg 200mg
RANBAXY U.K. LIMITED

COMPR. FILM.

1101
CALMOGEN

C07NAN1

COMBINATII
CAPS.
EUROPHARM SA

C07NAN1 COMBINATII C07NAN1 COMBINATII
DISTONOVAL

COMPR.
FABIOL S.A.

C07NAN1 COMBINATII
DISTONOCALM®

COMPR. FILM.
ZENTIVA S.A.

1102
DILCEREN® NIMOTOP®

C08CA06

NIMODIPINUM
SOL. PERF.
10mg/50ml 10mg/50ml SLOVAKOFARMA BAYER HEALTHCARE AG

C08CA06 NIMODIPINUM

10mg/50ml

C08CA06 NIMODIPINUM
NIMOTOP® 30mg

COMPR. FILM.
BAYER HEALTHCARE AG

30mg

1103
NIASPAN 1000 mg

C10AD02

ACIDUM NICOTINICUM
COMPR. ELIB. PREL.
1000mg 375mg 500mg 750mg MERCK KGAA

C10AD02 ACIDUM NICOTINICUM C10AD02 ACIDUM NICOTINICUM
NIASPAN 375 mg

1000mg 375mg 500mg 750mg

COMPR. ELIB. PREL.
MERCK KGAA

C10AD02 ACIDUM NICOTINICUM
NIASPAN 500 mg

COMPR. ELIB. PREL.
MERCK KGAA

C10AD02 ACIDUM NICOTINICUM
NIASPAN 750 mg

COMPR. ELIB. PREL.
MERCK KGAA

1104
TRAVOGEN

D01AC05

ISOCONAZOLUM
CREMA
10mg/1g INTENDIS GmbH

D01AC05 ISOCONAZOLUM

10mg/1g

1105

D01AC08

KETOCONAZOLUM
CREMA
20mg/g SC HYPERION SA

D01AC08 KETOCONAZOLUM
KETOCONAZOL CREMA

20mg/g 2mg/100mg
ANTIBIOTICE S.A.

D01AC08 KETOCONAZOLUM
KEFUNGIN 2mg/100mg

CREMA
2mg/100mg

D01AC08 KETOCONAZOLUM
KETOCONAZOL NIZORAL 2% 2%

CREMA
TIS FARMACEUTIC SA JANSSEN PHARMACEUTICA NV

2%

1106
MYCOHEAL® HC

D01AC52

COMBINATII
CREMA
DAR AL DAWA PHARMA S.R.L

D01AC52 COMBINATII

1108
PSORIANOL 0,5%

D05AC01

DITHRANOLUM
UNGUENT
0.5% HYPERION SA

D05AC01 DITHRANOLUM D05AC01 DITHRANOLUM

0.5% 1%

UNGUENT

147 / 153

DCI/DENUMIRE COMERCIALA
PSORIANOL 1%

CONCENTRATIE
1%

FORMA FARM.

FIRMA
HYPERION SA

PROTOCOL

1109
ASORIAN

D05AXN1

COMBINATII
SOL. CUT.
BIOFARM SA

D05AXN1 COMBINATII

1110
AFLODERM

D07AB10

ALCLOMETAZONUM
CREMA
0.5mg/g A & G MED TRADING S.R.L.

Protocol: D001L
0.5mg/g 0.5mg/g
A & G MED TRADING S.R.L.

D07AB10 ALCLOMETAZONUM D07AB10 ALCLOMETAZONUM
AFLODERM 0.5mg/g

UNGUENT

1111

D07AC04

FLUOCINOLONI ACETONIDUM
UNGUENT
0.025% LAROPHARM SRL

Protocol: D001L
25,00%

D07AC04 FLUOCINOLONI ACETONIDUM
FLUOCINOLON ACETONID 0,025%

1112
ULTRALAN CREMA

D07AC05

FLUOCORTOLONUM
CREMA
0.25% INTENDIS GMBH

Protocol: D001L
0.25% 0.25%
SCHERING AG

D07AC05 FLUOCORTOLONUM D07AC05 FLUOCORTOLONUM
ULTRALAN UNGUENT 0.25%

UNGUENT

1113
NIDOFLOR

D07CB01

COMBINATII
CREMA
ANTIBIOTICE SA

Protocol: D001L

D07CB01 COMBINATII D07CB01 COMBINATII
PANDERM

UNGUENT
GULF PHARMACEUTICAL INDUSTRIES S.R.L.

1114
FLUOCINOLON N

D07CC02

COMBINATII
UNGUENT
ANTIBIOTICE SA

Protocol: D001L

D07CC02 COMBINATII

1115
TRIAMCINOLON S

D07XB02

COMBINATII
CREMA
ANTIBIOTICE SA

Protocol: D001L

D07XB02 COMBINATII

1116
BELOSALIC DIPROSALIC

D07XC01

COMBINATII
SOL. CUT.
A & G MED TRADING S.R.L. SCHERING-PLOUGH EUROPE

Protocol: D001L

D07XC01 COMBINATII

D07XC01 COMBINATII
BELOSALIC DIPROSALIC

UNGUENT
A & G MED TRADING S.R.L. SCHERING-PLOUGH EUROPE

1117
TRAVOCORT

D07XC04

COMBINATII
CREMA
INTENDIS GmbH

Protocol: D001L

D07XC04 COMBINATII

1119
RETIN - A®

D10AD01

TRETINOINUM
CREMA
0.05% JOHNSON & JOHNSON D.O.O.

D10AD01 TRETINOINUM

0.05%

1121
ERYFLUID

D10AF02

ERYTHROMYCINUM
SOL. CUT.
4g PIERRE FABRE DERMATOLOGIE

D10AF02 ERYTHROMYCINUM

4g

1122
ZINERYT

D10AF52

COMBINATII
PULB. + SOLV. SOL. CUT.
40mg/12mg/ml ASTELLAS PHARMA EUROPE B.V.

D10AF52 COMBINATII

40mg/12mg/ml

1124
FLAGYL

G01AF01

METRONIDAZOLUM
OVULE
500mg LAB. AVENTIS

G01AF01 METRONIDAZOLUM

500mg

1126
COLPOSEPTINE®

G01AXN1

COMBINATII
COMPR. VAG.
LAB. THERAMEX

G01AXN1 COMBINATII

1127
TERGYNAN

G01BDN1

COMBINATII
COMPR. VAG.
LAB. BOUCHARA-RECORDATI

G01BDN1 COMBINATII

1128
DEPO-PROVERA

G03AC06

MEDROXYPROGESTERONUM
SUSP. INJ.
150mg PFIZER EUROPE MA EEIG

G03AC06 MEDROXYPROGESTERONUM

150mg

1129
LUTENYL®

G03DB04

NOMEGESTROLUM
COMPR.
5mg LAB. THERAMEX

G03DB04 NOMEGESTROLUM

5mg

1130

G03GA01
Prescriere limitata:

GONADOTROPHINUM CHORIONICUM

Infertilitate anovulatorie. Pentru tratamentul infertilitatii masculine ca urmare a hipogonadismului hipogonadotrop; Pentru tratamentul infertilitatii masculine asociata cu deficit de LH; Pentru tratamentul barbatilor care au insuficienta combinata de GH si gonadotropine si la care absenta caracterelor sexuale secundare indica o intarziere de maturare. Pentru tratamentul baietilor de peste 16 ani care au manifestari clinice ale hipogonadismului sau ale pubertatii intarziate. Tratamentul nu trebuie sa depaseasca 6 luni.

NOTA: Cu excepţia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fără efect (sarcina nu a fost obţinuta). Femeile care au urmat tratament pentru inducerea ovulaţiei cu alte clase de medicamente si nu au obţinut o sarcina necesita evaluare laparoscopică pentru a exclude alte cauze care împiedica apariţia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puţin douăsprezece luni sau amenoreea sa fie prezenta de cel puţin sase luni înaintea tratamentului. Înaintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

G03GA01 GONADOTROPHINUM CHORIONICUM
PREGNYL 5000 5000ui/ml 500ui/ml

LIOF. + SOLV. PT. SOL. INJ.
NV ORGANON

5000ui/ml 500ui/ml

G03GA01 GONADOTROPHINUM CHORIONICUM
PREGNYL 500

LIOF. + SOLV. PT. SOL. INJ.
ORGANON NV

148 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

1131

G03GA02

MENOTROPINUM
LIOF. SI SOLV.PT.SOL.INJ
75ui FSH / 75ui LH FERING GMBH FERRING LAEGEMIDLER A/S

G03GA02 MENOTROPINUM
MENOGON

75ui FSH / 75ui LH

G03GA02 MENOTROPINUM
MENOPUR

LIOF. + SOLV. PT. SOL. INJ.

1132
URALYT-U

G04BCN1

COMBINATII
GRAN. ORALE
MADAUS GMBH

G04BCN1 COMBINATII

1133
NOVOTHYRAL® 100

H03AA03

COMBINATII
COMPR.
100µg+20µg MERCK KGAA

H03AA03 COMBINATII

100µg+20µg

1134
J01CR50 J01CR50
AMPICLOX SULPERAZON® 2 g

J01CR50
COMBINATII

COMBINATII
PULB. PT. SOL. INJ.
1g+1g PFIZER EUROPE MA EEIG

1g+1g 250mg+250 mg

COMBINATII

CAPS.
250mg+250 mg EUROPHARM SA

1135
J01DB04
LYZOLIN

J01DB04
CEFAZOLINUM

CEFAZOLINUM
PULB. PT. SOL. INJ.
1g MEDICAROM GROUP S.R.L.

1g

1136
J01DE02
CEFROM® 1 g

J01DE02
CEFPIROMUM

CEFPIROMUM
PULB. PT. SOL. INJ./PERF.
1g LAB. AVENTIS

1g 2g

J01DE02
CEFROM® 2 g

CEFPIROMUM
2g

PULB. PT. SOL. INJ./PERF.
LAB. AVENTIS

1137
J01EB05
NEOXAZOL® 500 mg SULFAFURAZOL

J01EB05
SULFAFURAZOLUM

SULFAFURAZOLUM
COMPR.
500mg 500mg ZENTIVA S.A. ARENA GROUP SA

500mg

1138
J01FA06
ROXAMED® 150

J01FA06
ROXITHROMYCINUM

ROXITHROMYCINUM
COMPR. FILM.
150mg DAR AL DAWA PHARMA S.R.L

150mg

1139

J01GB03

GENTAMICINUM

Prescriere limitata: Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

J01GB03

GENTAMICINUM
40mg/ml 40mg/ml

SOL. INJ.
KRKA D.D. NOVO MESTO SANDOZ GMBH

40mg/ml

GENTAMICIN KRKA GENTAMICINA SANDOZ® 40 mg/ml

J01GB03

GENTAMICINUM
40mg/ml 40mg/ml

SOL. INJ.
KRKA D.D. NOVO MESTO SANDOZ GMBH

40mg/ml

GENTAMICIN KRKA GENTAMICINA SANDOZ® 40 mg/ml

J01GB03
LYRAMYCIN

GENTAMICINUM
40mg/ml

SOL. PARENT.
MEDICAROM GROUP S.R.L.

40mg/ml 80mg/2ml
KRKA D.D. NOVO MESTO

J01GB03 J01GB03

GENTAMICINUM
80mg/2ml

SOL. INJ. SOL.INJ.
80mg/2ml LAB. PANPHARMA

GENTAMICIN KRKA

GENTAMICINUM

80mg/2ml

PAN - GENTAMICINE

1140
J01GB07 J01GB07 J01GB07
NETROMYCINE®

J01GB07
NETILMICINUM NETILMICINUM NETILMICINUM

NETILMICINUM
SOL. INJ.
150mg/1.5ml SCHERING PLOUGH EUROPE

150mg/1.5ml 200mg/2ml
SCHERING PLOUGH EUROPE

SOL. INJ.
200mg/2ml

NETROMYCINE® NETROMYCINE®

SOL. INJ.
50mg/2ml SCHERING PLOUGH EUROPE

50mg/2ml

1143
J02AC03
VFEND 200mg

J02AC03
VORICONAZOLUM

VORICONAZOLUM **
COMPR. FILM.
200mg PFIZER LTD.

Protocol: J012B
200mg 40mg/ml 50mg
PFIZER LTD.

J02AC03 J02AC03
VFEND 50mg

VORICONAZOLUM
40mg/ml

PULB. PT. SUSP. ORALA
PFIZER LTD.

VFEND 40 mg/ml

VORICONAZOLUM
50mg

COMPR. FILM.

1144
ARTHROTEC 75

M01AB55

COMBINATII
COMPR. GASTROREZ.
PFIZER EUROPE MA EEIG

M01AB55 COMBINATII M01AB55 COMBINATII
NEODOLPASSE

SOL. PERF.
FRESENIUS KABI AUSTRIA GMBH

M01AB55 COMBINATII
ACECLOFEN

SUPOZ.
ANTIBIOTICE SA

1145

M01AE01

IBUPROFENUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AE01 IBUPROFENUM
IBALGIN BABY IBUGESIC® NUROFEN® PENTRU COPII, cu aroma de capsuni NUROFEN® PENTRU COPII, cu aroma de portocala

SUSP. ORALA
100mg/5ml 100mg/5ml 100mg/5ml 100mg/5ml

100mg/5ml
ZENTIVA AS DAR AL DAWA PHARMA S.R.L. RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED

M01AE01 IBUPROFENUM
PADUDEN® SR 300 mg 300mg

CAPS. ELIB. PREL.
TERAPIA SA

300mg

149 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
400mg

FORMA FARM.

FIRMA

PROTOCOL

M01AE01 IBUPROFENUM
MARCOFEN®

CAPS.
EUROPHARM SA

400mg 400mg
CIPLA (UK) LIMITED GULF PHARMACEUTICAL INDUSTRIES S.R.L. AC HELCOR SRL

M01AE01 IBUPROFENUM
IBUPROFEN 400 PROFINAL REUPROFEN® 400 mg 400mg 400mg 400mg

COMPR. FILM.

M01AE01 IBUPROFENUM
NUROFEN FORTE 400mg

DRAJ. COMPR. FILM.
600mg 600mg CIPLA (UK) LIMITED GULF PHARMACEUTICAL INDUSTRIES S.R.L.

400mg
RECKITT BENCKISER HEALTHCARE INT. LTD.

M01AE01 IBUPROFENUM
IBUPROFEN 600 PROFINAL

600mg

M01AE01 IBUPROFENUM
MARCOFEN® 400mg

CAPS.
EUROPHARM SA

400mg 400mg
CIPLA (UK) LIMITED GULF PHARMACEUTICAL INDUSTRIES S.R.L. AC HELCOR SRL

M01AE01 IBUPROFENUM
IBUPROFEN 400 PROFINAL REUPROFEN® 400 mg 400mg 400mg 400mg

COMPR. FILM.

M01AE01 IBUPROFENUM
NUROFEN FORTE 400mg

DRAJ.

400mg
RECKITT BENCKISER HEALTHCARE INT. LTD.

1146

M01AE02

NAPROXENUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AE02 NAPROXENUM
REUXEN 250 mg 250mg

COMPR.
AC HELCOR PHARMA SRL

250mg 500mg
AC HELCOR PHARMA SRL

M01AE02 NAPROXENUM
REUXEN 500 mg 500mg

COMPR.

1147

M01AG01

ACIDUM MEFENAMICUM

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale. Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.

M01AG01 ACIDUM MEFENAMICUM
VIDAN 500mg

COMPR. FILM.
VIANEX SA

500mg

1148

M01AH04
Prescriere limitata:

PARECOXIBUM
PULB. + SOLV. PT. SOL. INJ.
40mg 40mg PFIZER LIMITED

Tratamentul simptomatic antiinflamator la pacientii cu intoleranta la AINS neselective.

M01AH04 PARECOXIBUM
DYNASTAT 40mg

40mg 40mg

M01AH04 PARECOXIBUM
DYNASTAT 40mg

PULB. PT. SOL. INJ.
PFIZER LIMITED

1149

M01AX02

ACIDUM NIFLUMICUM
CAPS.
250mg BRISTOL MYERS SQUIBB KFT

A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.

M01AX02 ACIDUM NIFLUMICUM
NIFLURIL

250mg

1150

M01AA01

PHENYLBUTAZONUM
SUPOZ.
250mg SINTOFARM SA

M01AA01 PHENYLBUTAZONUM
FENILBUTAZONA 250 mg

250mg

1155
PERCUTALGINE

M02ACN3

COMBINATII
GEL
LABORATOIRES CHEMINEAU

M02ACN3 COMBINATII

1156

M03BB03

CHLORZOXAZONUM
COMPR.
250mg 250mg 250mg GEDEON RICHTER ROMANIA SA SINTOFARM SA ARENA GROUP SA

M03BB03 CHLORZOXAZONUM
CLORZOXAZON 250 mg CLORZOXAZONA CLORZOXAZONA 250 mg

250mg

1157
MYDOCALM

M03BX04

TOLPERISONUM
SOL. INJ.
100mg/ml GEDEON RICHTER LTD.

M03BX04 TOLPERISONUM M03BX04 TOLPERISONUM
MYDOCALM 150mg

100mg/ml 150mg
GEDEON RICHTER LTD.

COMPR. FILM. COMPR. FILM.
50mg GEDEON RICHTER LTD.

M03BX04 TOLPERISONUM
MYDOCALM

50mg 50mg
TERAPIA SA

M03BX04 TOLPERISONUM
TOLPERISON 50 mg 50mg

DRAJ.

1158
HYALGAN®

M09AX01

ACIDUM HIALURONICUM
SOL. INJ.
20mg/2ml CSC PHARMACEUTICALS HANDELS GMBH

M09AX01 ACIDUM HIALURONICUM

20mg/2ml

1159

N02AA59

COMBINATII
COMPR.
30mg+500mg ARENA GROUP S.A.

N02AA59 COMBINATII
PARADOREN 500mg/30mg

30mg+500mg 60mg+500mg
ARENA GROUP S.A.

N02AA59 COMBINATII
PARADOREN 500mg/60mg

COMPR.
60mg+500mg

1160
FASCONAL P FASCOREM

N02BA71

COMBINATII
COMPR.
GEDEON RICHTER ROMANIA SA REMEDIA SRL

N02BA71 COMBINATII

1161

N02BB02

METAMIZOLUM NATRIUM
SOL. INJ.
1g/2ml ZENTIVA S.A.

N02BB02 METAMIZOLUM NATRIUM
ALGOCALMIN® 1 g/2 ml

1g/2ml 500mg/ml
TERAPIA S.A.

N02BB02 METAMIZOLUM NATRIUM
NEVRALGIN 500mg/ml

PIC. ORALE, SOL.

150 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

1162
TRANXENE 10 mg

N05BA05

CLORAZEPAS DIKALII
CAPS.
10mg SANOFI-AVENTIS FRANCE

N05BA05 CLORAZEPAS DIKALII N05BA05 CLORAZEPAS DIKALII
TRANXENE 5 mg 5mg

10mg 5mg
SANOFI-AVENTIS FRANCE

CAPS.

1163
GRANDAXIN

N05BA23

TOFISOPAMUM
COMPR.
50mg EGIS PHARMACEUTICALS LTD.

N05BA23 TOFISOPAMUM

50mg

1164

N05CD08

MIDAZOLAMUM
SOL. INJ.
1mg/ml 1mg/ml ROCHE ROMANIA S.R.L. TORREX CHIESI PHARMA GMBH

N05CD08 MIDAZOLAMUM
DORMICUM® MIDAZOLAM TORREX 1 mg/ml

1mg/ml

N05CD08 MIDAZOLAMUM
FULSED 5 mg/ml MIDAZOLAM 5 mg/ml MIDAZOLAM TORREX 5 mg/ml 5mg/ml 5mg/ml 5mg/ml

SOL. INJ.
TERAPIA S.A. TERAPIA SA TORREX CHIESI PHARMA GMBH

5mg/ml

N05CD08 MIDAZOLAMUM
DORMICUM® DORMICUM® 7,5 mg 7.5mg 7.5mg

COMPR. FILM.
ROCHE ROMANIA S.R.L. TERAPIA SA

7.5mg

1165
GERODORM®

N05CD13

CINOLAZEPAMUM
COMPR.
40mg GEROT PHARMAZEUTIKA GMBH

N05CD13 CINOLAZEPAMUM

40mg

1166
CONCERTA XL 18 mg

N06BA04

METHYLFENIDATUM ***
COMPR. FILM. ELIB. PREL.
18mg JANSSEN PHARMACEUTICA N.V.

N06BA04 METHYLFENIDATUM
Prescriere limitata:
CONCERTA XL 36 mg

18mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA04 METHYLFENIDATUM
36mg

COMPR. FILM. ELIB. PREL.
JANSSEN PHARMACEUTICA N.V.

36mg

Prescriere limitata:
CONCERTA XL 54 mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA04 METHYLFENIDATUM
54mg

COMPR. FILM. ELIB. PREL.
JANSSEN PHARMACEUTICA N.V.

54mg

Prescriere limitata:

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

1167
STRATTERA 10 mg

N06BA09

ATOMOXETINUM ***
CAPS.
10mg ELI LILLY AND COMPANY LIMITED

N06BA09 ATOMOXETINUM
Prescriere limitata:
STRATTERA 18 mg

10mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA09 ATOMOXETINUM
18mg

CAPS.
ELI LILLY AND COMPANY LIMITED

18mg

Prescriere limitata:
STRATTERA 25 mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA09 ATOMOXETINUM
25mg

CAPS.
ELI LILLY AND COMPANY LIMITED

25mg

Prescriere limitata:
STRATTERA 40 mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA09 ATOMOXETINUM
40mg

CAPS.
ELI LILLY AND COMPANY LIMITED

40mg

Prescriere limitata:
STRATTERA 60 mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA09 ATOMOXETINUM
60mg

CAPS.
ELI LILLY AND COMPANY LIMITED

60mg

Prescriere limitata:

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

1168

N06BX02

PYRITINOLUM
DRAJ.
100mg MERCK KGAA

N06BX02 PYRITINOLUM
ENCEPHABOL® 100 mg

100mg 200mg
MERCK KGAA

N06BX02 PYRITINOLUM
ENCEPHABOL® FORTE 200mg

DRAJ. SUSP. ORALA
80.5mg/5ml MERCK KGAA

N06BX02 PYRITINOLUM
ENCEPHABOL® SUSPENSIE

80.5mg/5ml

1169
LUCETAM® 1200 mg NOOTROPIL® 1200 mg

N06BX03

PIRACETAMUM
COMPR. FILM.
1200mg 1200mg EGIS PHARMACEUTICALS LTD. U.C.B. SA

N06BX03 PIRACETAMUM

1200mg

N06BX03 PIRACETAMUM
NOOTROPIL 12g

SOL. PERF.
U.C.B. SA

12g 1g
U.C.B. SA

N06BX03 PIRACETAMUM
NOOTROPIL 1g

SOL. INJ. SOL. INJ.
1g/5ml 1g/5ml EGIS PHARMACEUTICALS LTD. ZENTIVA SA

N06BX03 PIRACETAMUM
LUCETAM® 1 g MEMOTAL1 g/5 ml

1g/5ml

N06BX03 PIRACETAMUM
LUCETAM® 3 g 3g/15ml

SOL. INJ.
EGIS PHARMACEUTICALS LTD.

3g/15ml 400 mg
ANTIBIOTICE SA

N06BX03 PIRACETAMUM
PIRACETAM 400 mg 400 mg

COMPR. COMPR.
400mg 400mg 400mg 400mg 400mg ZENTIVA S.A MEDUMAN SA MAGISTRA C & C LAROPHARM SRL FARMEX COMPANY SRL

N06BX03 PIRACETAMUM
MEMOTAL 400mg N - PIRACETAM PIRACETAM PIRACETAM 400 mg PIRACETAM FARMEX 400 mg

400mg

N06BX03 PIRACETAMUM
LUCETAM PIRACETAM 400 mg PIRACETAM LPH® 400 mg 400mg 400mg 400mg

COMPR. FILM.
EGIS PHARMACEUTICALS PLC GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA

400mg

151 / 153

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
800mg 800mg 800mg 800mg

FORMA FARM.

FIRMA

PROTOCOL

N06BX03 PIRACETAMUM
LUCETAM NOOTROPIL® 800 mg PIRACETAM 800 mg PIRACETAM LPH 800 mg

COMPR. FILM.
EGIS PHARMACEUTICALS PLC U.C.B. SA GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA

800mg

N06BX03 PIRACETAMUM
NOOTROPIL® 20%

SOL. ORALA
U.C.B. SA

20%

1170
CINARIZIN 25 mg CINARIZINA 25 mg N-CINARIZINA STUGERON 25 mg

N07CA02

CINNARIZINUM
COMPR.
25mg 25mg 25mg 25mg LAROPHARM SRL OZONE LABORATORIES MEDUMAN SA TERAPIA SA

N07CA02 CINNARIZINUM

25mg

1172
ATRICAN 250 mg

P01AX08

TENONITROZOLUM
CAPS. MOI GASTROREZ.
250mg LAB. INNOTECH INT.

P01AX08 TENONITROZOLUM

250mg

1173
HELMINTOX® 125 mg

P02CC01

PYRANTELUM
COMPR. FILM.
125mg LAB. INNOTECH INT.

P02CC01 PYRANTELUM P02CC01 PYRANTELUM
HELMINTOX® 250 mg 250mg

125mg 250mg
LAB. INNOTECH INT.

COMPR. FILM.

1174

P03AAN1

SULFUR
UNGUENT
8% GEDEON RICHTER ROMANIA SA

P03AAN1 SULFUR
UNGUENT CU SULF 8%

8,00%

1175
NIX

P03AC04

PERMETHRINUM
CREMA CAPILARA
1% GLAXO WELLCOME UK LTD.

P03AC04 PERMETHRINUM

1,00%

1176

P03AX01

BENZYLUM BENZOICUM
CREMA
25% FITERMAN PHARMA S.R.L.

P03AX01 BENZYLUM BENZOICUM
BENZOAT DE BENZIL MK

25,00%

1177
PIVALONE 1%

R01AD07

TIXOCORTOLUM
SUSP. NAZALA
1% PFIZER EUROPE MA EEG

R01AD07 TIXOCORTOLUM

1,00%

1178
BIORINIL

R01ADN1

COMBINATII
SPRAY NAZ.,SUSP.
FARMILA FARMACEUTICI MILANO SPA

R01ADN1 COMBINATII R01ADN1 COMBINATII
FLUORORINIL

SUSP. INHAL.
FARMILA - THEA FARMACEUTICI SPA

1179
CLARINASE®

R01BA52

COMBINATII
COMPR. ELIB. MODIF.
SCHERING PLOUGH EUROPE

R01BA52 COMBINATII

1180
BIOPAROX

R02AB03

FUSAFUNGINUM
SPRAY BUCOFARINGIAN SI NAZAL-SOL.
50mg/10ml LES LABORATOIRES SERVIER

R02AB03 FUSAFUNGINUM

50mg/10ml

1181
EFEDRINA 10 mg/ ml

R03CA02

EPHEDRINI HYDROCHLORIDUM
SOL. INJ.
10mg/ml ZENTIVA S.A.

R03CA02 EPHEDRINI HYDROCHLORIDUM R03CA02 EPHEDRINI HYDROCHLORIDUM
EFEDRINA 50 mg/ ml 50mg/ml

10mg/ml 50mg/ml
ZENTIVA S.A.

SOL. INJ.

1182
AIRONYL

R03CC03

TERBUTALINUM
SIROP
1.5mg/5ml SEDICO IMPEX S.R.L.

R03CC03 TERBUTALINUM

1.5mg/5ml

1183

R05CB01

ACETYLCYSTEINUM
SOL. INJ.
300mg/3ml HEXAL AG

R05CB01 ACETYLCYSTEINUM
ACC INJECT 300mg/3ml

300mg/3ml

1184

R05CB03

CARBOCISTEINUM
SIROP
100mg/5ml LAB. URGO

R05CB03 CARBOCISTEINUM
HUMEX EXPECTORANT PENTRU COPII SI SUGARI

100mg/5ml 100mg/5ml
TIS FARMACEUTIC SA

R05CB03 CARBOCISTEINUM
FLUIDOL 100mg/5ml

SOL. ORALA
100mg/5ml

R05CB03 CARBOCISTEINUM
MUCOTREIS 20mg/ml

SIROP
ECOBI PHARMACEUTICI SAS

20mg/ml 2%
SANOFI-AVENTIS OTC

R05CB03 CARBOCISTEINUM
RHINATHIOL 2% pentru copii si sugari 2%

SIROP

1186

R06AD02

PROMETHAZINUM
COMPR. FILM.
30mg ARENA GROUP S.A.

R06AD02 PROMETHAZINUM
PROMETAZINA ARENA 30 mg

30mg

Pot aparea efecte secundare semnificative

1187
PRIMALAN® 10 mg

R06AD07

MEQUITAZINUM
COMPR.
10mg LAB. PIERRE FABRE

R06AD07 MEQUITAZINUM

10mg

1188
EMETOSTOP

R06AE05

MECLOZINUM
COMPR.
30mg SPECIFAR SA

R06AE05 MECLOZINUM

30mg

1189
BIOHEPT

R06AX02

CYPROHEPTADINUM
SIROP
2mg/5ml BIOFARM S.A.

R06AX02 CYPROHEPTADINUM

2mg/5ml

152 / 153

DCI/DENUMIRE COMERCIALA
PERITOL

CONCENTRATIE
2mg/5ml

FORMA FARM.

FIRMA
EGIS PHARMACEUTICALS LTD.

PROTOCOL

R06AX02 CYPROHEPTADINUM
PERITOL 4mg

COMPR.
EGIS PHARMACEUTICALS LTD.

4mg

1190
CLARITINE SYMPHORAL® 1 mg/ml

R06AX13

LORATADINUM
SIROP
1mg/ml 1mg/ml SCHERING-PLOUGH EUROPE GEDEON RICHTER ROMANIA SA

R06AX13 LORATADINUM

1mg/ml

R06AX13 LORATADINUM
LORATADINA BIOFARM 5mg/5ml 5mg/5ml

SIROP
BIOFARM S.A.

5mg/5ml 5mg/5ml
LEK PHARMACEUTICALS D.D.

R06AX13 LORATADINUM
FLONIDAN 5mg/5ml

SUSP. ORALA

1191
SIFICETINA

S01AA01

CHLORAMPHENICOLUM
PULB. + SOLV. PT. SOL. OFT.
0.4% S.I.F.I. SPA

S01AA01 CHLORAMPHENICOLUM

0.4%

1192
FUCITHALMIC®

S01AA13

ACIDUM FUSIDICUM
GEL OFT.
1% LEO PHARMACEUTICAL PRODUCTS

S01AA13 ACIDUM FUSIDICUM

1,00%

1193

S01AA24

KANAMYCINUM
UNG. OFT.
1% ANTIBIOTICE SA

S01AA24 KANAMYCINUM
KANAMICINA SULFAT 1%

1,00%

1194
ANTIBIOPTAL

S01AA30

COMBINATII
PICATURI OFT.-SOL.
FARMILA FARMACEUTICI

S01AA30 COMBINATII S01AA30 COMBINATII
COLBIOCIN

PULB. + SOLV. PT. SOL. OFT.
S.I.F.I. SPA

S01AA30 COMBINATII
ENBECIN

UNG. OFT.
POLIPHARMA INDUSTRIES S.R.L.

1195

S01BA07

FLUOROMETHOLONUM
UNG. OFT.
1mg/g 2mg/ml FARMILA - THEA FARMACEUTICI SPA

S01BA07 FLUOROMETHOLONUM
FLUMETOL S UNGUENT OFTALMIC

1mg/g 2mg/ml

S01BA07 FLUOROMETHOLONUM
FLUMETOL S

PICATURI OFT.SUSP.
FARMILA - THEA FARMACEUTICI SPA

1196
PRENACID

S01BA11

DESONIDUM
PICATURI OFT.-SOL.
0.25% S.I.F.I. SPA

S01BA11 DESONIDUM

0.25%

1197
INDOCOLLYRE® 0.1%

S01BC01

INDOMETACINUM
PICATURI OFT.-SOL.
0.1% LAB. CHAUVIN

S01BC01 INDOMETACINUM

0.1%

1198
BRUXICAM 0,5%

S01BC06

PIROXICAMUM
PIC. OFT., SOL.
0.5% BRUSCHETTINI S.R.L.

S01BC06 PIROXICAMUM

0.5%

1199
DROPIL®

S01EB01

PILOCARPINUM
PICATURI OFT.-SOL.
2% BRUSCHETTINI

S01EB01 PILOCARPINUM

2,00%

1200
EMADINE 0.05%

S01GX06

EMEDASTINUM
PICATURI OFT.-SOL.
0.5mg/ml ALCON LABORATORIES LTD.

S01GX06 EMEDASTINUM

0.5mg/ml

1201
ZADITEN 0,25 mg/ml

S01GX08

KETOTIFENUM
PICATURI OFT.-SOL.
0.25mg/ml NOVARTIS PHARMA GMBH

S01GX08 KETOTIFENUM

0.25mg/ml

1203
KERATYL® 1%

S01XA11

NANDROLONUM
PICATURI OFT.-SOL.
1% LAB. CHAUVIN

S01XA11 NANDROLONUM

1,00%

1204
CORNEREGEL®

S01XA12

DEXPANTHENOLUM
GEL OFT.
5%

S01XA12 DEXPANTHENOLUM

5,00%
DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

1205

S02CA05

COMBINATII
SOL. AURICULARA
BIOFARM SA

S02CA05 COMBINATII
SOLUTIE AURICULARA CU CLORAMFENICOL SI FLUOCINOLON

1206

R03DX05
Prescriere limitata:

OMALIZUMABUM **

Tratamentul adjuvant pentru îmbunătăţirea controlului astmului bronşic la pacienţii adulţi şi adolescenţi (cu vârsta de 12 ani şi peste) cu astm alergic persistent sever care prezintă test cutanat pozitiv sau hiperreactivitate in vitro la un alergen permanent şi care au funcţia pulmonară redusă (FEV1 <80%), precum şi simptome frecvente în timpul zilei sau treziri bruşte în cursul nopţii şi care au avut multiple exacerbări astmatice confirmate, în ciuda administrării pe cale inhalatorie de doze mari de corticosteroizi şi agonişti beta2-adrenergici cu acţiune de lungă durată. NOTA: Tratamentul cu Xolair trebuie avut în vedere la pacienţii cu astm bronşic mediat cu certitudine prin intermediul IgE.

R03DX05 OMALIZUMABUM
XOLAIR 150 mg 150mg 150mg 75mg

PULB+SOLV.PT.SOL.INJ.
NOVARTIS EUROPHARM LTD.

150mg 75mg

R03DX05 OMALIZUMABUM
XOLAIR 150 mg XOLAIR 75 mg

PULB+SOLV.PT.SOL.INJ.
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

153 / 153

Sign up to vote on this title
UsefulNot useful